[{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504328,"endpoint-url":"\/ani\/endpoint\/100504328\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Week 51","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1.6 \u00b1 0.59, 1.2 \u00b1 0.29, 1.5 \u00b1 0.29, 2.5 \u00b1 1.48","Doses and responses":"0 mg\/kg-day: 1.6 \u00b1 0.59, 5 mg\/kg-day: 1.2 \u00b1 0.29, 30 mg\/kg-day: 1.5 \u00b1 0.29, 200 mg\/kg-day: 2.5 \u00b1 1.48","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504329,"endpoint-url":"\/ani\/endpoint\/100504329\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Week 104","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"3.1 \u00b1 1.96, 3.3 \u00b1 2.44, 3.7 \u00b1 4.23, 3.9 \u00b1 2.19","Doses and responses":"0 mg\/kg-day: 3.1 \u00b1 1.96, 5 mg\/kg-day: 3.3 \u00b1 2.44, 30 mg\/kg-day: 3.7 \u00b1 4.23, 200 mg\/kg-day: 3.9 \u00b1 2.19","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504252,"endpoint-url":"\/ani\/endpoint\/100504252\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"High Density Lipoprotein (HDL)","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"58.2 \u00b1 13.01, 56.8 \u00b1 17.27, 67.4 \u00b1 16.5, 57.1 \u00b1 13.84","Doses and responses":"0 mg\/kg-day: 58.2 \u00b1 13.01, 2.5 mg\/kg-day: 56.8 \u00b1 17.27, 15 mg\/kg-day: 67.4 \u00b1 16.5, 100 mg\/kg-day: 57.1 \u00b1 13.84","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504253,"endpoint-url":"\/ani\/endpoint\/100504253\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"High Density Lipoprotein (HDL)","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"76.9 \u00b1 19, 69.7 \u00b1 20.35, 86.8 \u00b1 27.63, 71.1 \u00b1 26.49","Doses and responses":"0 mg\/kg-day: 76.9 \u00b1 19, 2.5 mg\/kg-day: 69.7 \u00b1 20.35, 15 mg\/kg-day: 86.8 \u00b1 27.63, 100 mg\/kg-day: 71.1 \u00b1 26.49","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504254,"endpoint-url":"\/ani\/endpoint\/100504254\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"LDL + VLDL","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"5 \u00b1 1.4, 6 \u00b1 3.2, 7 \u00b1 3.4, 5 \u00b1 2.6","Doses and responses":"0 mg\/kg-day: 5 \u00b1 1.4, 2.5 mg\/kg-day: 6 \u00b1 3.2, 15 mg\/kg-day: 7 \u00b1 3.4, 100 mg\/kg-day: 5 \u00b1 2.6","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504255,"endpoint-url":"\/ani\/endpoint\/100504255\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"LDL + VLDL","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"11 \u00b1 5.3, 11 \u00b1 4, 16 \u00b1 10.1, 11 \u00b1 6.8","Doses and responses":"0 mg\/kg-day: 11 \u00b1 5.3, 2.5 mg\/kg-day: 11 \u00b1 4, 15 mg\/kg-day: 16 \u00b1 10.1, 100 mg\/kg-day: 11 \u00b1 6.8","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504256,"endpoint-url":"\/ani\/endpoint\/100504256\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Specific Gravity","endpoint-name":"Urine Specific Gravity","endpoint-observation_time":"Week 26","endpoint-response_units":"Specific Gravity","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1.04 \u00b1 0.01, 1.05 \u00b1 0.02, 1.05 \u00b1 0.01, 1.04 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 1.04 \u00b1 0.01, 2.5 mg\/kg-day: 1.05 \u00b1 0.02, 15 mg\/kg-day: 1.05 \u00b1 0.01, 100 mg\/kg-day: 1.04 \u00b1 0.01","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504257,"endpoint-url":"\/ani\/endpoint\/100504257\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Specific Gravity","endpoint-name":"Urine Specific Gravity","endpoint-observation_time":"Week 52","endpoint-response_units":"Specific Gravity","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1.03 \u00b1 0.01, 1.04 \u00b1 0.01, 1.05 \u00b1 0.01, 1.03 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 1.03 \u00b1 0.01, 2.5 mg\/kg-day: 1.04 \u00b1 0.01, 15 mg\/kg-day: 1.05 \u00b1 0.01, 100 mg\/kg-day: 1.03 \u00b1 0.01","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504258,"endpoint-url":"\/ani\/endpoint\/100504258\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"pH","endpoint-name":"Urine pH","endpoint-observation_time":"Week 26","endpoint-response_units":"pH","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"6.7 \u00b1 0.26, 6.4 \u00b1 0.32, 6.6 \u00b1 0.21, 6.3 \u00b1 0.34","Doses and responses":"0 mg\/kg-day: 6.7 \u00b1 0.26, 2.5 mg\/kg-day: 6.4 \u00b1 0.32, 15 mg\/kg-day: 6.6 \u00b1 0.21, 100 mg\/kg-day: 6.3 \u00b1 0.34","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504259,"endpoint-url":"\/ani\/endpoint\/100504259\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"pH","endpoint-name":"Urine pH","endpoint-observation_time":"Week 52","endpoint-response_units":"pH","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"6.8 \u00b1 0.35, 6.8 \u00b1 0.32, 6.7 \u00b1 0.26, 6.5 \u00b1 0.39","Doses and responses":"0 mg\/kg-day: 6.8 \u00b1 0.35, 2.5 mg\/kg-day: 6.8 \u00b1 0.32, 15 mg\/kg-day: 6.7 \u00b1 0.26, 100 mg\/kg-day: 6.5 \u00b1 0.39","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504260,"endpoint-url":"\/ani\/endpoint\/100504260\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urobilinogen","endpoint-name":"Urobilinogen","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"0.2 \u00b1 0, 0.4 \u00b1 0.34, 0.4 \u00b1 0.34, 0.2 \u00b1 0.18","Doses and responses":"0 mg\/kg-day: 0.2 \u00b1 0, 2.5 mg\/kg-day: 0.4 \u00b1 0.34, 15 mg\/kg-day: 0.4 \u00b1 0.34, 100 mg\/kg-day: 0.2 \u00b1 0.18","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504261,"endpoint-url":"\/ani\/endpoint\/100504261\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urobilinogen","endpoint-name":"Urobilinogen","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"0.2, 0.3 \u00b1 0.25, 0.5 \u00b1 0.41, 0.2","Doses and responses":"0 mg\/kg-day: 0.2, 2.5 mg\/kg-day: 0.3 \u00b1 0.25, 15 mg\/kg-day: 0.5 \u00b1 0.41, 100 mg\/kg-day: 0.2","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504667,"endpoint-url":"\/ani\/endpoint\/100504667\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Neoplasms","endpoint-name":"Heart, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504262,"endpoint-url":"\/ani\/endpoint\/100504262\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urine Volume","endpoint-name":"Total Urine Volume","endpoint-observation_time":"Week 26","endpoint-response_units":"mL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"9.2 \u00b1 3.19, 7.7 \u00b1 3.68, 8.3 \u00b1 3.2, 8.8 \u00b1 4.36","Doses and responses":"0 mg\/kg-day: 9.2 \u00b1 3.19, 2.5 mg\/kg-day: 7.7 \u00b1 3.68, 15 mg\/kg-day: 8.3 \u00b1 3.2, 100 mg\/kg-day: 8.8 \u00b1 4.36","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504263,"endpoint-url":"\/ani\/endpoint\/100504263\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urine Volume","endpoint-name":"Total Urine Volume","endpoint-observation_time":"Week 52","endpoint-response_units":"mL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"10.2 \u00b1 4.1, 8.4 \u00b1 3.66, 9.2 \u00b1 4.13, 11.8 \u00b1 3.86","Doses and responses":"0 mg\/kg-day: 10.2 \u00b1 4.1, 2.5 mg\/kg-day: 8.4 \u00b1 3.66, 15 mg\/kg-day: 9.2 \u00b1 4.13, 100 mg\/kg-day: 11.8 \u00b1 3.86","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504330,"endpoint-url":"\/ani\/endpoint\/100504330\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin","endpoint-name":"Albumin (A)","endpoint-observation_time":"Week 26","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"5.3 \u00b1 0.25, 5.1 \u00b1 0.34, 5.1 \u00b1 0.42, 5.2 \u00b1 0.44","Doses and responses":"0 mg\/kg-day: 5.3 \u00b1 0.25, 5 mg\/kg-day: 5.1 \u00b1 0.34, 30 mg\/kg-day: 5.1 \u00b1 0.42, 200 mg\/kg-day: 5.2 \u00b1 0.44","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504331,"endpoint-url":"\/ani\/endpoint\/100504331\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin","endpoint-name":"Albumin (A)","endpoint-observation_time":"Week 52","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"5.2 \u00b1 0.36, 5.2 \u00b1 0.24, 5.1 \u00b1 0.32, 5.3 \u00b1 0.25","Doses and responses":"0 mg\/kg-day: 5.2 \u00b1 0.36, 5 mg\/kg-day: 5.2 \u00b1 0.24, 30 mg\/kg-day: 5.1 \u00b1 0.32, 200 mg\/kg-day: 5.3 \u00b1 0.25","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504668,"endpoint-url":"\/ani\/endpoint\/100504668\/","endpoint-system":"Cancer","endpoint-organ":"Adrenal Cortex","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Cortex, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504669,"endpoint-url":"\/ani\/endpoint\/100504669\/","endpoint-system":"Cancer","endpoint-organ":"Adrenal Medulla","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Medulla, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=7-8)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504670,"endpoint-url":"\/ani\/endpoint\/100504670\/","endpoint-system":"Cancer","endpoint-organ":"Parathyroid Gland","endpoint-effect":"Histopathology","endpoint-name":"Parathyroid Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504671,"endpoint-url":"\/ani\/endpoint\/100504671\/","endpoint-system":"Cancer","endpoint-organ":"Pituitary Gland","endpoint-effect":"Histopathology","endpoint-name":"Pituitary Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504672,"endpoint-url":"\/ani\/endpoint\/100504672\/","endpoint-system":"Cancer","endpoint-organ":"Thyroid Gland","endpoint-effect":"Histopathology","endpoint-name":"Thyroid Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504673,"endpoint-url":"\/ani\/endpoint\/100504673\/","endpoint-system":"Whole Body","endpoint-organ":"Epididymis","endpoint-effect":"Neoplasms","endpoint-name":"Epididymis","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , 0, 0","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504674,"endpoint-url":"\/ani\/endpoint\/100504674\/","endpoint-system":"Cancer","endpoint-organ":"Preputial Gland","endpoint-effect":"Histopathology","endpoint-name":"Preputial Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504675,"endpoint-url":"\/ani\/endpoint\/100504675\/","endpoint-system":"Cancer","endpoint-organ":"Prostate","endpoint-effect":"Histopathology","endpoint-name":"Prostate, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504676,"endpoint-url":"\/ani\/endpoint\/100504676\/","endpoint-system":"Cancer","endpoint-organ":"Seminal Vesicle","endpoint-effect":"Histopathology","endpoint-name":"Seminal Vesicle, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504677,"endpoint-url":"\/ani\/endpoint\/100504677\/","endpoint-system":"Cancer","endpoint-organ":"Testis","endpoint-effect":"Histopathology","endpoint-name":"Testes, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504332,"endpoint-url":"\/ani\/endpoint\/100504332\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Week 26","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"7.6 \u00b1 0.41, 7.5 \u00b1 0.41, 7.5 \u00b1 0.43, 7.4 \u00b1 0.57","Doses and responses":"0 mg\/kg-day: 7.6 \u00b1 0.41, 5 mg\/kg-day: 7.5 \u00b1 0.41, 30 mg\/kg-day: 7.5 \u00b1 0.43, 200 mg\/kg-day: 7.4 \u00b1 0.57","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=1-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504678,"endpoint-url":"\/ani\/endpoint\/100504678\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Neoplasms","endpoint-name":"Lymph Node, Mandibular, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, , , , 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504679,"endpoint-url":"\/ani\/endpoint\/100504679\/","endpoint-system":"Muscoskeletal","endpoint-organ":"Bone","endpoint-effect":"Neoplasms","endpoint-name":"Bone Marrow, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504333,"endpoint-url":"\/ani\/endpoint\/100504333\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Week 52","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"7.7 \u00b1 0.34, 7.6 \u00b1 0.24, 7.8 \u00b1 0.36, 7.7 \u00b1 0.39","Doses and responses":"0 mg\/kg-day: 7.7 \u00b1 0.34, 5 mg\/kg-day: 7.6 \u00b1 0.24, 30 mg\/kg-day: 7.8 \u00b1 0.36, 200 mg\/kg-day: 7.7 \u00b1 0.39","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504265,"endpoint-url":"\/ani\/endpoint\/100504265\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Tubular Degeneration","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"4, 2, 0, 3","Doses and responses":"0 mg\/kg-day: 4, 2.5 mg\/kg-day: 2, 15 mg\/kg-day: 0, 100 mg\/kg-day: 3","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504367,"endpoint-url":"\/ani\/endpoint\/100504367\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Hemorrhage","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"2, 3, 0, 3","Doses and responses":"0 mg\/kg-day: 2, 5 mg\/kg-day: 3, 30 mg\/kg-day: 0, 200 mg\/kg-day: 3","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504334,"endpoint-url":"\/ani\/endpoint\/100504334\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Week 26","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"2.4 \u00b1 0.25, 2.4 \u00b1 0.23, 2.4 \u00b1 0.16, 2.2 \u00b1 0.18","Doses and responses":"0 mg\/kg-day: 2.4 \u00b1 0.25, 5 mg\/kg-day: 2.4 \u00b1 0.23, 30 mg\/kg-day: 2.4 \u00b1 0.16, 200 mg\/kg-day: 2.2 \u00b1 0.18","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504680,"endpoint-url":"\/ani\/endpoint\/100504680\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Neoplasms","endpoint-name":"Lymph Node, Mesenteric, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504266,"endpoint-url":"\/ani\/endpoint\/100504266\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Congestion","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"5, 9, 9, 19","Doses and responses":"0 mg\/kg-day: 5, 2.5 mg\/kg-day: 9, 15 mg\/kg-day: 9, 100 mg\/kg-day: 19","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504471,"endpoint-url":"\/ani\/endpoint\/100504471\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504681,"endpoint-url":"\/ani\/endpoint\/100504681\/","endpoint-system":"Whole Body","endpoint-organ":"Spleen","endpoint-effect":"Neoplasms","endpoint-name":"Spleen","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504472,"endpoint-url":"\/ani\/endpoint\/100504472\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504473,"endpoint-url":"\/ani\/endpoint\/100504473\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504335,"endpoint-url":"\/ani\/endpoint\/100504335\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Week 52","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"2.5 \u00b1 0.28, 2.4 \u00b1 0.24, 2.6 \u00b1 0.26, 2.4 \u00b1 0.28","Doses and responses":"0 mg\/kg-day: 2.5 \u00b1 0.28, 5 mg\/kg-day: 2.4 \u00b1 0.24, 30 mg\/kg-day: 2.6 \u00b1 0.26, 200 mg\/kg-day: 2.4 \u00b1 0.28","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504474,"endpoint-url":"\/ani\/endpoint\/100504474\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504475,"endpoint-url":"\/ani\/endpoint\/100504475\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504476,"endpoint-url":"\/ani\/endpoint\/100504476\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504267,"endpoint-url":"\/ani\/endpoint\/100504267\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Hemorrhage","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1, 5, 5, 10","Doses and responses":"0 mg\/kg-day: 1, 2.5 mg\/kg-day: 5, 15 mg\/kg-day: 5, 100 mg\/kg-day: 10","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504562,"endpoint-url":"\/ani\/endpoint\/100504562\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504336,"endpoint-url":"\/ani\/endpoint\/100504336\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio","endpoint-observation_time":"Week 26","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"2.25 \u00b1 0.21, 2.11 \u00b1 0.23, 2.11 \u00b1 0.24, 2.36 \u00b1 0.19","Doses and responses":"0 mg\/kg-day: 2.25 \u00b1 0.21, 5 mg\/kg-day: 2.11 \u00b1 0.23, 30 mg\/kg-day: 2.11 \u00b1 0.24, 200 mg\/kg-day: 2.36 \u00b1 0.19","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504563,"endpoint-url":"\/ani\/endpoint\/100504563\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504268,"endpoint-url":"\/ani\/endpoint\/100504268\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Alveolar Macrophages","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"5, 6, 13, 10","Doses and responses":"0 mg\/kg-day: 5, 2.5 mg\/kg-day: 6, 15 mg\/kg-day: 13, 100 mg\/kg-day: 10","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504269,"endpoint-url":"\/ani\/endpoint\/100504269\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Glandular Stomach","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Erosion","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1, 1, 2, 3","Doses and responses":"0 mg\/kg-day: 1, 2.5 mg\/kg-day: 1, 15 mg\/kg-day: 2, 100 mg\/kg-day: 3","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504337,"endpoint-url":"\/ani\/endpoint\/100504337\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio","endpoint-observation_time":"Week 52","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"2.16 \u00b1 0.33, 2.15 \u00b1 0.27, 1.97 \u00b1 0.23, 2.27 \u00b1 0.29","Doses and responses":"0 mg\/kg-day: 2.16 \u00b1 0.33, 5 mg\/kg-day: 2.15 \u00b1 0.27, 30 mg\/kg-day: 1.97 \u00b1 0.23, 200 mg\/kg-day: 2.27 \u00b1 0.29","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504338,"endpoint-url":"\/ani\/endpoint\/100504338\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Week 26","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"44 \u00b1 14.9, 51 \u00b1 15.9, 56 \u00b1 23.6, 47 \u00b1 22.5","Doses and responses":"0 mg\/kg-day: 44 \u00b1 14.9, 5 mg\/kg-day: 51 \u00b1 15.9, 30 mg\/kg-day: 56 \u00b1 23.6, 200 mg\/kg-day: 47 \u00b1 22.5","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504339,"endpoint-url":"\/ani\/endpoint\/100504339\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Week 52","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"50 \u00b1 14, 41 \u00b1 8.6, 52 \u00b1 30.9, 44 \u00b1 22.6","Doses and responses":"0 mg\/kg-day: 50 \u00b1 14, 5 mg\/kg-day: 41 \u00b1 8.6, 30 mg\/kg-day: 52 \u00b1 30.9, 200 mg\/kg-day: 44 \u00b1 22.6","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504340,"endpoint-url":"\/ani\/endpoint\/100504340\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Week 26","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"141 \u00b1 164.8, 203 \u00b1 297, 53 \u00b1 22.9, 60 \u00b1 65.9","Doses and responses":"0 mg\/kg-day: 141 \u00b1 164.8, 5 mg\/kg-day: 203 \u00b1 297, 30 mg\/kg-day: 53 \u00b1 22.9, 200 mg\/kg-day: 60 \u00b1 65.9","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504341,"endpoint-url":"\/ani\/endpoint\/100504341\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Week 52","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"60 \u00b1 26.2, 64 \u00b1 37.7, 51 \u00b1 16.5, 54 \u00b1 27","Doses and responses":"0 mg\/kg-day: 60 \u00b1 26.2, 5 mg\/kg-day: 64 \u00b1 37.7, 30 mg\/kg-day: 51 \u00b1 16.5, 200 mg\/kg-day: 54 \u00b1 27","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504270,"endpoint-url":"\/ani\/endpoint\/100504270\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Glandular Stomach","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Ulceration","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1, 1, 3, 0","Doses and responses":"0 mg\/kg-day: 1, 2.5 mg\/kg-day: 1, 15 mg\/kg-day: 3, 100 mg\/kg-day: 0","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504682,"endpoint-url":"\/ani\/endpoint\/100504682\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Neoplasms","endpoint-name":"Thymus, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504271,"endpoint-url":"\/ani\/endpoint\/100504271\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Non Glandular Stomach","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Erosion","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"0, 0, 1, 1","Doses and responses":"0 mg\/kg-day: 0, 2.5 mg\/kg-day: 0, 15 mg\/kg-day: 1, 100 mg\/kg-day: 1","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504565,"endpoint-url":"\/ani\/endpoint\/100504565\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504342,"endpoint-url":"\/ani\/endpoint\/100504342\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Aspartate Aminotransferase","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Week 26","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"290 \u00b1 390, 262 \u00b1 299.7, 103 \u00b1 33.7, 101 \u00b1 83.8","Doses and responses":"0 mg\/kg-day: 290 \u00b1 390, 5 mg\/kg-day: 262 \u00b1 299.7, 30 mg\/kg-day: 103 \u00b1 33.7, 200 mg\/kg-day: 101 \u00b1 83.8","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504343,"endpoint-url":"\/ani\/endpoint\/100504343\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Aspartate Aminotransferase","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Week 52","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"102 \u00b1 54.7, 113 \u00b1 50, 91 \u00b1 26.5, 87 \u00b1 21.9","Doses and responses":"0 mg\/kg-day: 102 \u00b1 54.7, 5 mg\/kg-day: 113 \u00b1 50, 30 mg\/kg-day: 91 \u00b1 26.5, 200 mg\/kg-day: 87 \u00b1 21.9","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504272,"endpoint-url":"\/ani\/endpoint\/100504272\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Non Glandular Stomach","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Ulceration","endpoint-observation_time":"Week 104","endpoint-response_units":"Ulceration","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"2, 2, 2, 0","Doses and responses":"0 mg\/kg-day: 2, 2.5 mg\/kg-day: 2, 15 mg\/kg-day: 2, 100 mg\/kg-day: 0","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504273,"endpoint-url":"\/ani\/endpoint\/100504273\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Congestion","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"15, 15, 16, 23","Doses and responses":"0 mg\/kg-day: 15, 2.5 mg\/kg-day: 15, 15 mg\/kg-day: 16, 100 mg\/kg-day: 23","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504683,"endpoint-url":"\/ani\/endpoint\/100504683\/","endpoint-system":"Cancer","endpoint-organ":"Mammary Gland","endpoint-effect":"Histopathology","endpoint-name":"Mammary Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504684,"endpoint-url":"\/ani\/endpoint\/100504684\/","endpoint-system":"Dermal","endpoint-organ":"Skin","endpoint-effect":"Neoplasms","endpoint-name":"Skin, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504685,"endpoint-url":"\/ani\/endpoint\/100504685\/","endpoint-system":"Muscoskeletal","endpoint-organ":"Bone","endpoint-effect":"Neoplasms","endpoint-name":"Bone, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504274,"endpoint-url":"\/ani\/endpoint\/100504274\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Hepatocellular Necrosis","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"4, 3, 5, 6","Doses and responses":"0 mg\/kg-day: 4, 2.5 mg\/kg-day: 3, 15 mg\/kg-day: 5, 100 mg\/kg-day: 6","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504415,"endpoint-url":"\/ani\/endpoint\/100504415\/","endpoint-system":"Hepatic","endpoint-organ":"Blood","endpoint-effect":"Albumin","endpoint-name":"Albumin (A)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"4.2 \u00b1 0.13, 4.3 \u00b1 0.18, 4.1 \u00b1 0.17, 4.1 \u00b1 0.15","Doses and responses":"0 mg\/kg-day: 4.2 \u00b1 0.13, 10 mg\/kg-day: 4.3 \u00b1 0.18, 50 mg\/kg-day: 4.1 \u00b1 0.17, 200 mg\/kg-day: 4.1 \u00b1 0.15","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504275,"endpoint-url":"\/ani\/endpoint\/100504275\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Hepatocellular Necrosis, Centrilobular","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"2, 3, 0, 1","Doses and responses":"0 mg\/kg-day: 2, 2.5 mg\/kg-day: 3, 15 mg\/kg-day: 0, 100 mg\/kg-day: 1","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504276,"endpoint-url":"\/ani\/endpoint\/100504276\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Week 51","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"17.3 \u00b1 0.79, 17.3 \u00b1 0.87, 17.5 \u00b1 0.68, 17.5 \u00b1 0.71","Doses and responses":"0 mg\/kg-day: 17.3 \u00b1 0.79, 2.5 mg\/kg-day: 17.3 \u00b1 0.87, 15 mg\/kg-day: 17.5 \u00b1 0.68, 100 mg\/kg-day: 17.5 \u00b1 0.71","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504264,"endpoint-url":"\/ani\/endpoint\/100504264\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Necrosis, Papillary","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 2.5 mg\/kg-day: 0, 15 mg\/kg-day: 0, 100 mg\/kg-day: 0","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504313,"endpoint-url":"\/ani\/endpoint\/100504313\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Week 51","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"44 \u00b1 2.95, 44.5 \u00b1 2.52, 44.2 \u00b1 2.28, 42.3 \u00b1 2.76","Doses and responses":"0 mg\/kg-day: 44 \u00b1 2.95, 5 mg\/kg-day: 44.5 \u00b1 2.52, 30 mg\/kg-day: 44.2 \u00b1 2.28, 200 mg\/kg-day: 42.3 \u00b1 2.76","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504239,"endpoint-url":"\/ani\/endpoint\/100504239\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Week 52","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"82 \u00b1 23.9, 70 \u00b1 15, 78 \u00b1 12.6, 80 \u00b1 15.4","Doses and responses":"0 mg\/kg-day: 82 \u00b1 23.9, 2.5 mg\/kg-day: 70 \u00b1 15, 15 mg\/kg-day: 78 \u00b1 12.6, 100 mg\/kg-day: 80 \u00b1 15.4","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504314,"endpoint-url":"\/ani\/endpoint\/100504314\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Week 104","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"39.2 \u00b1 4.08, 39.3 \u00b1 3.43, 39 \u00b1 6.22, 39.5 \u00b1 2.84","Doses and responses":"0 mg\/kg-day: 39.2 \u00b1 4.08, 5 mg\/kg-day: 39.3 \u00b1 3.43, 30 mg\/kg-day: 39 \u00b1 6.22, 200 mg\/kg-day: 39.5 \u00b1 2.84","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504277,"endpoint-url":"\/ani\/endpoint\/100504277\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Week 104","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"18 \u00b1 1.36, 17.4 \u00b1 1.2, 17.2 \u00b1 1.19, 17.8 \u00b1 1.72","Doses and responses":"0 mg\/kg-day: 18 \u00b1 1.36, 2.5 mg\/kg-day: 17.4 \u00b1 1.2, 15 mg\/kg-day: 17.2 \u00b1 1.19, 100 mg\/kg-day: 17.8 \u00b1 1.72","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504278,"endpoint-url":"\/ani\/endpoint\/100504278\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Mean Corpuscular Hemoglobin Concentration","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Week 25","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"35.5 \u00b1 0.65, 35.7 \u00b1 0.86, 35.7 \u00b1 0.48, 35.7 \u00b1 0.37","Doses and responses":"0 mg\/kg-day: 35.5 \u00b1 0.65, 2.5 mg\/kg-day: 35.7 \u00b1 0.86, 15 mg\/kg-day: 35.7 \u00b1 0.48, 100 mg\/kg-day: 35.7 \u00b1 0.37","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504240,"endpoint-url":"\/ani\/endpoint\/100504240\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Week 26","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"42 \u00b1 13.9, 46 \u00b1 20.7, 47 \u00b1 11.8, 91 \u00b1 177","Doses and responses":"0 mg\/kg-day: 42 \u00b1 13.9, 2.5 mg\/kg-day: 46 \u00b1 20.7, 15 mg\/kg-day: 47 \u00b1 11.8, 100 mg\/kg-day: 91 \u00b1 177","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504241,"endpoint-url":"\/ani\/endpoint\/100504241\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Week 52","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"48 \u00b1 15.2, 141 \u00b1 311.1, 49 \u00b1 12.4, 61 \u00b1 26.2","Doses and responses":"0 mg\/kg-day: 48 \u00b1 15.2, 2.5 mg\/kg-day: 141 \u00b1 311.1, 15 mg\/kg-day: 49 \u00b1 12.4, 100 mg\/kg-day: 61 \u00b1 26.2","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504242,"endpoint-url":"\/ani\/endpoint\/100504242\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Aspartate Aminotransferase","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Week 26","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"81 \u00b1 22.8, 84 \u00b1 15.3, 83 \u00b1 19.8, 132 \u00b1 181.6","Doses and responses":"0 mg\/kg-day: 81 \u00b1 22.8, 2.5 mg\/kg-day: 84 \u00b1 15.3, 15 mg\/kg-day: 83 \u00b1 19.8, 100 mg\/kg-day: 132 \u00b1 181.6","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504243,"endpoint-url":"\/ani\/endpoint\/100504243\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Aspartate Aminotransferase","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Week 52","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"91 \u00b1 34.1, 120 \u00b1 97.5, 90 \u00b1 30.9, 103 \u00b1 27.9","Doses and responses":"0 mg\/kg-day: 91 \u00b1 34.1, 2.5 mg\/kg-day: 120 \u00b1 97.5, 15 mg\/kg-day: 90 \u00b1 30.9, 100 mg\/kg-day: 103 \u00b1 27.9","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504245,"endpoint-url":"\/ani\/endpoint\/100504245\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Phosphorus (PHOS)","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"5.9 \u00b1 0.32, 6.3 \u00b1 0.51, 6.4 \u00b1 0.34, 6.3 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 5.9 \u00b1 0.32, 2.5 mg\/kg-day: 6.3 \u00b1 0.51, 15 mg\/kg-day: 6.4 \u00b1 0.34, 100 mg\/kg-day: 6.3 \u00b1 0.4","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=1-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504686,"endpoint-url":"\/ani\/endpoint\/100504686\/","endpoint-system":"Cancer","endpoint-organ":"Brain","endpoint-effect":"Histopathology","endpoint-name":"Brain, Meninges, Hamartoma, Lipomatous","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1, , , , , 0","Doses and responses":"0 mg\/kg-day: 1, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504687,"endpoint-url":"\/ani\/endpoint\/100504687\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Neoplasms","endpoint-name":"Lung, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504248,"endpoint-url":"\/ani\/endpoint\/100504248\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Triglycerides","endpoint-name":"Triglyceride (TRIG)","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"124 \u00b1 45.2, 103 \u00b1 24.4, 157 \u00b1 63.6, 120 \u00b1 45.7","Doses and responses":"0 mg\/kg-day: 124 \u00b1 45.2, 2.5 mg\/kg-day: 103 \u00b1 24.4, 15 mg\/kg-day: 157 \u00b1 63.6, 100 mg\/kg-day: 120 \u00b1 45.7","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504249,"endpoint-url":"\/ani\/endpoint\/100504249\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Triglycerides","endpoint-name":"Triglyceride (TRIG)","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"215 \u00b1 122.5, 113 \u00b1 38.2, 219 \u00b1 117.4, 123 \u00b1 48.7","Doses and responses":"0 mg\/kg-day: 215 \u00b1 122.5, 2.5 mg\/kg-day: 113 \u00b1 38.2, 15 mg\/kg-day: 219 \u00b1 117.4, 100 mg\/kg-day: 123 \u00b1 48.7","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504250,"endpoint-url":"\/ani\/endpoint\/100504250\/","endpoint-system":"Metabolic","endpoint-organ":"Blood","endpoint-effect":"Free Fatty Acids","endpoint-name":"Free Fatty Acids (FFA)","endpoint-observation_time":"Week 26","endpoint-response_units":"mEq\/l","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"0.59 \u00b1 0.14, 0.56 \u00b1 0.1, 0.56 \u00b1 0.14, 0.55 \u00b1 0.12","Doses and responses":"0 mg\/kg-day: 0.59 \u00b1 0.14, 2.5 mg\/kg-day: 0.56 \u00b1 0.1, 15 mg\/kg-day: 0.56 \u00b1 0.14, 100 mg\/kg-day: 0.55 \u00b1 0.12","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504374,"endpoint-url":"\/ani\/endpoint\/100504374\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Hepatocellular Necrosis, Centrilobular","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1, 0, 6, 4","Doses and responses":"0 mg\/kg-day: 1, 5 mg\/kg-day: 0, 30 mg\/kg-day: 6, 200 mg\/kg-day: 4","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504375,"endpoint-url":"\/ani\/endpoint\/100504375\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Congestion","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"6, 11, 4, 8","Doses and responses":"0 mg\/kg-day: 6, 5 mg\/kg-day: 11, 30 mg\/kg-day: 4, 200 mg\/kg-day: 8","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504279,"endpoint-url":"\/ani\/endpoint\/100504279\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Mean Corpuscular Hemoglobin Concentration","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Week 51","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"34.1 \u00b1 0.84, 33.9 \u00b1 0.53, 33.7 \u00b1 1.11, 33.9 \u00b1 0.65","Doses and responses":"0 mg\/kg-day: 34.1 \u00b1 0.84, 2.5 mg\/kg-day: 33.9 \u00b1 0.53, 15 mg\/kg-day: 33.7 \u00b1 1.11, 100 mg\/kg-day: 33.9 \u00b1 0.65","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504368,"endpoint-url":"\/ani\/endpoint\/100504368\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Alveolar Macrophages","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"3, 6, 7, 21","Doses and responses":"0 mg\/kg-day: 3, 5 mg\/kg-day: 6, 30 mg\/kg-day: 7, 200 mg\/kg-day: 21","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504369,"endpoint-url":"\/ani\/endpoint\/100504369\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Glandular Stomach","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Erosion","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"5, 4, 4, 16","Doses and responses":"0 mg\/kg-day: 5, 5 mg\/kg-day: 4, 30 mg\/kg-day: 4, 200 mg\/kg-day: 16","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504566,"endpoint-url":"\/ani\/endpoint\/100504566\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504370,"endpoint-url":"\/ani\/endpoint\/100504370\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Glandular Stomach","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Ulceration","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"3, 0, 1, 1","Doses and responses":"0 mg\/kg-day: 3, 5 mg\/kg-day: 0, 30 mg\/kg-day: 1, 200 mg\/kg-day: 1","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504371,"endpoint-url":"\/ani\/endpoint\/100504371\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Non Glandular Stomach","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Erosion","endpoint-observation_time":"Week 104","endpoint-response_units":"Tissues with Histopathologies","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 5 mg\/kg-day: 0, 30 mg\/kg-day: 0, 200 mg\/kg-day: 0","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504251,"endpoint-url":"\/ani\/endpoint\/100504251\/","endpoint-system":"Metabolic","endpoint-organ":"Blood","endpoint-effect":"Free Fatty Acids","endpoint-name":"Free Fatty Acids (FFA)","endpoint-observation_time":"Week 52","endpoint-response_units":"mEq\/l","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"0.62 \u00b1 0.14, 0.49 \u00b1 0.08, 0.52 \u00b1 0.09, 0.5 \u00b1 0.12","Doses and responses":"0 mg\/kg-day: 0.62 \u00b1 0.14, 2.5 mg\/kg-day: 0.49 \u00b1 0.08, 15 mg\/kg-day: 0.52 \u00b1 0.09, 100 mg\/kg-day: 0.5 \u00b1 0.12","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504372,"endpoint-url":"\/ani\/endpoint\/100504372\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Non Glandular Stomach","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Ulceration","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"5, 1, 7, 0","Doses and responses":"0 mg\/kg-day: 5, 5 mg\/kg-day: 1, 30 mg\/kg-day: 7, 200 mg\/kg-day: 0","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504280,"endpoint-url":"\/ani\/endpoint\/100504280\/","endpoint-system":"Male Reproductive","endpoint-organ":"","endpoint-effect":"Hormone Levels","endpoint-name":"Testosterone","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504205,"endpoint-url":"\/ani\/endpoint\/100504205\/","endpoint-system":"Whole Body","endpoint-organ":"","endpoint-effect":"Survival","endpoint-name":"Survival","endpoint-observation_time":"Week 104","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504206,"endpoint-url":"\/ani\/endpoint\/100504206\/","endpoint-system":"Whole Body","endpoint-organ":"","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Week 104","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504207,"endpoint-url":"\/ani\/endpoint\/100504207\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Week 25","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"10.75 \u00b1 2.14, 11.01 \u00b1 2.97, 12.05 \u00b1 2.58, 11.88 \u00b1 2.31","Doses and responses":"0 mg\/kg-day: 10.75 \u00b1 2.14, 2.5 mg\/kg-day: 11.01 \u00b1 2.97, 15 mg\/kg-day: 12.05 \u00b1 2.58, 100 mg\/kg-day: 11.88 \u00b1 2.31","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504208,"endpoint-url":"\/ani\/endpoint\/100504208\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Week 51","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"9.56 \u00b1 1.91, 11.13 \u00b1 4.3, 11.34 \u00b1 2.82, 10.79 \u00b1 3","Doses and responses":"0 mg\/kg-day: 9.56 \u00b1 1.91, 2.5 mg\/kg-day: 11.13 \u00b1 4.3, 15 mg\/kg-day: 11.34 \u00b1 2.82, 100 mg\/kg-day: 10.79 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504209,"endpoint-url":"\/ani\/endpoint\/100504209\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Week 104","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"10.23 \u00b1 3.17, 12.26 \u00b1 3.52, 10.65 \u00b1 4.1, 11.06 \u00b1 3.9","Doses and responses":"0 mg\/kg-day: 10.23 \u00b1 3.17, 2.5 mg\/kg-day: 12.26 \u00b1 3.52, 15 mg\/kg-day: 10.65 \u00b1 4.1, 100 mg\/kg-day: 11.06 \u00b1 3.9","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504210,"endpoint-url":"\/ani\/endpoint\/100504210\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Week 25","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"9.45 \u00b1 0.43, 9.16 \u00b1 0.41, 9.17 \u00b1 0.41, 9.1 \u00b1 0.43","Doses and responses":"0 mg\/kg-day: 9.45 \u00b1 0.43, 2.5 mg\/kg-day: 9.16 \u00b1 0.41, 15 mg\/kg-day: 9.17 \u00b1 0.41, 100 mg\/kg-day: 9.1 \u00b1 0.43","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504211,"endpoint-url":"\/ani\/endpoint\/100504211\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Week 51","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"9.2 \u00b1 0.17, 8.8 \u00b1 1.52, 8.66 \u00b1 0.92, 8.8 \u00b1 1","Doses and responses":"0 mg\/kg-day: 9.2 \u00b1 0.17, 2.5 mg\/kg-day: 8.8 \u00b1 1.52, 15 mg\/kg-day: 8.66 \u00b1 0.92, 100 mg\/kg-day: 8.8 \u00b1 1","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504212,"endpoint-url":"\/ani\/endpoint\/100504212\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Week 104","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"7.55 \u00b1 1.33, 7.02 \u00b1 1.05, 7.46 \u00b1 0.92, 6.93 \u00b1 1","Doses and responses":"0 mg\/kg-day: 7.55 \u00b1 1.33, 2.5 mg\/kg-day: 7.02 \u00b1 1.05, 15 mg\/kg-day: 7.46 \u00b1 0.92, 100 mg\/kg-day: 6.93 \u00b1 1","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504213,"endpoint-url":"\/ani\/endpoint\/100504213\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Week 25","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"16.4 \u00b1 0.55, 16.3 \u00b1 0.82, 16 \u00b1 0.65, 15.9 \u00b1 0.53","Doses and responses":"0 mg\/kg-day: 16.4 \u00b1 0.55, 2.5 mg\/kg-day: 16.3 \u00b1 0.82, 15 mg\/kg-day: 16 \u00b1 0.65, 100 mg\/kg-day: 15.9 \u00b1 0.53","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504214,"endpoint-url":"\/ani\/endpoint\/100504214\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Week 51","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"15.9 \u00b1 0.63, 15 \u00b1 2.47, 15.1 \u00b1 1.72, 15.4 \u00b1 1.02","Doses and responses":"0 mg\/kg-day: 15.9 \u00b1 0.63, 2.5 mg\/kg-day: 15 \u00b1 2.47, 15 mg\/kg-day: 15.1 \u00b1 1.72, 100 mg\/kg-day: 15.4 \u00b1 1.02","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504215,"endpoint-url":"\/ani\/endpoint\/100504215\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Week 104","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"13.5 \u00b1 2.14, 12.3 \u00b1 2.14, 12.9 \u00b1 1.98, 12.3 \u00b1 2.06","Doses and responses":"0 mg\/kg-day: 13.5 \u00b1 2.14, 2.5 mg\/kg-day: 12.3 \u00b1 2.14, 15 mg\/kg-day: 12.9 \u00b1 1.98, 100 mg\/kg-day: 12.3 \u00b1 2.06","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504216,"endpoint-url":"\/ani\/endpoint\/100504216\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Week 25","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"46 \u00b1 2.18, 45.7 \u00b1 2.96, 44.7 \u00b1 2.28, 44.5 \u00b1 1.55","Doses and responses":"0 mg\/kg-day: 46 \u00b1 2.18, 2.5 mg\/kg-day: 45.7 \u00b1 2.96, 15 mg\/kg-day: 44.7 \u00b1 2.28, 100 mg\/kg-day: 44.5 \u00b1 1.55","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504217,"endpoint-url":"\/ani\/endpoint\/100504217\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Week 51","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"46.6 \u00b1 2.03, 44.2 \u00b1 7.16, 44.8 \u00b1 4.36, 45.4 \u00b1 2.9","Doses and responses":"0 mg\/kg-day: 46.6 \u00b1 2.03, 2.5 mg\/kg-day: 44.2 \u00b1 7.16, 15 mg\/kg-day: 44.8 \u00b1 4.36, 100 mg\/kg-day: 45.4 \u00b1 2.9","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504218,"endpoint-url":"\/ani\/endpoint\/100504218\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Week 104","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"41.4 \u00b1 5.8, 37.7 \u00b1 5.85, 39.5 \u00b1 5.17, 38 \u00b1 5.51","Doses and responses":"0 mg\/kg-day: 41.4 \u00b1 5.8, 2.5 mg\/kg-day: 37.7 \u00b1 5.85, 15 mg\/kg-day: 39.5 \u00b1 5.17, 100 mg\/kg-day: 38 \u00b1 5.51","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504219,"endpoint-url":"\/ani\/endpoint\/100504219\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Mean Corpuscular Volume","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Week 25","endpoint-response_units":"fl","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"48.7 \u00b1 1.45, 49.9 \u00b1 2.65, 48.8 \u00b1 1.68, 48.9 \u00b1 1.56","Doses and responses":"0 mg\/kg-day: 48.7 \u00b1 1.45, 2.5 mg\/kg-day: 49.9 \u00b1 2.65, 15 mg\/kg-day: 48.8 \u00b1 1.68, 100 mg\/kg-day: 48.9 \u00b1 1.56","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504220,"endpoint-url":"\/ani\/endpoint\/100504220\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Erythrocytes","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Week 51","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"50.7 \u00b1 1.54, 51.1 \u00b1 2.39, 51.7 \u00b1 1.84, 51.7 \u00b1 2.45","Doses and responses":"0 mg\/kg-day: 50.7 \u00b1 1.54, 2.5 mg\/kg-day: 51.1 \u00b1 2.39, 15 mg\/kg-day: 51.7 \u00b1 1.84, 100 mg\/kg-day: 51.7 \u00b1 2.45","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504221,"endpoint-url":"\/ani\/endpoint\/100504221\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Week 104","endpoint-response_units":"fl","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"55.4 \u00b1 5.27, 53.8 \u00b1 2.98, 53 \u00b1 2.74, 55.2 \u00b1 5.65","Doses and responses":"0 mg\/kg-day: 55.4 \u00b1 5.27, 2.5 mg\/kg-day: 53.8 \u00b1 2.98, 15 mg\/kg-day: 53 \u00b1 2.74, 100 mg\/kg-day: 55.2 \u00b1 5.65","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504222,"endpoint-url":"\/ani\/endpoint\/100504222\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Week 25","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"17.3 \u00b1 0.61, 17.8 \u00b1 0.66, 17.4 \u00b1 0.46, 17.5 \u00b1 0.58","Doses and responses":"0 mg\/kg-day: 17.3 \u00b1 0.61, 2.5 mg\/kg-day: 17.8 \u00b1 0.66, 15 mg\/kg-day: 17.4 \u00b1 0.46, 100 mg\/kg-day: 17.5 \u00b1 0.58","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504223,"endpoint-url":"\/ani\/endpoint\/100504223\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Mean Corpuscular Hemoglobin Concentration","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Week 104","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"32.6 \u00b1 1.2, 32.4 \u00b1 1.33, 32.5 \u00b1 1.4, 32.3 \u00b1 1.36","Doses and responses":"0 mg\/kg-day: 32.6 \u00b1 1.2, 2.5 mg\/kg-day: 32.4 \u00b1 1.33, 15 mg\/kg-day: 32.5 \u00b1 1.4, 100 mg\/kg-day: 32.3 \u00b1 1.36","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504224,"endpoint-url":"\/ani\/endpoint\/100504224\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Week 25","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1174 \u00b1 160.4, 1125 \u00b1 187.3, 1292 \u00b1 140.5, 1112 \u00b1 180.8","Doses and responses":"0 mg\/kg-day: 1174 \u00b1 160.4, 2.5 mg\/kg-day: 1125 \u00b1 187.3, 15 mg\/kg-day: 1292 \u00b1 140.5, 100 mg\/kg-day: 1112 \u00b1 180.8","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504225,"endpoint-url":"\/ani\/endpoint\/100504225\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Week 51","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1142 \u00b1 269.8, 1253 \u00b1 167.6, 1275 \u00b1 274.6, 1133 \u00b1 167.4","Doses and responses":"0 mg\/kg-day: 1142 \u00b1 269.8, 2.5 mg\/kg-day: 1253 \u00b1 167.6, 15 mg\/kg-day: 1275 \u00b1 274.6, 100 mg\/kg-day: 1133 \u00b1 167.4","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504226,"endpoint-url":"\/ani\/endpoint\/100504226\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Week 104","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1417 \u00b1 380.3, 1535 \u00b1 475.9, 1628 \u00b1 569.2, 1508 \u00b1 369.8","Doses and responses":"0 mg\/kg-day: 1417 \u00b1 380.3, 2.5 mg\/kg-day: 1535 \u00b1 475.9, 15 mg\/kg-day: 1628 \u00b1 569.2, 100 mg\/kg-day: 1508 \u00b1 369.8","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504227,"endpoint-url":"\/ani\/endpoint\/100504227\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Week 25","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"2 \u00b1 0.41, 1.9 \u00b1 0.32, 2 \u00b1 0.29, 2.3 \u00b1 0.52","Doses and responses":"0 mg\/kg-day: 2 \u00b1 0.41, 2.5 mg\/kg-day: 1.9 \u00b1 0.32, 15 mg\/kg-day: 2 \u00b1 0.29, 100 mg\/kg-day: 2.3 \u00b1 0.52","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=9-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504228,"endpoint-url":"\/ani\/endpoint\/100504228\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Week 51","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1.4 \u00b1 0.24, 1.7 \u00b1 1.39, 2.4 \u00b1 2.29, 2 \u00b1 0.93","Doses and responses":"0 mg\/kg-day: 1.4 \u00b1 0.24, 2.5 mg\/kg-day: 1.7 \u00b1 1.39, 15 mg\/kg-day: 2.4 \u00b1 2.29, 100 mg\/kg-day: 2 \u00b1 0.93","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=18-24)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504229,"endpoint-url":"\/ani\/endpoint\/100504229\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Week 104","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"3.4 \u00b1 2.9, 4.1 \u00b1 3.4, 3.2 \u00b1 2.33, 4.4 \u00b1 3.29","Doses and responses":"0 mg\/kg-day: 3.4 \u00b1 2.9, 2.5 mg\/kg-day: 4.1 \u00b1 3.4, 15 mg\/kg-day: 3.2 \u00b1 2.33, 100 mg\/kg-day: 4.4 \u00b1 3.29","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504230,"endpoint-url":"\/ani\/endpoint\/100504230\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin","endpoint-name":"Albumin (A)","endpoint-observation_time":"Week 26","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"4.3 \u00b1 0.17, 4.3 \u00b1 0.26, 4.4 \u00b1 0.28, 4.2 \u00b1 0.24","Doses and responses":"0 mg\/kg-day: 4.3 \u00b1 0.17, 2.5 mg\/kg-day: 4.3 \u00b1 0.26, 15 mg\/kg-day: 4.4 \u00b1 0.28, 100 mg\/kg-day: 4.2 \u00b1 0.24","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504231,"endpoint-url":"\/ani\/endpoint\/100504231\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin","endpoint-name":"Albumin (A)","endpoint-observation_time":"Week 52","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"4.4 \u00b1 0.19, 4.4 \u00b1 0.27, 4.2 \u00b1 0.41, 4.3 \u00b1 0.28","Doses and responses":"0 mg\/kg-day: 4.4 \u00b1 0.19, 2.5 mg\/kg-day: 4.4 \u00b1 0.27, 15 mg\/kg-day: 4.2 \u00b1 0.41, 100 mg\/kg-day: 4.3 \u00b1 0.28","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504232,"endpoint-url":"\/ani\/endpoint\/100504232\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Week 26","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"7 \u00b1 0.24, 6.9 \u00b1 0.36, 7.2 \u00b1 0.28, 6.9 \u00b1 0.26","Doses and responses":"0 mg\/kg-day: 7 \u00b1 0.24, 2.5 mg\/kg-day: 6.9 \u00b1 0.36, 15 mg\/kg-day: 7.2 \u00b1 0.28, 100 mg\/kg-day: 6.9 \u00b1 0.26","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504233,"endpoint-url":"\/ani\/endpoint\/100504233\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Week 52","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"7.2 \u00b1 0.32, 7.1 \u00b1 0.29, 7.2 \u00b1 0.36, 7 \u00b1 0.24","Doses and responses":"0 mg\/kg-day: 7.2 \u00b1 0.32, 2.5 mg\/kg-day: 7.1 \u00b1 0.29, 15 mg\/kg-day: 7.2 \u00b1 0.36, 100 mg\/kg-day: 7 \u00b1 0.24","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504234,"endpoint-url":"\/ani\/endpoint\/100504234\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Week 26","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"2.7 \u00b1 0.19, 2.6 \u00b1 0.18, 2.8 \u00b1 0.29, 2.7 \u00b1 0.23","Doses and responses":"0 mg\/kg-day: 2.7 \u00b1 0.19, 2.5 mg\/kg-day: 2.6 \u00b1 0.18, 15 mg\/kg-day: 2.8 \u00b1 0.29, 100 mg\/kg-day: 2.7 \u00b1 0.23","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504235,"endpoint-url":"\/ani\/endpoint\/100504235\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Week 52","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"2.8 \u00b1 0.26, 2.7 \u00b1 0.1, 2.9 \u00b1 0.4, 2.7 \u00b1 0.24","Doses and responses":"0 mg\/kg-day: 2.8 \u00b1 0.26, 2.5 mg\/kg-day: 2.7 \u00b1 0.1, 15 mg\/kg-day: 2.9 \u00b1 0.4, 100 mg\/kg-day: 2.7 \u00b1 0.24","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504236,"endpoint-url":"\/ani\/endpoint\/100504236\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio","endpoint-observation_time":"Week 26","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1.61 \u00b1 0.11, 1.63 \u00b1 0.11, 1.59 \u00b1 0.23, 1.58 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 1.61 \u00b1 0.11, 2.5 mg\/kg-day: 1.63 \u00b1 0.11, 15 mg\/kg-day: 1.59 \u00b1 0.23, 100 mg\/kg-day: 1.58 \u00b1 0.2","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504237,"endpoint-url":"\/ani\/endpoint\/100504237\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio","endpoint-observation_time":"Week 52","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"1.59 \u00b1 0.19, 1.64 \u00b1 0.11, 1.49 \u00b1 0.33, 1.58 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 1.59 \u00b1 0.19, 2.5 mg\/kg-day: 1.64 \u00b1 0.11, 15 mg\/kg-day: 1.49 \u00b1 0.33, 100 mg\/kg-day: 1.58 \u00b1 0.2","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504238,"endpoint-url":"\/ani\/endpoint\/100504238\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Week 26","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"89 \u00b1 20.5, 85 \u00b1 12.5, 90 \u00b1 14.9, 88 \u00b1 15.9","Doses and responses":"0 mg\/kg-day: 89 \u00b1 20.5, 2.5 mg\/kg-day: 85 \u00b1 12.5, 15 mg\/kg-day: 90 \u00b1 14.9, 100 mg\/kg-day: 88 \u00b1 15.9","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504281,"endpoint-url":"\/ani\/endpoint\/100504281\/","endpoint-system":"Male Reproductive","endpoint-organ":"","endpoint-effect":"Hormone Levels","endpoint-name":"Luteinizing Hormone","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504282,"endpoint-url":"\/ani\/endpoint\/100504282\/","endpoint-system":"Nervous","endpoint-organ":"Whole Body","endpoint-effect":"Functional Observation Battery","endpoint-name":"Functional Observational Battery (FOB)","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504283,"endpoint-url":"\/ani\/endpoint\/100504283\/","endpoint-system":"Nervous","endpoint-organ":"Whole Body","endpoint-effect":"Locomotor Activity","endpoint-name":"Locomotor Activity","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504315,"endpoint-url":"\/ani\/endpoint\/100504315\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Week 25","endpoint-response_units":"fl","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"52.1 \u00b1 1.14, 51.5 \u00b1 1.57, 52.8 \u00b1 2.16, 52.7 \u00b1 1.9","Doses and responses":"0 mg\/kg-day: 52.1 \u00b1 1.14, 5 mg\/kg-day: 51.5 \u00b1 1.57, 30 mg\/kg-day: 52.8 \u00b1 2.16, 200 mg\/kg-day: 52.7 \u00b1 1.9","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504316,"endpoint-url":"\/ani\/endpoint\/100504316\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Erythrocytes","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Week 51","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"54.1 \u00b1 0.83, 54.3 \u00b1 3.02, 54.4 \u00b1 2.37, 56.7 \u00b1 3.62","Doses and responses":"0 mg\/kg-day: 54.1 \u00b1 0.83, 5 mg\/kg-day: 54.3 \u00b1 3.02, 30 mg\/kg-day: 54.4 \u00b1 2.37, 200 mg\/kg-day: 56.7 \u00b1 3.62","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504317,"endpoint-url":"\/ani\/endpoint\/100504317\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Week 104","endpoint-response_units":"fl","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"57.8 \u00b1 3.43, 59.1 \u00b1 5.02, 58.8 \u00b1 4.44, 58.5 \u00b1 7.51","Doses and responses":"0 mg\/kg-day: 57.8 \u00b1 3.43, 5 mg\/kg-day: 59.1 \u00b1 5.02, 30 mg\/kg-day: 58.8 \u00b1 4.44, 200 mg\/kg-day: 58.5 \u00b1 7.51","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504284,"endpoint-url":"\/ani\/endpoint\/100504284\/","endpoint-system":"Nervous","endpoint-organ":"Whole Body","endpoint-effect":"Grip Strength","endpoint-name":"Grip Strength","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504285,"endpoint-url":"\/ani\/endpoint\/100504285\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Histopathology","endpoint-name":"Brain Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504363,"endpoint-url":"\/ani\/endpoint\/100504363\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urine Volume","endpoint-name":"Total Urine Volume","endpoint-observation_time":"Week 52","endpoint-response_units":"mL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"9.7 \u00b1 3.65, 8.6 \u00b1 4.79, 10.4 \u00b1 3.57, 13.4 \u00b1 8.06","Doses and responses":"0 mg\/kg-day: 9.7 \u00b1 3.65, 5 mg\/kg-day: 8.6 \u00b1 4.79, 30 mg\/kg-day: 10.4 \u00b1 3.57, 200 mg\/kg-day: 13.4 \u00b1 8.06","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504364,"endpoint-url":"\/ani\/endpoint\/100504364\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Necrosis, Papillary","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"0, 0, 0, 17","Doses and responses":"0 mg\/kg-day: 0, 5 mg\/kg-day: 0, 30 mg\/kg-day: 0, 200 mg\/kg-day: 17","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504365,"endpoint-url":"\/ani\/endpoint\/100504365\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Tubular Degeneration","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1, 0, 2, 7","Doses and responses":"0 mg\/kg-day: 1, 5 mg\/kg-day: 0, 30 mg\/kg-day: 2, 200 mg\/kg-day: 7","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504366,"endpoint-url":"\/ani\/endpoint\/100504366\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Congestion","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"8, 6, 1, 2","Doses and responses":"0 mg\/kg-day: 8, 5 mg\/kg-day: 6, 30 mg\/kg-day: 1, 200 mg\/kg-day: 2","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504286,"endpoint-url":"\/ani\/endpoint\/100504286\/","endpoint-system":"Nervous","endpoint-organ":"Sciatic Nerve","endpoint-effect":"Histopathology","endpoint-name":"Sciatic Nerve Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504287,"endpoint-url":"\/ani\/endpoint\/100504287\/","endpoint-system":"Nervous","endpoint-organ":"Spinal Cord","endpoint-effect":"Histopathology","endpoint-name":"Spinal Cord Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504288,"endpoint-url":"\/ani\/endpoint\/100504288\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Histopathology","endpoint-name":"Heart Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504318,"endpoint-url":"\/ani\/endpoint\/100504318\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Week 25","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"19.1 \u00b1 0.33, 18.6 \u00b1 0.52, 19.4 \u00b1 0.73, 19.1 \u00b1 0.76","Doses and responses":"0 mg\/kg-day: 19.1 \u00b1 0.33, 5 mg\/kg-day: 18.6 \u00b1 0.52, 30 mg\/kg-day: 19.4 \u00b1 0.73, 200 mg\/kg-day: 19.1 \u00b1 0.76","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504319,"endpoint-url":"\/ani\/endpoint\/100504319\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Week 51","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"19 \u00b1 0.2, 18.9 \u00b1 0.89, 19.1 \u00b1 0.91, 19.7 \u00b1 1.22","Doses and responses":"0 mg\/kg-day: 19 \u00b1 0.2, 5 mg\/kg-day: 18.9 \u00b1 0.89, 30 mg\/kg-day: 19.1 \u00b1 0.91, 200 mg\/kg-day: 19.7 \u00b1 1.22","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504320,"endpoint-url":"\/ani\/endpoint\/100504320\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Week 104","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"19 \u00b1 0.68, 19.4 \u00b1 1.19, 19.4 \u00b1 0.96, 18.9 \u00b1 2.06","Doses and responses":"0 mg\/kg-day: 19 \u00b1 0.68, 5 mg\/kg-day: 19.4 \u00b1 1.19, 30 mg\/kg-day: 19.4 \u00b1 0.96, 200 mg\/kg-day: 18.9 \u00b1 2.06","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504321,"endpoint-url":"\/ani\/endpoint\/100504321\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Week 25","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"36.6 \u00b1 0.53, 36.2 \u00b1 0.94, 36.8 \u00b1 0.7, 26.2 \u00b1 0.52","Doses and responses":"0 mg\/kg-day: 36.6 \u00b1 0.53, 5 mg\/kg-day: 36.2 \u00b1 0.94, 30 mg\/kg-day: 36.8 \u00b1 0.7, 200 mg\/kg-day: 26.2 \u00b1 0.52","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504289,"endpoint-url":"\/ani\/endpoint\/100504289\/","endpoint-system":"Cardiovascular","endpoint-organ":"Aorta","endpoint-effect":"Histopathology","endpoint-name":"Aorta Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504290,"endpoint-url":"\/ani\/endpoint\/100504290\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Histopathology","endpoint-name":"Spleen, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504291,"endpoint-url":"\/ani\/endpoint\/100504291\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Histopathology","endpoint-name":"Thymus, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504292,"endpoint-url":"\/ani\/endpoint\/100504292\/","endpoint-system":"Immune","endpoint-organ":"Lymph Nodes","endpoint-effect":"Histopathology","endpoint-name":"Lymph Nodes, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504293,"endpoint-url":"\/ani\/endpoint\/100504293\/","endpoint-system":"Immune","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Glands, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504322,"endpoint-url":"\/ani\/endpoint\/100504322\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Week 51","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"35.2 \u00b1 0.55, 34.9 \u00b1 0.67, 35.2 \u00b1 0.49, 34.7 \u00b1 0.62","Doses and responses":"0 mg\/kg-day: 35.2 \u00b1 0.55, 5 mg\/kg-day: 34.9 \u00b1 0.67, 30 mg\/kg-day: 35.2 \u00b1 0.49, 200 mg\/kg-day: 34.7 \u00b1 0.62","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504323,"endpoint-url":"\/ani\/endpoint\/100504323\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Week 104","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"32.9 \u00b1 0.97, 32.9 \u00b1 1.05, 33 \u00b1 1.26, 32.5 \u00b1 0.98","Doses and responses":"0 mg\/kg-day: 32.9 \u00b1 0.97, 5 mg\/kg-day: 32.9 \u00b1 1.05, 30 mg\/kg-day: 33 \u00b1 1.26, 200 mg\/kg-day: 32.5 \u00b1 0.98","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504324,"endpoint-url":"\/ani\/endpoint\/100504324\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Week 25","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1163 \u00b1 158, 1188 \u00b1 126.8, 1182 \u00b1 99.2, 1218 \u00b1 135.6","Doses and responses":"0 mg\/kg-day: 1163 \u00b1 158, 5 mg\/kg-day: 1188 \u00b1 126.8, 30 mg\/kg-day: 1182 \u00b1 99.2, 200 mg\/kg-day: 1218 \u00b1 135.6","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504294,"endpoint-url":"\/ani\/endpoint\/100504294\/","endpoint-system":"Immune","endpoint-organ":"Pituitary Gland","endpoint-effect":"Histopathology","endpoint-name":"Pituitary Glands, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504295,"endpoint-url":"\/ani\/endpoint\/100504295\/","endpoint-system":"Immune","endpoint-organ":"Thyroid with Parathyroid","endpoint-effect":"Histopathology","endpoint-name":"Thyroid with Parathyroid, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504296,"endpoint-url":"\/ani\/endpoint\/100504296\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Histopathology","endpoint-name":"Kidney Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504297,"endpoint-url":"\/ani\/endpoint\/100504297\/","endpoint-system":"Endocrine","endpoint-organ":"Pancreas","endpoint-effect":"Histopathology","endpoint-name":"Pancreas, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504298,"endpoint-url":"\/ani\/endpoint\/100504298\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Histopathology","endpoint-name":"Liver Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504325,"endpoint-url":"\/ani\/endpoint\/100504325\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Week 51","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1098 \u00b1 243.4, 969 \u00b1 106.4, 993 \u00b1 173.5, 1081 \u00b1 174.9","Doses and responses":"0 mg\/kg-day: 1098 \u00b1 243.4, 5 mg\/kg-day: 969 \u00b1 106.4, 30 mg\/kg-day: 993 \u00b1 173.5, 200 mg\/kg-day: 1081 \u00b1 174.9","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504326,"endpoint-url":"\/ani\/endpoint\/100504326\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Week 104","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1323 \u00b1 335.7, 1379 \u00b1 375.4, 1192 \u00b1 313, 1524 \u00b1 560.7","Doses and responses":"0 mg\/kg-day: 1323 \u00b1 335.7, 5 mg\/kg-day: 1379 \u00b1 375.4, 30 mg\/kg-day: 1192 \u00b1 313, 200 mg\/kg-day: 1524 \u00b1 560.7","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504327,"endpoint-url":"\/ani\/endpoint\/100504327\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Week 25","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1.9 \u00b1 0.32, 1.8 \u00b1 0.26, 2.1 \u00b1 0.37, 2.4 \u00b1 0.61","Doses and responses":"0 mg\/kg-day: 1.9 \u00b1 0.32, 5 mg\/kg-day: 1.8 \u00b1 0.26, 30 mg\/kg-day: 2.1 \u00b1 0.37, 200 mg\/kg-day: 2.4 \u00b1 0.61","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504299,"endpoint-url":"\/ani\/endpoint\/100504299\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Histopathology","endpoint-name":"Testes, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504300,"endpoint-url":"\/ani\/endpoint\/100504300\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Histopathology","endpoint-name":"Epididymis, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504301,"endpoint-url":"\/ani\/endpoint\/100504301\/","endpoint-system":"Male Reproductive","endpoint-organ":"Prostate","endpoint-effect":"Histopathology","endpoint-name":"Prostate, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504302,"endpoint-url":"\/ani\/endpoint\/100504302\/","endpoint-system":"Whole Body","endpoint-organ":"","endpoint-effect":"Survival","endpoint-name":"Survival","endpoint-observation_time":"Week 104","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504303,"endpoint-url":"\/ani\/endpoint\/100504303\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Week 25","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"7.14 \u00b1 1.14, 7.55 \u00b1 1.62, 7.58 \u00b1 2.2, 8.65 \u00b1 2.47","Doses and responses":"0 mg\/kg-day: 7.14 \u00b1 1.14, 5 mg\/kg-day: 7.55 \u00b1 1.62, 30 mg\/kg-day: 7.58 \u00b1 2.2, 200 mg\/kg-day: 8.65 \u00b1 2.47","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504304,"endpoint-url":"\/ani\/endpoint\/100504304\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Week 51","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"7.1 \u00b1 1.77, 7.27 \u00b1 3.47, 6.74 \u00b1 1.86, 6.66 \u00b1 1.8","Doses and responses":"0 mg\/kg-day: 7.1 \u00b1 1.77, 5 mg\/kg-day: 7.27 \u00b1 3.47, 30 mg\/kg-day: 6.74 \u00b1 1.86, 200 mg\/kg-day: 6.66 \u00b1 1.8","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504305,"endpoint-url":"\/ani\/endpoint\/100504305\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Week 104","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"10.04 \u00b1 5.29, 9.69 \u00b1 7.01, 7.93 \u00b1 4.14, 8.24 \u00b1 2.58","Doses and responses":"0 mg\/kg-day: 10.04 \u00b1 5.29, 5 mg\/kg-day: 9.69 \u00b1 7.01, 30 mg\/kg-day: 7.93 \u00b1 4.14, 200 mg\/kg-day: 8.24 \u00b1 2.58","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504306,"endpoint-url":"\/ani\/endpoint\/100504306\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Week 25","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"8.06 \u00b1 0.36, 8.42 \u00b1 0.47, 7.93 \u00b1 0.43, 7.97 \u00b1 0.39","Doses and responses":"0 mg\/kg-day: 8.06 \u00b1 0.36, 5 mg\/kg-day: 8.42 \u00b1 0.47, 30 mg\/kg-day: 7.93 \u00b1 0.43, 200 mg\/kg-day: 7.97 \u00b1 0.39","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504307,"endpoint-url":"\/ani\/endpoint\/100504307\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Week 51","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"8.14 \u00b1 0.52, 8.23 \u00b1 0.58, 8.12 \u00b1 0.37, 7.48 \u00b1 0.68","Doses and responses":"0 mg\/kg-day: 8.14 \u00b1 0.52, 5 mg\/kg-day: 8.23 \u00b1 0.58, 30 mg\/kg-day: 8.12 \u00b1 0.37, 200 mg\/kg-day: 7.48 \u00b1 0.68","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504308,"endpoint-url":"\/ani\/endpoint\/100504308\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Week 104","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"6.8 \u00b1 0.76, 6.71 \u00b1 0.89, 6.69 \u00b1 1.22, 6.86 \u00b1 0.96","Doses and responses":"0 mg\/kg-day: 6.8 \u00b1 0.76, 5 mg\/kg-day: 6.71 \u00b1 0.89, 30 mg\/kg-day: 6.69 \u00b1 1.22, 200 mg\/kg-day: 6.86 \u00b1 0.96","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504309,"endpoint-url":"\/ani\/endpoint\/100504309\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Week 25","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"15.3 \u00b1 0.73, 15.7 \u00b1 0.77, 15.4 \u00b1 0.88, 15.2 \u00b1 0.57","Doses and responses":"0 mg\/kg-day: 15.3 \u00b1 0.73, 5 mg\/kg-day: 15.7 \u00b1 0.77, 30 mg\/kg-day: 15.4 \u00b1 0.88, 200 mg\/kg-day: 15.2 \u00b1 0.57","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504310,"endpoint-url":"\/ani\/endpoint\/100504310\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Week 51","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"15.5 \u00b1 0.97, 15.7 \u00b1 0.73, 15.5 \u00b1 0.79, 14.7 \u00b1 0.91","Doses and responses":"0 mg\/kg-day: 15.5 \u00b1 0.97, 5 mg\/kg-day: 15.7 \u00b1 0.73, 30 mg\/kg-day: 15.5 \u00b1 0.79, 200 mg\/kg-day: 14.7 \u00b1 0.91","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=2-21)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504311,"endpoint-url":"\/ani\/endpoint\/100504311\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Week 104","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"12.9 \u00b1 1.41, 12.9 \u00b1 1.3, 12.9 \u00b1 2.31, 12.8 \u00b1 1.12","Doses and responses":"0 mg\/kg-day: 12.9 \u00b1 1.41, 5 mg\/kg-day: 12.9 \u00b1 1.3, 30 mg\/kg-day: 12.9 \u00b1 2.31, 200 mg\/kg-day: 12.8 \u00b1 1.12","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504312,"endpoint-url":"\/ani\/endpoint\/100504312\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Week 25","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"42 \u00b1 2.42, 43.4 \u00b1 3.08, 41.9 \u00b1 2.47, 42 \u00b1 1.55","Doses and responses":"0 mg\/kg-day: 42 \u00b1 2.42, 5 mg\/kg-day: 43.4 \u00b1 3.08, 30 mg\/kg-day: 41.9 \u00b1 2.47, 200 mg\/kg-day: 42 \u00b1 1.55","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504348,"endpoint-url":"\/ani\/endpoint\/100504348\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Triglycerides","endpoint-name":"Triglyceride (TRIG)","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"83 \u00b1 35.5, 68 \u00b1 10.4, 77 \u00b1 26.5, 138 \u00b1 73.3","Doses and responses":"0 mg\/kg-day: 83 \u00b1 35.5, 5 mg\/kg-day: 68 \u00b1 10.4, 30 mg\/kg-day: 77 \u00b1 26.5, 200 mg\/kg-day: 138 \u00b1 73.3","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504349,"endpoint-url":"\/ani\/endpoint\/100504349\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Triglycerides","endpoint-name":"Triglyceride (TRIG)","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"136 \u00b1 18.3, 120 \u00b1 33, 107 \u00b1 33.8, 173 \u00b1 121.6","Doses and responses":"0 mg\/kg-day: 136 \u00b1 18.3, 5 mg\/kg-day: 120 \u00b1 33, 30 mg\/kg-day: 107 \u00b1 33.8, 200 mg\/kg-day: 173 \u00b1 121.6","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504350,"endpoint-url":"\/ani\/endpoint\/100504350\/","endpoint-system":"Metabolic","endpoint-organ":"Blood","endpoint-effect":"Free Fatty Acids","endpoint-name":"Free Fatty Acids (FFA)","endpoint-observation_time":"Week 26","endpoint-response_units":"mEq\/l","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"0.52 \u00b1 0.08, 0.57 \u00b1 0.14, 0.5 \u00b1 0.11, 0.58 \u00b1 0.11","Doses and responses":"0 mg\/kg-day: 0.52 \u00b1 0.08, 5 mg\/kg-day: 0.57 \u00b1 0.14, 30 mg\/kg-day: 0.5 \u00b1 0.11, 200 mg\/kg-day: 0.58 \u00b1 0.11","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504351,"endpoint-url":"\/ani\/endpoint\/100504351\/","endpoint-system":"Metabolic","endpoint-organ":"Blood","endpoint-effect":"Free Fatty Acids","endpoint-name":"Free Fatty Acids (FFA)","endpoint-observation_time":"Week 52","endpoint-response_units":"mEq\/l","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"0.63 \u00b1 0.23, 0.65 \u00b1 0.16, 0.56 \u00b1 0.1, 0.61 \u00b1 0.17","Doses and responses":"0 mg\/kg-day: 0.63 \u00b1 0.23, 5 mg\/kg-day: 0.65 \u00b1 0.16, 30 mg\/kg-day: 0.56 \u00b1 0.1, 200 mg\/kg-day: 0.61 \u00b1 0.17","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504352,"endpoint-url":"\/ani\/endpoint\/100504352\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"High Density Lipoprotein (HDL)","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"77.1 \u00b1 16.28, 66.4 \u00b1 11.27, 72.4 \u00b1 9.42, 67.1 \u00b1 11.75","Doses and responses":"0 mg\/kg-day: 77.1 \u00b1 16.28, 5 mg\/kg-day: 66.4 \u00b1 11.27, 30 mg\/kg-day: 72.4 \u00b1 9.42, 200 mg\/kg-day: 67.1 \u00b1 11.75","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504353,"endpoint-url":"\/ani\/endpoint\/100504353\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"High Density Lipoprotein (HDL)","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"77.3 \u00b1 8.2, 84.6 \u00b1 13.73, 77 \u00b1 13.28, 70.6 \u00b1 14.93","Doses and responses":"0 mg\/kg-day: 77.3 \u00b1 8.2, 5 mg\/kg-day: 84.6 \u00b1 13.73, 30 mg\/kg-day: 77 \u00b1 13.28, 200 mg\/kg-day: 70.6 \u00b1 14.93","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504354,"endpoint-url":"\/ani\/endpoint\/100504354\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"LDL + VLDL","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"9 \u00b1 4.1, 7 \u00b1 3.5, 7 \u00b1 2, 5 \u00b1 2.3","Doses and responses":"0 mg\/kg-day: 9 \u00b1 4.1, 5 mg\/kg-day: 7 \u00b1 3.5, 30 mg\/kg-day: 7 \u00b1 2, 200 mg\/kg-day: 5 \u00b1 2.3","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504355,"endpoint-url":"\/ani\/endpoint\/100504355\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"LDL + VLDL","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"10 \u00b1 5.2, 10 \u00b1 4.4, 7 \u00b1 2.9, 7 \u00b1 3.7","Doses and responses":"0 mg\/kg-day: 10 \u00b1 5.2, 5 mg\/kg-day: 10 \u00b1 4.4, 30 mg\/kg-day: 7 \u00b1 2.9, 200 mg\/kg-day: 7 \u00b1 3.7","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504356,"endpoint-url":"\/ani\/endpoint\/100504356\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Specific Gravity","endpoint-name":"Urine Specific Gravity","endpoint-observation_time":"Week 26","endpoint-response_units":"Specific Gravity","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1.04 \u00b1 0.01, 1.04 \u00b1 0.02, 1.04 \u00b1 0.01, 1.03 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 1.04 \u00b1 0.01, 5 mg\/kg-day: 1.04 \u00b1 0.02, 30 mg\/kg-day: 1.04 \u00b1 0.01, 200 mg\/kg-day: 1.03 \u00b1 0.01","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504357,"endpoint-url":"\/ani\/endpoint\/100504357\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Specific Gravity","endpoint-name":"Urine Specific Gravity","endpoint-observation_time":"Week 52","endpoint-response_units":"Specific Gravity","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"1.03 \u00b1 0.01, 1.03 \u00b1 0.01, 1.03 \u00b1 0.01, 1.03 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 1.03 \u00b1 0.01, 5 mg\/kg-day: 1.03 \u00b1 0.01, 30 mg\/kg-day: 1.03 \u00b1 0.01, 200 mg\/kg-day: 1.03 \u00b1 0.01","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504358,"endpoint-url":"\/ani\/endpoint\/100504358\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"pH","endpoint-name":"Urine pH","endpoint-observation_time":"Week 26","endpoint-response_units":"pH","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"6 \u00b1 0.28, 6 \u00b1 0.47, 6, 5.9 \u00b1 0.22","Doses and responses":"0 mg\/kg-day: 6 \u00b1 0.28, 5 mg\/kg-day: 6 \u00b1 0.47, 30 mg\/kg-day: 6, 200 mg\/kg-day: 5.9 \u00b1 0.22","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504359,"endpoint-url":"\/ani\/endpoint\/100504359\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"pH","endpoint-name":"Urine pH","endpoint-observation_time":"Week 52","endpoint-response_units":"pH","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"6.1 \u00b1 0.16, 6.1 \u00b1 0.21, 6.1 \u00b1 0.32, 6 \u00b1 0.11","Doses and responses":"0 mg\/kg-day: 6.1 \u00b1 0.16, 5 mg\/kg-day: 6.1 \u00b1 0.21, 30 mg\/kg-day: 6.1 \u00b1 0.32, 200 mg\/kg-day: 6 \u00b1 0.11","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504360,"endpoint-url":"\/ani\/endpoint\/100504360\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urobilinogen","endpoint-name":"Urobilinogen","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"0.3 \u00b1 0.25, 0.3 \u00b1 0.25, 0.2, 0.2 \u00b1 0.18","Doses and responses":"0 mg\/kg-day: 0.3 \u00b1 0.25, 5 mg\/kg-day: 0.3 \u00b1 0.25, 30 mg\/kg-day: 0.2, 200 mg\/kg-day: 0.2 \u00b1 0.18","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504361,"endpoint-url":"\/ani\/endpoint\/100504361\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urobilinogen","endpoint-name":"Urobilinogen","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"0.2, 0.2 \u00b1 0.22, 0.2, 0.2","Doses and responses":"0 mg\/kg-day: 0.2, 5 mg\/kg-day: 0.2 \u00b1 0.22, 30 mg\/kg-day: 0.2, 200 mg\/kg-day: 0.2","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504362,"endpoint-url":"\/ani\/endpoint\/100504362\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urine Volume","endpoint-name":"Total Urine Volume","endpoint-observation_time":"Week 26","endpoint-response_units":"mL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"4.3 \u00b1 2.63, 5.9 \u00b1 3.78, 6.1 \u00b1 2.85, 9 \u00b1 5.09","Doses and responses":"0 mg\/kg-day: 4.3 \u00b1 2.63, 5 mg\/kg-day: 5.9 \u00b1 3.78, 30 mg\/kg-day: 6.1 \u00b1 2.85, 200 mg\/kg-day: 9 \u00b1 5.09","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504347,"endpoint-url":"\/ani\/endpoint\/100504347\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Sodium (NA)","endpoint-observation_time":"Week 52","endpoint-response_units":"mEq\/l","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"143 \u00b1 1.5, 143 \u00b1 1, 143 \u00b1 1.6, 142 \u00b1 1.2","Doses and responses":"0 mg\/kg-day: 143 \u00b1 1.5, 5 mg\/kg-day: 143 \u00b1 1, 30 mg\/kg-day: 143 \u00b1 1.6, 200 mg\/kg-day: 142 \u00b1 1.2","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=60-70)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504373,"endpoint-url":"\/ani\/endpoint\/100504373\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Nonneoplastic Histopathology","endpoint-name":"Hepatocellular Necrosis","endpoint-observation_time":"Week 104","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"2, 0, 3, 12","Doses and responses":"0 mg\/kg-day: 2, 5 mg\/kg-day: 0, 30 mg\/kg-day: 3, 200 mg\/kg-day: 12","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504376,"endpoint-url":"\/ani\/endpoint\/100504376\/","endpoint-system":"Female Reproductive","endpoint-organ":"","endpoint-effect":"Hormone Levels","endpoint-name":"Testosterone","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504377,"endpoint-url":"\/ani\/endpoint\/100504377\/","endpoint-system":"Female Reproductive","endpoint-organ":"","endpoint-effect":"Hormone Levels","endpoint-name":"Luteinizing Hormone","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504420,"endpoint-url":"\/ani\/endpoint\/100504420\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Day 90","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"17.6 \u00b1 0.62, 17.4 \u00b1 0.53, 17.4 \u00b1 0.75, 17.5 \u00b1 0.38","Doses and responses":"0 mg\/kg-day: 17.6 \u00b1 0.62, 10 mg\/kg-day: 17.4 \u00b1 0.53, 50 mg\/kg-day: 17.4 \u00b1 0.75, 200 mg\/kg-day: 17.5 \u00b1 0.38","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504378,"endpoint-url":"\/ani\/endpoint\/100504378\/","endpoint-system":"Female Reproductive","endpoint-organ":"","endpoint-effect":"Hormone Levels","endpoint-name":"Estradiol","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504379,"endpoint-url":"\/ani\/endpoint\/100504379\/","endpoint-system":"Nervous","endpoint-organ":"Whole Body","endpoint-effect":"Functional Observational Battery (FOB)","endpoint-name":"Functional Observational Battery (FOB)","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504380,"endpoint-url":"\/ani\/endpoint\/100504380\/","endpoint-system":"Nervous","endpoint-organ":"Whole Body","endpoint-effect":"Locomotor Activity","endpoint-name":"Locomotor Activity","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504381,"endpoint-url":"\/ani\/endpoint\/100504381\/","endpoint-system":"Nervous","endpoint-organ":"Whole Body","endpoint-effect":"Grip Strength","endpoint-name":"Grip Strength","endpoint-observation_time":"Week 104","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504405,"endpoint-url":"\/ani\/endpoint\/100504405\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0.732 \u00b1 0.027, 0.787 \u00b1 0.0522, 0.785 \u00b1 0.0282, 0.799 \u00b1 0.0554","Doses and responses":"0 mg\/kg-day: 0.732 \u00b1 0.027, 10 mg\/kg-day: 0.787 \u00b1 0.0522, 50 mg\/kg-day: 0.785 \u00b1 0.0282, 200 mg\/kg-day: 0.799 \u00b1 0.0554","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504406,"endpoint-url":"\/ani\/endpoint\/100504406\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"13.62 \u00b1 1.828, 12.69 \u00b1 2.218, 12.16 \u00b1 2.875, 15.66 \u00b1 2.041","Doses and responses":"0 mg\/kg-day: 13.62 \u00b1 1.828, 10 mg\/kg-day: 12.69 \u00b1 2.218, 50 mg\/kg-day: 12.16 \u00b1 2.875, 200 mg\/kg-day: 15.66 \u00b1 2.041","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504412,"endpoint-url":"\/ani\/endpoint\/100504412\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio","endpoint-observation_time":"Day 90","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.51 \u00b1 0.142, 1.65 \u00b1 0.154, 1.65 \u00b1 0.228, 1.69 \u00b1 0.165","Doses and responses":"0 mg\/kg-day: 1.51 \u00b1 0.142, 10 mg\/kg-day: 1.65 \u00b1 0.154, 50 mg\/kg-day: 1.65 \u00b1 0.228, 200 mg\/kg-day: 1.69 \u00b1 0.165","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504413,"endpoint-url":"\/ani\/endpoint\/100504413\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.8 \u00b1 0.24, 2.6 \u00b1 0.24, 2.5 \u00b1 0.29, 2.5 \u00b1 0.23","Doses and responses":"0 mg\/kg-day: 2.8 \u00b1 0.24, 10 mg\/kg-day: 2.6 \u00b1 0.24, 50 mg\/kg-day: 2.5 \u00b1 0.29, 200 mg\/kg-day: 2.5 \u00b1 0.23","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504382,"endpoint-url":"\/ani\/endpoint\/100504382\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Histopathology","endpoint-name":"Brain Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504383,"endpoint-url":"\/ani\/endpoint\/100504383\/","endpoint-system":"Nervous","endpoint-organ":"Sciatic Nerve","endpoint-effect":"Histopathology","endpoint-name":"Sciatic Nerve Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=7-8)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504622,"endpoint-url":"\/ani\/endpoint\/100504622\/","endpoint-system":"Endocrine","endpoint-organ":"Parathyroid","endpoint-effect":"Histopathology","endpoint-name":"Parathyroid Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504384,"endpoint-url":"\/ani\/endpoint\/100504384\/","endpoint-system":"Nervous","endpoint-organ":"Spinal Cord","endpoint-effect":"Histopathology","endpoint-name":"Spinal Cord Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504385,"endpoint-url":"\/ani\/endpoint\/100504385\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Histopathology","endpoint-name":"Heart Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504386,"endpoint-url":"\/ani\/endpoint\/100504386\/","endpoint-system":"Cardiovascular","endpoint-organ":"Aorta","endpoint-effect":"Histopathology","endpoint-name":"Aorta Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504414,"endpoint-url":"\/ani\/endpoint\/100504414\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"7 \u00b1 0.22, 6.8 \u00b1 0.29, 6.7 \u00b1 0.3, 6.6 \u00b1 0.3","Doses and responses":"0 mg\/kg-day: 7 \u00b1 0.22, 10 mg\/kg-day: 6.8 \u00b1 0.29, 50 mg\/kg-day: 6.7 \u00b1 0.3, 200 mg\/kg-day: 6.6 \u00b1 0.3","Response direction":"\u2193"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504387,"endpoint-url":"\/ani\/endpoint\/100504387\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Histopathology","endpoint-name":"Spleen, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504388,"endpoint-url":"\/ani\/endpoint\/100504388\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Histopathology","endpoint-name":"Thymus, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504421,"endpoint-url":"\/ani\/endpoint\/100504421\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"51.2 \u00b1 2.13, 49.9 \u00b1 1.56, 49.9 \u00b1 2.37, 46.9 \u00b1 2.98","Doses and responses":"0 mg\/kg-day: 51.2 \u00b1 2.13, 10 mg\/kg-day: 49.9 \u00b1 1.56, 50 mg\/kg-day: 49.9 \u00b1 2.37, 200 mg\/kg-day: 46.9 \u00b1 2.98","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504422,"endpoint-url":"\/ani\/endpoint\/100504422\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"30.5 \u00b1 0.77, 30.7 \u00b1 0.58, 30.9 \u00b1 0.55, 30.5 \u00b1 0.63","Doses and responses":"0 mg\/kg-day: 30.5 \u00b1 0.77, 10 mg\/kg-day: 30.7 \u00b1 0.58, 50 mg\/kg-day: 30.9 \u00b1 0.55, 200 mg\/kg-day: 30.5 \u00b1 0.63","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504389,"endpoint-url":"\/ani\/endpoint\/100504389\/","endpoint-system":"Immune","endpoint-organ":"Lymph Nodes","endpoint-effect":"Histopathology","endpoint-name":"Lymph Nodes, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504390,"endpoint-url":"\/ani\/endpoint\/100504390\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Glands, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504408,"endpoint-url":"\/ani\/endpoint\/100504408\/","endpoint-system":"Hepatic","endpoint-organ":"Blood","endpoint-effect":"Cholesterol","endpoint-name":"Cholesterol (CHOL)","endpoint-observation_time":"Day 90","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"57 \u00b1 12.5, 47 \u00b1 9.1, 42 \u00b1 9.4, 45 \u00b1 7","Doses and responses":"0 mg\/kg-day: 57 \u00b1 12.5, 10 mg\/kg-day: 47 \u00b1 9.1, 50 mg\/kg-day: 42 \u00b1 9.4, 200 mg\/kg-day: 45 \u00b1 7","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504409,"endpoint-url":"\/ani\/endpoint\/100504409\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Aspartate Aminotransferase","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Day 90","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"88 \u00b1 16, 85 \u00b1 9.2, 102 \u00b1 34.3, 184 \u00b1 172.1","Doses and responses":"0 mg\/kg-day: 88 \u00b1 16, 10 mg\/kg-day: 85 \u00b1 9.2, 50 mg\/kg-day: 102 \u00b1 34.3, 200 mg\/kg-day: 184 \u00b1 172.1","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504410,"endpoint-url":"\/ani\/endpoint\/100504410\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Day 90","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"41 \u00b1 4.6, 46 \u00b1 4.9, 50 \u00b1 18.3, 138 \u00b1 143.1","Doses and responses":"0 mg\/kg-day: 41 \u00b1 4.6, 10 mg\/kg-day: 46 \u00b1 4.9, 50 mg\/kg-day: 50 \u00b1 18.3, 200 mg\/kg-day: 138 \u00b1 143.1","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504411,"endpoint-url":"\/ani\/endpoint\/100504411\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"95 \u00b1 19.8, 93 \u00b1 15, 109 \u00b1 23, 127 \u00b1 31","Doses and responses":"0 mg\/kg-day: 95 \u00b1 19.8, 10 mg\/kg-day: 93 \u00b1 15, 50 mg\/kg-day: 109 \u00b1 23, 200 mg\/kg-day: 127 \u00b1 31","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504391,"endpoint-url":"\/ani\/endpoint\/100504391\/","endpoint-system":"Endocrine","endpoint-organ":"Pituitary Gland","endpoint-effect":"Histopathology","endpoint-name":"Pituitary Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504392,"endpoint-url":"\/ani\/endpoint\/100504392\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid with Parathyroid","endpoint-effect":"Histopathology","endpoint-name":"Thyroid with Parathyroid, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504393,"endpoint-url":"\/ani\/endpoint\/100504393\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Histopathology","endpoint-name":"Kidney Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504423,"endpoint-url":"\/ani\/endpoint\/100504423\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Day 90","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"57.7 \u00b1 2.42, 56.5 \u00b1 1.52, 56.3 \u00b1 2.06, 57.5 \u00b1 1.36","Doses and responses":"0 mg\/kg-day: 57.7 \u00b1 2.42, 10 mg\/kg-day: 56.5 \u00b1 1.52, 50 mg\/kg-day: 56.3 \u00b1 2.06, 200 mg\/kg-day: 57.5 \u00b1 1.36","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504573,"endpoint-url":"\/ani\/endpoint\/100504573\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504394,"endpoint-url":"\/ani\/endpoint\/100504394\/","endpoint-system":"Endocrine","endpoint-organ":"Pancreas","endpoint-effect":"Histopathology","endpoint-name":"Pancreas, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504395,"endpoint-url":"\/ani\/endpoint\/100504395\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Histopathology","endpoint-name":"Liver Histopathology","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504396,"endpoint-url":"\/ani\/endpoint\/100504396\/","endpoint-system":"Female Reproductive","endpoint-organ":"Ovaries","endpoint-effect":"Histopathology","endpoint-name":"Ovaries, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504397,"endpoint-url":"\/ani\/endpoint\/100504397\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Histopathology","endpoint-name":"Uterus, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504398,"endpoint-url":"\/ani\/endpoint\/100504398\/","endpoint-system":"Female Reproductive","endpoint-organ":"Cervix","endpoint-effect":"Histopathology","endpoint-name":"Cervix, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504424,"endpoint-url":"\/ani\/endpoint\/100504424\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"15.6 \u00b1 0.51, 15.4 \u00b1 0.58, 15.4 \u00b1 0.65, 14.3 \u00b1 1.08","Doses and responses":"0 mg\/kg-day: 15.6 \u00b1 0.51, 10 mg\/kg-day: 15.4 \u00b1 0.58, 50 mg\/kg-day: 15.4 \u00b1 0.65, 200 mg\/kg-day: 14.3 \u00b1 1.08","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504609,"endpoint-url":"\/ani\/endpoint\/100504609\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Liver, Infiltration Cellular, Mixed Cell","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"3, 1, 0, 2, 5, 0","Doses and responses":"0 mg\/kg-day: 3, 62.5 mg\/kg-day: 1, 125 mg\/kg-day: 0, 250 mg\/kg-day: 2, 500 mg\/kg-day: 5, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504399,"endpoint-url":"\/ani\/endpoint\/100504399\/","endpoint-system":"Female Reproductive","endpoint-organ":"Vagina","endpoint-effect":"Histopathology","endpoint-name":"Vagina, Non-Neoplastic Lesions","endpoint-observation_time":"Week 104","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504400,"endpoint-url":"\/ani\/endpoint\/100504400\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Peroxisomal B-Oxidation","endpoint-name":"Peroxisomal Beta Oxidation ","endpoint-observation_time":"Day 90","endpoint-response_units":"nmol\/mg","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"4.75 \u00b1 0.832, , , 6.53 \u00b1 1.066","Doses and responses":"0 mg\/kg-day: 4.75 \u00b1 0.832, 200 mg\/kg-day: 6.53 \u00b1 1.066","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504401,"endpoint-url":"\/ani\/endpoint\/100504401\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative to Brain","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/100g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"649.312 \u00b1 78.6276, 611.737 \u00b1 96.941, 589.604 \u00b1 126.77, 760.757 \u00b1 81.2759","Doses and responses":"0 mg\/kg-day: 649.312 \u00b1 78.6276, 10 mg\/kg-day: 611.737 \u00b1 96.941, 50 mg\/kg-day: 589.604 \u00b1 126.77, 200 mg\/kg-day: 760.757 \u00b1 81.2759","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504402,"endpoint-url":"\/ani\/endpoint\/100504402\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative to Brain","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/100g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"173.964 \u00b1 12.377, 174.102 \u00b1 18.375, 166.893 \u00b1 26.1349, 182.037 \u00b1 17.4782","Doses and responses":"0 mg\/kg-day: 173.964 \u00b1 12.377, 10 mg\/kg-day: 174.102 \u00b1 18.375, 50 mg\/kg-day: 166.893 \u00b1 26.1349, 200 mg\/kg-day: 182.037 \u00b1 17.4782","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504403,"endpoint-url":"\/ani\/endpoint\/100504403\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Absolute","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.1 \u00b1 0.073, 2.07 \u00b1 0.084, 2.05 \u00b1 0.116, 2.05 \u00b1 0.063","Doses and responses":"0 mg\/kg-day: 2.1 \u00b1 0.073, 10 mg\/kg-day: 2.07 \u00b1 0.084, 50 mg\/kg-day: 2.05 \u00b1 0.116, 200 mg\/kg-day: 2.05 \u00b1 0.063","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504404,"endpoint-url":"\/ani\/endpoint\/100504404\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.723 \u00b1 0.186, 2.748 \u00b1 0.1567, 2.75 \u00b1 0.2236, 3.334 \u00b1 0.1841","Doses and responses":"0 mg\/kg-day: 2.723 \u00b1 0.186, 10 mg\/kg-day: 2.748 \u00b1 0.1567, 50 mg\/kg-day: 2.75 \u00b1 0.2236, 200 mg\/kg-day: 3.334 \u00b1 0.1841","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504416,"endpoint-url":"\/ani\/endpoint\/100504416\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"8.73 \u00b1 2.341, 7.94 \u00b1 2.153, 8.47 \u00b1 1.499, 8.49 \u00b1 1.63","Doses and responses":"0 mg\/kg-day: 8.73 \u00b1 2.341, 10 mg\/kg-day: 7.94 \u00b1 2.153, 50 mg\/kg-day: 8.47 \u00b1 1.499, 200 mg\/kg-day: 8.49 \u00b1 1.63","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504417,"endpoint-url":"\/ani\/endpoint\/100504417\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.5 \u00b1 0.13, 1.4 \u00b1 0.23, 1.3 \u00b1 0.4, 2.7 \u00b1 1.9","Doses and responses":"0 mg\/kg-day: 1.5 \u00b1 0.13, 10 mg\/kg-day: 1.4 \u00b1 0.23, 50 mg\/kg-day: 1.3 \u00b1 0.4, 200 mg\/kg-day: 2.7 \u00b1 1.9","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504418,"endpoint-url":"\/ani\/endpoint\/100504418\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"133.6 \u00b1 15.11, 127.5 \u00b1 39.89, 116 \u00b1 31.45, 212.3 \u00b1 119.03","Doses and responses":"0 mg\/kg-day: 133.6 \u00b1 15.11, 10 mg\/kg-day: 127.5 \u00b1 39.89, 50 mg\/kg-day: 116 \u00b1 31.45, 200 mg\/kg-day: 212.3 \u00b1 119.03","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504419,"endpoint-url":"\/ani\/endpoint\/100504419\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"795 \u00b1 197.7, 1053 \u00b1 101, 978 \u00b1 69.8, 945 \u00b1 233.2","Doses and responses":"0 mg\/kg-day: 795 \u00b1 197.7, 10 mg\/kg-day: 1053 \u00b1 101, 50 mg\/kg-day: 978 \u00b1 69.8, 200 mg\/kg-day: 945 \u00b1 233.2","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504610,"endpoint-url":"\/ani\/endpoint\/100504610\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Liver, Hepatocyte, Cytoplasmic Alteration","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 2, 10","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 2, 1000 mg\/kg-day: 10","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504425,"endpoint-url":"\/ani\/endpoint\/100504425\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Day 90","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"8.89 \u00b1 0.32, 8.84 \u00b1 0.281, 8.88 \u00b1 0.69, 8.17 \u00b1 0.593","Doses and responses":"0 mg\/kg-day: 8.89 \u00b1 0.32, 10 mg\/kg-day: 8.84 \u00b1 0.281, 50 mg\/kg-day: 8.88 \u00b1 0.69, 200 mg\/kg-day: 8.17 \u00b1 0.593","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504426,"endpoint-url":"\/ani\/endpoint\/100504426\/","endpoint-system":"Nervous","endpoint-organ":"NA","endpoint-effect":"Motor Activity","endpoint-name":"Locomotor Activity","endpoint-observation_time":"Week 12","endpoint-response_units":"Mean Total Counts","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504427,"endpoint-url":"\/ani\/endpoint\/100504427\/","endpoint-system":"Whole Body","endpoint-organ":"NA","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"499 \u00b1 39, 460 \u00b1 57.9, 438 \u00b1 77, 469 \u00b1 48.8","Doses and responses":"0 mg\/kg-day: 499 \u00b1 39, 10 mg\/kg-day: 460 \u00b1 57.9, 50 mg\/kg-day: 438 \u00b1 77, 200 mg\/kg-day: 469 \u00b1 48.8","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504428,"endpoint-url":"\/ani\/endpoint\/100504428\/","endpoint-system":"Nervous","endpoint-organ":"NA","endpoint-effect":"Functional Observation Battery","endpoint-name":"Functional Observation Battery (FOB)","endpoint-observation_time":"Week 12","endpoint-response_units":"Mean Total Counts","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504429,"endpoint-url":"\/ani\/endpoint\/100504429\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Relative","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0.423 \u00b1 0.357, 0.456 \u00b1 0.0508, 0.481 \u00b1 0.0766, 0.442 \u00b1 0.0431","Doses and responses":"0 mg\/kg-day: 0.423 \u00b1 0.357, 10 mg\/kg-day: 0.456 \u00b1 0.0508, 50 mg\/kg-day: 0.481 \u00b1 0.0766, 200 mg\/kg-day: 0.442 \u00b1 0.0431","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504430,"endpoint-url":"\/ani\/endpoint\/100504430\/","endpoint-system":"Hepatic","endpoint-organ":"Blood","endpoint-effect":"Albumin","endpoint-name":"Albumin (A), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"4.3 \u00b1 0.17, , , 4.2 \u00b1 0.18","Doses and responses":"0 mg\/kg-day: 4.3 \u00b1 0.17, 200 mg\/kg-day: 4.2 \u00b1 0.18","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504431,"endpoint-url":"\/ani\/endpoint\/100504431\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"7.2 \u00b1 0.24, , , 6.8 \u00b1 0.28","Doses and responses":"0 mg\/kg-day: 7.2 \u00b1 0.24, 200 mg\/kg-day: 6.8 \u00b1 0.28","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504432,"endpoint-url":"\/ani\/endpoint\/100504432\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.9 \u00b1 0.27, , , 2.6 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 2.9 \u00b1 0.27, 200 mg\/kg-day: 2.6 \u00b1 0.2","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504433,"endpoint-url":"\/ani\/endpoint\/100504433\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.47 \u00b1 0.16, , , 1.61 \u00b1 0.127","Doses and responses":"0 mg\/kg-day: 1.47 \u00b1 0.16, 200 mg\/kg-day: 1.61 \u00b1 0.127","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504434,"endpoint-url":"\/ani\/endpoint\/100504434\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"80 \u00b1 15.4, , , 94 \u00b1 15.7","Doses and responses":"0 mg\/kg-day: 80 \u00b1 15.4, 200 mg\/kg-day: 94 \u00b1 15.7","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504435,"endpoint-url":"\/ani\/endpoint\/100504435\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"44 \u00b1 7.8, , , 44 \u00b1 6.1","Doses and responses":"0 mg\/kg-day: 44 \u00b1 7.8, 200 mg\/kg-day: 44 \u00b1 6.1","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504436,"endpoint-url":"\/ani\/endpoint\/100504436\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Aspartate Aminotransferase","endpoint-name":"Aspartate Aminotransferase (AST), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"98 \u00b1 20.6, , , 108 \u00b1 34.2","Doses and responses":"0 mg\/kg-day: 98 \u00b1 20.6, 200 mg\/kg-day: 108 \u00b1 34.2","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504437,"endpoint-url":"\/ani\/endpoint\/100504437\/","endpoint-system":"Hepatic","endpoint-organ":"Blood","endpoint-effect":"Cholesterol","endpoint-name":"Cholesterol (CHOL), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"61 \u00b1 17.7, , , 47 \u00b1 8.6","Doses and responses":"0 mg\/kg-day: 61 \u00b1 17.7, 200 mg\/kg-day: 47 \u00b1 8.6","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504470,"endpoint-url":"\/ani\/endpoint\/100504470\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504439,"endpoint-url":"\/ani\/endpoint\/100504439\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Absolute, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.1 \u00b1 0.094, , , 2.04 \u00b1 0.133","Doses and responses":"0 mg\/kg-day: 2.1 \u00b1 0.094, 200 mg\/kg-day: 2.04 \u00b1 0.133","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504440,"endpoint-url":"\/ani\/endpoint\/100504440\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"14.4 \u00b1 1.58, , , 13.55 \u00b1 2.03","Doses and responses":"0 mg\/kg-day: 14.4 \u00b1 1.58, 200 mg\/kg-day: 13.55 \u00b1 2.03","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504441,"endpoint-url":"\/ani\/endpoint\/100504441\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Absolute, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"3.61 \u00b1 0.624, , , 3.63 \u00b1 0.249","Doses and responses":"0 mg\/kg-day: 3.61 \u00b1 0.624, 200 mg\/kg-day: 3.63 \u00b1 0.249","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504442,"endpoint-url":"\/ani\/endpoint\/100504442\/","endpoint-system":"Whole Body","endpoint-organ":"NA","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"539 \u00b1 52.8, , , 493 \u00b1 63.8","Doses and responses":"0 mg\/kg-day: 539 \u00b1 52.8, 200 mg\/kg-day: 493 \u00b1 63.8","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504443,"endpoint-url":"\/ani\/endpoint\/100504443\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Relative, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0.392 \u00b1 0.0314, , , 0.418 \u00b1 0.451","Doses and responses":"0 mg\/kg-day: 0.392 \u00b1 0.0314, 200 mg\/kg-day: 0.418 \u00b1 0.451","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504444,"endpoint-url":"\/ani\/endpoint\/100504444\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.672 \u00b1 0.1245, , , 2.746 \u00b1 0.1453","Doses and responses":"0 mg\/kg-day: 2.672 \u00b1 0.1245, 200 mg\/kg-day: 2.746 \u00b1 0.1453","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504445,"endpoint-url":"\/ani\/endpoint\/100504445\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0.668 \u00b1 0.0637, , , 0.743 \u00b1 0.0597","Doses and responses":"0 mg\/kg-day: 0.668 \u00b1 0.0637, 200 mg\/kg-day: 0.743 \u00b1 0.0597","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504446,"endpoint-url":"\/ani\/endpoint\/100504446\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative to Brain, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/100g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"685.715 \u00b1 69.0976, , , 666.385 \u00b1 98.1586","Doses and responses":"0 mg\/kg-day: 685.715 \u00b1 69.0976, 200 mg\/kg-day: 666.385 \u00b1 98.1586","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504447,"endpoint-url":"\/ani\/endpoint\/100504447\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative to Brain, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/100g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"171.757 \u00b1 26.5964, , , 178.749 \u00b1 13.66","Doses and responses":"0 mg\/kg-day: 171.757 \u00b1 26.5964, 200 mg\/kg-day: 178.749 \u00b1 13.66","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504448,"endpoint-url":"\/ani\/endpoint\/100504448\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Absolute","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"3.65 \u00b1 0.318, 3.61 \u00b1 0.411, 3.44 \u00b1 0.607, 3.74 \u00b1 0.423","Doses and responses":"0 mg\/kg-day: 3.65 \u00b1 0.318, 10 mg\/kg-day: 3.61 \u00b1 0.411, 50 mg\/kg-day: 3.44 \u00b1 0.607, 200 mg\/kg-day: 3.74 \u00b1 0.423","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504449,"endpoint-url":"\/ani\/endpoint\/100504449\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"15.8 \u00b1 0.64, , , 15.6 \u00b1 0.81","Doses and responses":"0 mg\/kg-day: 15.8 \u00b1 0.64, 200 mg\/kg-day: 15.6 \u00b1 0.81","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504450,"endpoint-url":"\/ani\/endpoint\/100504450\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"9.28 \u00b1 0.559, , , 9.01 \u00b1 0.606","Doses and responses":"0 mg\/kg-day: 9.28 \u00b1 0.559, 200 mg\/kg-day: 9.01 \u00b1 0.606","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504451,"endpoint-url":"\/ani\/endpoint\/100504451\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hematocrit (HCT), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"50.9 \u00b1 2.27, , , 50.6 \u00b1 2.85","Doses and responses":"0 mg\/kg-day: 50.9 \u00b1 2.27, 200 mg\/kg-day: 50.6 \u00b1 2.85","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504452,"endpoint-url":"\/ani\/endpoint\/100504452\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"54.9 \u00b1 1.02, , , 56.2 \u00b1 1.92","Doses and responses":"0 mg\/kg-day: 54.9 \u00b1 1.02, 200 mg\/kg-day: 56.2 \u00b1 1.92","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504453,"endpoint-url":"\/ani\/endpoint\/100504453\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"31.1 \u00b1 0.33, , , 30.9 \u00b1 0.57","Doses and responses":"0 mg\/kg-day: 31.1 \u00b1 0.33, 200 mg\/kg-day: 30.9 \u00b1 0.57","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504454,"endpoint-url":"\/ani\/endpoint\/100504454\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"960 \u00b1 222.8, , , 938 \u00b1 162","Doses and responses":"0 mg\/kg-day: 960 \u00b1 222.8, 200 mg\/kg-day: 938 \u00b1 162","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504455,"endpoint-url":"\/ani\/endpoint\/100504455\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"140.5 \u00b1 14.22, , , 113.8 \u00b1 28.85","Doses and responses":"0 mg\/kg-day: 140.5 \u00b1 14.22, 200 mg\/kg-day: 113.8 \u00b1 28.85","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504456,"endpoint-url":"\/ani\/endpoint\/100504456\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"8.36 \u00b1 1.672, , , 7.65 \u00b1 1.939","Doses and responses":"0 mg\/kg-day: 8.36 \u00b1 1.672, 200 mg\/kg-day: 7.65 \u00b1 1.939","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504457,"endpoint-url":"\/ani\/endpoint\/100504457\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Hepatocellular Hypertrophy","endpoint-name":"Hepatocellular Hypertrophy, Centrilobular","endpoint-observation_time":"Day 90","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0, 0, 0, 7","Doses and responses":"0 mg\/kg-day: 0, 10 mg\/kg-day: 0, 50 mg\/kg-day: 0, 200 mg\/kg-day: 7","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504458,"endpoint-url":"\/ani\/endpoint\/100504458\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Necrosis","endpoint-name":"Hepatocellular Necrosis","endpoint-observation_time":"Day 90","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 10 mg\/kg-day: 0, 50 mg\/kg-day: 0, 200 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504459,"endpoint-url":"\/ani\/endpoint\/100504459\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Organ Weight","endpoint-name":"Testes Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504460,"endpoint-url":"\/ani\/endpoint\/100504460\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Organ Weight","endpoint-name":"Testes Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504461,"endpoint-url":"\/ani\/endpoint\/100504461\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Organ Weight","endpoint-name":"Testes Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504462,"endpoint-url":"\/ani\/endpoint\/100504462\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Organ Weight","endpoint-name":"Epididymides Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504463,"endpoint-url":"\/ani\/endpoint\/100504463\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Organ Weight","endpoint-name":"Epididymides Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504464,"endpoint-url":"\/ani\/endpoint\/100504464\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Organ Weight","endpoint-name":"Epididymides Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504465,"endpoint-url":"\/ani\/endpoint\/100504465\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504466,"endpoint-url":"\/ani\/endpoint\/100504466\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504467,"endpoint-url":"\/ani\/endpoint\/100504467\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504468,"endpoint-url":"\/ani\/endpoint\/100504468\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504469,"endpoint-url":"\/ani\/endpoint\/100504469\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504477,"endpoint-url":"\/ani\/endpoint\/100504477\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Histopathology","endpoint-name":"Brain Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"Mean Total Counts","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504620,"endpoint-url":"\/ani\/endpoint\/100504620\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Cortex","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Cortex, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504478,"endpoint-url":"\/ani\/endpoint\/100504478\/","endpoint-system":"Nervous","endpoint-organ":"Sciatic Nerve","endpoint-effect":"Histopathology","endpoint-name":"Sciatic Nerve Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"Mean Total Counts","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504479,"endpoint-url":"\/ani\/endpoint\/100504479\/","endpoint-system":"Nervous","endpoint-organ":"Spinal Cord","endpoint-effect":"Histopathology","endpoint-name":"Spinal Cord Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504480,"endpoint-url":"\/ani\/endpoint\/100504480\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Histopathology","endpoint-name":"Heart Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504481,"endpoint-url":"\/ani\/endpoint\/100504481\/","endpoint-system":"Cardiovascular","endpoint-organ":"Aorta","endpoint-effect":"Histopathology","endpoint-name":"Aorta Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504502,"endpoint-url":"\/ani\/endpoint\/100504502\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Day 90","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"18.1 \u00b1 0.52, 18.5 \u00b1 0.32, 18.2 \u00b1 0.46, 18.5 \u00b1 0.68","Doses and responses":"0 mg\/kg-day: 18.1 \u00b1 0.52, 10 mg\/kg-day: 18.5 \u00b1 0.32, 50 mg\/kg-day: 18.2 \u00b1 0.46, 200 mg\/kg-day: 18.5 \u00b1 0.68","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504564,"endpoint-url":"\/ani\/endpoint\/100504564\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504482,"endpoint-url":"\/ani\/endpoint\/100504482\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Histopathology","endpoint-name":"Spleen, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504629,"endpoint-url":"\/ani\/endpoint\/100504629\/","endpoint-system":"Whole Body","endpoint-organ":"Testes","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Testes, Germinal Epithelium, Atrophy","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 1, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 1, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504508,"endpoint-url":"\/ani\/endpoint\/100504508\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"7.4 \u00b1 0.32, 7.7 \u00b1 0.43, 7.6 \u00b1 0.7, 7.1 \u00b1 0.54","Doses and responses":"0 mg\/kg-day: 7.4 \u00b1 0.32, 10 mg\/kg-day: 7.7 \u00b1 0.43, 50 mg\/kg-day: 7.6 \u00b1 0.7, 200 mg\/kg-day: 7.1 \u00b1 0.54","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504509,"endpoint-url":"\/ani\/endpoint\/100504509\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.7 \u00b1 0.22, 2.7 \u00b1 0.2, 2.7 \u00b1 0.2, 2.3 \u00b1 0.26","Doses and responses":"0 mg\/kg-day: 2.7 \u00b1 0.22, 10 mg\/kg-day: 2.7 \u00b1 0.2, 50 mg\/kg-day: 2.7 \u00b1 0.2, 200 mg\/kg-day: 2.3 \u00b1 0.26","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504483,"endpoint-url":"\/ani\/endpoint\/100504483\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Histopathology","endpoint-name":"Thymus, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504484,"endpoint-url":"\/ani\/endpoint\/100504484\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Histopathology","endpoint-name":"Lymph Nodes, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504485,"endpoint-url":"\/ani\/endpoint\/100504485\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Glands, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504486,"endpoint-url":"\/ani\/endpoint\/100504486\/","endpoint-system":"Endocrine","endpoint-organ":"Pituitary Gland","endpoint-effect":"Histopathology","endpoint-name":"Pituitary Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504487,"endpoint-url":"\/ani\/endpoint\/100504487\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid with Parathyroid","endpoint-effect":"Histopathology","endpoint-name":"Thyroid with Parathyroid, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504510,"endpoint-url":"\/ani\/endpoint\/100504510\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio","endpoint-observation_time":"Day 90","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.79 \u00b1 0.231, 1.89 \u00b1 0.189, 1.88 \u00b1 0.22, 2.04 \u00b1 0.237","Doses and responses":"0 mg\/kg-day: 1.79 \u00b1 0.231, 10 mg\/kg-day: 1.89 \u00b1 0.189, 50 mg\/kg-day: 1.88 \u00b1 0.22, 200 mg\/kg-day: 2.04 \u00b1 0.237","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504511,"endpoint-url":"\/ani\/endpoint\/100504511\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Day 90","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"55 \u00b1 13, 52 \u00b1 12.7, 43 \u00b1 10.9, 57 \u00b1 11.6","Doses and responses":"0 mg\/kg-day: 55 \u00b1 13, 10 mg\/kg-day: 52 \u00b1 12.7, 50 mg\/kg-day: 43 \u00b1 10.9, 200 mg\/kg-day: 57 \u00b1 11.6","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504488,"endpoint-url":"\/ani\/endpoint\/100504488\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Histopathology","endpoint-name":"Kidney Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504489,"endpoint-url":"\/ani\/endpoint\/100504489\/","endpoint-system":"Endocrine","endpoint-organ":"Pancreas","endpoint-effect":"Histopathology","endpoint-name":"Pancreas, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504490,"endpoint-url":"\/ani\/endpoint\/100504490\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Histopathology","endpoint-name":"Liver Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504491,"endpoint-url":"\/ani\/endpoint\/100504491\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testes","endpoint-effect":"Histopathology","endpoint-name":"Testes, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504503,"endpoint-url":"\/ani\/endpoint\/100504503\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"867 \u00b1 231.6, 823 \u00b1 138, 958 \u00b1 125.5, 1033 \u00b1 182","Doses and responses":"0 mg\/kg-day: 867 \u00b1 231.6, 10 mg\/kg-day: 823 \u00b1 138, 50 mg\/kg-day: 958 \u00b1 125.5, 200 mg\/kg-day: 1033 \u00b1 182","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504504,"endpoint-url":"\/ani\/endpoint\/100504504\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"135.4 \u00b1 36.63, 127.1 \u00b1 39.89, 124.7 \u00b1 33.25, 165.9 \u00b1 63.19","Doses and responses":"0 mg\/kg-day: 135.4 \u00b1 36.63, 10 mg\/kg-day: 127.1 \u00b1 39.89, 50 mg\/kg-day: 124.7 \u00b1 33.25, 200 mg\/kg-day: 165.9 \u00b1 63.19","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504505,"endpoint-url":"\/ani\/endpoint\/100504505\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.6 \u00b1 0.44, 1.5 \u00b1 0.37, 1.5 \u00b1 0.4, 2.1 \u00b1 0.8","Doses and responses":"0 mg\/kg-day: 1.6 \u00b1 0.44, 10 mg\/kg-day: 1.5 \u00b1 0.37, 50 mg\/kg-day: 1.5 \u00b1 0.4, 200 mg\/kg-day: 2.1 \u00b1 0.8","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504506,"endpoint-url":"\/ani\/endpoint\/100504506\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"8.19 \u00b1 2.451, 6.63 \u00b1 1.164, 7.8 \u00b1 2.629, 7.26 \u00b1 1.788","Doses and responses":"0 mg\/kg-day: 8.19 \u00b1 2.451, 10 mg\/kg-day: 6.63 \u00b1 1.164, 50 mg\/kg-day: 7.8 \u00b1 2.629, 200 mg\/kg-day: 7.26 \u00b1 1.788","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504666,"endpoint-url":"\/ani\/endpoint\/100504666\/","endpoint-system":"Cancer","endpoint-organ":"Blood","endpoint-effect":"Histopathology","endpoint-name":"Blood Vessel, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504492,"endpoint-url":"\/ani\/endpoint\/100504492\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Histopathology","endpoint-name":"Epididymis Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504512,"endpoint-url":"\/ani\/endpoint\/100504512\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Day 90","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"35 \u00b1 6.5, 56 \u00b1 41.3, 45 \u00b1 19.2, 36 \u00b1 10.2","Doses and responses":"0 mg\/kg-day: 35 \u00b1 6.5, 10 mg\/kg-day: 56 \u00b1 41.3, 50 mg\/kg-day: 45 \u00b1 19.2, 200 mg\/kg-day: 36 \u00b1 10.2","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504621,"endpoint-url":"\/ani\/endpoint\/100504621\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Medulla, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504493,"endpoint-url":"\/ani\/endpoint\/100504493\/","endpoint-system":"Male Reproductive","endpoint-organ":"Prostate","endpoint-effect":"Histopathology","endpoint-name":"Prostate, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504494,"endpoint-url":"\/ani\/endpoint\/100504494\/","endpoint-system":"Male Reproductive","endpoint-organ":"Seminal Vesicles","endpoint-effect":"Histopathology","endpoint-name":"Seminal Vesicles Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504495,"endpoint-url":"\/ani\/endpoint\/100504495\/","endpoint-system":"Nervous","endpoint-organ":"Whole Body","endpoint-effect":"Functional Observation Battery","endpoint-name":"Functional Observation Battery (FOB)","endpoint-observation_time":"Week 12","endpoint-response_units":"Mean Total Motor","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504496,"endpoint-url":"\/ani\/endpoint\/100504496\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"264 \u00b1 27.5, 261 \u00b1 30.2, 252 \u00b1 22, 257 \u00b1 22.6","Doses and responses":"0 mg\/kg-day: 264 \u00b1 27.5, 10 mg\/kg-day: 261 \u00b1 30.2, 50 mg\/kg-day: 252 \u00b1 22, 200 mg\/kg-day: 257 \u00b1 22.6","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504497,"endpoint-url":"\/ani\/endpoint\/100504497\/","endpoint-system":"Nervous","endpoint-organ":"NA","endpoint-effect":"Motor Activity","endpoint-name":"Locomotor Activity","endpoint-observation_time":"Week 12","endpoint-response_units":"mean total counts","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504498,"endpoint-url":"\/ani\/endpoint\/100504498\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Day 90","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"8.62 \u00b1 0.338, 8.53 \u00b1 0.696, 8.32 \u00b1 0.491, 7.93 \u00b1 0.43","Doses and responses":"0 mg\/kg-day: 8.62 \u00b1 0.338, 10 mg\/kg-day: 8.53 \u00b1 0.696, 50 mg\/kg-day: 8.32 \u00b1 0.491, 200 mg\/kg-day: 7.93 \u00b1 0.43","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504499,"endpoint-url":"\/ani\/endpoint\/100504499\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"50.9 \u00b1 2.32, 51.1 \u00b1 5.13, 48.6 \u00b1 2.88, 47.7 \u00b1 2.54","Doses and responses":"0 mg\/kg-day: 50.9 \u00b1 2.32, 10 mg\/kg-day: 51.1 \u00b1 5.13, 50 mg\/kg-day: 48.6 \u00b1 2.88, 200 mg\/kg-day: 47.7 \u00b1 2.54","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504500,"endpoint-url":"\/ani\/endpoint\/100504500\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Day 90","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"59 \u00b1 2.36, 59.9 \u00b1 1.5, 58.5 \u00b1 2.06, 60.3 \u00b1 2.31","Doses and responses":"0 mg\/kg-day: 59 \u00b1 2.36, 10 mg\/kg-day: 59.9 \u00b1 1.5, 50 mg\/kg-day: 58.5 \u00b1 2.06, 200 mg\/kg-day: 60.3 \u00b1 2.31","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504501,"endpoint-url":"\/ani\/endpoint\/100504501\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"30.7 \u00b1 0.58, 30.9 \u00b1 0.78, 31.1 \u00b1 0.76, 30.6 \u00b1 0.82","Doses and responses":"0 mg\/kg-day: 30.7 \u00b1 0.58, 10 mg\/kg-day: 30.9 \u00b1 0.78, 50 mg\/kg-day: 31.1 \u00b1 0.76, 200 mg\/kg-day: 30.6 \u00b1 0.82","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504507,"endpoint-url":"\/ani\/endpoint\/100504507\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin","endpoint-name":"Albumin (A)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"4.7 \u00b1 0.32, 5 \u00b1 0.36, 5 \u00b1 0.62, 4.7 \u00b1 0.39","Doses and responses":"0 mg\/kg-day: 4.7 \u00b1 0.32, 10 mg\/kg-day: 5 \u00b1 0.36, 50 mg\/kg-day: 5 \u00b1 0.62, 200 mg\/kg-day: 4.7 \u00b1 0.39","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504571,"endpoint-url":"\/ani\/endpoint\/100504571\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504513,"endpoint-url":"\/ani\/endpoint\/100504513\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Aspartate Aminotransferase","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Day 90","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"78 \u00b1 16.2, 108 \u00b1 54.3, 92 \u00b1 22.2, 82 \u00b1 15.3","Doses and responses":"0 mg\/kg-day: 78 \u00b1 16.2, 10 mg\/kg-day: 108 \u00b1 54.3, 50 mg\/kg-day: 92 \u00b1 22.2, 200 mg\/kg-day: 82 \u00b1 15.3","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504514,"endpoint-url":"\/ani\/endpoint\/100504514\/","endpoint-system":"Hepatic","endpoint-organ":"Blood","endpoint-effect":"Cholesterol","endpoint-name":"Cholesterol (CHOL)","endpoint-observation_time":"Day 90","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"74 \u00b1 20.1, 81 \u00b1 23.5, 83 \u00b1 23.7, 71 \u00b1 9.5","Doses and responses":"0 mg\/kg-day: 74 \u00b1 20.1, 10 mg\/kg-day: 81 \u00b1 23.5, 50 mg\/kg-day: 83 \u00b1 23.7, 200 mg\/kg-day: 71 \u00b1 9.5","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504516,"endpoint-url":"\/ani\/endpoint\/100504516\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Relative","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0.73 \u00b1 0.0567, 0.747 \u00b1 0.0953, 0.755 \u00b1 0.0545, 0.74 \u00b1 0.0526","Doses and responses":"0 mg\/kg-day: 0.73 \u00b1 0.0567, 10 mg\/kg-day: 0.747 \u00b1 0.0953, 50 mg\/kg-day: 0.755 \u00b1 0.0545, 200 mg\/kg-day: 0.74 \u00b1 0.0526","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504517,"endpoint-url":"\/ani\/endpoint\/100504517\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.92 \u00b1 0.1244, 3.036 \u00b1 0.2566, 3.108 \u00b1 0.2155, 3.078 \u00b1 0.2013","Doses and responses":"0 mg\/kg-day: 2.92 \u00b1 0.1244, 10 mg\/kg-day: 3.036 \u00b1 0.2566, 50 mg\/kg-day: 3.108 \u00b1 0.2155, 200 mg\/kg-day: 3.078 \u00b1 0.2013","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504518,"endpoint-url":"\/ani\/endpoint\/100504518\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0.785 \u00b1 0.0502, 0.791 \u00b1 0.0492, 0.879 \u00b1 0.0665, 0.84 \u00b1 0.0847","Doses and responses":"0 mg\/kg-day: 0.785 \u00b1 0.0502, 10 mg\/kg-day: 0.791 \u00b1 0.0492, 50 mg\/kg-day: 0.879 \u00b1 0.0665, 200 mg\/kg-day: 0.84 \u00b1 0.0847","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504519,"endpoint-url":"\/ani\/endpoint\/100504519\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative to Brain","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/100g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"107.779 \u00b1 5.4246, 107.198 \u00b1 13.6578, 117.122 \u00b1 12.6756, 113.343 \u00b1 5.6379","Doses and responses":"0 mg\/kg-day: 107.779 \u00b1 5.4246, 10 mg\/kg-day: 107.198 \u00b1 13.6578, 50 mg\/kg-day: 117.122 \u00b1 12.6756, 200 mg\/kg-day: 113.343 \u00b1 5.6379","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504520,"endpoint-url":"\/ani\/endpoint\/100504520\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative to Brain","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/100g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"401.207 \u00b1 23.5147, 412.442 \u00b1 65.029, 414.858 \u00b1 51.3977, 417.55 \u00b1 39.4","Doses and responses":"0 mg\/kg-day: 401.207 \u00b1 23.5147, 10 mg\/kg-day: 412.442 \u00b1 65.029, 50 mg\/kg-day: 414.858 \u00b1 51.3977, 200 mg\/kg-day: 417.55 \u00b1 39.4","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504521,"endpoint-url":"\/ani\/endpoint\/100504521\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Peroxisomal B-Oxidation","endpoint-name":"Peroxisomal Beta Oxidation ","endpoint-observation_time":"Day 90","endpoint-response_units":"nmol\/mg","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"6.94 \u00b1 1.545, , , 7.82 \u00b1 0.414","Doses and responses":"0 mg\/kg-day: 6.94 \u00b1 1.545, 200 mg\/kg-day: 7.82 \u00b1 0.414","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504522,"endpoint-url":"\/ani\/endpoint\/100504522\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"7.69 \u00b1 0.716, 7.93 \u00b1 1.192, 7.85 \u00b1 1.022, 7.9 \u00b1 0.763","Doses and responses":"0 mg\/kg-day: 7.69 \u00b1 0.716, 10 mg\/kg-day: 7.93 \u00b1 1.192, 50 mg\/kg-day: 7.85 \u00b1 1.022, 200 mg\/kg-day: 7.9 \u00b1 0.763","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504523,"endpoint-url":"\/ani\/endpoint\/100504523\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Absolute","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.06 \u00b1 0.175, 2.06 \u00b1 0.238, 2.21 \u00b1 0.23, 2.15 \u00b1 0.108","Doses and responses":"0 mg\/kg-day: 2.06 \u00b1 0.175, 10 mg\/kg-day: 2.06 \u00b1 0.238, 50 mg\/kg-day: 2.21 \u00b1 0.23, 200 mg\/kg-day: 2.15 \u00b1 0.108","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504524,"endpoint-url":"\/ani\/endpoint\/100504524\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Absolute","endpoint-observation_time":"Day 90","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.91 \u00b1 0.095, 1.93 \u00b1 0.072, 1.89 \u00b1 0.068, 1.9 \u00b1 0.107","Doses and responses":"0 mg\/kg-day: 1.91 \u00b1 0.095, 10 mg\/kg-day: 1.93 \u00b1 0.072, 50 mg\/kg-day: 1.89 \u00b1 0.068, 200 mg\/kg-day: 1.9 \u00b1 0.107","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504525,"endpoint-url":"\/ani\/endpoint\/100504525\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin","endpoint-name":"Albumin (A), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"5 \u00b1 0.26, , , 5.1 \u00b1 0.26","Doses and responses":"0 mg\/kg-day: 5 \u00b1 0.26, 200 mg\/kg-day: 5.1 \u00b1 0.26","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504526,"endpoint-url":"\/ani\/endpoint\/100504526\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"7.6 \u00b1 0.36, , , 7.8 \u00b1 0.34","Doses and responses":"0 mg\/kg-day: 7.6 \u00b1 0.36, 200 mg\/kg-day: 7.8 \u00b1 0.34","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504527,"endpoint-url":"\/ani\/endpoint\/100504527\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.7 \u00b1 0.24, , , 2.7 \u00b1 0.23","Doses and responses":"0 mg\/kg-day: 2.7 \u00b1 0.24, 200 mg\/kg-day: 2.7 \u00b1 0.23","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504528,"endpoint-url":"\/ani\/endpoint\/100504528\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.85 \u00b1 0.197, , , 1.9 \u00b1 0.191","Doses and responses":"0 mg\/kg-day: 1.85 \u00b1 0.197, 200 mg\/kg-day: 1.9 \u00b1 0.191","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504529,"endpoint-url":"\/ani\/endpoint\/100504529\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"40 \u00b1 9.1, , , 46 \u00b1 8.6","Doses and responses":"0 mg\/kg-day: 40 \u00b1 9.1, 200 mg\/kg-day: 46 \u00b1 8.6","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504530,"endpoint-url":"\/ani\/endpoint\/100504530\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"41 \u00b1 16.9, , , 46 \u00b1 20.5","Doses and responses":"0 mg\/kg-day: 41 \u00b1 16.9, 200 mg\/kg-day: 46 \u00b1 20.5","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504531,"endpoint-url":"\/ani\/endpoint\/100504531\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Aspartate Aminotransferase","endpoint-name":"Aspartate Aminotransferase (AST), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"98 \u00b1 27.6, , , 102 \u00b1 20.9","Doses and responses":"0 mg\/kg-day: 98 \u00b1 27.6, 200 mg\/kg-day: 102 \u00b1 20.9","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504532,"endpoint-url":"\/ani\/endpoint\/100504532\/","endpoint-system":"Hepatic","endpoint-organ":"Blood","endpoint-effect":"Cholesterol","endpoint-name":"Cholesterol (CHOL), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"81 \u00b1 17.1, , , 83 \u00b1 11.9","Doses and responses":"0 mg\/kg-day: 81 \u00b1 17.1, 200 mg\/kg-day: 83 \u00b1 11.9","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504561,"endpoint-url":"\/ani\/endpoint\/100504561\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Organ Weight","endpoint-name":"Uterus Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504534,"endpoint-url":"\/ani\/endpoint\/100504534\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Absolute, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.89 \u00b1 0.092, , , 1.96 \u00b1 0.086","Doses and responses":"0 mg\/kg-day: 1.89 \u00b1 0.092, 200 mg\/kg-day: 1.96 \u00b1 0.086","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504535,"endpoint-url":"\/ani\/endpoint\/100504535\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"7.82 \u00b1 0.878, , , 7.72 \u00b1 0.711","Doses and responses":"0 mg\/kg-day: 7.82 \u00b1 0.878, 200 mg\/kg-day: 7.72 \u00b1 0.711","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504536,"endpoint-url":"\/ani\/endpoint\/100504536\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Absolute, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.01 \u00b1 0.219, , , 2.06 \u00b1 0.157","Doses and responses":"0 mg\/kg-day: 2.01 \u00b1 0.219, 200 mg\/kg-day: 2.06 \u00b1 0.157","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504537,"endpoint-url":"\/ani\/endpoint\/100504537\/","endpoint-system":"Whole Body","endpoint-organ":"NA","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"287 \u00b1 31.9, , , 269 \u00b1 20.8","Doses and responses":"0 mg\/kg-day: 287 \u00b1 31.9, 200 mg\/kg-day: 269 \u00b1 20.8","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504538,"endpoint-url":"\/ani\/endpoint\/100504538\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Relative, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0.663 \u00b1 0.0687, , , 0.731 \u00b1 0.0586","Doses and responses":"0 mg\/kg-day: 0.663 \u00b1 0.0687, 200 mg\/kg-day: 0.731 \u00b1 0.0586","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504539,"endpoint-url":"\/ani\/endpoint\/100504539\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"2.729 \u00b1 0.1897, , , 2.871 \u00b1 0.19","Doses and responses":"0 mg\/kg-day: 2.729 \u00b1 0.1897, 200 mg\/kg-day: 2.871 \u00b1 0.19","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504572,"endpoint-url":"\/ani\/endpoint\/100504572\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504540,"endpoint-url":"\/ani\/endpoint\/100504540\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0.702 \u00b1 0.0678, , , 0.768 \u00b1 0.0502","Doses and responses":"0 mg\/kg-day: 0.702 \u00b1 0.0678, 200 mg\/kg-day: 0.768 \u00b1 0.0502","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504541,"endpoint-url":"\/ani\/endpoint\/100504541\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative to Brain, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/100g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"414.39 \u00b1 35.79, , , 394.9 \u00b1 41.41","Doses and responses":"0 mg\/kg-day: 414.39 \u00b1 35.79, 200 mg\/kg-day: 394.9 \u00b1 41.41","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504542,"endpoint-url":"\/ani\/endpoint\/100504542\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative to Brain, Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/100g","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"106.46 \u00b1 10.35, , , 105.32 \u00b1 6.7","Doses and responses":"0 mg\/kg-day: 106.46 \u00b1 10.35, 200 mg\/kg-day: 105.32 \u00b1 6.7","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504543,"endpoint-url":"\/ani\/endpoint\/100504543\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"15.6 \u00b1 0.46, 15.8 \u00b1 1.4, 15.2 \u00b1 0.85, 14.6 \u00b1 0.83","Doses and responses":"0 mg\/kg-day: 15.6 \u00b1 0.46, 10 mg\/kg-day: 15.8 \u00b1 1.4, 50 mg\/kg-day: 15.2 \u00b1 0.85, 200 mg\/kg-day: 14.6 \u00b1 0.83","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504544,"endpoint-url":"\/ani\/endpoint\/100504544\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"15.2 \u00b1 0.6, , , 15.5 \u00b1 0.59","Doses and responses":"0 mg\/kg-day: 15.2 \u00b1 0.6, 200 mg\/kg-day: 15.5 \u00b1 0.59","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504545,"endpoint-url":"\/ani\/endpoint\/100504545\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"8.23 \u00b1 0.515, , , 8.43 \u00b1 0.317","Doses and responses":"0 mg\/kg-day: 8.23 \u00b1 0.515, 200 mg\/kg-day: 8.43 \u00b1 0.317","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504546,"endpoint-url":"\/ani\/endpoint\/100504546\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hematocrit (HCT), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"48.7 \u00b1 1.92, , , 50.8 \u00b1 1.82","Doses and responses":"0 mg\/kg-day: 48.7 \u00b1 1.92, 200 mg\/kg-day: 50.8 \u00b1 1.82","Response direction":"\u2191"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504547,"endpoint-url":"\/ani\/endpoint\/100504547\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"59.2 \u00b1 2.39, , , 60.2 \u00b1 1.16","Doses and responses":"0 mg\/kg-day: 59.2 \u00b1 2.39, 200 mg\/kg-day: 60.2 \u00b1 1.16","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504548,"endpoint-url":"\/ani\/endpoint\/100504548\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"18.5 \u00b1 0.82, , , 18.5 \u00b1 0.62","Doses and responses":"0 mg\/kg-day: 18.5 \u00b1 0.82, 200 mg\/kg-day: 18.5 \u00b1 0.62","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504549,"endpoint-url":"\/ani\/endpoint\/100504549\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"31.2 \u00b1 0.45, , , 30.7 \u00b1 0.6","Doses and responses":"0 mg\/kg-day: 31.2 \u00b1 0.45, 200 mg\/kg-day: 30.7 \u00b1 0.6","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504550,"endpoint-url":"\/ani\/endpoint\/100504550\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"975 \u00b1 102.6, , , 827 \u00b1 161.9","Doses and responses":"0 mg\/kg-day: 975 \u00b1 102.6, 200 mg\/kg-day: 827 \u00b1 161.9","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504551,"endpoint-url":"\/ani\/endpoint\/100504551\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"122.2 \u00b1 24.49, , , 109.5 \u00b1 25.87","Doses and responses":"0 mg\/kg-day: 122.2 \u00b1 24.49, 200 mg\/kg-day: 109.5 \u00b1 25.87","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504552,"endpoint-url":"\/ani\/endpoint\/100504552\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"1.5 \u00b1 0.29, , , 1.3 \u00b1 0.28","Doses and responses":"0 mg\/kg-day: 1.5 \u00b1 0.29, 200 mg\/kg-day: 1.3 \u00b1 0.28","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504553,"endpoint-url":"\/ani\/endpoint\/100504553\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC), Recovery","endpoint-observation_time":"Day 90","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"6.06 \u00b1 1.253, , , 6.3 \u00b1 1.676","Doses and responses":"0 mg\/kg-day: 6.06 \u00b1 1.253, 200 mg\/kg-day: 6.3 \u00b1 1.676","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504554,"endpoint-url":"\/ani\/endpoint\/100504554\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Hepatocellular Hypertrophy","endpoint-name":"Hepatocellular Hypertrophy, Centrilobular","endpoint-observation_time":"Day 90","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 10 mg\/kg-day: 0, 50 mg\/kg-day: 0, 200 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504555,"endpoint-url":"\/ani\/endpoint\/100504555\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Necrosis","endpoint-name":"Hepatocellular Necrosis","endpoint-observation_time":"Day 90","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 10 mg\/kg-day: 0, 50 mg\/kg-day: 0, 200 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504556,"endpoint-url":"\/ani\/endpoint\/100504556\/","endpoint-system":"Female Reproductive","endpoint-organ":"Ovary","endpoint-effect":"Organ Weight","endpoint-name":"Ovaries with Oviducts Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504557,"endpoint-url":"\/ani\/endpoint\/100504557\/","endpoint-system":"Female Reproductive","endpoint-organ":"Ovary","endpoint-effect":"Organ Weight","endpoint-name":"Ovaries with Oviducts Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504558,"endpoint-url":"\/ani\/endpoint\/100504558\/","endpoint-system":"Female Reproductive","endpoint-organ":"Ovary","endpoint-effect":"Organ Weight","endpoint-name":"Ovaries with Oviducts Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504559,"endpoint-url":"\/ani\/endpoint\/100504559\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Organ Weight","endpoint-name":"Uterus Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504560,"endpoint-url":"\/ani\/endpoint\/100504560\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Organ Weight","endpoint-name":"Uterus Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504567,"endpoint-url":"\/ani\/endpoint\/100504567\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504568,"endpoint-url":"\/ani\/endpoint\/100504568\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Absolute","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504569,"endpoint-url":"\/ani\/endpoint\/100504569\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Relative","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504570,"endpoint-url":"\/ani\/endpoint\/100504570\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Relative to Brain","endpoint-observation_time":"Week 12","endpoint-response_units":"NA","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504623,"endpoint-url":"\/ani\/endpoint\/100504623\/","endpoint-system":"Endocrine","endpoint-organ":"Pituitary Gland","endpoint-effect":"Histopathology","endpoint-name":"Pituitary Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504624,"endpoint-url":"\/ani\/endpoint\/100504624\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid Gland","endpoint-effect":"Histopathology","endpoint-name":"Thyroid Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504625,"endpoint-url":"\/ani\/endpoint\/100504625\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Histopathology","endpoint-name":"Epididymis, Duct, Exfoliated Germ Cell","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504626,"endpoint-url":"\/ani\/endpoint\/100504626\/","endpoint-system":"Male Reproductive","endpoint-organ":"Preputial Gland","endpoint-effect":"Histopathology","endpoint-name":"Preputial Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504627,"endpoint-url":"\/ani\/endpoint\/100504627\/","endpoint-system":"Male Reproductive","endpoint-organ":"Prostate","endpoint-effect":"Histopathology","endpoint-name":"Prostate, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504628,"endpoint-url":"\/ani\/endpoint\/100504628\/","endpoint-system":"Male Reproductive","endpoint-organ":"Seminal Vesicle","endpoint-effect":"Histopathology","endpoint-name":"Seminal Vesicle, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504574,"endpoint-url":"\/ani\/endpoint\/100504574\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Histopathology","endpoint-name":"Brain Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"Mean Total Counts","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504575,"endpoint-url":"\/ani\/endpoint\/100504575\/","endpoint-system":"Nervous","endpoint-organ":"Sciatic Nerve","endpoint-effect":"Histopathology","endpoint-name":"Sciatic Nerve Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"Mean Total Counts","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504576,"endpoint-url":"\/ani\/endpoint\/100504576\/","endpoint-system":"Nervous","endpoint-organ":"Spinal Cord","endpoint-effect":"Histopathology","endpoint-name":"Spinal Cord Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504577,"endpoint-url":"\/ani\/endpoint\/100504577\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Histopathology","endpoint-name":"Heart Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504578,"endpoint-url":"\/ani\/endpoint\/100504578\/","endpoint-system":"Cardiovascular","endpoint-organ":"Aorta","endpoint-effect":"Histopathology","endpoint-name":"Aorta Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504611,"endpoint-url":"\/ani\/endpoint\/100504611\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Hepatocellular Hypertrophy","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 9, 10","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 9, 1000 mg\/kg-day: 10","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504612,"endpoint-url":"\/ani\/endpoint\/100504612\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Liver, Hepatocyte, Necrosis","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504613,"endpoint-url":"\/ani\/endpoint\/100504613\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Pancreas","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Pancreas, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504579,"endpoint-url":"\/ani\/endpoint\/100504579\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Histopathology","endpoint-name":"Spleen, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504580,"endpoint-url":"\/ani\/endpoint\/100504580\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Histopathology","endpoint-name":"Thymus, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504581,"endpoint-url":"\/ani\/endpoint\/100504581\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Histopathology","endpoint-name":"Lymph Nodes, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504582,"endpoint-url":"\/ani\/endpoint\/100504582\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Glands, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504583,"endpoint-url":"\/ani\/endpoint\/100504583\/","endpoint-system":"Endocrine","endpoint-organ":"Pituitary Gland","endpoint-effect":"Histopathology","endpoint-name":"Pituitary Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504614,"endpoint-url":"\/ani\/endpoint\/100504614\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Salivary Glands","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Salivary Glands, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504615,"endpoint-url":"\/ani\/endpoint\/100504615\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Stomach","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Stomach, Forestomach, Epithelium, Ulcer","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504616,"endpoint-url":"\/ani\/endpoint\/100504616\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Stomach","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Stomach, Glandular, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504584,"endpoint-url":"\/ani\/endpoint\/100504584\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid with Parathyroid","endpoint-effect":"Histopathology","endpoint-name":"Thyroid with Parathyroid, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504585,"endpoint-url":"\/ani\/endpoint\/100504585\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Histopathology","endpoint-name":"Kidney Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504586,"endpoint-url":"\/ani\/endpoint\/100504586\/","endpoint-system":"Endocrine","endpoint-organ":"Pancreas","endpoint-effect":"Histopathology","endpoint-name":"Pancreas, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504587,"endpoint-url":"\/ani\/endpoint\/100504587\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Histopathology","endpoint-name":"Liver Histopathology","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504588,"endpoint-url":"\/ani\/endpoint\/100504588\/","endpoint-system":"Female Reproductive","endpoint-organ":"Ovaries","endpoint-effect":"Histopathology","endpoint-name":"Ovaries, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504617,"endpoint-url":"\/ani\/endpoint\/100504617\/","endpoint-system":"Cardiovascular","endpoint-organ":"Blood Vessel","endpoint-effect":"Histopathology","endpoint-name":"Blood Vessel, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504618,"endpoint-url":"\/ani\/endpoint\/100504618\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Heart, Cardiomyopathy","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1, , , , , 0","Doses and responses":"0 mg\/kg-day: 1, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504619,"endpoint-url":"\/ani\/endpoint\/100504619\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Heart, Infiltration Cellular, Mononuclear Cell","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1, , , , , 0","Doses and responses":"0 mg\/kg-day: 1, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504589,"endpoint-url":"\/ani\/endpoint\/100504589\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Histopathology","endpoint-name":"Uterus, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504590,"endpoint-url":"\/ani\/endpoint\/100504590\/","endpoint-system":"Female Reproductive","endpoint-organ":"Cervix","endpoint-effect":"Histopathology","endpoint-name":"Cervix, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504591,"endpoint-url":"\/ani\/endpoint\/100504591\/","endpoint-system":"Female Reproductive","endpoint-organ":"Cervix","endpoint-effect":"Histopathology","endpoint-name":"Cervix, Non-Neoplastic Lesions","endpoint-observation_time":"Week 12","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"NTP, 2012, 3899858","study-study_identifier":"","experiment-chemical":"Perfluorhexanoic acid","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504592,"endpoint-url":"\/ani\/endpoint\/100504592\/","endpoint-system":"","endpoint-organ":"","endpoint-effect":"","endpoint-name":"Endpoint 1","endpoint-observation_time":"","endpoint-response_units":"","Dose units":"mg\/kg","Doses":"0, 31.3, 62.5, 125, 250, 500","Responses":"","Doses and responses":"","Response direction":"\u2194"},{"study-short_citation":"Ebbens, 1980, 3921144","study-study_identifier":"3921144","experiment-chemical":"PFHxA","animal_group-name":"Male Albino Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Albino (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"acute  (single dose)","species-name":"Rat","strain-name":"Albino","endpoint-id":100504593,"endpoint-url":"\/ani\/endpoint\/100504593\/","endpoint-system":"Whole Body","endpoint-organ":"","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Day 14","endpoint-response_units":"","Dose units":"mg\/kg","Doses":"0, 500, 1000, 5000","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Ebbens, 1980, 3921144","study-study_identifier":"3921144","experiment-chemical":"PFHxA","animal_group-name":"Male Albino Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Albino (\u2642, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"acute  (single dose)","species-name":"Rat","strain-name":"Albino","endpoint-id":100504594,"endpoint-url":"\/ani\/endpoint\/100504594\/","endpoint-system":"Whole Body","endpoint-organ":"","endpoint-effect":"Mortality","endpoint-name":"Mortality","endpoint-observation_time":"Day 14","endpoint-response_units":"%","Dose units":"mg\/kg","Doses":"0, 500, 1000, 5000","Responses":", 20, 100, 100","Doses and responses":"500 mg\/kg: 20, 1000 mg\/kg: 100, 5000 mg\/kg: 100","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504595,"endpoint-url":"\/ani\/endpoint\/100504595\/","endpoint-system":"Whole Body","endpoint-organ":"","endpoint-effect":"Survival","endpoint-name":"Survival","endpoint-observation_time":"","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":", , , , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504596,"endpoint-url":"\/ani\/endpoint\/100504596\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Discharge","endpoint-name":"Nasal\/Eye Discharge","endpoint-observation_time":"Day 15","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1, 1, 0, 0, 1, 0","Doses and responses":"0 mg\/kg-day: 1, 62.5 mg\/kg-day: 1, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 1, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504597,"endpoint-url":"\/ani\/endpoint\/100504597\/","endpoint-system":"Whole Body","endpoint-organ":"Dermal","endpoint-effect":"Ruffled Furr","endpoint-name":"Ruffled Furr","endpoint-observation_time":"Day 15","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504598,"endpoint-url":"\/ani\/endpoint\/100504598\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Thin","endpoint-observation_time":"Day 15","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504599,"endpoint-url":"\/ani\/endpoint\/100504599\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Esophagus","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Esophagus Inflammation, Suppurative, Focal","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504600,"endpoint-url":"\/ani\/endpoint\/100504600\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Esophagus","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Esophagus Ulcer, Focal","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504601,"endpoint-url":"\/ani\/endpoint\/100504601\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Large Intestine, Cecum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504602,"endpoint-url":"\/ani\/endpoint\/100504602\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Large Intestine, Colon, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504603,"endpoint-url":"\/ani\/endpoint\/100504603\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Large Intestine, Rectum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504604,"endpoint-url":"\/ani\/endpoint\/100504604\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Small Intestine, Duodenum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504605,"endpoint-url":"\/ani\/endpoint\/100504605\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Small Intestine, Ileum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504606,"endpoint-url":"\/ani\/endpoint\/100504606\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Small Intestine, Jejunum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504607,"endpoint-url":"\/ani\/endpoint\/100504607\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Liver, Clear Cell Focus","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 1, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 1, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504608,"endpoint-url":"\/ani\/endpoint\/100504608\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Liver, Hepatodiaphragmatic Nodule","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 1, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 1, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504630,"endpoint-url":"\/ani\/endpoint\/100504630\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Histopathology","endpoint-name":"Testes, Interstitial Cell, Atrophy","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504631,"endpoint-url":"\/ani\/endpoint\/100504631\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Histopathology","endpoint-name":"Testes, Seminiferous Tubule, Spermatid Retention","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1, 0, 0, 0, 0, 2","Doses and responses":"0 mg\/kg-day: 1, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 2","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504632,"endpoint-url":"\/ani\/endpoint\/100504632\/","endpoint-system":"Muscoskeletal","endpoint-organ":"Bone","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Bone Marrow, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504633,"endpoint-url":"\/ani\/endpoint\/100504633\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Histopathology","endpoint-name":"Lymph Node, Mediastinal, Inflammation, Granulomatous","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 1, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 1, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504634,"endpoint-url":"\/ani\/endpoint\/100504634\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Histopathology","endpoint-name":"Lymph Node, Mandibular, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504635,"endpoint-url":"\/ani\/endpoint\/100504635\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Histopathology","endpoint-name":"Lymph Node, Mesenteric, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504636,"endpoint-url":"\/ani\/endpoint\/100504636\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Histopathology","endpoint-name":"Spleen, Extramedullary Hematopoiesis","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 6, 10","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 6, 1000 mg\/kg-day: 10","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504637,"endpoint-url":"\/ani\/endpoint\/100504637\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Histopathology","endpoint-name":"Thymus, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504638,"endpoint-url":"\/ani\/endpoint\/100504638\/","endpoint-system":"Male Reproductive","endpoint-organ":"Mammary Gland","endpoint-effect":"Histopathology","endpoint-name":"Mammary Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504639,"endpoint-url":"\/ani\/endpoint\/100504639\/","endpoint-system":"Dermal","endpoint-organ":"Skin","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Skin Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504640,"endpoint-url":"\/ani\/endpoint\/100504640\/","endpoint-system":"Musculoskeletal","endpoint-organ":"Bone","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Bone, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504641,"endpoint-url":"\/ani\/endpoint\/100504641\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Histopathology","endpoint-name":"Brain, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504642,"endpoint-url":"\/ani\/endpoint\/100504642\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Lung, Fibrosis","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504643,"endpoint-url":"\/ani\/endpoint\/100504643\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Lung, Bronchiole, Hyperplasia","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504644,"endpoint-url":"\/ani\/endpoint\/100504644\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Lung, Bronchiole, Infiltration Cellular, Histiocyte","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504645,"endpoint-url":"\/ani\/endpoint\/100504645\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Nose, Olfactory Epithelium, Degeneration","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 1, 6, 6, 6","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 1, 250 mg\/kg-day: 6, 500 mg\/kg-day: 6, 1000 mg\/kg-day: 6","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504646,"endpoint-url":"\/ani\/endpoint\/100504646\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Nose, Olfactory Epithelium, Hyperplasia","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 6, 5, 6","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 6, 500 mg\/kg-day: 5, 1000 mg\/kg-day: 6","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504647,"endpoint-url":"\/ani\/endpoint\/100504647\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Nose, Olfactory Epithelium, Inflammation, Suppurative","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 3, 6","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 3, 1000 mg\/kg-day: 6","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504648,"endpoint-url":"\/ani\/endpoint\/100504648\/","endpoint-system":"Respiratory","endpoint-organ":"Trachea","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Trachea, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504649,"endpoint-url":"\/ani\/endpoint\/100504649\/","endpoint-system":"Ocular","endpoint-organ":"Eye","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Eye, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504650,"endpoint-url":"\/ani\/endpoint\/100504650\/","endpoint-system":"Ocular","endpoint-organ":"Eye","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Harderian Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504651,"endpoint-url":"\/ani\/endpoint\/100504651\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Kidney, Cyst","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 1, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 1, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504652,"endpoint-url":"\/ani\/endpoint\/100504652\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Kidney, Nephropathy, Chronic Progressive","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"3, 8, 3, 8, 2, 6","Doses and responses":"0 mg\/kg-day: 3, 62.5 mg\/kg-day: 8, 125 mg\/kg-day: 3, 250 mg\/kg-day: 8, 500 mg\/kg-day: 2, 1000 mg\/kg-day: 6","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504653,"endpoint-url":"\/ani\/endpoint\/100504653\/","endpoint-system":"Urinary","endpoint-organ":"Bladder","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Bladder, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504654,"endpoint-url":"\/ani\/endpoint\/100504654\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Esophagus","endpoint-effect":"Neoplasms","endpoint-name":"Esophagus, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504655,"endpoint-url":"\/ani\/endpoint\/100504655\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Large Intestine, Cecum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504656,"endpoint-url":"\/ani\/endpoint\/100504656\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Large Intestine, Colon, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504657,"endpoint-url":"\/ani\/endpoint\/100504657\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Large Intestine, Rectum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504658,"endpoint-url":"\/ani\/endpoint\/100504658\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Small Intestine, Duodenum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504659,"endpoint-url":"\/ani\/endpoint\/100504659\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Small Intestine, Ileum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504660,"endpoint-url":"\/ani\/endpoint\/100504660\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Small Intestine, Jejunum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504661,"endpoint-url":"\/ani\/endpoint\/100504661\/","endpoint-system":"Whole Body","endpoint-organ":"Liver","endpoint-effect":"Neoplasms","endpoint-name":"Liver","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504662,"endpoint-url":"\/ani\/endpoint\/100504662\/","endpoint-system":"Whole Body","endpoint-organ":"Pancreas","endpoint-effect":"Neoplasms","endpoint-name":"Pancreas","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504663,"endpoint-url":"\/ani\/endpoint\/100504663\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Salivary Glands","endpoint-effect":"Neoplasms","endpoint-name":"Salivary Glands, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504664,"endpoint-url":"\/ani\/endpoint\/100504664\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Stomach","endpoint-effect":"Neoplasms","endpoint-name":"Stomach, Forestomach, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504665,"endpoint-url":"\/ani\/endpoint\/100504665\/","endpoint-system":"Whole Body","endpoint-organ":"Stomach","endpoint-effect":"Neoplasms","endpoint-name":"Stomach, Glandular","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504688,"endpoint-url":"\/ani\/endpoint\/100504688\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Neoplasms","endpoint-name":"Nose, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504689,"endpoint-url":"\/ani\/endpoint\/100504689\/","endpoint-system":"Respiratory","endpoint-organ":"Trachea","endpoint-effect":"Neoplasms","endpoint-name":"Trachea, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504690,"endpoint-url":"\/ani\/endpoint\/100504690\/","endpoint-system":"Ocular","endpoint-organ":"Eye","endpoint-effect":"Neoplasms","endpoint-name":"Eye, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504691,"endpoint-url":"\/ani\/endpoint\/100504691\/","endpoint-system":"Ocular","endpoint-organ":"Eye","endpoint-effect":"Neoplasms","endpoint-name":"Harderian Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504692,"endpoint-url":"\/ani\/endpoint\/100504692\/","endpoint-system":"Whole Body","endpoint-organ":"Kidney","endpoint-effect":"Neoplasms","endpoint-name":"Kidney","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504693,"endpoint-url":"\/ani\/endpoint\/100504693\/","endpoint-system":"Urinary","endpoint-organ":"Bladder","endpoint-effect":"Neoplasms","endpoint-name":"Bladder, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504694,"endpoint-url":"\/ani\/endpoint\/100504694\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Gland Weight, Right, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.0213 \u00b1 0.0011, 0.0213 \u00b1 0.0006, 0.0195 \u00b1 0.001, 0.019 \u00b1 0.0007, 0.0178 \u00b1 0.0007, 0.0197 \u00b1 0.001","Doses and responses":"0 mg\/kg-day: 0.0213 \u00b1 0.0011, 62.5 mg\/kg-day: 0.0213 \u00b1 0.0006, 125 mg\/kg-day: 0.0195 \u00b1 0.001, 250 mg\/kg-day: 0.019 \u00b1 0.0007, 500 mg\/kg-day: 0.0178 \u00b1 0.0007, 1000 mg\/kg-day: 0.0197 \u00b1 0.001","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504695,"endpoint-url":"\/ani\/endpoint\/100504695\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Terminal Body Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"331 \u00b1 5.2, 339.8 \u00b1 5.1, 362.2 \u00b1 9.3, 327.3 \u00b1 4.7, 318.9 \u00b1 7.2, 287 \u00b1 8.2","Doses and responses":"0 mg\/kg-day: 331 \u00b1 5.2, 62.5 mg\/kg-day: 339.8 \u00b1 5.1, 125 mg\/kg-day: 362.2 \u00b1 9.3, 250 mg\/kg-day: 327.3 \u00b1 4.7, 500 mg\/kg-day: 318.9 \u00b1 7.2, 1000 mg\/kg-day: 287 \u00b1 8.2","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504696,"endpoint-url":"\/ani\/endpoint\/100504696\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1.17 \u00b1 0.03, 1.18 \u00b1 0.03, 1.14 \u00b1 0.03, 1.14 \u00b1 0.02, 1.11 \u00b1 0.03, 1.04 \u00b1 0.02","Doses and responses":"0 mg\/kg-day: 1.17 \u00b1 0.03, 62.5 mg\/kg-day: 1.18 \u00b1 0.03, 125 mg\/kg-day: 1.14 \u00b1 0.03, 250 mg\/kg-day: 1.14 \u00b1 0.02, 500 mg\/kg-day: 1.11 \u00b1 0.03, 1000 mg\/kg-day: 1.04 \u00b1 0.02","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504697,"endpoint-url":"\/ani\/endpoint\/100504697\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Right, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1.01 \u00b1 0.01, 1.03 \u00b1 0.03, 1.01 \u00b1 0.04, 1.02 \u00b1 0.03, 1.09 \u00b1 0.04, 1.04 \u00b1 0.03","Doses and responses":"0 mg\/kg-day: 1.01 \u00b1 0.01, 62.5 mg\/kg-day: 1.03 \u00b1 0.03, 125 mg\/kg-day: 1.01 \u00b1 0.04, 250 mg\/kg-day: 1.02 \u00b1 0.03, 500 mg\/kg-day: 1.09 \u00b1 0.04, 1000 mg\/kg-day: 1.04 \u00b1 0.03","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504698,"endpoint-url":"\/ani\/endpoint\/100504698\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"11.41 \u00b1 0.28, 12.63 \u00b1 0.85, 12.01 \u00b1 0.48, 12.88 \u00b1 0.22, 14.49 \u00b1 0.56, 16.19 \u00b1 0.6","Doses and responses":"0 mg\/kg-day: 11.41 \u00b1 0.28, 62.5 mg\/kg-day: 12.63 \u00b1 0.85, 125 mg\/kg-day: 12.01 \u00b1 0.48, 250 mg\/kg-day: 12.88 \u00b1 0.22, 500 mg\/kg-day: 14.49 \u00b1 0.56, 1000 mg\/kg-day: 16.19 \u00b1 0.6","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504699,"endpoint-url":"\/ani\/endpoint\/100504699\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Organ Weight","endpoint-name":"Lung Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1.84 \u00b1 0.07, 1.91 \u00b1 0.11, 1.81 \u00b1 0.12, 1.86 \u00b1 0.06, 1.94 \u00b1 0.11, 1.93 \u00b1 0.08","Doses and responses":"0 mg\/kg-day: 1.84 \u00b1 0.07, 62.5 mg\/kg-day: 1.91 \u00b1 0.11, 125 mg\/kg-day: 1.81 \u00b1 0.12, 250 mg\/kg-day: 1.86 \u00b1 0.06, 500 mg\/kg-day: 1.94 \u00b1 0.11, 1000 mg\/kg-day: 1.93 \u00b1 0.08","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504700,"endpoint-url":"\/ani\/endpoint\/100504700\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.715 \u00b1 0.024, 0.709 \u00b1 0.019, 0.642 \u00b1 0.018, 0.664 \u00b1 0.031, 0.69 \u00b1 0.029, 0.8 \u00b1 0.05","Doses and responses":"0 mg\/kg-day: 0.715 \u00b1 0.024, 62.5 mg\/kg-day: 0.709 \u00b1 0.019, 125 mg\/kg-day: 0.642 \u00b1 0.018, 250 mg\/kg-day: 0.664 \u00b1 0.031, 500 mg\/kg-day: 0.69 \u00b1 0.029, 1000 mg\/kg-day: 0.8 \u00b1 0.05","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504701,"endpoint-url":"\/ani\/endpoint\/100504701\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Organ Weight","endpoint-name":"Right Testis Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1.815 \u00b1 0.028, 1.816 \u00b1 0.048, 1.746 \u00b1 0.054, 1.802 \u00b1 0.032, 1.818 \u00b1 0.057, 1.773 \u00b1 0.048","Doses and responses":"0 mg\/kg-day: 1.815 \u00b1 0.028, 62.5 mg\/kg-day: 1.816 \u00b1 0.048, 125 mg\/kg-day: 1.746 \u00b1 0.054, 250 mg\/kg-day: 1.802 \u00b1 0.032, 500 mg\/kg-day: 1.818 \u00b1 0.057, 1000 mg\/kg-day: 1.773 \u00b1 0.048","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504702,"endpoint-url":"\/ani\/endpoint\/100504702\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.414 \u00b1 0.025, 0.463 \u00b1 0.032, 0.407 \u00b1 0.028, 0.416 \u00b1 0.024, 0.411 \u00b1 0.024, 0.3 \u00b1 0.012","Doses and responses":"0 mg\/kg-day: 0.414 \u00b1 0.025, 62.5 mg\/kg-day: 0.463 \u00b1 0.032, 125 mg\/kg-day: 0.407 \u00b1 0.028, 250 mg\/kg-day: 0.416 \u00b1 0.024, 500 mg\/kg-day: 0.411 \u00b1 0.024, 1000 mg\/kg-day: 0.3 \u00b1 0.012","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504703,"endpoint-url":"\/ani\/endpoint\/100504703\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Organ Weight","endpoint-name":"Thyroid Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.03, 0.0306 \u00b1 0.0018, 0.0321 \u00b1 0.002, 0.0325 \u00b1 0.0021, 0.032 \u00b1 0.0018, 0.0308 \u00b1 0.0017","Doses and responses":"0 mg\/kg-day: 0.03, 62.5 mg\/kg-day: 0.0306 \u00b1 0.0018, 125 mg\/kg-day: 0.0321 \u00b1 0.002, 250 mg\/kg-day: 0.0325 \u00b1 0.0021, 500 mg\/kg-day: 0.032 \u00b1 0.0018, 1000 mg\/kg-day: 0.0308 \u00b1 0.0017","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504704,"endpoint-url":"\/ani\/endpoint\/100504704\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Blood Urea Nitrogen","endpoint-name":"Blood Urea Nitrogen (BUN)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"17.5 \u00b1 0.5, 17.4 \u00b1 0.5, 17.4 \u00b1 0.6, 18 \u00b1 0.6, 18.6 \u00b1 0.7, 18 \u00b1 0.7","Doses and responses":"0 mg\/kg-day: 17.5 \u00b1 0.5, 62.5 mg\/kg-day: 17.4 \u00b1 0.5, 125 mg\/kg-day: 17.4 \u00b1 0.6, 250 mg\/kg-day: 18 \u00b1 0.6, 500 mg\/kg-day: 18.6 \u00b1 0.7, 1000 mg\/kg-day: 18 \u00b1 0.7","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504705,"endpoint-url":"\/ani\/endpoint\/100504705\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Creatinine","endpoint-name":"Creatinine (CREAT)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.72 \u00b1 0.01, 0.71 \u00b1 0.02, 0.7 \u00b1 0, 0.71 \u00b1 0.01, 0.68 \u00b1 0.02, 0.63 \u00b1 0.02","Doses and responses":"0 mg\/kg-day: 0.72 \u00b1 0.01, 62.5 mg\/kg-day: 0.71 \u00b1 0.02, 125 mg\/kg-day: 0.7 \u00b1 0, 250 mg\/kg-day: 0.71 \u00b1 0.01, 500 mg\/kg-day: 0.68 \u00b1 0.02, 1000 mg\/kg-day: 0.63 \u00b1 0.02","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504707,"endpoint-url":"\/ani\/endpoint\/100504707\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"6.53 \u00b1 0.08, 6.24 \u00b1 0.12, 6.06 \u00b1 0.1, 6.05 \u00b1 0.05, 5.87 \u00b1 0.1, 5.23 \u00b1 0.12","Doses and responses":"0 mg\/kg-day: 6.53 \u00b1 0.08, 62.5 mg\/kg-day: 6.24 \u00b1 0.12, 125 mg\/kg-day: 6.06 \u00b1 0.1, 250 mg\/kg-day: 6.05 \u00b1 0.05, 500 mg\/kg-day: 5.87 \u00b1 0.1, 1000 mg\/kg-day: 5.23 \u00b1 0.12","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504708,"endpoint-url":"\/ani\/endpoint\/100504708\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"2.49 \u00b1 0.06, 2.32 \u00b1 0.08, 2.26 \u00b1 0.08, 2.13 \u00b1 0.05, 1.9 \u00b1 0.09, 1.49 \u00b1 0.1","Doses and responses":"0 mg\/kg-day: 2.49 \u00b1 0.06, 62.5 mg\/kg-day: 2.32 \u00b1 0.08, 125 mg\/kg-day: 2.26 \u00b1 0.08, 250 mg\/kg-day: 2.13 \u00b1 0.05, 500 mg\/kg-day: 1.9 \u00b1 0.09, 1000 mg\/kg-day: 1.49 \u00b1 0.1","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504709,"endpoint-url":"\/ani\/endpoint\/100504709\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio","endpoint-observation_time":"Day 29","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1.63 \u00b1 0.05, 1.7 \u00b1 0.05, 1.7 \u00b1 0.06, 1.85 \u00b1 0.05, 2.13 \u00b1 0.1, 2.6 \u00b1 0.17","Doses and responses":"0 mg\/kg-day: 1.63 \u00b1 0.05, 62.5 mg\/kg-day: 1.7 \u00b1 0.05, 125 mg\/kg-day: 1.7 \u00b1 0.06, 250 mg\/kg-day: 1.85 \u00b1 0.05, 500 mg\/kg-day: 2.13 \u00b1 0.1, 1000 mg\/kg-day: 2.6 \u00b1 0.17","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504710,"endpoint-url":"\/ani\/endpoint\/100504710\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin","endpoint-name":"Albumin (A)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"4.04 \u00b1 0.05, 3.92 \u00b1 0.05, 3.8 \u00b1 0.04, 3.92 \u00b1 0.04, 3.97 \u00b1 0.04, 3.74 \u00b1 0.06","Doses and responses":"0 mg\/kg-day: 4.04 \u00b1 0.05, 62.5 mg\/kg-day: 3.92 \u00b1 0.05, 125 mg\/kg-day: 3.8 \u00b1 0.04, 250 mg\/kg-day: 3.92 \u00b1 0.04, 500 mg\/kg-day: 3.97 \u00b1 0.04, 1000 mg\/kg-day: 3.74 \u00b1 0.06","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504711,"endpoint-url":"\/ani\/endpoint\/100504711\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bilirubin","endpoint-name":"Total Bilirubin (TBILI)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.174 \u00b1 0.013, 0.168 \u00b1 0.021, 0.142 \u00b1 0.009, 0.154 \u00b1 0.013, 0.124 \u00b1 0.007, 0.103 \u00b1 0.006","Doses and responses":"0 mg\/kg-day: 0.174 \u00b1 0.013, 62.5 mg\/kg-day: 0.168 \u00b1 0.021, 125 mg\/kg-day: 0.142 \u00b1 0.009, 250 mg\/kg-day: 0.154 \u00b1 0.013, 500 mg\/kg-day: 0.124 \u00b1 0.007, 1000 mg\/kg-day: 0.103 \u00b1 0.006","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504712,"endpoint-url":"\/ani\/endpoint\/100504712\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bilirubin","endpoint-name":"Direct Bilirubin","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.023 \u00b1 0.002, 0.024 \u00b1 0.003, 0.025 \u00b1 0.002, 0.025 \u00b1 0.002, 0.023 \u00b1 0.002, 0.022 \u00b1 0.001","Doses and responses":"0 mg\/kg-day: 0.023 \u00b1 0.002, 62.5 mg\/kg-day: 0.024 \u00b1 0.003, 125 mg\/kg-day: 0.025 \u00b1 0.002, 250 mg\/kg-day: 0.025 \u00b1 0.002, 500 mg\/kg-day: 0.023 \u00b1 0.002, 1000 mg\/kg-day: 0.022 \u00b1 0.001","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504713,"endpoint-url":"\/ani\/endpoint\/100504713\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bilirubin","endpoint-name":"Indirect Bilirubin","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.151 \u00b1 0.014, 0.144 \u00b1 0.021, 0.117 \u00b1 0.008, 0.129 \u00b1 0.012, 0.101 \u00b1 0.008, 0.081 \u00b1 0.006","Doses and responses":"0 mg\/kg-day: 0.151 \u00b1 0.014, 62.5 mg\/kg-day: 0.144 \u00b1 0.021, 125 mg\/kg-day: 0.117 \u00b1 0.008, 250 mg\/kg-day: 0.129 \u00b1 0.012, 500 mg\/kg-day: 0.101 \u00b1 0.008, 1000 mg\/kg-day: 0.081 \u00b1 0.006","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504714,"endpoint-url":"\/ani\/endpoint\/100504714\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"Cholesterol (CHOL)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"125.6 \u00b1 3.6, 100.9 \u00b1 4.1, 105.4 \u00b1 4.3, 104.5 \u00b1 3.4, 102.8 \u00b1 4.9, 97.8 \u00b1 4.7","Doses and responses":"0 mg\/kg-day: 125.6 \u00b1 3.6, 62.5 mg\/kg-day: 100.9 \u00b1 4.1, 125 mg\/kg-day: 105.4 \u00b1 4.3, 250 mg\/kg-day: 104.5 \u00b1 3.4, 500 mg\/kg-day: 102.8 \u00b1 4.9, 1000 mg\/kg-day: 97.8 \u00b1 4.7","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504715,"endpoint-url":"\/ani\/endpoint\/100504715\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Triglycerides","endpoint-name":"Triglyceride (TRIG)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"120.6 \u00b1 16.7, 107.7 \u00b1 14, 141.8 \u00b1 20.1, 146.3 \u00b1 15.6, 123.5 \u00b1 10.8, 127 \u00b1 12.9","Doses and responses":"0 mg\/kg-day: 120.6 \u00b1 16.7, 62.5 mg\/kg-day: 107.7 \u00b1 14, 125 mg\/kg-day: 141.8 \u00b1 20.1, 250 mg\/kg-day: 146.3 \u00b1 15.6, 500 mg\/kg-day: 123.5 \u00b1 10.8, 1000 mg\/kg-day: 127 \u00b1 12.9","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504716,"endpoint-url":"\/ani\/endpoint\/100504716\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Day 29","endpoint-response_units":"IU\/L","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"48 \u00b1 1.24, 49.7 \u00b1 1.73, 50 \u00b1 1.61, 51.6 \u00b1 1.63, 60.6 \u00b1 1.26, 78.7 \u00b1 2.7","Doses and responses":"0 mg\/kg-day: 48 \u00b1 1.24, 62.5 mg\/kg-day: 49.7 \u00b1 1.73, 125 mg\/kg-day: 50 \u00b1 1.61, 250 mg\/kg-day: 51.6 \u00b1 1.63, 500 mg\/kg-day: 60.6 \u00b1 1.26, 1000 mg\/kg-day: 78.7 \u00b1 2.7","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504717,"endpoint-url":"\/ani\/endpoint\/100504717\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Day 29","endpoint-response_units":"IU\/L","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"199.7 \u00b1 7.5, 191.2 \u00b1 5.7, 195.3 \u00b1 6.3, 203.2 \u00b1 11.1, 244.5 \u00b1 9.6, 300.7 \u00b1 19.3","Doses and responses":"0 mg\/kg-day: 199.7 \u00b1 7.5, 62.5 mg\/kg-day: 191.2 \u00b1 5.7, 125 mg\/kg-day: 195.3 \u00b1 6.3, 250 mg\/kg-day: 203.2 \u00b1 11.1, 500 mg\/kg-day: 244.5 \u00b1 9.6, 1000 mg\/kg-day: 300.7 \u00b1 19.3","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504718,"endpoint-url":"\/ani\/endpoint\/100504718\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Creatine Kinase","endpoint-name":"Creatine Kinase (CK)","endpoint-observation_time":"Day 29","endpoint-response_units":"IU\/L","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"84 \u00b1 3.6, 89.3 \u00b1 4.5, 87.7 \u00b1 3.3, 79.8 \u00b1 3.7, 83.2 \u00b1 5.6, 86.7 \u00b1 1.8","Doses and responses":"0 mg\/kg-day: 84 \u00b1 3.6, 62.5 mg\/kg-day: 89.3 \u00b1 4.5, 125 mg\/kg-day: 87.7 \u00b1 3.3, 250 mg\/kg-day: 79.8 \u00b1 3.7, 500 mg\/kg-day: 83.2 \u00b1 5.6, 1000 mg\/kg-day: 86.7 \u00b1 1.8","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504719,"endpoint-url":"\/ani\/endpoint\/100504719\/","endpoint-system":"Systemic","endpoint-organ":"Blood","endpoint-effect":"Sorbitol Dehydrogenase","endpoint-name":"Sorbitol Dehydrogenase (SDH)","endpoint-observation_time":"Day 29","endpoint-response_units":"IU\/L","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"2.8 \u00b1 0.3, 4.2 \u00b1 0.6, 4.1 \u00b1 0.5, 3.9 \u00b1 0.5, 3.4 \u00b1 0.5, 4.6 \u00b1 0.5","Doses and responses":"0 mg\/kg-day: 2.8 \u00b1 0.3, 62.5 mg\/kg-day: 4.2 \u00b1 0.6, 125 mg\/kg-day: 4.1 \u00b1 0.5, 250 mg\/kg-day: 3.9 \u00b1 0.5, 500 mg\/kg-day: 3.4 \u00b1 0.5, 1000 mg\/kg-day: 4.6 \u00b1 0.5","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504720,"endpoint-url":"\/ani\/endpoint\/100504720\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bile Acid","endpoint-name":"Bile Salt\/Acids","endpoint-observation_time":"Day 29","endpoint-response_units":"umol\/L","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"11.1 \u00b1 3.5, 9.9 \u00b1 2.6, 8.4 \u00b1 1.9, 13.8 \u00b1 3.1, 16.8 \u00b1 2.5, 24.2 \u00b1 2.6","Doses and responses":"0 mg\/kg-day: 11.1 \u00b1 3.5, 62.5 mg\/kg-day: 9.9 \u00b1 2.6, 125 mg\/kg-day: 8.4 \u00b1 1.9, 250 mg\/kg-day: 13.8 \u00b1 3.1, 500 mg\/kg-day: 16.8 \u00b1 2.5, 1000 mg\/kg-day: 24.2 \u00b1 2.6","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504721,"endpoint-url":"\/ani\/endpoint\/100504721\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"51.9 \u00b1 0.5, 49.6 \u00b1 0.7, 48.6 \u00b1 0.7, 48.7 \u00b1 0.6, 43.3 \u00b1 0.9, 34.2 \u00b1 1.8","Doses and responses":"0 mg\/kg-day: 51.9 \u00b1 0.5, 62.5 mg\/kg-day: 49.6 \u00b1 0.7, 125 mg\/kg-day: 48.6 \u00b1 0.7, 250 mg\/kg-day: 48.7 \u00b1 0.6, 500 mg\/kg-day: 43.3 \u00b1 0.9, 1000 mg\/kg-day: 34.2 \u00b1 1.8","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504752,"endpoint-url":"\/ani\/endpoint\/100504752\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Sperm Parameters","endpoint-name":"Sperm Count per mg Cauda Epididymis","endpoint-observation_time":"Day 29","endpoint-response_units":"10^3\/mg","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"586.4 \u00b1 34.9, , , 526.7 \u00b1 25.8, 566.4 \u00b1 20.2, 478.4 \u00b1 28.2","Doses and responses":"0 mg\/kg-day: 586.4 \u00b1 34.9, 250 mg\/kg-day: 526.7 \u00b1 25.8, 500 mg\/kg-day: 566.4 \u00b1 20.2, 1000 mg\/kg-day: 478.4 \u00b1 28.2","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504722,"endpoint-url":"\/ani\/endpoint\/100504722\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Manual Hematocrit","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"47 \u00b1 0, 45 \u00b1 1, 44 \u00b1 1, 44 \u00b1 0, 39 \u00b1 1, 33 \u00b1 2","Doses and responses":"0 mg\/kg-day: 47 \u00b1 0, 62.5 mg\/kg-day: 45 \u00b1 1, 125 mg\/kg-day: 44 \u00b1 1, 250 mg\/kg-day: 44 \u00b1 0, 500 mg\/kg-day: 39 \u00b1 1, 1000 mg\/kg-day: 33 \u00b1 2","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504723,"endpoint-url":"\/ani\/endpoint\/100504723\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hemoglobin","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"15.5 \u00b1 0.2, 15 \u00b1 0.2, 14.7 \u00b1 0.2, 14.6 \u00b1 0.2, 12.6 \u00b1 0.3, 9.3 \u00b1 0.6","Doses and responses":"0 mg\/kg-day: 15.5 \u00b1 0.2, 62.5 mg\/kg-day: 15 \u00b1 0.2, 125 mg\/kg-day: 14.7 \u00b1 0.2, 250 mg\/kg-day: 14.6 \u00b1 0.2, 500 mg\/kg-day: 12.6 \u00b1 0.3, 1000 mg\/kg-day: 9.3 \u00b1 0.6","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504724,"endpoint-url":"\/ani\/endpoint\/100504724\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Day 29","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"8.69 \u00b1 0.08, 8.28 \u00b1 0.11, 8.24 \u00b1 0.12, 7.91 \u00b1 0.1, 6.68 \u00b1 0.22, 4.56 \u00b1 0.32","Doses and responses":"0 mg\/kg-day: 8.69 \u00b1 0.08, 62.5 mg\/kg-day: 8.28 \u00b1 0.11, 125 mg\/kg-day: 8.24 \u00b1 0.12, 250 mg\/kg-day: 7.91 \u00b1 0.1, 500 mg\/kg-day: 6.68 \u00b1 0.22, 1000 mg\/kg-day: 4.56 \u00b1 0.32","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504786,"endpoint-url":"\/ani\/endpoint\/100504786\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Cortex, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504725,"endpoint-url":"\/ani\/endpoint\/100504725\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"207.9 \u00b1 6, 196.5 \u00b1 8.7, 176.3 \u00b1 7.6, 238.6 \u00b1 9.6, 523.7 \u00b1 71.7, 947.7 \u00b1 43","Doses and responses":"0 mg\/kg-day: 207.9 \u00b1 6, 62.5 mg\/kg-day: 196.5 \u00b1 8.7, 125 mg\/kg-day: 176.3 \u00b1 7.6, 250 mg\/kg-day: 238.6 \u00b1 9.6, 500 mg\/kg-day: 523.7 \u00b1 71.7, 1000 mg\/kg-day: 947.7 \u00b1 43","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504726,"endpoint-url":"\/ani\/endpoint\/100504726\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Day 29","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"59.7 \u00b1 0.4, 59.9 \u00b1 0.4, 59 \u00b1 0.7, 61.6 \u00b1 0.5, 65.2 \u00b1 1.1, 75.8 \u00b1 1.9","Doses and responses":"0 mg\/kg-day: 59.7 \u00b1 0.4, 62.5 mg\/kg-day: 59.9 \u00b1 0.4, 125 mg\/kg-day: 59 \u00b1 0.7, 250 mg\/kg-day: 61.6 \u00b1 0.5, 500 mg\/kg-day: 65.2 \u00b1 1.1, 1000 mg\/kg-day: 75.8 \u00b1 1.9","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504727,"endpoint-url":"\/ani\/endpoint\/100504727\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Day 29","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"17.9 \u00b1 0.1, 18.1 \u00b1 0.1, 17.8 \u00b1 0.2, 18.5 \u00b1 0.2, 19 \u00b1 0.2, 20.4 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 17.9 \u00b1 0.1, 62.5 mg\/kg-day: 18.1 \u00b1 0.1, 125 mg\/kg-day: 17.8 \u00b1 0.2, 250 mg\/kg-day: 18.5 \u00b1 0.2, 500 mg\/kg-day: 19 \u00b1 0.2, 1000 mg\/kg-day: 20.4 \u00b1 0.4","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504728,"endpoint-url":"\/ani\/endpoint\/100504728\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"29.9 \u00b1 0.1, 30.2 \u00b1 0.1, 30.2 \u00b1 0.1, 30 \u00b1 0.1, 29.1 \u00b1 0.3, 27 \u00b1 0.3","Doses and responses":"0 mg\/kg-day: 29.9 \u00b1 0.1, 62.5 mg\/kg-day: 30.2 \u00b1 0.1, 125 mg\/kg-day: 30.2 \u00b1 0.1, 250 mg\/kg-day: 30 \u00b1 0.1, 500 mg\/kg-day: 29.1 \u00b1 0.3, 1000 mg\/kg-day: 27 \u00b1 0.3","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504729,"endpoint-url":"\/ani\/endpoint\/100504729\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"927 \u00b1 26, 913 \u00b1 28, 979 \u00b1 40, 939 \u00b1 36, 1115 \u00b1 44, 1381 \u00b1 69","Doses and responses":"0 mg\/kg-day: 927 \u00b1 26, 62.5 mg\/kg-day: 913 \u00b1 28, 125 mg\/kg-day: 979 \u00b1 40, 250 mg\/kg-day: 939 \u00b1 36, 500 mg\/kg-day: 1115 \u00b1 44, 1000 mg\/kg-day: 1381 \u00b1 69","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504730,"endpoint-url":"\/ani\/endpoint\/100504730\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"11.48 \u00b1 0.75, 10.82 \u00b1 0.38, 10.46 \u00b1 0.49, 10.6 \u00b1 0.68, 9.89 \u00b1 0.6, 11.43 \u00b1 0.63","Doses and responses":"0 mg\/kg-day: 11.48 \u00b1 0.75, 62.5 mg\/kg-day: 10.82 \u00b1 0.38, 125 mg\/kg-day: 10.46 \u00b1 0.49, 250 mg\/kg-day: 10.6 \u00b1 0.68, 500 mg\/kg-day: 9.89 \u00b1 0.6, 1000 mg\/kg-day: 11.43 \u00b1 0.63","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504731,"endpoint-url":"\/ani\/endpoint\/100504731\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Neutrophils","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1.81 \u00b1 0.59, 1.04 \u00b1 0.06, 1.03 \u00b1 0.07, 1.03 \u00b1 0.09, 1.07 \u00b1 0.11, 2.56 \u00b1 0.32","Doses and responses":"0 mg\/kg-day: 1.81 \u00b1 0.59, 62.5 mg\/kg-day: 1.04 \u00b1 0.06, 125 mg\/kg-day: 1.03 \u00b1 0.07, 250 mg\/kg-day: 1.03 \u00b1 0.09, 500 mg\/kg-day: 1.07 \u00b1 0.11, 1000 mg\/kg-day: 2.56 \u00b1 0.32","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504732,"endpoint-url":"\/ani\/endpoint\/100504732\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Lymphocyte","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"9.25 \u00b1 0.46, 9.45 \u00b1 0.34, 9.12 \u00b1 0.46, 9.27 \u00b1 0.62, 8.52 \u00b1 0.48, 8.39 \u00b1 0.38","Doses and responses":"0 mg\/kg-day: 9.25 \u00b1 0.46, 62.5 mg\/kg-day: 9.45 \u00b1 0.34, 125 mg\/kg-day: 9.12 \u00b1 0.46, 250 mg\/kg-day: 9.27 \u00b1 0.62, 500 mg\/kg-day: 8.52 \u00b1 0.48, 1000 mg\/kg-day: 8.39 \u00b1 0.38","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504733,"endpoint-url":"\/ani\/endpoint\/100504733\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Lymphocyte","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"9.32 \u00b1 0.46, 9.5 \u00b1 0.34, 9.18 \u00b1 0.47, 9.31 \u00b1 0.63, 8.58 \u00b1 0.48, 8.46 \u00b1 0.39","Doses and responses":"0 mg\/kg-day: 9.32 \u00b1 0.46, 62.5 mg\/kg-day: 9.5 \u00b1 0.34, 125 mg\/kg-day: 9.18 \u00b1 0.47, 250 mg\/kg-day: 9.31 \u00b1 0.63, 500 mg\/kg-day: 8.58 \u00b1 0.48, 1000 mg\/kg-day: 8.46 \u00b1 0.39","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504734,"endpoint-url":"\/ani\/endpoint\/100504734\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Monocytes","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.23 \u00b1 0.03, 0.19 \u00b1 0.02, 0.16 \u00b1 0.01, 0.18 \u00b1 0.03, 0.17 \u00b1 0.02, 0.32 \u00b1 0.02","Doses and responses":"0 mg\/kg-day: 0.23 \u00b1 0.03, 62.5 mg\/kg-day: 0.19 \u00b1 0.02, 125 mg\/kg-day: 0.16 \u00b1 0.01, 250 mg\/kg-day: 0.18 \u00b1 0.03, 500 mg\/kg-day: 0.17 \u00b1 0.02, 1000 mg\/kg-day: 0.32 \u00b1 0.02","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504735,"endpoint-url":"\/ani\/endpoint\/100504735\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Basophils","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.02 \u00b1 0, 0.01 \u00b1 0, 0.01 \u00b1 0, 0.01 \u00b1 0, 0.01 \u00b1 0, 0.01 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.02 \u00b1 0, 62.5 mg\/kg-day: 0.01 \u00b1 0, 125 mg\/kg-day: 0.01 \u00b1 0, 250 mg\/kg-day: 0.01 \u00b1 0, 500 mg\/kg-day: 0.01 \u00b1 0, 1000 mg\/kg-day: 0.01 \u00b1 0","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504736,"endpoint-url":"\/ani\/endpoint\/100504736\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Eosinophils","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.09 \u00b1 0.02, 0.07 \u00b1 0.01, 0.08 \u00b1 0.01, 0.06 \u00b1 0.01, 0.06 \u00b1 0.01, 0.09 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.09 \u00b1 0.02, 62.5 mg\/kg-day: 0.07 \u00b1 0.01, 125 mg\/kg-day: 0.08 \u00b1 0.01, 250 mg\/kg-day: 0.06 \u00b1 0.01, 500 mg\/kg-day: 0.06 \u00b1 0.01, 1000 mg\/kg-day: 0.09 \u00b1 0.01","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504737,"endpoint-url":"\/ani\/endpoint\/100504737\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Acetyl-CoA","endpoint-name":"Acetyl Co-A","endpoint-observation_time":"Day 29","endpoint-response_units":"nmol\/min.mg","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"2.204 \u00b1 0.073, 2.166 \u00b1 0.092, 2.596 \u00b1 0.155, 5.303 \u00b1 0.174, 8.436 \u00b1 0.367, 16.08 \u00b1 0.797","Doses and responses":"0 mg\/kg-day: 2.204 \u00b1 0.073, 62.5 mg\/kg-day: 2.166 \u00b1 0.092, 125 mg\/kg-day: 2.596 \u00b1 0.155, 250 mg\/kg-day: 5.303 \u00b1 0.174, 500 mg\/kg-day: 8.436 \u00b1 0.367, 1000 mg\/kg-day: 16.08 \u00b1 0.797","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504738,"endpoint-url":"\/ani\/endpoint\/100504738\/","endpoint-system":"Systemic","endpoint-organ":"Plasma","endpoint-effect":"PFHxA Tissue Concentration","endpoint-name":"Plasma PFHxA Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/ml","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 378.2 \u00b1 177.8, 503.2 \u00b1 66.2, 1296.8 \u00b1 264.7, 3339 \u00b1 497.2, 10898.6 \u00b1 2516.1","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 378.2 \u00b1 177.8, 125 mg\/kg-day: 503.2 \u00b1 66.2, 250 mg\/kg-day: 1296.8 \u00b1 264.7, 500 mg\/kg-day: 3339 \u00b1 497.2, 1000 mg\/kg-day: 10898.6 \u00b1 2516.1","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504739,"endpoint-url":"\/ani\/endpoint\/100504739\/","endpoint-system":"Systemic","endpoint-organ":"Plasma","endpoint-effect":"PFHxA Tissue Concentration","endpoint-name":"Plasma PFHxA  Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"u\/M","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 1.2 \u00b1 0.6, 1.6 \u00b1 0.2, 4.1 \u00b1 0.8, 10.6 \u00b1 1.6, 34.7 \u00b1 8","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 1.2 \u00b1 0.6, 125 mg\/kg-day: 1.6 \u00b1 0.2, 250 mg\/kg-day: 4.1 \u00b1 0.8, 500 mg\/kg-day: 10.6 \u00b1 1.6, 1000 mg\/kg-day: 34.7 \u00b1 8","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504740,"endpoint-url":"\/ani\/endpoint\/100504740\/","endpoint-system":"Systemic","endpoint-organ":"Plasma","endpoint-effect":"PFHxA Tissue Concentration","endpoint-name":"Normalized PFHxA Plasma Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"uM\/mol\/kg","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 6 \u00b1 2.8, 4 \u00b1 0.5, 5.2 \u00b1 1.1, 6.7 \u00b1 1, 10.9 \u00b1 2.5","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 6 \u00b1 2.8, 125 mg\/kg-day: 4 \u00b1 0.5, 250 mg\/kg-day: 5.2 \u00b1 1.1, 500 mg\/kg-day: 6.7 \u00b1 1, 1000 mg\/kg-day: 10.9 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504741,"endpoint-url":"\/ani\/endpoint\/100504741\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"PFHxA Tissue Concentration","endpoint-name":"Liver PFHxA Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0, 0, 0, 654.6 \u00b1 148, 1552.1 \u00b1 221.6, 4844.9 \u00b1 1055.8","Doses and responses":"0 mg\/kg-day: 0, 62.5 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 654.6 \u00b1 148, 500 mg\/kg-day: 1552.1 \u00b1 221.6, 1000 mg\/kg-day: 4844.9 \u00b1 1055.8","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504742,"endpoint-url":"\/ani\/endpoint\/100504742\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"PFHxA Tissue Concentration","endpoint-name":"Liver PFHxA Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"uM","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":", , , 2.1 \u00b1 0.5, 4.9 \u00b1 0.7, 15.4 \u00b1 3.4","Doses and responses":"250 mg\/kg-day: 2.1 \u00b1 0.5, 500 mg\/kg-day: 4.9 \u00b1 0.7, 1000 mg\/kg-day: 15.4 \u00b1 3.4","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504743,"endpoint-url":"\/ani\/endpoint\/100504743\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"PFHxA Tissue Concentration","endpoint-name":"Normalized Liver PFHxA Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"uM\/mol\/kg","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":", , , 2.6 \u00b1 0.6, 3.1 \u00b1 0.4, 4.8 \u00b1 1.1","Doses and responses":"250 mg\/kg-day: 2.6 \u00b1 0.6, 500 mg\/kg-day: 3.1 \u00b1 0.4, 1000 mg\/kg-day: 4.8 \u00b1 1.1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504744,"endpoint-url":"\/ani\/endpoint\/100504744\/","endpoint-system":"Whole Body","endpoint-organ":"","endpoint-effect":"PFHxA Tissue Concentration","endpoint-name":"Liver\/Plasma PFHxA Ratio","endpoint-observation_time":"Day 29","endpoint-response_units":"uM\/mol\/kg","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":", , , 0.52 \u00b1 0.06, 0.47 \u00b1 0.01, 0.44 \u00b1 0.02","Doses and responses":"250 mg\/kg-day: 0.52 \u00b1 0.06, 500 mg\/kg-day: 0.47 \u00b1 0.01, 1000 mg\/kg-day: 0.44 \u00b1 0.02","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504745,"endpoint-url":"\/ani\/endpoint\/100504745\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Organ Weight","endpoint-name":"Testis Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1.814 \u00b1 0.035, , , 1.821 \u00b1 0.028, 1.851 \u00b1 0.057, 1.798 \u00b1 0.043","Doses and responses":"0 mg\/kg-day: 1.814 \u00b1 0.035, 250 mg\/kg-day: 1.821 \u00b1 0.028, 500 mg\/kg-day: 1.851 \u00b1 0.057, 1000 mg\/kg-day: 1.798 \u00b1 0.043","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504746,"endpoint-url":"\/ani\/endpoint\/100504746\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Sperm Parameters","endpoint-name":"Testicular Spermatid Count","endpoint-observation_time":"Day 29","endpoint-response_units":"10^6","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"377 \u00b1 7.9, , , 356.5 \u00b1 11, 376 \u00b1 11.6, 352.3 \u00b1 12.4","Doses and responses":"0 mg\/kg-day: 377 \u00b1 7.9, 250 mg\/kg-day: 356.5 \u00b1 11, 500 mg\/kg-day: 376 \u00b1 11.6, 1000 mg\/kg-day: 352.3 \u00b1 12.4","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504747,"endpoint-url":"\/ani\/endpoint\/100504747\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Sperm Parameters","endpoint-name":"Testicular Spermatid Count per mg Testis","endpoint-observation_time":"Day 29","endpoint-response_units":"10^3\/mg","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"208.3 \u00b1 4.8, , , 195.9 \u00b1 5.4, 203.9 \u00b1 6.1, 196 \u00b1 5","Doses and responses":"0 mg\/kg-day: 208.3 \u00b1 4.8, 250 mg\/kg-day: 195.9 \u00b1 5.4, 500 mg\/kg-day: 203.9 \u00b1 6.1, 1000 mg\/kg-day: 196 \u00b1 5","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504748,"endpoint-url":"\/ani\/endpoint\/100504748\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Sperm Parameters","endpoint-name":"Percent Motile Sperm","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"87.9 \u00b1 0.4, , , 87.8 \u00b1 0.3, 87.2 \u00b1 0.4, 87.4 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 87.9 \u00b1 0.4, 250 mg\/kg-day: 87.8 \u00b1 0.3, 500 mg\/kg-day: 87.2 \u00b1 0.4, 1000 mg\/kg-day: 87.4 \u00b1 0.4","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504749,"endpoint-url":"\/ani\/endpoint\/100504749\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Organ Weight","endpoint-name":"Epididymis Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.527 \u00b1 0.01, , , 0.523 \u00b1 0.013, 0.524 \u00b1 0.011, 0.496 \u00b1 0.014","Doses and responses":"0 mg\/kg-day: 0.527 \u00b1 0.01, 250 mg\/kg-day: 0.523 \u00b1 0.013, 500 mg\/kg-day: 0.524 \u00b1 0.011, 1000 mg\/kg-day: 0.496 \u00b1 0.014","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504750,"endpoint-url":"\/ani\/endpoint\/100504750\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Organ Weight","endpoint-name":"Cauda Epididymis Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.19 \u00b1 0.005, , , 0.195 \u00b1 0.005, 0.186 \u00b1 0.005, 0.176 \u00b1 0.005","Doses and responses":"0 mg\/kg-day: 0.19 \u00b1 0.005, 250 mg\/kg-day: 0.195 \u00b1 0.005, 500 mg\/kg-day: 0.186 \u00b1 0.005, 1000 mg\/kg-day: 0.176 \u00b1 0.005","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504751,"endpoint-url":"\/ani\/endpoint\/100504751\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Sperm Parameters","endpoint-name":"Cauda Epididymis Sperm Count","endpoint-observation_time":"Day 29","endpoint-response_units":"Millions","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"111.9 \u00b1 8.4, , , 102.5 \u00b1 5.2, 105.1 \u00b1 4.3, 83.7 \u00b1 4.7","Doses and responses":"0 mg\/kg-day: 111.9 \u00b1 8.4, 250 mg\/kg-day: 102.5 \u00b1 5.2, 500 mg\/kg-day: 105.1 \u00b1 4.3, 1000 mg\/kg-day: 83.7 \u00b1 4.7","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504753,"endpoint-url":"\/ani\/endpoint\/100504753\/","endpoint-system":"Male Reproductive","endpoint-organ":"","endpoint-effect":"Hormone Levels","endpoint-name":"Testosterone","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/mL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"3.814 \u00b1 0.805, 3.525 \u00b1 0.53, 3.629 \u00b1 1.021, 3.609 \u00b1 0.461, 3.555 \u00b1 0.586, 2.93 \u00b1 0.713","Doses and responses":"0 mg\/kg-day: 3.814 \u00b1 0.805, 62.5 mg\/kg-day: 3.525 \u00b1 0.53, 125 mg\/kg-day: 3.629 \u00b1 1.021, 250 mg\/kg-day: 3.609 \u00b1 0.461, 500 mg\/kg-day: 3.555 \u00b1 0.586, 1000 mg\/kg-day: 2.93 \u00b1 0.713","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504754,"endpoint-url":"\/ani\/endpoint\/100504754\/","endpoint-system":"Endocrine","endpoint-organ":"Blood","endpoint-effect":"Hormone","endpoint-name":"Thyroid Stimulating Hormone (TSH)","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/mL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"23.08 \u00b1 2.634, 25.156 \u00b1 3.381, 24.278 \u00b1 3.044, 24.469 \u00b1 2.989, 20.946 \u00b1 2.845, 18.291 \u00b1 3.564","Doses and responses":"0 mg\/kg-day: 23.08 \u00b1 2.634, 62.5 mg\/kg-day: 25.156 \u00b1 3.381, 125 mg\/kg-day: 24.278 \u00b1 3.044, 250 mg\/kg-day: 24.469 \u00b1 2.989, 500 mg\/kg-day: 20.946 \u00b1 2.845, 1000 mg\/kg-day: 18.291 \u00b1 3.564","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504755,"endpoint-url":"\/ani\/endpoint\/100504755\/","endpoint-system":"Endocrine","endpoint-organ":"Blood","endpoint-effect":"Hormone","endpoint-name":"Triiodothyronine (T3)","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"84.17 \u00b1 5.249, 68.88 \u00b1 3.76, 62.156 \u00b1 3.508, 71.59 \u00b1 3.881, 71.03 \u00b1 4.091, 60.07 \u00b1 4.739","Doses and responses":"0 mg\/kg-day: 84.17 \u00b1 5.249, 62.5 mg\/kg-day: 68.88 \u00b1 3.76, 125 mg\/kg-day: 62.156 \u00b1 3.508, 250 mg\/kg-day: 71.59 \u00b1 3.881, 500 mg\/kg-day: 71.03 \u00b1 4.091, 1000 mg\/kg-day: 60.07 \u00b1 4.739","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504756,"endpoint-url":"\/ani\/endpoint\/100504756\/","endpoint-system":"Endocrine","endpoint-organ":"Serum","endpoint-effect":"Hormone","endpoint-name":"Thyroxine (T4), Free","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"2.876 \u00b1 0.086, 2.158 \u00b1 0.168, 1.782 \u00b1 0.124, 1.74 \u00b1 0.092, 1.295 \u00b1 0.068, 0.767 \u00b1 0.097","Doses and responses":"0 mg\/kg-day: 2.876 \u00b1 0.086, 62.5 mg\/kg-day: 2.158 \u00b1 0.168, 125 mg\/kg-day: 1.782 \u00b1 0.124, 250 mg\/kg-day: 1.74 \u00b1 0.092, 500 mg\/kg-day: 1.295 \u00b1 0.068, 1000 mg\/kg-day: 0.767 \u00b1 0.097","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504757,"endpoint-url":"\/ani\/endpoint\/100504757\/","endpoint-system":"Endocrine","endpoint-organ":"Serum","endpoint-effect":"Hormone","endpoint-name":"Total Thyroxine (T4)","endpoint-observation_time":"Day 29","endpoint-response_units":"ug\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"4.26 \u00b1 0.146, 3.4 \u00b1 0.231, 2.933 \u00b1 0.161, 2.9 \u00b1 0.165, 2.37 \u00b1 0.102, 1.77 \u00b1 0.173","Doses and responses":"0 mg\/kg-day: 4.26 \u00b1 0.146, 62.5 mg\/kg-day: 3.4 \u00b1 0.231, 125 mg\/kg-day: 2.933 \u00b1 0.161, 250 mg\/kg-day: 2.9 \u00b1 0.165, 500 mg\/kg-day: 2.37 \u00b1 0.102, 1000 mg\/kg-day: 1.77 \u00b1 0.173","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504758,"endpoint-url":"\/ani\/endpoint\/100504758\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Day 29","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"57.44 \u00b1 1.68, 58.9 \u00b1 1.57, 58.2 \u00b1 1.91, 61.1 \u00b1 1.21, 66.8 \u00b1 1.6, 78.4 \u00b1 2.63","Doses and responses":"0 mg\/kg-day: 57.44 \u00b1 1.68, 62.5 mg\/kg-day: 58.9 \u00b1 1.57, 125 mg\/kg-day: 58.2 \u00b1 1.91, 250 mg\/kg-day: 61.1 \u00b1 1.21, 500 mg\/kg-day: 66.8 \u00b1 1.6, 1000 mg\/kg-day: 78.4 \u00b1 2.63","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504759,"endpoint-url":"\/ani\/endpoint\/100504759\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Gland Weight, Right, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.06 \u00b1 0, 0.06 \u00b1 0, 0.06 \u00b1 0, 0.06 \u00b1 0, 0.06 \u00b1 0, 0.07 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.06 \u00b1 0, 62.5 mg\/kg-day: 0.06 \u00b1 0, 125 mg\/kg-day: 0.06 \u00b1 0, 250 mg\/kg-day: 0.06 \u00b1 0, 500 mg\/kg-day: 0.06 \u00b1 0, 1000 mg\/kg-day: 0.07 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504760,"endpoint-url":"\/ani\/endpoint\/100504760\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"3.54 \u00b1 0.06, 3.46 \u00b1 0.07, 3.5 \u00b1 0.07, 3.48 \u00b1 0.06, 3.47 \u00b1 0.07, 3.64 \u00b1 0.05","Doses and responses":"0 mg\/kg-day: 3.54 \u00b1 0.06, 62.5 mg\/kg-day: 3.46 \u00b1 0.07, 125 mg\/kg-day: 3.5 \u00b1 0.07, 250 mg\/kg-day: 3.48 \u00b1 0.06, 500 mg\/kg-day: 3.47 \u00b1 0.07, 1000 mg\/kg-day: 3.64 \u00b1 0.05","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504761,"endpoint-url":"\/ani\/endpoint\/100504761\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Right, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"3.04 \u00b1 0.04, 3.04 \u00b1 0.07, 3.1 \u00b1 0.03, 3.11 \u00b1 0.07, 3.4 \u00b1 0.09, 3.61 \u00b1 0.04","Doses and responses":"0 mg\/kg-day: 3.04 \u00b1 0.04, 62.5 mg\/kg-day: 3.04 \u00b1 0.07, 125 mg\/kg-day: 3.1 \u00b1 0.03, 250 mg\/kg-day: 3.11 \u00b1 0.07, 500 mg\/kg-day: 3.4 \u00b1 0.09, 1000 mg\/kg-day: 3.61 \u00b1 0.04","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504762,"endpoint-url":"\/ani\/endpoint\/100504762\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"34.44 \u00b1 0.41, 37.26 \u00b1 2.62, 36.7 \u00b1 0.5, 39.35 \u00b1 0.29, 45.33 \u00b1 0.85, 56.35 \u00b1 1.07","Doses and responses":"0 mg\/kg-day: 34.44 \u00b1 0.41, 62.5 mg\/kg-day: 37.26 \u00b1 2.62, 125 mg\/kg-day: 36.7 \u00b1 0.5, 250 mg\/kg-day: 39.35 \u00b1 0.29, 500 mg\/kg-day: 45.33 \u00b1 0.85, 1000 mg\/kg-day: 56.35 \u00b1 1.07","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504763,"endpoint-url":"\/ani\/endpoint\/100504763\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Organ Weight","endpoint-name":"Lung Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"5.56 \u00b1 0.18, 5.62 \u00b1 0.31, 5.53 \u00b1 0.29, 5.7 \u00b1 0.22, 6.06 \u00b1 0.3, 6.74 \u00b1 0.26","Doses and responses":"0 mg\/kg-day: 5.56 \u00b1 0.18, 62.5 mg\/kg-day: 5.62 \u00b1 0.31, 125 mg\/kg-day: 5.53 \u00b1 0.29, 250 mg\/kg-day: 5.7 \u00b1 0.22, 500 mg\/kg-day: 6.06 \u00b1 0.3, 1000 mg\/kg-day: 6.74 \u00b1 0.26","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504764,"endpoint-url":"\/ani\/endpoint\/100504764\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"2.16 \u00b1 0.05, 2.09 \u00b1 0.05, 1.97 \u00b1 0.05, 2.03 \u00b1 0.08, 2.16 \u00b1 0.08, 2.79 \u00b1 0.16","Doses and responses":"0 mg\/kg-day: 2.16 \u00b1 0.05, 62.5 mg\/kg-day: 2.09 \u00b1 0.05, 125 mg\/kg-day: 1.97 \u00b1 0.05, 250 mg\/kg-day: 2.03 \u00b1 0.08, 500 mg\/kg-day: 2.16 \u00b1 0.08, 1000 mg\/kg-day: 2.79 \u00b1 0.16","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504765,"endpoint-url":"\/ani\/endpoint\/100504765\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Organ Weight","endpoint-name":"Right Testis Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"5.49 \u00b1 0.07, 5.35 \u00b1 0.12, 5.37 \u00b1 0.15, 5.51 \u00b1 0.11, 5.69 \u00b1 0.08, 6.19 \u00b1 0.11","Doses and responses":"0 mg\/kg-day: 5.49 \u00b1 0.07, 62.5 mg\/kg-day: 5.35 \u00b1 0.12, 125 mg\/kg-day: 5.37 \u00b1 0.15, 250 mg\/kg-day: 5.51 \u00b1 0.11, 500 mg\/kg-day: 5.69 \u00b1 0.08, 1000 mg\/kg-day: 6.19 \u00b1 0.11","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504766,"endpoint-url":"\/ani\/endpoint\/100504766\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"1.25 \u00b1 0.06, 1.36 \u00b1 0.09, 1.24 \u00b1 0.05, 1.27 \u00b1 0.07, 1.28 \u00b1 0.06, 1.04 \u00b1 0.02","Doses and responses":"0 mg\/kg-day: 1.25 \u00b1 0.06, 62.5 mg\/kg-day: 1.36 \u00b1 0.09, 125 mg\/kg-day: 1.24 \u00b1 0.05, 250 mg\/kg-day: 1.27 \u00b1 0.07, 500 mg\/kg-day: 1.28 \u00b1 0.06, 1000 mg\/kg-day: 1.04 \u00b1 0.02","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504767,"endpoint-url":"\/ani\/endpoint\/100504767\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Organ Weight","endpoint-name":"Thyroid Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"0.09 \u00b1 0, 0.09 \u00b1 0.01, 0.1 \u00b1 0.01, 0.1 \u00b1 0.01, 0.1 \u00b1 0.01, 0.11 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.09 \u00b1 0, 62.5 mg\/kg-day: 0.09 \u00b1 0.01, 125 mg\/kg-day: 0.1 \u00b1 0.01, 250 mg\/kg-day: 0.1 \u00b1 0.01, 500 mg\/kg-day: 0.1 \u00b1 0.01, 1000 mg\/kg-day: 0.11 \u00b1 0.01","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504768,"endpoint-url":"\/ani\/endpoint\/100504768\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Estrous Cycle","endpoint-name":"Estrous Cycle","endpoint-observation_time":"","endpoint-response_units":"","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":", , , , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504769,"endpoint-url":"\/ani\/endpoint\/100504769\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Discharge","endpoint-name":"Nasal\/Eye Discharge","endpoint-observation_time":"Day 8","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 3","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 3","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504770,"endpoint-url":"\/ani\/endpoint\/100504770\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Esophagus","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Esophagus, Focal Ulcer","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504771,"endpoint-url":"\/ani\/endpoint\/100504771\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Large Intestine, Cecum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504772,"endpoint-url":"\/ani\/endpoint\/100504772\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Large Intestine, Colon, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504773,"endpoint-url":"\/ani\/endpoint\/100504773\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Large Intestine, Rectum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504774,"endpoint-url":"\/ani\/endpoint\/100504774\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Small Intestine, Duodenum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504775,"endpoint-url":"\/ani\/endpoint\/100504775\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Small Intestine, Ileum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504776,"endpoint-url":"\/ani\/endpoint\/100504776\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Small Intestine, Jejunum, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504974,"endpoint-url":"\/ani\/endpoint\/100504974\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability, Litters with Stillborn Pups","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 7 mg\/kg-day: 0, 35 mg\/kg-day: 0, 175 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504974,"endpoint-url":"\/ani\/endpoint\/100504974\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability, Litters with Stillborn Pups","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0, 0, 0, 1","Doses and responses":"0 mg\/mL: 0, 1.4 mg\/mL: 0, 7 mg\/mL: 0, 35 mg\/mL: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504777,"endpoint-url":"\/ani\/endpoint\/100504777\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Liver, Infiltration Cellular, Mixed Cell","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"1, 2, 0, 1, 0, 1","Doses and responses":"0 mg\/kg-day: 1, 62.6 mg\/kg-day: 2, 125 mg\/kg-day: 0, 250 mg\/kg-day: 1, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504778,"endpoint-url":"\/ani\/endpoint\/100504778\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Liver, Hepatocyte, Cytoplasmic Alteration","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 9","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 9","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504779,"endpoint-url":"\/ani\/endpoint\/100504779\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Hepatocellular Hypertrophy","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 9","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 9","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504780,"endpoint-url":"\/ani\/endpoint\/100504780\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Pancreas","endpoint-effect":"Histopathology","endpoint-name":"Pancreas, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504781,"endpoint-url":"\/ani\/endpoint\/100504781\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Salivary Glands","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Salivary Glands, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504782,"endpoint-url":"\/ani\/endpoint\/100504782\/","endpoint-system":"Whole Body","endpoint-organ":"Stomach","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Stomach, Forestomach, Epithelium, Hyperplasia","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 2","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 2","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504783,"endpoint-url":"\/ani\/endpoint\/100504783\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Stomach","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Stomach, Glandular, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504784,"endpoint-url":"\/ani\/endpoint\/100504784\/","endpoint-system":"Cardiovascular","endpoint-organ":"Blood Vessels","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Blood Vessel, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504785,"endpoint-url":"\/ani\/endpoint\/100504785\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Heart, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504787,"endpoint-url":"\/ani\/endpoint\/100504787\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Medulla, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=7-8)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504788,"endpoint-url":"\/ani\/endpoint\/100504788\/","endpoint-system":"Endocrine","endpoint-organ":"Parathyroid Gland","endpoint-effect":"Histopathology","endpoint-name":"Parathyroid Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504789,"endpoint-url":"\/ani\/endpoint\/100504789\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid Gland","endpoint-effect":"Histopathology","endpoint-name":"Thyroid Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504790,"endpoint-url":"\/ani\/endpoint\/100504790\/","endpoint-system":"Female Reproductive","endpoint-organ":"Clitoral Gland","endpoint-effect":"Histopathology","endpoint-name":"Clitoral Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504791,"endpoint-url":"\/ani\/endpoint\/100504791\/","endpoint-system":"Female Reproductive","endpoint-organ":"Ovary","endpoint-effect":"Histopathology","endpoint-name":"Ovaries, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=1-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504792,"endpoint-url":"\/ani\/endpoint\/100504792\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Histopathology","endpoint-name":"Uterus, Bilateral Dilation","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"1, 2, 1, 2, 3, 1","Doses and responses":"0 mg\/kg-day: 1, 62.6 mg\/kg-day: 2, 125 mg\/kg-day: 1, 250 mg\/kg-day: 2, 500 mg\/kg-day: 3, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504793,"endpoint-url":"\/ani\/endpoint\/100504793\/","endpoint-system":"Muscoskeletal","endpoint-organ":"Bone","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Bone Marrow, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504794,"endpoint-url":"\/ani\/endpoint\/100504794\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Histopathology","endpoint-name":"Lymph Node, Mandibular, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504795,"endpoint-url":"\/ani\/endpoint\/100504795\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Histopathology","endpoint-name":"Lymph Node, Mesenteric, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504796,"endpoint-url":"\/ani\/endpoint\/100504796\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Histopathology","endpoint-name":"Spleen, Extramedullary Hematopoiesis","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 2, 9","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 2, 1000 mg\/kg-day: 9","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504797,"endpoint-url":"\/ani\/endpoint\/100504797\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Histopathology","endpoint-name":"Thymus, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504798,"endpoint-url":"\/ani\/endpoint\/100504798\/","endpoint-system":"Female Reproductive","endpoint-organ":"Mammary Gland","endpoint-effect":"Histopathology","endpoint-name":"Mammary Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504799,"endpoint-url":"\/ani\/endpoint\/100504799\/","endpoint-system":"Muscoskeletal","endpoint-organ":"Bone","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Bone, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504800,"endpoint-url":"\/ani\/endpoint\/100504800\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Histopathology","endpoint-name":"Brain, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504801,"endpoint-url":"\/ani\/endpoint\/100504801\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Lung, Fibrosis","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504802,"endpoint-url":"\/ani\/endpoint\/100504802\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Lung, Bronchiole, Hyperplasia","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504803,"endpoint-url":"\/ani\/endpoint\/100504803\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Lung, Bronchiole, Infiltration Cellular, Histiocyte","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 1","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504804,"endpoint-url":"\/ani\/endpoint\/100504804\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Nose, Olfactory Epithelium, Degeneration","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 1, 3, 9, 9, 6","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 1, 125 mg\/kg-day: 3, 250 mg\/kg-day: 9, 500 mg\/kg-day: 9, 1000 mg\/kg-day: 6","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504805,"endpoint-url":"\/ani\/endpoint\/100504805\/","endpoint-system":"Whole Body","endpoint-organ":"Nose","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Nose, Olfactory Epithelium, Hyperplasia","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 3, 4, 7, 3","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 3, 250 mg\/kg-day: 4, 500 mg\/kg-day: 7, 1000 mg\/kg-day: 3","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504806,"endpoint-url":"\/ani\/endpoint\/100504806\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Nose, Olfactory Epithelium, Inflammation, Suppurative","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 1, 5, 8","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 1, 500 mg\/kg-day: 5, 1000 mg\/kg-day: 8","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504807,"endpoint-url":"\/ani\/endpoint\/100504807\/","endpoint-system":"Respiratory","endpoint-organ":"Trachea","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Trachea, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504808,"endpoint-url":"\/ani\/endpoint\/100504808\/","endpoint-system":"Ocular","endpoint-organ":"Eye","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Eye, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504809,"endpoint-url":"\/ani\/endpoint\/100504809\/","endpoint-system":"Ocular","endpoint-organ":"Eye","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Harderian Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504810,"endpoint-url":"\/ani\/endpoint\/100504810\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Kidney, Cyst, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505129,"endpoint-url":"\/ani\/endpoint\/100505129\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Metabolic Indicators","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Day 93","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"51 \u00b1 19, 43 \u00b1 12, 63 \u00b1 18, 42 \u00b1 17","Doses and responses":"0 mg\/kg-day: 51 \u00b1 19, 20 mg\/kg-day: 43 \u00b1 12, 100 mg\/kg-day: 63 \u00b1 18, 500 mg\/kg-day: 42 \u00b1 17","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504811,"endpoint-url":"\/ani\/endpoint\/100504811\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Kidney, Nephropathy, Chronic Progressive","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"2, 4, 4, 1, 3, 8","Doses and responses":"0 mg\/kg-day: 2, 62.6 mg\/kg-day: 4, 125 mg\/kg-day: 4, 250 mg\/kg-day: 1, 500 mg\/kg-day: 3, 1000 mg\/kg-day: 8","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504812,"endpoint-url":"\/ani\/endpoint\/100504812\/","endpoint-system":"Urinary","endpoint-organ":"Bladder","endpoint-effect":"Non-Neoplastic Lesions","endpoint-name":"Bladder, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504813,"endpoint-url":"\/ani\/endpoint\/100504813\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Esophagus","endpoint-effect":"Neoplasms","endpoint-name":"Esophagus, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504814,"endpoint-url":"\/ani\/endpoint\/100504814\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Large Intestine, Cecum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504815,"endpoint-url":"\/ani\/endpoint\/100504815\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Large Intestine, Colon, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504816,"endpoint-url":"\/ani\/endpoint\/100504816\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Large Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Large Intestine, Rectum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504817,"endpoint-url":"\/ani\/endpoint\/100504817\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Small Intestine, Duodenum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504818,"endpoint-url":"\/ani\/endpoint\/100504818\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Small Intestine, Ileum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504819,"endpoint-url":"\/ani\/endpoint\/100504819\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Small Intestine","endpoint-effect":"Neoplasms","endpoint-name":"Small Intestine, Jejunum, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504820,"endpoint-url":"\/ani\/endpoint\/100504820\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Neoplasms","endpoint-name":"Liver, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504821,"endpoint-url":"\/ani\/endpoint\/100504821\/","endpoint-system":"Cancer","endpoint-organ":"Pancreas","endpoint-effect":"Histopathology","endpoint-name":"Pancreas, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504822,"endpoint-url":"\/ani\/endpoint\/100504822\/","endpoint-system":"Whole Body","endpoint-organ":"Salivary Glands","endpoint-effect":"Neoplasms","endpoint-name":"Salivary Glands, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504823,"endpoint-url":"\/ani\/endpoint\/100504823\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Stomach","endpoint-effect":"Neoplasms","endpoint-name":"Stomach, Forestomach, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , 0, 0","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504824,"endpoint-url":"\/ani\/endpoint\/100504824\/","endpoint-system":"Gastrointestinal","endpoint-organ":"Stomach","endpoint-effect":"Neoplasms","endpoint-name":"Stomach, Glandular, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504825,"endpoint-url":"\/ani\/endpoint\/100504825\/","endpoint-system":"Cardiovascular","endpoint-organ":"Blood Vessels","endpoint-effect":"Neoplasms","endpoint-name":"Blood Vessel, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504826,"endpoint-url":"\/ani\/endpoint\/100504826\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Neoplasms","endpoint-name":"Heart, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504827,"endpoint-url":"\/ani\/endpoint\/100504827\/","endpoint-system":"Cancer","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Cortex, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504828,"endpoint-url":"\/ani\/endpoint\/100504828\/","endpoint-system":"Cancer","endpoint-organ":"Adrenal Gland","endpoint-effect":"Histopathology","endpoint-name":"Adrenal Medulla, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=7-8)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504829,"endpoint-url":"\/ani\/endpoint\/100504829\/","endpoint-system":"Cancer","endpoint-organ":"Parathyroid Gland","endpoint-effect":"Histopathology","endpoint-name":"Parathyroid Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504830,"endpoint-url":"\/ani\/endpoint\/100504830\/","endpoint-system":"Cancer","endpoint-organ":"Thyroid Gland","endpoint-effect":"Histopathology","endpoint-name":"Thyroid Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504831,"endpoint-url":"\/ani\/endpoint\/100504831\/","endpoint-system":"Cancer","endpoint-organ":"Clitoral Gland","endpoint-effect":"Histopathology","endpoint-name":"Clitoral Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504832,"endpoint-url":"\/ani\/endpoint\/100504832\/","endpoint-system":"Cancer","endpoint-organ":"Ovary","endpoint-effect":"Histopathology","endpoint-name":"Ovary, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=1-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504833,"endpoint-url":"\/ani\/endpoint\/100504833\/","endpoint-system":"Cancer","endpoint-organ":"Uterus","endpoint-effect":"Histopathology","endpoint-name":"Uterus, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504834,"endpoint-url":"\/ani\/endpoint\/100504834\/","endpoint-system":"Muscoskeletal","endpoint-organ":"Bone","endpoint-effect":"Neoplasms","endpoint-name":"Bone Marrow, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504835,"endpoint-url":"\/ani\/endpoint\/100504835\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Neoplasms","endpoint-name":"Lymph Node, Mandibular, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504836,"endpoint-url":"\/ani\/endpoint\/100504836\/","endpoint-system":"Immune","endpoint-organ":"Lymph Node","endpoint-effect":"Neoplasms","endpoint-name":"Lymph Node, Mesenteric, Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504837,"endpoint-url":"\/ani\/endpoint\/100504837\/","endpoint-system":"Whole Body","endpoint-organ":"Spleen","endpoint-effect":"Neoplasms","endpoint-name":"Spleen, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504838,"endpoint-url":"\/ani\/endpoint\/100504838\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Neoplasms","endpoint-name":"Thymus, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504839,"endpoint-url":"\/ani\/endpoint\/100504839\/","endpoint-system":"Cancer","endpoint-organ":"Mammary Gland","endpoint-effect":"Histopathology","endpoint-name":"Mammary Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504840,"endpoint-url":"\/ani\/endpoint\/100504840\/","endpoint-system":"Dermal","endpoint-organ":"Skin","endpoint-effect":"Neoplasms","endpoint-name":"Skin, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504841,"endpoint-url":"\/ani\/endpoint\/100504841\/","endpoint-system":"Muscoskeletal","endpoint-organ":"Bone","endpoint-effect":"Neoplasms","endpoint-name":"Bone, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504842,"endpoint-url":"\/ani\/endpoint\/100504842\/","endpoint-system":"Cancer","endpoint-organ":"Brain","endpoint-effect":"Histopathology","endpoint-name":"Brain, Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504843,"endpoint-url":"\/ani\/endpoint\/100504843\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Neoplasms","endpoint-name":"Lung, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504844,"endpoint-url":"\/ani\/endpoint\/100504844\/","endpoint-system":"Respiratory","endpoint-organ":"Nose","endpoint-effect":"Neoplasms","endpoint-name":"Nose, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504845,"endpoint-url":"\/ani\/endpoint\/100504845\/","endpoint-system":"Respiratory","endpoint-organ":"Trachea","endpoint-effect":"Neoplasms","endpoint-name":"Trachea, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504846,"endpoint-url":"\/ani\/endpoint\/100504846\/","endpoint-system":"Ocular","endpoint-organ":"Eye","endpoint-effect":"Neoplasms","endpoint-name":"Eye, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504847,"endpoint-url":"\/ani\/endpoint\/100504847\/","endpoint-system":"Ocular","endpoint-organ":"Eye","endpoint-effect":"Neoplasms","endpoint-name":"Harderian Gland, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504848,"endpoint-url":"\/ani\/endpoint\/100504848\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Neoplasms","endpoint-name":"Kidney, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0, 0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504849,"endpoint-url":"\/ani\/endpoint\/100504849\/","endpoint-system":"Urinary","endpoint-organ":"Urinary Bladder","endpoint-effect":"Neoplasms","endpoint-name":"Bladder, Neoplasms","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, , , , , 0","Doses and responses":"0 mg\/kg-day: 0, 1000 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504850,"endpoint-url":"\/ani\/endpoint\/100504850\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Gland Weight, Right, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.0274 \u00b1 0.0009, 0.0254 \u00b1 0.0008, 0.0261 \u00b1 0.0009, 0.0289 \u00b1 0.00012, 0.0242 \u00b1 0.0017, 0.0276 \u00b1 0.0012","Doses and responses":"0 mg\/kg-day: 0.0274 \u00b1 0.0009, 62.6 mg\/kg-day: 0.0254 \u00b1 0.0008, 125 mg\/kg-day: 0.0261 \u00b1 0.0009, 250 mg\/kg-day: 0.0289 \u00b1 0.00012, 500 mg\/kg-day: 0.0242 \u00b1 0.0017, 1000 mg\/kg-day: 0.0276 \u00b1 0.0012","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504851,"endpoint-url":"\/ani\/endpoint\/100504851\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Terminal Body Weight","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"225.1 \u00b1 2.8, 226.6 \u00b1 2, 229.2 \u00b1 4.4, 228.4 \u00b1 4.7, 222.9 \u00b1 2.9, 220.1 \u00b1 4.3","Doses and responses":"0 mg\/kg-day: 225.1 \u00b1 2.8, 62.6 mg\/kg-day: 226.6 \u00b1 2, 125 mg\/kg-day: 229.2 \u00b1 4.4, 250 mg\/kg-day: 228.4 \u00b1 4.7, 500 mg\/kg-day: 222.9 \u00b1 2.9, 1000 mg\/kg-day: 220.1 \u00b1 4.3","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504852,"endpoint-url":"\/ani\/endpoint\/100504852\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.82 \u00b1 0.01, 0.82 \u00b1 0.02, 0.85 \u00b1 0.02, 0.87 \u00b1 0.02, 0.81 \u00b1 0.02, 0.81 \u00b1 0.02","Doses and responses":"0 mg\/kg-day: 0.82 \u00b1 0.01, 62.6 mg\/kg-day: 0.82 \u00b1 0.02, 125 mg\/kg-day: 0.85 \u00b1 0.02, 250 mg\/kg-day: 0.87 \u00b1 0.02, 500 mg\/kg-day: 0.81 \u00b1 0.02, 1000 mg\/kg-day: 0.81 \u00b1 0.02","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504853,"endpoint-url":"\/ani\/endpoint\/100504853\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Right, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.68 \u00b1 0.02, 0.67 \u00b1 0.01, 0.69 \u00b1 0.01, 0.69 \u00b1 0.01, 0.69 \u00b1 0.01, 0.74 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.68 \u00b1 0.02, 62.6 mg\/kg-day: 0.67 \u00b1 0.01, 125 mg\/kg-day: 0.69 \u00b1 0.01, 250 mg\/kg-day: 0.69 \u00b1 0.01, 500 mg\/kg-day: 0.69 \u00b1 0.01, 1000 mg\/kg-day: 0.74 \u00b1 0.01","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504854,"endpoint-url":"\/ani\/endpoint\/100504854\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"7.24 \u00b1 0.15, 7.4 \u00b1 0.19, 7.53 \u00b1 0.19, 7.84 \u00b1 0.21, 8.26 \u00b1 0.2, 10.44 \u00b1 0.29","Doses and responses":"0 mg\/kg-day: 7.24 \u00b1 0.15, 62.6 mg\/kg-day: 7.4 \u00b1 0.19, 125 mg\/kg-day: 7.53 \u00b1 0.19, 250 mg\/kg-day: 7.84 \u00b1 0.21, 500 mg\/kg-day: 8.26 \u00b1 0.2, 1000 mg\/kg-day: 10.44 \u00b1 0.29","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504855,"endpoint-url":"\/ani\/endpoint\/100504855\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Organ Weight","endpoint-name":"Lung Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"1.6 \u00b1 0.04, 1.43 \u00b1 0.05, 1.61 \u00b1 0.05, 1.55 \u00b1 0.04, 1.38 \u00b1 0.05, 1.47 \u00b1 0.06","Doses and responses":"0 mg\/kg-day: 1.6 \u00b1 0.04, 62.6 mg\/kg-day: 1.43 \u00b1 0.05, 125 mg\/kg-day: 1.61 \u00b1 0.05, 250 mg\/kg-day: 1.55 \u00b1 0.04, 500 mg\/kg-day: 1.38 \u00b1 0.05, 1000 mg\/kg-day: 1.47 \u00b1 0.06","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504856,"endpoint-url":"\/ani\/endpoint\/100504856\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.569 \u00b1 0.014, 0.569 \u00b1 0.022, 0.571 \u00b1 0.036, 0.565 \u00b1 0.016, 0.592 \u00b1 0.011, 0.631 \u00b1 0.017","Doses and responses":"0 mg\/kg-day: 0.569 \u00b1 0.014, 62.6 mg\/kg-day: 0.569 \u00b1 0.022, 125 mg\/kg-day: 0.571 \u00b1 0.036, 250 mg\/kg-day: 0.565 \u00b1 0.016, 500 mg\/kg-day: 0.592 \u00b1 0.011, 1000 mg\/kg-day: 0.631 \u00b1 0.017","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504857,"endpoint-url":"\/ani\/endpoint\/100504857\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.286 \u00b1 0.022, 0.299 \u00b1 0.016, 0.305 \u00b1 0.014, 0.301 \u00b1 0.014, 0.29 \u00b1 0.016, 0.232 \u00b1 0.018","Doses and responses":"0 mg\/kg-day: 0.286 \u00b1 0.022, 62.6 mg\/kg-day: 0.299 \u00b1 0.016, 125 mg\/kg-day: 0.305 \u00b1 0.014, 250 mg\/kg-day: 0.301 \u00b1 0.014, 500 mg\/kg-day: 0.29 \u00b1 0.016, 1000 mg\/kg-day: 0.232 \u00b1 0.018","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504981,"endpoint-url":"\/ani\/endpoint\/100504981\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change, Gestation","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"24.767, 25.93, 23.489, 22.559","Doses and responses":"0 mg\/kg-day: 24.767, 7 mg\/kg-day: 25.93, 35 mg\/kg-day: 23.489, 175 mg\/kg-day: 22.559","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504981,"endpoint-url":"\/ani\/endpoint\/100504981\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change, Gestation","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"24.767, 25.93, 23.489, 22.559","Doses and responses":"0 mg\/mL: 24.767, 1.4 mg\/mL: 25.93, 7 mg\/mL: 23.489, 35 mg\/mL: 22.559","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504858,"endpoint-url":"\/ani\/endpoint\/100504858\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid Gland","endpoint-effect":"Organ Weight","endpoint-name":"Thyroid Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.0229 \u00b1 0.0021, 0.0235 \u00b1 0.0019, 0.0254 \u00b1 0.0018, 0.0252 \u00b1 0.0019, 0.0257 \u00b1 0.0015, 0.0222 \u00b1 0.0015","Doses and responses":"0 mg\/kg-day: 0.0229 \u00b1 0.0021, 62.6 mg\/kg-day: 0.0235 \u00b1 0.0019, 125 mg\/kg-day: 0.0254 \u00b1 0.0018, 250 mg\/kg-day: 0.0252 \u00b1 0.0019, 500 mg\/kg-day: 0.0257 \u00b1 0.0015, 1000 mg\/kg-day: 0.0222 \u00b1 0.0015","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504859,"endpoint-url":"\/ani\/endpoint\/100504859\/","endpoint-system":"Respiratory","endpoint-organ":"Uterus","endpoint-effect":"Organ Weight","endpoint-name":"Uterus Weight, Absolute","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.839 \u00b1 0.118, 0.87 \u00b1 0.163, 0.785 \u00b1 0.105, 0.939 \u00b1 0.1, 0.969 \u00b1 0.093, 0.815 \u00b1 0.199","Doses and responses":"0 mg\/kg-day: 0.839 \u00b1 0.118, 62.6 mg\/kg-day: 0.87 \u00b1 0.163, 125 mg\/kg-day: 0.785 \u00b1 0.105, 250 mg\/kg-day: 0.939 \u00b1 0.1, 500 mg\/kg-day: 0.969 \u00b1 0.093, 1000 mg\/kg-day: 0.815 \u00b1 0.199","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504860,"endpoint-url":"\/ani\/endpoint\/100504860\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Blood Urea Nitrogen","endpoint-name":"Blood Urea Nitrogen (BUN)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"18 \u00b1 0.9, 17.6 \u00b1 0.5, 18 \u00b1 0.5, 16.7 \u00b1 0.5, 18.7 \u00b1 1.4, 21.4 \u00b1 1.4","Doses and responses":"0 mg\/kg-day: 18 \u00b1 0.9, 62.6 mg\/kg-day: 17.6 \u00b1 0.5, 125 mg\/kg-day: 18 \u00b1 0.5, 250 mg\/kg-day: 16.7 \u00b1 0.5, 500 mg\/kg-day: 18.7 \u00b1 1.4, 1000 mg\/kg-day: 21.4 \u00b1 1.4","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504861,"endpoint-url":"\/ani\/endpoint\/100504861\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Creatinine","endpoint-name":"Creatinine (CREAT)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.79 \u00b1 0.03, 0.77 \u00b1 0.02, 0.76 \u00b1 0.02, 0.77 \u00b1 0.02, 0.81 \u00b1 0.01, 0.76 \u00b1 0.02","Doses and responses":"0 mg\/kg-day: 0.79 \u00b1 0.03, 62.6 mg\/kg-day: 0.77 \u00b1 0.02, 125 mg\/kg-day: 0.76 \u00b1 0.02, 250 mg\/kg-day: 0.77 \u00b1 0.02, 500 mg\/kg-day: 0.81 \u00b1 0.01, 1000 mg\/kg-day: 0.76 \u00b1 0.02","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504863,"endpoint-url":"\/ani\/endpoint\/100504863\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"6.37 \u00b1 0.09, 6.4 \u00b1 0.09, 6.43 \u00b1 0.08, 6.32 \u00b1 0.05, 6.31 \u00b1 0.07, 5.93 \u00b1 0.06","Doses and responses":"0 mg\/kg-day: 6.37 \u00b1 0.09, 62.6 mg\/kg-day: 6.4 \u00b1 0.09, 125 mg\/kg-day: 6.43 \u00b1 0.08, 250 mg\/kg-day: 6.32 \u00b1 0.05, 500 mg\/kg-day: 6.31 \u00b1 0.07, 1000 mg\/kg-day: 5.93 \u00b1 0.06","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504864,"endpoint-url":"\/ani\/endpoint\/100504864\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"1.92 \u00b1 0.07, 1.81 \u00b1 0.07, 1.85 \u00b1 0.07, 1.75 \u00b1 0.04, 1.79 \u00b1 0.06, 1.38 \u00b1 0.05","Doses and responses":"0 mg\/kg-day: 1.92 \u00b1 0.07, 62.6 mg\/kg-day: 1.81 \u00b1 0.07, 125 mg\/kg-day: 1.85 \u00b1 0.07, 250 mg\/kg-day: 1.75 \u00b1 0.04, 500 mg\/kg-day: 1.79 \u00b1 0.06, 1000 mg\/kg-day: 1.38 \u00b1 0.05","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504865,"endpoint-url":"\/ani\/endpoint\/100504865\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin\/Globulin Ratio","endpoint-name":"Albumin\/Globulin (A\/G) Ratio","endpoint-observation_time":"Day 29","endpoint-response_units":"Ratio","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"2.35 \u00b1 0.1, 2.57 \u00b1 0.12, 2.51 \u00b1 0.11, 2.63 \u00b1 0.09, 2.55 \u00b1 0.1, 3.34 \u00b1 0.15","Doses and responses":"0 mg\/kg-day: 2.35 \u00b1 0.1, 62.6 mg\/kg-day: 2.57 \u00b1 0.12, 125 mg\/kg-day: 2.51 \u00b1 0.11, 250 mg\/kg-day: 2.63 \u00b1 0.09, 500 mg\/kg-day: 2.55 \u00b1 0.1, 1000 mg\/kg-day: 3.34 \u00b1 0.15","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504866,"endpoint-url":"\/ani\/endpoint\/100504866\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Albumin","endpoint-name":"Albumin (A)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"4.45 \u00b1 0.06, 4.59 \u00b1 0.06, 4.58 \u00b1 0.07, 4.57 \u00b1 0.06, 4.52 \u00b1 0.06, 4.55 \u00b1 0.06","Doses and responses":"0 mg\/kg-day: 4.45 \u00b1 0.06, 62.6 mg\/kg-day: 4.59 \u00b1 0.06, 125 mg\/kg-day: 4.58 \u00b1 0.07, 250 mg\/kg-day: 4.57 \u00b1 0.06, 500 mg\/kg-day: 4.52 \u00b1 0.06, 1000 mg\/kg-day: 4.55 \u00b1 0.06","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504867,"endpoint-url":"\/ani\/endpoint\/100504867\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bilirubin","endpoint-name":"Total Bilirubin (TBILI)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.14 \u00b1 0.008, 0.131 \u00b1 0.007, 0.122 \u00b1 0.006, 0.115 \u00b1 0.005, 0.124 \u00b1 0.006, 0.114 \u00b1 0.004","Doses and responses":"0 mg\/kg-day: 0.14 \u00b1 0.008, 62.6 mg\/kg-day: 0.131 \u00b1 0.007, 125 mg\/kg-day: 0.122 \u00b1 0.006, 250 mg\/kg-day: 0.115 \u00b1 0.005, 500 mg\/kg-day: 0.124 \u00b1 0.006, 1000 mg\/kg-day: 0.114 \u00b1 0.004","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504868,"endpoint-url":"\/ani\/endpoint\/100504868\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bilirubin","endpoint-name":"Direct Bilirubin","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.025 \u00b1 0.002, 0.026 \u00b1 0.001, 0.029 \u00b1 0.002, 0.023 \u00b1 0.002, 0.025 \u00b1 0.002, 0.023 \u00b1 0.002","Doses and responses":"0 mg\/kg-day: 0.025 \u00b1 0.002, 62.6 mg\/kg-day: 0.026 \u00b1 0.001, 125 mg\/kg-day: 0.029 \u00b1 0.002, 250 mg\/kg-day: 0.023 \u00b1 0.002, 500 mg\/kg-day: 0.025 \u00b1 0.002, 1000 mg\/kg-day: 0.023 \u00b1 0.002","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504869,"endpoint-url":"\/ani\/endpoint\/100504869\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bilirubin","endpoint-name":"Indirect Bilirubin","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.114 \u00b1 0.009, 0.105 \u00b1 0.008, 0.093 \u00b1 0.006, 0.092 \u00b1 0.005, 0.099 \u00b1 0.007, 0.091 \u00b1 0.004","Doses and responses":"0 mg\/kg-day: 0.114 \u00b1 0.009, 62.6 mg\/kg-day: 0.105 \u00b1 0.008, 125 mg\/kg-day: 0.093 \u00b1 0.006, 250 mg\/kg-day: 0.092 \u00b1 0.005, 500 mg\/kg-day: 0.099 \u00b1 0.007, 1000 mg\/kg-day: 0.091 \u00b1 0.004","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504870,"endpoint-url":"\/ani\/endpoint\/100504870\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Cholesterol","endpoint-name":"Cholesterol (CHOL)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"105 \u00b1 7, 103.5 \u00b1 4.1, 107.2 \u00b1 5.5, 109.8 \u00b1 5.6, 122 \u00b1 5, 112.9 \u00b1 4.1","Doses and responses":"0 mg\/kg-day: 105 \u00b1 7, 62.6 mg\/kg-day: 103.5 \u00b1 4.1, 125 mg\/kg-day: 107.2 \u00b1 5.5, 250 mg\/kg-day: 109.8 \u00b1 5.6, 500 mg\/kg-day: 122 \u00b1 5, 1000 mg\/kg-day: 112.9 \u00b1 4.1","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504871,"endpoint-url":"\/ani\/endpoint\/100504871\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Triglycerides","endpoint-name":"Triglyceride (TRIG)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"77.2 \u00b1 10.5, 67.2 \u00b1 4.1, 77.3 \u00b1 4.8, 65.9 \u00b1 7.8, 76.9 \u00b1 6.1, 115.5 \u00b1 15.8","Doses and responses":"0 mg\/kg-day: 77.2 \u00b1 10.5, 62.6 mg\/kg-day: 67.2 \u00b1 4.1, 125 mg\/kg-day: 77.3 \u00b1 4.8, 250 mg\/kg-day: 65.9 \u00b1 7.8, 500 mg\/kg-day: 76.9 \u00b1 6.1, 1000 mg\/kg-day: 115.5 \u00b1 15.8","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504872,"endpoint-url":"\/ani\/endpoint\/100504872\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alanine Aminotransferase","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Day 29","endpoint-response_units":"IU\/L","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"39.8 \u00b1 1.17, 44.3 \u00b1 2.28, 45.8 \u00b1 1.81, 43.8 \u00b1 2.5, 53.7 \u00b1 1.86, 57.3 \u00b1 3.06","Doses and responses":"0 mg\/kg-day: 39.8 \u00b1 1.17, 62.6 mg\/kg-day: 44.3 \u00b1 2.28, 125 mg\/kg-day: 45.8 \u00b1 1.81, 250 mg\/kg-day: 43.8 \u00b1 2.5, 500 mg\/kg-day: 53.7 \u00b1 1.86, 1000 mg\/kg-day: 57.3 \u00b1 3.06","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504873,"endpoint-url":"\/ani\/endpoint\/100504873\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Day 29","endpoint-response_units":"IU\/L","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"137.6 \u00b1 4.3, 148.6 \u00b1 8.3, 163.2 \u00b1 6.6, 140.8 \u00b1 5.4, 147.2 \u00b1 6.9, 190.2 \u00b1 9.9","Doses and responses":"0 mg\/kg-day: 137.6 \u00b1 4.3, 62.6 mg\/kg-day: 148.6 \u00b1 8.3, 125 mg\/kg-day: 163.2 \u00b1 6.6, 250 mg\/kg-day: 140.8 \u00b1 5.4, 500 mg\/kg-day: 147.2 \u00b1 6.9, 1000 mg\/kg-day: 190.2 \u00b1 9.9","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504874,"endpoint-url":"\/ani\/endpoint\/100504874\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Alkaline Phosphatase","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Day 29","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"56 \u00b1 3.12, 55.3 \u00b1 2.1, 55.8 \u00b1 1.44, 55.9 \u00b1 1.32, 62.4 \u00b1 1.29, 66 \u00b1 2.86","Doses and responses":"0 mg\/kg-day: 56 \u00b1 3.12, 62.6 mg\/kg-day: 55.3 \u00b1 2.1, 125 mg\/kg-day: 55.8 \u00b1 1.44, 250 mg\/kg-day: 55.9 \u00b1 1.32, 500 mg\/kg-day: 62.4 \u00b1 1.29, 1000 mg\/kg-day: 66 \u00b1 2.86","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504875,"endpoint-url":"\/ani\/endpoint\/100504875\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Creatine Kinase","endpoint-name":"Creatine Kinase (CK)","endpoint-observation_time":"Day 29","endpoint-response_units":"IU\/L","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"68.6 \u00b1 3.4, 64.8 \u00b1 1.6, 69.2 \u00b1 1.9, 62.1 \u00b1 1, 71.5 \u00b1 4, 72.6 \u00b1 3.2","Doses and responses":"0 mg\/kg-day: 68.6 \u00b1 3.4, 62.6 mg\/kg-day: 64.8 \u00b1 1.6, 125 mg\/kg-day: 69.2 \u00b1 1.9, 250 mg\/kg-day: 62.1 \u00b1 1, 500 mg\/kg-day: 71.5 \u00b1 4, 1000 mg\/kg-day: 72.6 \u00b1 3.2","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504876,"endpoint-url":"\/ani\/endpoint\/100504876\/","endpoint-system":"Systemic","endpoint-organ":"Blood","endpoint-effect":"Sorbitol Dehydrogenase","endpoint-name":"Sorbitol Dehydrogenase (SDH)","endpoint-observation_time":"Day 29","endpoint-response_units":"IU\/L","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"4.1 \u00b1 0.4, 3.9 \u00b1 0.5, 4.1 \u00b1 0.3, 4.1 \u00b1 0.3, 4.9 \u00b1 0.5, 4.6 \u00b1 0.3","Doses and responses":"0 mg\/kg-day: 4.1 \u00b1 0.4, 62.6 mg\/kg-day: 3.9 \u00b1 0.5, 125 mg\/kg-day: 4.1 \u00b1 0.3, 250 mg\/kg-day: 4.1 \u00b1 0.3, 500 mg\/kg-day: 4.9 \u00b1 0.5, 1000 mg\/kg-day: 4.6 \u00b1 0.3","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504877,"endpoint-url":"\/ani\/endpoint\/100504877\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bile Acid","endpoint-name":"Bile Salt\/Acids","endpoint-observation_time":"Day 29","endpoint-response_units":"umol\/L","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"10.1 \u00b1 2.5, 13 \u00b1 3.3, 10.9 \u00b1 2.5, 12.4 \u00b1 2.6, 11.8 \u00b1 2.2, 26.5 \u00b1 3.3","Doses and responses":"0 mg\/kg-day: 10.1 \u00b1 2.5, 62.6 mg\/kg-day: 13 \u00b1 3.3, 125 mg\/kg-day: 10.9 \u00b1 2.5, 250 mg\/kg-day: 12.4 \u00b1 2.6, 500 mg\/kg-day: 11.8 \u00b1 2.2, 1000 mg\/kg-day: 26.5 \u00b1 3.3","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504878,"endpoint-url":"\/ani\/endpoint\/100504878\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"45.1 \u00b1 0.5, 44.8 \u00b1 0.3, 45.1 \u00b1 0.4, 42.1 \u00b1 0.3, 41.7 \u00b1 0.7, 37.6 \u00b1 1.2","Doses and responses":"0 mg\/kg-day: 45.1 \u00b1 0.5, 62.6 mg\/kg-day: 44.8 \u00b1 0.3, 125 mg\/kg-day: 45.1 \u00b1 0.4, 250 mg\/kg-day: 42.1 \u00b1 0.3, 500 mg\/kg-day: 41.7 \u00b1 0.7, 1000 mg\/kg-day: 37.6 \u00b1 1.2","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504879,"endpoint-url":"\/ani\/endpoint\/100504879\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hematocrit","endpoint-name":"Manual Hematocrit","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"41 \u00b1 1, 41 \u00b1 1, 41 \u00b1 0, 38 \u00b1 0, 38 \u00b1 1, 35 \u00b1 1","Doses and responses":"0 mg\/kg-day: 41 \u00b1 1, 62.6 mg\/kg-day: 41 \u00b1 1, 125 mg\/kg-day: 41 \u00b1 0, 250 mg\/kg-day: 38 \u00b1 0, 500 mg\/kg-day: 38 \u00b1 1, 1000 mg\/kg-day: 35 \u00b1 1","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504880,"endpoint-url":"\/ani\/endpoint\/100504880\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Hemoglobin","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"14 \u00b1 0.2, 14 \u00b1 0.1, 13.9 \u00b1 0.1, 13.1 \u00b1 0.1, 12.9 \u00b1 0.2, 11.3 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 14 \u00b1 0.2, 62.6 mg\/kg-day: 14 \u00b1 0.1, 125 mg\/kg-day: 13.9 \u00b1 0.1, 250 mg\/kg-day: 13.1 \u00b1 0.1, 500 mg\/kg-day: 12.9 \u00b1 0.2, 1000 mg\/kg-day: 11.3 \u00b1 0.4","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504881,"endpoint-url":"\/ani\/endpoint\/100504881\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Day 29","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"7.66 \u00b1 0.07, 7.61 \u00b1 0.07, 7.78 \u00b1 0.11, 7.1 \u00b1 0.09, 6.88 \u00b1 0.15, 5.64 \u00b1 0.18","Doses and responses":"0 mg\/kg-day: 7.66 \u00b1 0.07, 62.6 mg\/kg-day: 7.61 \u00b1 0.07, 125 mg\/kg-day: 7.78 \u00b1 0.11, 250 mg\/kg-day: 7.1 \u00b1 0.09, 500 mg\/kg-day: 6.88 \u00b1 0.15, 1000 mg\/kg-day: 5.64 \u00b1 0.18","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504882,"endpoint-url":"\/ani\/endpoint\/100504882\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"177.9 \u00b1 17.2, 177.9 \u00b1 11.5, 173.7 \u00b1 14.5, 213.3 \u00b1 17.5, 335.8 \u00b1 28.1, 574.2 \u00b1 38.2","Doses and responses":"0 mg\/kg-day: 177.9 \u00b1 17.2, 62.6 mg\/kg-day: 177.9 \u00b1 11.5, 125 mg\/kg-day: 173.7 \u00b1 14.5, 250 mg\/kg-day: 213.3 \u00b1 17.5, 500 mg\/kg-day: 335.8 \u00b1 28.1, 1000 mg\/kg-day: 574.2 \u00b1 38.2","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504883,"endpoint-url":"\/ani\/endpoint\/100504883\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Day 29","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"58.8 \u00b1 0.2, 58.8 \u00b1 0.5, 57.9 \u00b1 0.6, 59.4 \u00b1 0.6, 60.7 \u00b1 0.6, 66.6 \u00b1 0.7","Doses and responses":"0 mg\/kg-day: 58.8 \u00b1 0.2, 62.6 mg\/kg-day: 58.8 \u00b1 0.5, 125 mg\/kg-day: 57.9 \u00b1 0.6, 250 mg\/kg-day: 59.4 \u00b1 0.6, 500 mg\/kg-day: 60.7 \u00b1 0.6, 1000 mg\/kg-day: 66.6 \u00b1 0.7","Response direction":"\u2191"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504982,"endpoint-url":"\/ani\/endpoint\/100504982\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change, Lactation","endpoint-observation_time":"PND 0-20","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"9.535, 9.419, 8.372, 10.814","Doses and responses":"0 mg\/kg-day: 9.535, 7 mg\/kg-day: 9.419, 35 mg\/kg-day: 8.372, 175 mg\/kg-day: 10.814","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504982,"endpoint-url":"\/ani\/endpoint\/100504982\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change, Lactation","endpoint-observation_time":"PND 0-20","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"9.535, 9.419, 8.372, 10.814","Doses and responses":"0 mg\/mL: 9.535, 1.4 mg\/mL: 9.419, 7 mg\/mL: 8.372, 35 mg\/mL: 10.814","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504884,"endpoint-url":"\/ani\/endpoint\/100504884\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Day 29","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"31.2 \u00b1 0.1, 31.2 \u00b1 0.1, 30.9 \u00b1 0.1, 31.1 \u00b1 0.1, 31 \u00b1 0.1, 30.1 \u00b1 0.1","Doses and responses":"0 mg\/kg-day: 31.2 \u00b1 0.1, 62.6 mg\/kg-day: 31.2 \u00b1 0.1, 125 mg\/kg-day: 30.9 \u00b1 0.1, 250 mg\/kg-day: 31.1 \u00b1 0.1, 500 mg\/kg-day: 31 \u00b1 0.1, 1000 mg\/kg-day: 30.1 \u00b1 0.1","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504885,"endpoint-url":"\/ani\/endpoint\/100504885\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"976 \u00b1 20, 998 \u00b1 39, 1049 \u00b1 28, 985 \u00b1 21, 1021 \u00b1 45, 1151 \u00b1 55","Doses and responses":"0 mg\/kg-day: 976 \u00b1 20, 62.6 mg\/kg-day: 998 \u00b1 39, 125 mg\/kg-day: 1049 \u00b1 28, 250 mg\/kg-day: 985 \u00b1 21, 500 mg\/kg-day: 1021 \u00b1 45, 1000 mg\/kg-day: 1151 \u00b1 55","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504886,"endpoint-url":"\/ani\/endpoint\/100504886\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"8.15 \u00b1 0.39, 8.34 \u00b1 0.44, 8.08 \u00b1 0.59, 8.22 \u00b1 0.58, 7.2 \u00b1 0.36, 9.34 \u00b1 0.62","Doses and responses":"0 mg\/kg-day: 8.15 \u00b1 0.39, 62.6 mg\/kg-day: 8.34 \u00b1 0.44, 125 mg\/kg-day: 8.08 \u00b1 0.59, 250 mg\/kg-day: 8.22 \u00b1 0.58, 500 mg\/kg-day: 7.2 \u00b1 0.36, 1000 mg\/kg-day: 9.34 \u00b1 0.62","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504887,"endpoint-url":"\/ani\/endpoint\/100504887\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Neutrophils","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.83 \u00b1 0.08, 0.86 \u00b1 0.09, 0.82 \u00b1 0.11, 0.87 \u00b1 0.08, 0.87 \u00b1 0.07, 1.8 \u00b1 0.3","Doses and responses":"0 mg\/kg-day: 0.83 \u00b1 0.08, 62.6 mg\/kg-day: 0.86 \u00b1 0.09, 125 mg\/kg-day: 0.82 \u00b1 0.11, 250 mg\/kg-day: 0.87 \u00b1 0.08, 500 mg\/kg-day: 0.87 \u00b1 0.07, 1000 mg\/kg-day: 1.8 \u00b1 0.3","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504888,"endpoint-url":"\/ani\/endpoint\/100504888\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Lymphocyte","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"7.05 \u00b1 0.36, 7.2 \u00b1 0.38, 7 \u00b1 0.51, 7.08 \u00b1 0.51, 6.08 \u00b1 0.31, 7.18 \u00b1 0.51","Doses and responses":"0 mg\/kg-day: 7.05 \u00b1 0.36, 62.6 mg\/kg-day: 7.2 \u00b1 0.38, 125 mg\/kg-day: 7 \u00b1 0.51, 250 mg\/kg-day: 7.08 \u00b1 0.51, 500 mg\/kg-day: 6.08 \u00b1 0.31, 1000 mg\/kg-day: 7.18 \u00b1 0.51","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504889,"endpoint-url":"\/ani\/endpoint\/100504889\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Lymphocyte","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"7.1 \u00b1 0.37, 7.26 \u00b1 0.38, 7.05 \u00b1 0.51, 7.13 \u00b1 0.51, 6.13 \u00b1 0.32, 7.23 \u00b1 0.51","Doses and responses":"0 mg\/kg-day: 7.1 \u00b1 0.37, 62.6 mg\/kg-day: 7.26 \u00b1 0.38, 125 mg\/kg-day: 7.05 \u00b1 0.51, 250 mg\/kg-day: 7.13 \u00b1 0.51, 500 mg\/kg-day: 6.13 \u00b1 0.32, 1000 mg\/kg-day: 7.23 \u00b1 0.51","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504890,"endpoint-url":"\/ani\/endpoint\/100504890\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Monocytes","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.13 \u00b1 0.01, 0.14 \u00b1 0.02, 0.13 \u00b1 0.02, 0.14 \u00b1 0.02, 0.12 \u00b1 0.01, 0.22 \u00b1 0.02","Doses and responses":"0 mg\/kg-day: 0.13 \u00b1 0.01, 62.6 mg\/kg-day: 0.14 \u00b1 0.02, 125 mg\/kg-day: 0.13 \u00b1 0.02, 250 mg\/kg-day: 0.14 \u00b1 0.02, 500 mg\/kg-day: 0.12 \u00b1 0.01, 1000 mg\/kg-day: 0.22 \u00b1 0.02","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504891,"endpoint-url":"\/ani\/endpoint\/100504891\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Basophils","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.01 \u00b1 0, 0.01 \u00b1 0, 0.01 \u00b1 0, 0.01 \u00b1 0, 0.01 \u00b1 0, 0.01 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.01 \u00b1 0, 62.6 mg\/kg-day: 0.01 \u00b1 0, 125 mg\/kg-day: 0.01 \u00b1 0, 250 mg\/kg-day: 0.01 \u00b1 0, 500 mg\/kg-day: 0.01 \u00b1 0, 1000 mg\/kg-day: 0.01 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504892,"endpoint-url":"\/ani\/endpoint\/100504892\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Eosinophils","endpoint-observation_time":"Day 29","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.09 \u00b1 0.01, 0.08 \u00b1 0.01, 0.08 \u00b1 0.01, 0.07 \u00b1 0.01, 0.07 \u00b1 0.01, 0.09 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.09 \u00b1 0.01, 62.6 mg\/kg-day: 0.08 \u00b1 0.01, 125 mg\/kg-day: 0.08 \u00b1 0.01, 250 mg\/kg-day: 0.07 \u00b1 0.01, 500 mg\/kg-day: 0.07 \u00b1 0.01, 1000 mg\/kg-day: 0.09 \u00b1 0.01","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504893,"endpoint-url":"\/ani\/endpoint\/100504893\/","endpoint-system":"Systemic","endpoint-organ":"Plasma","endpoint-effect":"PFHxA Concentration","endpoint-name":"Plasma PFHxA Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/ml","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 128.9 \u00b1 16.1, 291.5 \u00b1 57.6, 475.4 \u00b1 76.9, 1667.6 \u00b1 373.2, 6712 \u00b1 840.5","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 128.9 \u00b1 16.1, 125 mg\/kg-day: 291.5 \u00b1 57.6, 250 mg\/kg-day: 475.4 \u00b1 76.9, 500 mg\/kg-day: 1667.6 \u00b1 373.2, 1000 mg\/kg-day: 6712 \u00b1 840.5","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504894,"endpoint-url":"\/ani\/endpoint\/100504894\/","endpoint-system":"Systemic","endpoint-organ":"Plasma","endpoint-effect":"PFHxA Tissue Concentration","endpoint-name":"Plasma PFHxA Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"uM","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 0.4 \u00b1 0.1, 0.9 \u00b1 0.2, 1.5 \u00b1 0.2, 5.3 \u00b1 1.2, 21.4 \u00b1 2.7","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 0.4 \u00b1 0.1, 125 mg\/kg-day: 0.9 \u00b1 0.2, 250 mg\/kg-day: 1.5 \u00b1 0.2, 500 mg\/kg-day: 5.3 \u00b1 1.2, 1000 mg\/kg-day: 21.4 \u00b1 2.7","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504895,"endpoint-url":"\/ani\/endpoint\/100504895\/","endpoint-system":"Systemic","endpoint-organ":"Plasma","endpoint-effect":"PFHxA Concentration","endpoint-name":"Normalized Plasma PFHxA Concentration","endpoint-observation_time":"Day 29","endpoint-response_units":"uM\/mol\/kg","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0, 2.1 \u00b1 0.3, 2.3 \u00b1 0.5, 1.9 \u00b1 0.3, 3.3 \u00b1 0.7, 6.7 \u00b1 0.8","Doses and responses":"0 mg\/kg-day: 0, 62.6 mg\/kg-day: 2.1 \u00b1 0.3, 125 mg\/kg-day: 2.3 \u00b1 0.5, 250 mg\/kg-day: 1.9 \u00b1 0.3, 500 mg\/kg-day: 3.3 \u00b1 0.7, 1000 mg\/kg-day: 6.7 \u00b1 0.8","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504896,"endpoint-url":"\/ani\/endpoint\/100504896\/","endpoint-system":"Female Reproductive","endpoint-organ":"","endpoint-effect":"Hormone Levels","endpoint-name":"Testosterone","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/mL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.301 \u00b1 0.035, 0.329 \u00b1 0.025, 0.321 \u00b1 0.029, 0.337 \u00b1 0.033, 0.256 \u00b1 0.04, 0.37 \u00b1 0.023","Doses and responses":"0 mg\/kg-day: 0.301 \u00b1 0.035, 62.6 mg\/kg-day: 0.329 \u00b1 0.025, 125 mg\/kg-day: 0.321 \u00b1 0.029, 250 mg\/kg-day: 0.337 \u00b1 0.033, 500 mg\/kg-day: 0.256 \u00b1 0.04, 1000 mg\/kg-day: 0.37 \u00b1 0.023","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504897,"endpoint-url":"\/ani\/endpoint\/100504897\/","endpoint-system":"Endocrine","endpoint-organ":"Serum","endpoint-effect":"Hormone","endpoint-name":"Thyroid Stimulating Hormone (TSH)","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/mL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"17.32 \u00b1 1.404, 14.75 \u00b1 1.173, 15.867 \u00b1 0.897, 15.73 \u00b1 1.06, 24.18 \u00b1 9.455, 15.69 \u00b1 0.774","Doses and responses":"0 mg\/kg-day: 17.32 \u00b1 1.404, 62.6 mg\/kg-day: 14.75 \u00b1 1.173, 125 mg\/kg-day: 15.867 \u00b1 0.897, 250 mg\/kg-day: 15.73 \u00b1 1.06, 500 mg\/kg-day: 24.18 \u00b1 9.455, 1000 mg\/kg-day: 15.69 \u00b1 0.774","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504898,"endpoint-url":"\/ani\/endpoint\/100504898\/","endpoint-system":"Endocrine","endpoint-organ":"Blood","endpoint-effect":"Hormone","endpoint-name":"Triiodothyronine (T3)","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"98.19 \u00b1 8.944, 97.12 \u00b1 6.101, 92.57 \u00b1 6.159, 101.26 \u00b1 7.496, 111.58 \u00b1 6.369, 94.95 \u00b1 7.914","Doses and responses":"0 mg\/kg-day: 98.19 \u00b1 8.944, 62.6 mg\/kg-day: 97.12 \u00b1 6.101, 125 mg\/kg-day: 92.57 \u00b1 6.159, 250 mg\/kg-day: 101.26 \u00b1 7.496, 500 mg\/kg-day: 111.58 \u00b1 6.369, 1000 mg\/kg-day: 94.95 \u00b1 7.914","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504899,"endpoint-url":"\/ani\/endpoint\/100504899\/","endpoint-system":"Endocrine","endpoint-organ":"Blood","endpoint-effect":"Hormone","endpoint-name":"Thyroxine (T4), Free","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"1.97 \u00b1 0.131, 1.955 \u00b1 0.13, 1.888 \u00b1 0.128, 2.139 \u00b1 0.187, 1.896 \u00b1 0.126, 1.605 \u00b1 0.146","Doses and responses":"0 mg\/kg-day: 1.97 \u00b1 0.131, 62.6 mg\/kg-day: 1.955 \u00b1 0.13, 125 mg\/kg-day: 1.888 \u00b1 0.128, 250 mg\/kg-day: 2.139 \u00b1 0.187, 500 mg\/kg-day: 1.896 \u00b1 0.126, 1000 mg\/kg-day: 1.605 \u00b1 0.146","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504900,"endpoint-url":"\/ani\/endpoint\/100504900\/","endpoint-system":"Endocrine","endpoint-organ":"Blood","endpoint-effect":"Hormone","endpoint-name":"Total Thyroxine (T4)","endpoint-observation_time":"Day 29","endpoint-response_units":"ng\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"3.62 \u00b1 0.3, 3.38 \u00b1 0.227, 3.21 \u00b1 0.177, 3.45 \u00b1 0.275, 3.3 \u00b1 0.163, 2.95 \u00b1 0.213","Doses and responses":"0 mg\/kg-day: 3.62 \u00b1 0.3, 62.6 mg\/kg-day: 3.38 \u00b1 0.227, 125 mg\/kg-day: 3.21 \u00b1 0.177, 250 mg\/kg-day: 3.45 \u00b1 0.275, 500 mg\/kg-day: 3.3 \u00b1 0.163, 1000 mg\/kg-day: 2.95 \u00b1 0.213","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504901,"endpoint-url":"\/ani\/endpoint\/100504901\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Estrous Cycle","endpoint-name":"Proestrus Cycle","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"3.5, , 8.1, 4.4, 6.9, ","Doses and responses":"0 mg\/kg-day: 3.5, 125 mg\/kg-day: 8.1, 250 mg\/kg-day: 4.4, 500 mg\/kg-day: 6.9","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504902,"endpoint-url":"\/ani\/endpoint\/100504902\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Estrous Cycle","endpoint-name":"Estrus Cycle","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"29.2, , 36.9, 37.5, 36.9, ","Doses and responses":"0 mg\/kg-day: 29.2, 125 mg\/kg-day: 36.9, 250 mg\/kg-day: 37.5, 500 mg\/kg-day: 36.9","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504903,"endpoint-url":"\/ani\/endpoint\/100504903\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Estrous Cycle","endpoint-name":"Metestrus Cycle","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"2.8, , 0.6, 2.5, 3.8, ","Doses and responses":"0 mg\/kg-day: 2.8, 125 mg\/kg-day: 0.6, 250 mg\/kg-day: 2.5, 500 mg\/kg-day: 3.8","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504904,"endpoint-url":"\/ani\/endpoint\/100504904\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Estrous Cycle","endpoint-name":"Diestrus Cycle","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"61.8, , 53.1, 55, 52.5, ","Doses and responses":"0 mg\/kg-day: 61.8, 125 mg\/kg-day: 53.1, 250 mg\/kg-day: 55, 500 mg\/kg-day: 52.5","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=6-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504905,"endpoint-url":"\/ani\/endpoint\/100504905\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Estrous Cycle","endpoint-name":"Estrous Cycle Length","endpoint-observation_time":"Day 29","endpoint-response_units":"Mean Days","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"7.2 \u00b1 1.45, , 5 \u00b1 0.12, 5 \u00b1 0.13, 4.8 \u00b1 0.2, ","Doses and responses":"0 mg\/kg-day: 7.2 \u00b1 1.45, 125 mg\/kg-day: 5 \u00b1 0.12, 250 mg\/kg-day: 5 \u00b1 0.13, 500 mg\/kg-day: 4.8 \u00b1 0.2","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=6-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504906,"endpoint-url":"\/ani\/endpoint\/100504906\/","endpoint-system":"Female Reproductive","endpoint-organ":"Uterus","endpoint-effect":"Estrous Cycle","endpoint-name":"Estrous Cycle Number","endpoint-observation_time":"Day 29","endpoint-response_units":"Mean Days","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"1.7 \u00b1 0.33, , 1.9 \u00b1 0.11, 1.9 \u00b1 0.1, 1.7 \u00b1 0.15, ","Doses and responses":"0 mg\/kg-day: 1.7 \u00b1 0.33, 125 mg\/kg-day: 1.9 \u00b1 0.11, 250 mg\/kg-day: 1.9 \u00b1 0.1, 500 mg\/kg-day: 1.7 \u00b1 0.15","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504907,"endpoint-url":"\/ani\/endpoint\/100504907\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Day 29","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"18.3 \u00b1 0.1, 18.4 \u00b1 0.2, 17.9 \u00b1 0.2, 18.5 \u00b1 0.2, 18.8 \u00b1 0.2, 20.1 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 18.3 \u00b1 0.1, 62.6 mg\/kg-day: 18.4 \u00b1 0.2, 125 mg\/kg-day: 17.9 \u00b1 0.2, 250 mg\/kg-day: 18.5 \u00b1 0.2, 500 mg\/kg-day: 18.8 \u00b1 0.2, 1000 mg\/kg-day: 20.1 \u00b1 0.2","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504908,"endpoint-url":"\/ani\/endpoint\/100504908\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Gland Weight, Right, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.12 \u00b1 0, 0.11 \u00b1 0, 0.11 \u00b1 0, 0.13 \u00b1 0.01, 0.11 \u00b1 0.01, 0.13 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.12 \u00b1 0, 62.6 mg\/kg-day: 0.11 \u00b1 0, 125 mg\/kg-day: 0.11 \u00b1 0, 250 mg\/kg-day: 0.13 \u00b1 0.01, 500 mg\/kg-day: 0.11 \u00b1 0.01, 1000 mg\/kg-day: 0.13 \u00b1 0.01","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504909,"endpoint-url":"\/ani\/endpoint\/100504909\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"3.66 \u00b1 0.06, 3.64 \u00b1 0.07, 3.7 \u00b1 0.04, 3.82 \u00b1 0.07, 3.62 \u00b1 0.05, 3.7 \u00b1 0.05","Doses and responses":"0 mg\/kg-day: 3.66 \u00b1 0.06, 62.6 mg\/kg-day: 3.64 \u00b1 0.07, 125 mg\/kg-day: 3.7 \u00b1 0.04, 250 mg\/kg-day: 3.82 \u00b1 0.07, 500 mg\/kg-day: 3.62 \u00b1 0.05, 1000 mg\/kg-day: 3.7 \u00b1 0.05","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505046,"endpoint-url":"\/ani\/endpoint\/100505046\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Metabolic Indicators","endpoint-name":"Alkaline Phosphatase (ALP)","endpoint-observation_time":"Day 92","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"81 \u00b1 13, 95 \u00b1 26, 97 \u00b1 20, 211 \u00b1 89","Doses and responses":"0 mg\/kg-day: 81 \u00b1 13, 20 mg\/kg-day: 95 \u00b1 26, 100 mg\/kg-day: 97 \u00b1 20, 500 mg\/kg-day: 211 \u00b1 89","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504910,"endpoint-url":"\/ani\/endpoint\/100504910\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Right, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"3.02 \u00b1 0.07, 2.95 \u00b1 0.05, 3.01 \u00b1 0.06, 3.02 \u00b1 0.06, 3.1 \u00b1 0.08, 3.37 \u00b1 0.05","Doses and responses":"0 mg\/kg-day: 3.02 \u00b1 0.07, 62.6 mg\/kg-day: 2.95 \u00b1 0.05, 125 mg\/kg-day: 3.01 \u00b1 0.06, 250 mg\/kg-day: 3.02 \u00b1 0.06, 500 mg\/kg-day: 3.1 \u00b1 0.08, 1000 mg\/kg-day: 3.37 \u00b1 0.05","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504911,"endpoint-url":"\/ani\/endpoint\/100504911\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"32.18 \u00b1 0.74, 32.63 \u00b1 0.67, 32.82 \u00b1 0.46, 34.37 \u00b1 0.94, 37.06 \u00b1 0.73, 47.45 \u00b1 0.99","Doses and responses":"0 mg\/kg-day: 32.18 \u00b1 0.74, 62.6 mg\/kg-day: 32.63 \u00b1 0.67, 125 mg\/kg-day: 32.82 \u00b1 0.46, 250 mg\/kg-day: 34.37 \u00b1 0.94, 500 mg\/kg-day: 37.06 \u00b1 0.73, 1000 mg\/kg-day: 47.45 \u00b1 0.99","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504912,"endpoint-url":"\/ani\/endpoint\/100504912\/","endpoint-system":"Respiratory","endpoint-organ":"Lung","endpoint-effect":"Organ Weight","endpoint-name":"Lung Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"7.14 \u00b1 0.22, 6.29 \u00b1 0.19, 7.02 \u00b1 0.24, 6.83 \u00b1 0.26, 6.19 \u00b1 0.23, 6.7 \u00b1 0.33","Doses and responses":"0 mg\/kg-day: 7.14 \u00b1 0.22, 62.6 mg\/kg-day: 6.29 \u00b1 0.19, 125 mg\/kg-day: 7.02 \u00b1 0.24, 250 mg\/kg-day: 6.83 \u00b1 0.26, 500 mg\/kg-day: 6.19 \u00b1 0.23, 1000 mg\/kg-day: 6.7 \u00b1 0.33","Response direction":"\u2193"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504913,"endpoint-url":"\/ani\/endpoint\/100504913\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"2.53 \u00b1 0.06, 2.51 \u00b1 0.1, 2.48 \u00b1 0.12, 2.47 \u00b1 0.06, 2.66 \u00b1 0.07, 2.87 \u00b1 0.07","Doses and responses":"0 mg\/kg-day: 2.53 \u00b1 0.06, 62.6 mg\/kg-day: 2.51 \u00b1 0.1, 125 mg\/kg-day: 2.48 \u00b1 0.12, 250 mg\/kg-day: 2.47 \u00b1 0.06, 500 mg\/kg-day: 2.66 \u00b1 0.07, 1000 mg\/kg-day: 2.87 \u00b1 0.07","Response direction":"\u2191"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504914,"endpoint-url":"\/ani\/endpoint\/100504914\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"1.27 \u00b1 0.09, 1.32 \u00b1 0.07, 1.33 \u00b1 0.06, 1.32 \u00b1 0.06, 1.3 \u00b1 0.07, 1.05 \u00b1 0.07","Doses and responses":"0 mg\/kg-day: 1.27 \u00b1 0.09, 62.6 mg\/kg-day: 1.32 \u00b1 0.07, 125 mg\/kg-day: 1.33 \u00b1 0.06, 250 mg\/kg-day: 1.32 \u00b1 0.06, 500 mg\/kg-day: 1.3 \u00b1 0.07, 1000 mg\/kg-day: 1.05 \u00b1 0.07","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504915,"endpoint-url":"\/ani\/endpoint\/100504915\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid Gland","endpoint-effect":"Organ Weight","endpoint-name":"Thyroid Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"0.1 \u00b1 0.01, 0.1 \u00b1 0.01, 0.11 \u00b1 0.01, 0.11 \u00b1 0.01, 0.12 \u00b1 0.01, 0.1 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.1 \u00b1 0.01, 62.6 mg\/kg-day: 0.1 \u00b1 0.01, 125 mg\/kg-day: 0.11 \u00b1 0.01, 250 mg\/kg-day: 0.11 \u00b1 0.01, 500 mg\/kg-day: 0.12 \u00b1 0.01, 1000 mg\/kg-day: 0.1 \u00b1 0.01","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504916,"endpoint-url":"\/ani\/endpoint\/100504916\/","endpoint-system":"Respiratory","endpoint-organ":"Uterus","endpoint-effect":"Organ Weight","endpoint-name":"Uterus Weight, Relative","endpoint-observation_time":"Day 29","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"3.74 \u00b1 0.56, 3.8 \u00b1 0.67, 3.47 \u00b1 0.5, 4.13 \u00b1 0.46, 4.36 \u00b1 0.44, 3.67 \u00b1 0.85","Doses and responses":"0 mg\/kg-day: 3.74 \u00b1 0.56, 62.6 mg\/kg-day: 3.8 \u00b1 0.67, 125 mg\/kg-day: 3.47 \u00b1 0.5, 250 mg\/kg-day: 4.13 \u00b1 0.46, 500 mg\/kg-day: 4.36 \u00b1 0.44, 1000 mg\/kg-day: 3.67 \u00b1 0.85","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504917,"endpoint-url":"\/ani\/endpoint\/100504917\/","endpoint-system":"Endocrine","endpoint-organ":"Pituitary","endpoint-effect":"Histopathology","endpoint-name":"Pituitary Gland, Non-Neoplastic Lesions","endpoint-observation_time":"Day 29","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"10, 0, 0, 0, 0, 10","Doses and responses":"0 mg\/kg-day: 10, 62.6 mg\/kg-day: 0, 125 mg\/kg-day: 0, 250 mg\/kg-day: 0, 500 mg\/kg-day: 0, 1000 mg\/kg-day: 10","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504918,"endpoint-url":"\/ani\/endpoint\/100504918\/","endpoint-system":"","endpoint-organ":"","endpoint-effect":"","endpoint-name":"Endpoint 1","endpoint-observation_time":"","endpoint-response_units":".","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504918,"endpoint-url":"\/ani\/endpoint\/100504918\/","endpoint-system":"","endpoint-organ":"","endpoint-effect":"","endpoint-name":"Endpoint 1","endpoint-observation_time":"","endpoint-response_units":".","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":", , , ","Doses and responses":"","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504919,"endpoint-url":"\/ani\/endpoint\/100504919\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"No. of Pregnancies","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"19, 19, 20, 18","Doses and responses":"0 mg\/kg-day: 19, 100 mg\/kg-day: 19, 350 mg\/kg-day: 20, 500 mg\/kg-day: 18","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504919,"endpoint-url":"\/ani\/endpoint\/100504919\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"No. of Pregnancies","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"19, 19, 20, 18","Doses and responses":"0 mg\/mL: 19, 20 mg\/mL: 19, 70 mg\/mL: 20, 100 mg\/mL: 18","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504920,"endpoint-url":"\/ani\/endpoint\/100504920\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"GD 6-18","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"7.136 \u00b1 0.515, 7.438 \u00b1 0.685, 7.178 \u00b1 0.572, 7.188 \u00b1 0.772","Doses and responses":"0 mg\/kg-day: 7.136 \u00b1 0.515, 100 mg\/kg-day: 7.438 \u00b1 0.685, 350 mg\/kg-day: 7.178 \u00b1 0.572, 500 mg\/kg-day: 7.188 \u00b1 0.772","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504920,"endpoint-url":"\/ani\/endpoint\/100504920\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"GD 6-18","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"7.136 \u00b1 0.515, 7.438 \u00b1 0.685, 7.178 \u00b1 0.572, 7.188 \u00b1 0.772","Doses and responses":"0 mg\/mL: 7.136 \u00b1 0.515, 20 mg\/mL: 7.438 \u00b1 0.685, 70 mg\/mL: 7.178 \u00b1 0.572, 100 mg\/mL: 7.188 \u00b1 0.772","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504921,"endpoint-url":"\/ani\/endpoint\/100504921\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"No. of Litters Delivered","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"19, 19, 19, 17","Doses and responses":"0 mg\/kg-day: 19, 100 mg\/kg-day: 19, 350 mg\/kg-day: 19, 500 mg\/kg-day: 17","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504921,"endpoint-url":"\/ani\/endpoint\/100504921\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"No. of Litters Delivered","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"19, 19, 19, 17","Doses and responses":"0 mg\/mL: 19, 20 mg\/mL: 19, 70 mg\/mL: 19, 100 mg\/mL: 17","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504922,"endpoint-url":"\/ani\/endpoint\/100504922\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Length of Gestation","endpoint-observation_time":"GD 6-18","endpoint-response_units":"d","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"19.9 \u00b1 0.6, 19.9 \u00b1 0.2, 19.9 \u00b1 0.6, 20.2 \u00b1 1.1","Doses and responses":"0 mg\/kg-day: 19.9 \u00b1 0.6, 100 mg\/kg-day: 19.9 \u00b1 0.2, 350 mg\/kg-day: 19.9 \u00b1 0.6, 500 mg\/kg-day: 20.2 \u00b1 1.1","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504922,"endpoint-url":"\/ani\/endpoint\/100504922\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Length of Gestation","endpoint-observation_time":"GD 6-18","endpoint-response_units":"d","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"19.9 \u00b1 0.6, 19.9 \u00b1 0.2, 19.9 \u00b1 0.6, 20.2 \u00b1 1.1","Doses and responses":"0 mg\/mL: 19.9 \u00b1 0.6, 20 mg\/mL: 19.9 \u00b1 0.2, 70 mg\/mL: 19.9 \u00b1 0.6, 100 mg\/mL: 20.2 \u00b1 1.1","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=16-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504923,"endpoint-url":"\/ani\/endpoint\/100504923\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Implantation Sites, Per Delivered Litter","endpoint-observation_time":"GD 6-18","endpoint-response_units":"No.","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"12.9 \u00b1 4.3, 14.5 \u00b1 1.8, 14 \u00b1 3.6, 14 \u00b1 2.4","Doses and responses":"0 mg\/kg-day: 12.9 \u00b1 4.3, 100 mg\/kg-day: 14.5 \u00b1 1.8, 350 mg\/kg-day: 14 \u00b1 3.6, 500 mg\/kg-day: 14 \u00b1 2.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=16-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504923,"endpoint-url":"\/ani\/endpoint\/100504923\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Implantation Sites, Per Delivered Litter","endpoint-observation_time":"GD 6-18","endpoint-response_units":"No.","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"12.9 \u00b1 4.3, 14.5 \u00b1 1.8, 14 \u00b1 3.6, 14 \u00b1 2.4","Doses and responses":"0 mg\/mL: 12.9 \u00b1 4.3, 20 mg\/mL: 14.5 \u00b1 1.8, 70 mg\/mL: 14 \u00b1 3.6, 100 mg\/mL: 14 \u00b1 2.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504924,"endpoint-url":"\/ani\/endpoint\/100504924\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability, Litters with No Stillborn Pups","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"2, 0, 5, 7","Doses and responses":"0 mg\/kg-day: 2, 100 mg\/kg-day: 0, 350 mg\/kg-day: 5, 500 mg\/kg-day: 7","Response direction":"\u2191"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504924,"endpoint-url":"\/ani\/endpoint\/100504924\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability, Litters with No Stillborn Pups","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"2, 0, 5, 7","Doses and responses":"0 mg\/mL: 2, 20 mg\/mL: 0, 70 mg\/mL: 5, 100 mg\/mL: 7","Response direction":"\u2191"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504925,"endpoint-url":"\/ani\/endpoint\/100504925\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 100 mg\/kg-day: 0, 350 mg\/kg-day: 0, 500 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504925,"endpoint-url":"\/ani\/endpoint\/100504925\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"0, 0, 0, 1","Doses and responses":"0 mg\/mL: 0, 20 mg\/mL: 0, 70 mg\/mL: 0, 100 mg\/mL: 1","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504926,"endpoint-url":"\/ani\/endpoint\/100504926\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Gestation index","endpoint-observation_time":"GD 6-18","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"19, 19, 19, 16","Doses and responses":"0 mg\/kg-day: 19, 100 mg\/kg-day: 19, 350 mg\/kg-day: 19, 500 mg\/kg-day: 16","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504926,"endpoint-url":"\/ani\/endpoint\/100504926\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Gestation index","endpoint-observation_time":"GD 6-18","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"19, 19, 19, 16","Doses and responses":"0 mg\/mL: 19, 20 mg\/mL: 19, 70 mg\/mL: 19, 100 mg\/mL: 16","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504927,"endpoint-url":"\/ani\/endpoint\/100504927\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 0-3","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"1, 0, 2, 5","Doses and responses":"0 mg\/kg-day: 1, 100 mg\/kg-day: 0, 350 mg\/kg-day: 2, 500 mg\/kg-day: 5","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504927,"endpoint-url":"\/ani\/endpoint\/100504927\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 0-3","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"1, 0, 2, 5","Doses and responses":"0 mg\/mL: 1, 20 mg\/mL: 0, 70 mg\/mL: 2, 100 mg\/mL: 5","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504928,"endpoint-url":"\/ani\/endpoint\/100504928\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 100 mg\/kg-day: 0, 350 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504928,"endpoint-url":"\/ani\/endpoint\/100504928\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/mL: 0, 20 mg\/mL: 0, 70 mg\/mL: 0, 100 mg\/mL: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504929,"endpoint-url":"\/ani\/endpoint\/100504929\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"43.8 \u00b1 2.8, 43.1 \u00b1 3.1, 45.7 \u00b1 4.4, 40.1 \u00b1 3.6","Doses and responses":"0 mg\/kg-day: 43.8 \u00b1 2.8, 100 mg\/kg-day: 43.1 \u00b1 3.1, 350 mg\/kg-day: 45.7 \u00b1 4.4, 500 mg\/kg-day: 40.1 \u00b1 3.6","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504929,"endpoint-url":"\/ani\/endpoint\/100504929\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"43.8 \u00b1 2.8, 43.1 \u00b1 3.1, 45.7 \u00b1 4.4, 40.1 \u00b1 3.6","Doses and responses":"0 mg\/mL: 43.8 \u00b1 2.8, 20 mg\/mL: 43.1 \u00b1 3.1, 70 mg\/mL: 45.7 \u00b1 4.4, 100 mg\/mL: 40.1 \u00b1 3.6","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504930,"endpoint-url":"\/ani\/endpoint\/100504930\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"3.124 \u00b1 0.252, 3.2 \u00b1 0.34, 3.272 \u00b1 0.321, 2.866 \u00b1 0.157","Doses and responses":"0 mg\/kg-day: 3.124 \u00b1 0.252, 100 mg\/kg-day: 3.2 \u00b1 0.34, 350 mg\/kg-day: 3.272 \u00b1 0.321, 500 mg\/kg-day: 2.866 \u00b1 0.157","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504930,"endpoint-url":"\/ani\/endpoint\/100504930\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"3.124 \u00b1 0.252, 3.2 \u00b1 0.34, 3.272 \u00b1 0.321, 2.866 \u00b1 0.157","Doses and responses":"0 mg\/mL: 3.124 \u00b1 0.252, 20 mg\/mL: 3.2 \u00b1 0.34, 70 mg\/mL: 3.272 \u00b1 0.321, 100 mg\/mL: 2.866 \u00b1 0.157","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504931,"endpoint-url":"\/ani\/endpoint\/100504931\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change, Gestation","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"26.627, 29.277, 26.145, 26.506","Doses and responses":"0 mg\/kg-day: 26.627, 100 mg\/kg-day: 29.277, 350 mg\/kg-day: 26.145, 500 mg\/kg-day: 26.506","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504931,"endpoint-url":"\/ani\/endpoint\/100504931\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change, Gestation","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"26.627, 29.277, 26.145, 26.506","Doses and responses":"0 mg\/mL: 26.627, 20 mg\/mL: 29.277, 70 mg\/mL: 26.145, 100 mg\/mL: 26.506","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504932,"endpoint-url":"\/ani\/endpoint\/100504932\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change, Lactation","endpoint-observation_time":"PND 0-20","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"8.795, 8.313, 9.277, 5.783","Doses and responses":"0 mg\/kg-day: 8.795, 100 mg\/kg-day: 8.313, 350 mg\/kg-day: 9.277, 500 mg\/kg-day: 5.783","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-19)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504932,"endpoint-url":"\/ani\/endpoint\/100504932\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change, Lactation","endpoint-observation_time":"PND 0-20","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 20, 70, 100","Responses":"8.795, 8.313, 9.277, 5.783","Doses and responses":"0 mg\/mL: 8.795, 20 mg\/mL: 8.313, 70 mg\/mL: 9.277, 100 mg\/mL: 5.783","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=177-250)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504933,"endpoint-url":"\/ani\/endpoint\/100504933\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Liveborn","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"217, 250, 232, 150","Doses and responses":"0 mg\/kg-day: 217, 100 mg\/kg-day: 250, 350 mg\/kg-day: 232, 500 mg\/kg-day: 150","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=177-250)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504934,"endpoint-url":"\/ani\/endpoint\/100504934\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Stillborn","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0, 0, 8, 11","Doses and responses":"0 mg\/kg-day: 0, 100 mg\/kg-day: 0, 350 mg\/kg-day: 8, 500 mg\/kg-day: 11","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504935,"endpoint-url":"\/ani\/endpoint\/100504935\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 10","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0.4 \u00b1 1.7, 0.4 \u00b1 1.5, 0.5 \u00b1 2.2, 0 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.4 \u00b1 1.7, 100 mg\/kg-day: 0.4 \u00b1 1.5, 350 mg\/kg-day: 0.5 \u00b1 2.2, 500 mg\/kg-day: 0 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504936,"endpoint-url":"\/ani\/endpoint\/100504936\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 20","endpoint-response_units":".","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11, 10, 9, 10","Doses and responses":"0 mg\/kg-day: 11, 100 mg\/kg-day: 10, 350 mg\/kg-day: 9, 500 mg\/kg-day: 10","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=150-250)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504937,"endpoint-url":"\/ani\/endpoint\/100504937\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0, 0, 3, 21","Doses and responses":"0 mg\/kg-day: 0, 100 mg\/kg-day: 0, 350 mg\/kg-day: 3, 500 mg\/kg-day: 21","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=129-250)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504938,"endpoint-url":"\/ani\/endpoint\/100504938\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 1-4","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"2, 3, 25, 20","Doses and responses":"0 mg\/kg-day: 2, 100 mg\/kg-day: 3, 350 mg\/kg-day: 25, 500 mg\/kg-day: 20","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=109-247)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504939,"endpoint-url":"\/ani\/endpoint\/100504939\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 5-7","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"1, 1, 3, 0","Doses and responses":"0 mg\/kg-day: 1, 100 mg\/kg-day: 1, 350 mg\/kg-day: 3, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=109-244)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504940,"endpoint-url":"\/ani\/endpoint\/100504940\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 8-14","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0, 1, 3, 0","Doses and responses":"0 mg\/kg-day: 0, 100 mg\/kg-day: 1, 350 mg\/kg-day: 3, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=109-215)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504941,"endpoint-url":"\/ani\/endpoint\/100504941\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 15-20","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0, 2, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 100 mg\/kg-day: 2, 350 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505012,"endpoint-url":"\/ani\/endpoint\/100505012\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 12","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"3.5 \u00b1 6.5, 7 \u00b1 10.7, 5.5 \u00b1 6.6, 2.8 \u00b1 4","Doses and responses":"0 mg\/kg-day: 3.5 \u00b1 6.5, 7 mg\/kg-day: 7 \u00b1 10.7, 35 mg\/kg-day: 5.5 \u00b1 6.6, 175 mg\/kg-day: 2.8 \u00b1 4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505012,"endpoint-url":"\/ani\/endpoint\/100505012\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 12","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"3.5 \u00b1 6.5, 7 \u00b1 10.7, 5.5 \u00b1 6.6, 2.8 \u00b1 4","Doses and responses":"0 mg\/mL: 3.5 \u00b1 6.5, 1.4 mg\/mL: 7 \u00b1 10.7, 7 mg\/mL: 5.5 \u00b1 6.6, 35 mg\/mL: 2.8 \u00b1 4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=150-250)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504942,"endpoint-url":"\/ani\/endpoint\/100504942\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 0-4","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"215, 247, 204, 109","Doses and responses":"0 mg\/kg-day: 215, 100 mg\/kg-day: 247, 350 mg\/kg-day: 204, 500 mg\/kg-day: 109","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=150-250)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504943,"endpoint-url":"\/ani\/endpoint\/100504943\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 0-7","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"214, 246, 201, 109","Doses and responses":"0 mg\/kg-day: 214, 100 mg\/kg-day: 246, 350 mg\/kg-day: 201, 500 mg\/kg-day: 109","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=109-217)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504944,"endpoint-url":"\/ani\/endpoint\/100504944\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"214, 213, 198, 109","Doses and responses":"0 mg\/kg-day: 214, 100 mg\/kg-day: 213, 350 mg\/kg-day: 198, 500 mg\/kg-day: 109","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504945,"endpoint-url":"\/ani\/endpoint\/100504945\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Litter Size, Total","endpoint-observation_time":"PND 0","endpoint-response_units":"Mean","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.6 \u00b1 4.2, 13.2 \u00b1 1.6, 12.9 \u00b1 3.8, 11.1 \u00b1 2.4","Doses and responses":"0 mg\/kg-day: 11.6 \u00b1 4.2, 100 mg\/kg-day: 13.2 \u00b1 1.6, 350 mg\/kg-day: 12.9 \u00b1 3.8, 500 mg\/kg-day: 11.1 \u00b1 2.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504946,"endpoint-url":"\/ani\/endpoint\/100504946\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Mean Litter Size, Liveborn","endpoint-observation_time":"PND 0","endpoint-response_units":"Mean","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.4 \u00b1 4.5, 13.2 \u00b1 1.6, 12.2 \u00b1 3.4, 9.4 \u00b1 3.9","Doses and responses":"0 mg\/kg-day: 11.4 \u00b1 4.5, 100 mg\/kg-day: 13.2 \u00b1 1.6, 350 mg\/kg-day: 12.2 \u00b1 3.4, 500 mg\/kg-day: 9.4 \u00b1 3.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504947,"endpoint-url":"\/ani\/endpoint\/100504947\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Stillborn","endpoint-observation_time":"PND 0","endpoint-response_units":"Mean","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0.2 \u00b1 0.7, 0 \u00b1 0, 0.3 \u00b1 0.4, 1 \u00b1 2.2","Doses and responses":"0 mg\/kg-day: 0.2 \u00b1 0.7, 100 mg\/kg-day: 0 \u00b1 0, 350 mg\/kg-day: 0.3 \u00b1 0.4, 500 mg\/kg-day: 1 \u00b1 2.2","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504948,"endpoint-url":"\/ani\/endpoint\/100504948\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Surviving pups\/litter","endpoint-observation_time":"PND 0","endpoint-response_units":"pups\/litter","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.4 \u00b1 4.5, 13.2 \u00b1 1.6, 12.2 \u00b1 3.4, 9.4 \u00b1 3.9","Doses and responses":"0 mg\/kg-day: 11.4 \u00b1 4.5, 100 mg\/kg-day: 13.2 \u00b1 1.6, 350 mg\/kg-day: 12.2 \u00b1 3.4, 500 mg\/kg-day: 9.4 \u00b1 3.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=15-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504949,"endpoint-url":"\/ani\/endpoint\/100504949\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Surviving pups\/litter","endpoint-observation_time":"PND 20","endpoint-response_units":"pups\/litter","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.3 \u00b1 4.6, 12.3 \u00b1 1.2, 10.4 \u00b1 4.9, 6.8 \u00b1 5","Doses and responses":"0 mg\/kg-day: 11.3 \u00b1 4.6, 100 mg\/kg-day: 12.3 \u00b1 1.2, 350 mg\/kg-day: 10.4 \u00b1 4.9, 500 mg\/kg-day: 6.8 \u00b1 5","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504950,"endpoint-url":"\/ani\/endpoint\/100504950\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Percent male pups per Number of pups sexed","endpoint-observation_time":"PND 0","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"45.8 \u00b1 18.6, 48.8 \u00b1 10.5, 55.4 \u00b1 16.2, 44 \u00b1 17.3","Doses and responses":"0 mg\/kg-day: 45.8 \u00b1 18.6, 100 mg\/kg-day: 48.8 \u00b1 10.5, 350 mg\/kg-day: 55.4 \u00b1 16.2, 500 mg\/kg-day: 44 \u00b1 17.3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-18)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504951,"endpoint-url":"\/ani\/endpoint\/100504951\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Percent male pups per Number of pups sexed","endpoint-observation_time":"PND 20","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"48.3 \u00b1 15.3, 52.3 \u00b1 9.7, 56 \u00b1 16.5, 47.6 \u00b1 11.3","Doses and responses":"0 mg\/kg-day: 48.3 \u00b1 15.3, 100 mg\/kg-day: 52.3 \u00b1 9.7, 350 mg\/kg-day: 56 \u00b1 16.5, 500 mg\/kg-day: 47.6 \u00b1 11.3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=13-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504952,"endpoint-url":"\/ani\/endpoint\/100504952\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 0","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.4 \u00b1 4.5, 13.2 \u00b1 1.6, 12 \u00b1 3.5, 9.9 \u00b1 2.9","Doses and responses":"0 mg\/kg-day: 11.4 \u00b1 4.5, 100 mg\/kg-day: 13.2 \u00b1 1.6, 350 mg\/kg-day: 12 \u00b1 3.5, 500 mg\/kg-day: 9.9 \u00b1 2.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504953,"endpoint-url":"\/ani\/endpoint\/100504953\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 4","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.9 \u00b1 3.8, 13 \u00b1 1.7, 12 \u00b1 3.6, 9.9 \u00b1 2","Doses and responses":"0 mg\/kg-day: 11.9 \u00b1 3.8, 100 mg\/kg-day: 13 \u00b1 1.7, 350 mg\/kg-day: 12 \u00b1 3.6, 500 mg\/kg-day: 9.9 \u00b1 2","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504954,"endpoint-url":"\/ani\/endpoint\/100504954\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 7","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.9 \u00b1 3.8, 13 \u00b1 1.7, 12 \u00b1 3.6, 9.9 \u00b1 2","Doses and responses":"0 mg\/kg-day: 11.9 \u00b1 3.8, 100 mg\/kg-day: 13 \u00b1 1.7, 350 mg\/kg-day: 12 \u00b1 3.6, 500 mg\/kg-day: 9.9 \u00b1 2","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-18)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504955,"endpoint-url":"\/ani\/endpoint\/100504955\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 14","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.9 \u00b1 3.8, 12.4 \u00b1 1.4, 11.6 \u00b1 3.4, 9.9 \u00b1 2","Doses and responses":"0 mg\/kg-day: 11.9 \u00b1 3.8, 100 mg\/kg-day: 12.4 \u00b1 1.4, 350 mg\/kg-day: 11.6 \u00b1 3.4, 500 mg\/kg-day: 9.9 \u00b1 2","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-18)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504956,"endpoint-url":"\/ani\/endpoint\/100504956\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 20","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"11.9 \u00b1 3.8, 12.3 \u00b1 1.2, 11.6 \u00b1 3.4, 9.9 \u00b1 2","Doses and responses":"0 mg\/kg-day: 11.9 \u00b1 3.8, 100 mg\/kg-day: 12.3 \u00b1 1.2, 350 mg\/kg-day: 11.6 \u00b1 3.4, 500 mg\/kg-day: 9.9 \u00b1 2","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=13-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504957,"endpoint-url":"\/ani\/endpoint\/100504957\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 0","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"1.6 \u00b1 0.2, 1.5 \u00b1 0.1, 1.4 \u00b1 0.2, 1.4 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 1.6 \u00b1 0.2, 100 mg\/kg-day: 1.5 \u00b1 0.1, 350 mg\/kg-day: 1.4 \u00b1 0.2, 500 mg\/kg-day: 1.4 \u00b1 0.2","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504958,"endpoint-url":"\/ani\/endpoint\/100504958\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 4","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"3 \u00b1 0.4, 2.8 \u00b1 0.2, 2.2 \u00b1 0.6, 2.4 \u00b1 0.5","Doses and responses":"0 mg\/kg-day: 3 \u00b1 0.4, 100 mg\/kg-day: 2.8 \u00b1 0.2, 350 mg\/kg-day: 2.2 \u00b1 0.6, 500 mg\/kg-day: 2.4 \u00b1 0.5","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504959,"endpoint-url":"\/ani\/endpoint\/100504959\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 7","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"4.4 \u00b1 0.8, 4.1 \u00b1 0.4, 3.6 \u00b1 1, 3.9 \u00b1 0.8","Doses and responses":"0 mg\/kg-day: 4.4 \u00b1 0.8, 100 mg\/kg-day: 4.1 \u00b1 0.4, 350 mg\/kg-day: 3.6 \u00b1 1, 500 mg\/kg-day: 3.9 \u00b1 0.8","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-18)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504960,"endpoint-url":"\/ani\/endpoint\/100504960\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 14","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"7.4 \u00b1 1.9, 6.8 \u00b1 0.8, 6.4 \u00b1 1.4, 6.8 \u00b1 1.1","Doses and responses":"0 mg\/kg-day: 7.4 \u00b1 1.9, 100 mg\/kg-day: 6.8 \u00b1 0.8, 350 mg\/kg-day: 6.4 \u00b1 1.4, 500 mg\/kg-day: 6.8 \u00b1 1.1","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504961,"endpoint-url":"\/ani\/endpoint\/100504961\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 11","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"0.4 \u00b1 1.7, 0.4 \u00b1 1.5, 0.5 \u00b1 2.2, 0 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.4 \u00b1 1.7, 100 mg\/kg-day: 0.4 \u00b1 1.5, 350 mg\/kg-day: 0.5 \u00b1 2.2, 500 mg\/kg-day: 0 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504962,"endpoint-url":"\/ani\/endpoint\/100504962\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 12","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"6.8 \u00b1 23.4, 0.8 \u00b1 2.4, 1.1 \u00b1 3, 1.3 \u00b1 4.3","Doses and responses":"0 mg\/kg-day: 6.8 \u00b1 23.4, 100 mg\/kg-day: 0.8 \u00b1 2.4, 350 mg\/kg-day: 1.1 \u00b1 3, 500 mg\/kg-day: 1.3 \u00b1 4.3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504963,"endpoint-url":"\/ani\/endpoint\/100504963\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 13","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"31.7 \u00b1 37.9, 14 \u00b1 19.2, 13.2 \u00b1 25.8, 14.2 \u00b1 29.4","Doses and responses":"0 mg\/kg-day: 31.7 \u00b1 37.9, 100 mg\/kg-day: 14 \u00b1 19.2, 350 mg\/kg-day: 13.2 \u00b1 25.8, 500 mg\/kg-day: 14.2 \u00b1 29.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504964,"endpoint-url":"\/ani\/endpoint\/100504964\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 14","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"82.5 \u00b1 24.4, 68.6 \u00b1 34.9, 42 \u00b1 39.5, 50.2 \u00b1 38","Doses and responses":"0 mg\/kg-day: 82.5 \u00b1 24.4, 100 mg\/kg-day: 68.6 \u00b1 34.9, 350 mg\/kg-day: 42 \u00b1 39.5, 500 mg\/kg-day: 50.2 \u00b1 38","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504965,"endpoint-url":"\/ani\/endpoint\/100504965\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 15","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"98.4 \u00b1 3.7, 88.2 \u00b1 25.6, 76.1 \u00b1 37.8, 73.4 \u00b1 42.4","Doses and responses":"0 mg\/kg-day: 98.4 \u00b1 3.7, 100 mg\/kg-day: 88.2 \u00b1 25.6, 350 mg\/kg-day: 76.1 \u00b1 37.8, 500 mg\/kg-day: 73.4 \u00b1 42.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504966,"endpoint-url":"\/ani\/endpoint\/100504966\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 16","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"100 \u00b1 0, 99.2 \u00b1 3.3, 91.1 \u00b1 22.7, 99.2 \u00b1 2.5","Doses and responses":"0 mg\/kg-day: 100 \u00b1 0, 100 mg\/kg-day: 99.2 \u00b1 3.3, 350 mg\/kg-day: 91.1 \u00b1 22.7, 500 mg\/kg-day: 99.2 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504967,"endpoint-url":"\/ani\/endpoint\/100504967\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 17","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"100, 100, 100, 100","Doses and responses":"0 mg\/kg-day: 100, 100 mg\/kg-day: 100, 350 mg\/kg-day: 100, 500 mg\/kg-day: 100","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 1)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=11-19)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504968,"endpoint-url":"\/ani\/endpoint\/100504968\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening, Criterion Day","endpoint-observation_time":"Critertion Day","endpoint-response_units":"Mean Days","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"13.8 \u00b1 0.7, 14.2 \u00b1 0.8, 14.9 \u00b1 1.1, 14.5 \u00b1 1","Doses and responses":"0 mg\/kg-day: 13.8 \u00b1 0.7, 100 mg\/kg-day: 14.2 \u00b1 0.8, 350 mg\/kg-day: 14.9 \u00b1 1.1, 500 mg\/kg-day: 14.5 \u00b1 1","Response direction":"\u2191"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504969,"endpoint-url":"\/ani\/endpoint\/100504969\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"No. of Pregnancies","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"20, 20, 20, 20","Doses and responses":"0 mg\/kg-day: 20, 7 mg\/kg-day: 20, 35 mg\/kg-day: 20, 175 mg\/kg-day: 20","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504969,"endpoint-url":"\/ani\/endpoint\/100504969\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"No. of Pregnancies","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"20, 20, 20, 20","Doses and responses":"0 mg\/mL: 20, 1.4 mg\/mL: 20, 7 mg\/mL: 20, 35 mg\/mL: 20","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504970,"endpoint-url":"\/ani\/endpoint\/100504970\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"GD 6-18","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"7.172 \u00b1 0.361, 7.418 \u00b1 0.497, 7.97 \u00b1 0.964, 6.906 \u00b1 0.362","Doses and responses":"0 mg\/kg-day: 7.172 \u00b1 0.361, 7 mg\/kg-day: 7.418 \u00b1 0.497, 35 mg\/kg-day: 7.97 \u00b1 0.964, 175 mg\/kg-day: 6.906 \u00b1 0.362","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504970,"endpoint-url":"\/ani\/endpoint\/100504970\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"GD 6-18","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"7.172 \u00b1 0.361, 7.418 \u00b1 0.497, 7.97 \u00b1 0.964, 6.906 \u00b1 0.362","Doses and responses":"0 mg\/mL: 7.172 \u00b1 0.361, 1.4 mg\/mL: 7.418 \u00b1 0.497, 7 mg\/mL: 7.97 \u00b1 0.964, 35 mg\/mL: 6.906 \u00b1 0.362","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504971,"endpoint-url":"\/ani\/endpoint\/100504971\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"No. of Litters Delivered","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"20, 17, 20, 20","Doses and responses":"0 mg\/kg-day: 20, 7 mg\/kg-day: 17, 35 mg\/kg-day: 20, 175 mg\/kg-day: 20","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504971,"endpoint-url":"\/ani\/endpoint\/100504971\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"No. of Litters Delivered","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"20, 17, 20, 20","Doses and responses":"0 mg\/mL: 20, 1.4 mg\/mL: 17, 7 mg\/mL: 20, 35 mg\/mL: 20","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504972,"endpoint-url":"\/ani\/endpoint\/100504972\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Length of Gestation","endpoint-observation_time":"GD 6-18","endpoint-response_units":"d","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"19.6 \u00b1 0.5, 19.8 \u00b1 0.8, 19.8 \u00b1 0.4, 19.7 \u00b1 0.5","Doses and responses":"0 mg\/kg-day: 19.6 \u00b1 0.5, 7 mg\/kg-day: 19.8 \u00b1 0.8, 35 mg\/kg-day: 19.8 \u00b1 0.4, 175 mg\/kg-day: 19.7 \u00b1 0.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504972,"endpoint-url":"\/ani\/endpoint\/100504972\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Length of Gestation","endpoint-observation_time":"GD 6-18","endpoint-response_units":"d","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"19.6 \u00b1 0.5, 19.8 \u00b1 0.8, 19.8 \u00b1 0.4, 19.7 \u00b1 0.5","Doses and responses":"0 mg\/mL: 19.6 \u00b1 0.5, 1.4 mg\/mL: 19.8 \u00b1 0.8, 7 mg\/mL: 19.8 \u00b1 0.4, 35 mg\/mL: 19.7 \u00b1 0.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504973,"endpoint-url":"\/ani\/endpoint\/100504973\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Implantation Sites, Per Delivered Litter","endpoint-observation_time":"GD 6-18","endpoint-response_units":"No.","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"13 \u00b1 2.3, 12.9 \u00b1 2.5, 12.6 \u00b1 1.8, 12.6 \u00b1 1.7","Doses and responses":"0 mg\/kg-day: 13 \u00b1 2.3, 7 mg\/kg-day: 12.9 \u00b1 2.5, 35 mg\/kg-day: 12.6 \u00b1 1.8, 175 mg\/kg-day: 12.6 \u00b1 1.7","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504973,"endpoint-url":"\/ani\/endpoint\/100504973\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Implantation Sites, Per Delivered Litter","endpoint-observation_time":"GD 6-18","endpoint-response_units":"No.","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"13 \u00b1 2.3, 12.9 \u00b1 2.5, 12.6 \u00b1 1.8, 12.6 \u00b1 1.7","Doses and responses":"0 mg\/mL: 13 \u00b1 2.3, 1.4 mg\/mL: 12.9 \u00b1 2.5, 7 mg\/mL: 12.6 \u00b1 1.8, 35 mg\/mL: 12.6 \u00b1 1.7","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504975,"endpoint-url":"\/ani\/endpoint\/100504975\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 7 mg\/kg-day: 0, 35 mg\/kg-day: 0, 175 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504975,"endpoint-url":"\/ani\/endpoint\/100504975\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/mL: 0, 1.4 mg\/mL: 0, 7 mg\/mL: 0, 35 mg\/mL: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504976,"endpoint-url":"\/ani\/endpoint\/100504976\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Gestation index","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"20, 17, 19, 20","Doses and responses":"0 mg\/kg-day: 20, 7 mg\/kg-day: 17, 35 mg\/kg-day: 19, 175 mg\/kg-day: 20","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504976,"endpoint-url":"\/ani\/endpoint\/100504976\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Gestation index","endpoint-observation_time":"GD 6-18","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"20, 17, 19, 20","Doses and responses":"0 mg\/mL: 20, 1.4 mg\/mL: 17, 7 mg\/mL: 19, 35 mg\/mL: 20","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504977,"endpoint-url":"\/ani\/endpoint\/100504977\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 0-3","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0, 1, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 7 mg\/kg-day: 1, 35 mg\/kg-day: 0, 175 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504977,"endpoint-url":"\/ani\/endpoint\/100504977\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 0-3","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0, 1, 0, 0","Doses and responses":"0 mg\/mL: 0, 1.4 mg\/mL: 1, 7 mg\/mL: 0, 35 mg\/mL: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504978,"endpoint-url":"\/ani\/endpoint\/100504978\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 7 mg\/kg-day: 0, 35 mg\/kg-day: 0, 175 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=17-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504978,"endpoint-url":"\/ani\/endpoint\/100504978\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Total Litter Loss","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/mL: 0, 1.4 mg\/mL: 0, 7 mg\/mL: 0, 35 mg\/mL: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504979,"endpoint-url":"\/ani\/endpoint\/100504979\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"3.03 \u00b1 0.208, 3.194 \u00b1 0.356, 3.506 \u00b1 0.517, 3.172 \u00b1 0.345","Doses and responses":"0 mg\/kg-day: 3.03 \u00b1 0.208, 7 mg\/kg-day: 3.194 \u00b1 0.356, 35 mg\/kg-day: 3.506 \u00b1 0.517, 175 mg\/kg-day: 3.172 \u00b1 0.345","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504979,"endpoint-url":"\/ani\/endpoint\/100504979\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"3.03 \u00b1 0.208, 3.194 \u00b1 0.356, 3.506 \u00b1 0.517, 3.172 \u00b1 0.345","Doses and responses":"0 mg\/mL: 3.03 \u00b1 0.208, 1.4 mg\/mL: 3.194 \u00b1 0.356, 7 mg\/mL: 3.506 \u00b1 0.517, 35 mg\/mL: 3.172 \u00b1 0.345","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504980,"endpoint-url":"\/ani\/endpoint\/100504980\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"42.4 \u00b1 4.4, 43.1 \u00b1 5.1, 44 \u00b1 4.4, 45.8 \u00b1 2.8","Doses and responses":"0 mg\/kg-day: 42.4 \u00b1 4.4, 7 mg\/kg-day: 43.1 \u00b1 5.1, 35 mg\/kg-day: 44 \u00b1 4.4, 175 mg\/kg-day: 45.8 \u00b1 2.8","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F0 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"P0 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"reproductive (GD6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504980,"endpoint-url":"\/ani\/endpoint\/100504980\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"GD 6-18","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"42.4 \u00b1 4.4, 43.1 \u00b1 5.1, 44 \u00b1 4.4, 45.8 \u00b1 2.8","Doses and responses":"0 mg\/mL: 42.4 \u00b1 4.4, 1.4 mg\/mL: 43.1 \u00b1 5.1, 7 mg\/mL: 44 \u00b1 4.4, 35 mg\/mL: 45.8 \u00b1 2.8","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=213-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504983,"endpoint-url":"\/ani\/endpoint\/100504983\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Liveborn","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.4 \u00b1 2.5, 12.4 \u00b1 3.4, 12.2 \u00b1 1.7, 11.9 \u00b1 2.5","Doses and responses":"0 mg\/kg-day: 12.4 \u00b1 2.5, 7 mg\/kg-day: 12.4 \u00b1 3.4, 35 mg\/kg-day: 12.2 \u00b1 1.7, 175 mg\/kg-day: 11.9 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=213-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504983,"endpoint-url":"\/ani\/endpoint\/100504983\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Liveborn","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.4 \u00b1 2.5, 12.4 \u00b1 3.4, 12.2 \u00b1 1.7, 11.9 \u00b1 2.5","Doses and responses":"0 mg\/mL: 12.4 \u00b1 2.5, 1.4 mg\/mL: 12.4 \u00b1 3.4, 7 mg\/mL: 12.2 \u00b1 1.7, 35 mg\/mL: 11.9 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=213-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504984,"endpoint-url":"\/ani\/endpoint\/100504984\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Stillborn","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0 \u00b1 0, 0 \u00b1 0, 0 \u00b1 0, 0.2 \u00b1 0.7","Doses and responses":"0 mg\/kg-day: 0 \u00b1 0, 7 mg\/kg-day: 0 \u00b1 0, 35 mg\/kg-day: 0 \u00b1 0, 175 mg\/kg-day: 0.2 \u00b1 0.7","Response direction":"\u2191"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=213-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504984,"endpoint-url":"\/ani\/endpoint\/100504984\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Stillborn","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0 \u00b1 0, 0 \u00b1 0, 0 \u00b1 0, 0.2 \u00b1 0.7","Doses and responses":"0 mg\/mL: 0 \u00b1 0, 1.4 mg\/mL: 0 \u00b1 0, 7 mg\/mL: 0 \u00b1 0, 35 mg\/mL: 0.2 \u00b1 0.7","Response direction":"\u2191"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504985,"endpoint-url":"\/ani\/endpoint\/100504985\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Litter Size, Total","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"249, 213, 232, 241","Doses and responses":"0 mg\/kg-day: 249, 7 mg\/kg-day: 213, 35 mg\/kg-day: 232, 175 mg\/kg-day: 241","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504985,"endpoint-url":"\/ani\/endpoint\/100504985\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Litter Size, Total","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"249, 213, 232, 241","Doses and responses":"0 mg\/mL: 249, 1.4 mg\/mL: 213, 7 mg\/mL: 232, 35 mg\/mL: 241","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=211-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504986,"endpoint-url":"\/ani\/endpoint\/100504986\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0, 0, 0, 4","Doses and responses":"0 mg\/kg-day: 0, 7 mg\/kg-day: 0, 35 mg\/kg-day: 0, 175 mg\/kg-day: 4","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=211-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504986,"endpoint-url":"\/ani\/endpoint\/100504986\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 0","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0, 0, 0, 4","Doses and responses":"0 mg\/mL: 0, 1.4 mg\/mL: 0, 7 mg\/mL: 0, 35 mg\/mL: 4","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=211-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504987,"endpoint-url":"\/ani\/endpoint\/100504987\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 1-4","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"3, 6, 2, 2","Doses and responses":"0 mg\/kg-day: 3, 7 mg\/kg-day: 6, 35 mg\/kg-day: 2, 175 mg\/kg-day: 2","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=211-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504987,"endpoint-url":"\/ani\/endpoint\/100504987\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 1-4","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"3, 6, 2, 2","Doses and responses":"0 mg\/mL: 3, 1.4 mg\/mL: 6, 7 mg\/mL: 2, 35 mg\/mL: 2","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-246)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504988,"endpoint-url":"\/ani\/endpoint\/100504988\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 5-7","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"1, 0, 0, 3","Doses and responses":"0 mg\/kg-day: 1, 7 mg\/kg-day: 0, 35 mg\/kg-day: 0, 175 mg\/kg-day: 3","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-246)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504988,"endpoint-url":"\/ani\/endpoint\/100504988\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 5-7","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"1, 0, 0, 3","Doses and responses":"0 mg\/mL: 1, 1.4 mg\/mL: 0, 7 mg\/mL: 0, 35 mg\/mL: 3","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-245)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504989,"endpoint-url":"\/ani\/endpoint\/100504989\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 8-14","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 7 mg\/kg-day: 0, 35 mg\/kg-day: 0, 175 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-245)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504989,"endpoint-url":"\/ani\/endpoint\/100504989\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 8-14","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/mL: 0, 1.4 mg\/mL: 0, 7 mg\/mL: 0, 35 mg\/mL: 0","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-245)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504990,"endpoint-url":"\/ani\/endpoint\/100504990\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 15-20","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0, 0, 0, 1","Doses and responses":"0 mg\/kg-day: 0, 7 mg\/kg-day: 0, 35 mg\/kg-day: 0, 175 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-245)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504990,"endpoint-url":"\/ani\/endpoint\/100504990\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Mortality","endpoint-name":"Pups found dead, or presumed cannibalized","endpoint-observation_time":"PND 15-20","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0, 0, 0, 1","Doses and responses":"0 mg\/mL: 0, 1.4 mg\/mL: 0, 7 mg\/mL: 0, 35 mg\/mL: 1","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=211-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504991,"endpoint-url":"\/ani\/endpoint\/100504991\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 0-4","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"246, 205, 230, 231","Doses and responses":"0 mg\/kg-day: 246, 7 mg\/kg-day: 205, 35 mg\/kg-day: 230, 175 mg\/kg-day: 231","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=211-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504991,"endpoint-url":"\/ani\/endpoint\/100504991\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 0-4","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"246, 205, 230, 231","Doses and responses":"0 mg\/mL: 246, 1.4 mg\/mL: 205, 7 mg\/mL: 230, 35 mg\/mL: 231","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=211-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504992,"endpoint-url":"\/ani\/endpoint\/100504992\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 0-7","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"245, 205, 230, 228","Doses and responses":"0 mg\/kg-day: 245, 7 mg\/kg-day: 205, 35 mg\/kg-day: 230, 175 mg\/kg-day: 228","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=211-249)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504992,"endpoint-url":"\/ani\/endpoint\/100504992\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 0-7","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"245, 205, 230, 228","Doses and responses":"0 mg\/mL: 245, 1.4 mg\/mL: 205, 7 mg\/mL: 230, 35 mg\/mL: 228","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-246)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504993,"endpoint-url":"\/ani\/endpoint\/100504993\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"245, 205, 230, 227","Doses and responses":"0 mg\/kg-day: 245, 7 mg\/kg-day: 205, 35 mg\/kg-day: 230, 175 mg\/kg-day: 227","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-246)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504993,"endpoint-url":"\/ani\/endpoint\/100504993\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"245, 205, 230, 227","Doses and responses":"0 mg\/mL: 245, 1.4 mg\/mL: 205, 7 mg\/mL: 230, 35 mg\/mL: 227","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504994,"endpoint-url":"\/ani\/endpoint\/100504994\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Stillborn","endpoint-observation_time":"PND 0","endpoint-response_units":"Mean\/Litter","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0 \u00b1 0, 0 \u00b1 0, 0 \u00b1 0, 0.2 \u00b1 0.7","Doses and responses":"0 mg\/kg-day: 0 \u00b1 0, 7 mg\/kg-day: 0 \u00b1 0, 35 mg\/kg-day: 0 \u00b1 0, 175 mg\/kg-day: 0.2 \u00b1 0.7","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504994,"endpoint-url":"\/ani\/endpoint\/100504994\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"No. of Pups, Stillborn","endpoint-observation_time":"PND 0","endpoint-response_units":"Mean\/Litter","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0 \u00b1 0, 0 \u00b1 0, 0 \u00b1 0, 0.2 \u00b1 0.7","Doses and responses":"0 mg\/mL: 0 \u00b1 0, 1.4 mg\/mL: 0 \u00b1 0, 7 mg\/mL: 0 \u00b1 0, 35 mg\/mL: 0.2 \u00b1 0.7","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504995,"endpoint-url":"\/ani\/endpoint\/100504995\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Mean Litter Size, Liveborn","endpoint-observation_time":"PND 0","endpoint-response_units":"Mean\/Litter","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.4 \u00b1 2.5, 12.4 \u00b1 3.4, 12.2 \u00b1 1.7, 11.9 \u00b1 2.5","Doses and responses":"0 mg\/kg-day: 12.4 \u00b1 2.5, 7 mg\/kg-day: 12.4 \u00b1 3.4, 35 mg\/kg-day: 12.2 \u00b1 1.7, 175 mg\/kg-day: 11.9 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504995,"endpoint-url":"\/ani\/endpoint\/100504995\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Fertility","endpoint-name":"Mean Litter Size, Liveborn","endpoint-observation_time":"PND 0","endpoint-response_units":"Mean\/Litter","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.4 \u00b1 2.5, 12.4 \u00b1 3.4, 12.2 \u00b1 1.7, 11.9 \u00b1 2.5","Doses and responses":"0 mg\/mL: 12.4 \u00b1 2.5, 1.4 mg\/mL: 12.4 \u00b1 3.4, 7 mg\/mL: 12.2 \u00b1 1.7, 35 mg\/mL: 11.9 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504996,"endpoint-url":"\/ani\/endpoint\/100504996\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Surviving pups\/litter","endpoint-observation_time":"PND 0","endpoint-response_units":"pups\/litter","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.4 \u00b1 2.5, 12.4 \u00b1 3.4, 12.2 \u00b1 1.7, 11.9 \u00b1 2.5","Doses and responses":"0 mg\/kg-day: 12.4 \u00b1 2.5, 7 mg\/kg-day: 12.4 \u00b1 3.4, 35 mg\/kg-day: 12.2 \u00b1 1.7, 175 mg\/kg-day: 11.9 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504996,"endpoint-url":"\/ani\/endpoint\/100504996\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Surviving pups\/litter","endpoint-observation_time":"PND 0","endpoint-response_units":"pups\/litter","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.4 \u00b1 2.5, 12.4 \u00b1 3.4, 12.2 \u00b1 1.7, 11.9 \u00b1 2.5","Doses and responses":"0 mg\/mL: 12.4 \u00b1 2.5, 1.4 mg\/mL: 12.4 \u00b1 3.4, 7 mg\/mL: 12.2 \u00b1 1.7, 35 mg\/mL: 11.9 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504997,"endpoint-url":"\/ani\/endpoint\/100504997\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Surviving pups\/litter","endpoint-observation_time":"PND 20","endpoint-response_units":"pups\/litter","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.2 \u00b1 2.5, 12 \u00b1 3.5, 12.1 \u00b1 1.7, 11.4 \u00b1 3","Doses and responses":"0 mg\/kg-day: 12.2 \u00b1 2.5, 7 mg\/kg-day: 12 \u00b1 3.5, 35 mg\/kg-day: 12.1 \u00b1 1.7, 175 mg\/kg-day: 11.4 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504997,"endpoint-url":"\/ani\/endpoint\/100504997\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Surviving pups\/litter","endpoint-observation_time":"PND 20","endpoint-response_units":"pups\/litter","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.2 \u00b1 2.5, 12 \u00b1 3.5, 12.1 \u00b1 1.7, 11.4 \u00b1 3","Doses and responses":"0 mg\/mL: 12.2 \u00b1 2.5, 1.4 mg\/mL: 12 \u00b1 3.5, 7 mg\/mL: 12.1 \u00b1 1.7, 35 mg\/mL: 11.4 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504998,"endpoint-url":"\/ani\/endpoint\/100504998\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Percent male pups per Number of pups sexed","endpoint-observation_time":"PND 0","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"52.3 \u00b1 13.2, 54 \u00b1 18.5, 52.4 \u00b1 15, 53.1 \u00b1 12.9","Doses and responses":"0 mg\/kg-day: 52.3 \u00b1 13.2, 7 mg\/kg-day: 54 \u00b1 18.5, 35 mg\/kg-day: 52.4 \u00b1 15, 175 mg\/kg-day: 53.1 \u00b1 12.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504998,"endpoint-url":"\/ani\/endpoint\/100504998\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Percent male pups per Number of pups sexed","endpoint-observation_time":"PND 0","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"52.3 \u00b1 13.2, 54 \u00b1 18.5, 52.4 \u00b1 15, 53.1 \u00b1 12.9","Doses and responses":"0 mg\/mL: 52.3 \u00b1 13.2, 1.4 mg\/mL: 54 \u00b1 18.5, 7 mg\/mL: 52.4 \u00b1 15, 35 mg\/mL: 53.1 \u00b1 12.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504999,"endpoint-url":"\/ani\/endpoint\/100504999\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Percent male pups per Number of pups sexed","endpoint-observation_time":"PND 20","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"52.8 \u00b1 13.2, 51.4 \u00b1 14.7, 52.3 \u00b1 15, 53.2 \u00b1 13.7","Doses and responses":"0 mg\/kg-day: 52.8 \u00b1 13.2, 7 mg\/kg-day: 51.4 \u00b1 14.7, 35 mg\/kg-day: 52.3 \u00b1 15, 175 mg\/kg-day: 53.2 \u00b1 13.7","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100504999,"endpoint-url":"\/ani\/endpoint\/100504999\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Percent male pups per Number of pups sexed","endpoint-observation_time":"PND 20","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"52.8 \u00b1 13.2, 51.4 \u00b1 14.7, 52.3 \u00b1 15, 53.2 \u00b1 13.7","Doses and responses":"0 mg\/mL: 52.8 \u00b1 13.2, 1.4 mg\/mL: 51.4 \u00b1 14.7, 7 mg\/mL: 52.3 \u00b1 15, 35 mg\/mL: 53.2 \u00b1 13.7","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505000,"endpoint-url":"\/ani\/endpoint\/100505000\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 0","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.4 \u00b1 2.5, 12.4 \u00b1 3.4, 12.2 \u00b1 1.7, 11.7 \u00b1 2.8","Doses and responses":"0 mg\/kg-day: 12.4 \u00b1 2.5, 7 mg\/kg-day: 12.4 \u00b1 3.4, 35 mg\/kg-day: 12.2 \u00b1 1.7, 175 mg\/kg-day: 11.7 \u00b1 2.8","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=17-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505000,"endpoint-url":"\/ani\/endpoint\/100505000\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 0","endpoint-response_units":"Litter size","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.4 \u00b1 2.5, 12.4 \u00b1 3.4, 12.2 \u00b1 1.7, 11.7 \u00b1 2.8","Doses and responses":"0 mg\/mL: 12.4 \u00b1 2.5, 1.4 mg\/mL: 12.4 \u00b1 3.4, 7 mg\/mL: 12.2 \u00b1 1.7, 35 mg\/mL: 11.7 \u00b1 2.8","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505001,"endpoint-url":"\/ani\/endpoint\/100505001\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 4","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.3 \u00b1 2.4, 12.8 \u00b1 1.7, 12.1 \u00b1 1.7, 11.6 \u00b1 3","Doses and responses":"0 mg\/kg-day: 12.3 \u00b1 2.4, 7 mg\/kg-day: 12.8 \u00b1 1.7, 35 mg\/kg-day: 12.1 \u00b1 1.7, 175 mg\/kg-day: 11.6 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505001,"endpoint-url":"\/ani\/endpoint\/100505001\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 4","endpoint-response_units":"Litter size","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.3 \u00b1 2.4, 12.8 \u00b1 1.7, 12.1 \u00b1 1.7, 11.6 \u00b1 3","Doses and responses":"0 mg\/mL: 12.3 \u00b1 2.4, 1.4 mg\/mL: 12.8 \u00b1 1.7, 7 mg\/mL: 12.1 \u00b1 1.7, 35 mg\/mL: 11.6 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505002,"endpoint-url":"\/ani\/endpoint\/100505002\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 7","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.3 \u00b1 2.4, 12.8 \u00b1 1.7, 12.1 \u00b1 0.7, 11.4 \u00b1 3","Doses and responses":"0 mg\/kg-day: 12.3 \u00b1 2.4, 7 mg\/kg-day: 12.8 \u00b1 1.7, 35 mg\/kg-day: 12.1 \u00b1 0.7, 175 mg\/kg-day: 11.4 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505002,"endpoint-url":"\/ani\/endpoint\/100505002\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 7","endpoint-response_units":"Litter size","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.3 \u00b1 2.4, 12.8 \u00b1 1.7, 12.1 \u00b1 0.7, 11.4 \u00b1 3","Doses and responses":"0 mg\/mL: 12.3 \u00b1 2.4, 1.4 mg\/mL: 12.8 \u00b1 1.7, 7 mg\/mL: 12.1 \u00b1 0.7, 35 mg\/mL: 11.4 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505003,"endpoint-url":"\/ani\/endpoint\/100505003\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 14","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.3 \u00b1 2.4, 12.8 \u00b1 1.7, 12.1 \u00b1 0.7, 11.4 \u00b1 3","Doses and responses":"0 mg\/kg-day: 12.3 \u00b1 2.4, 7 mg\/kg-day: 12.8 \u00b1 1.7, 35 mg\/kg-day: 12.1 \u00b1 0.7, 175 mg\/kg-day: 11.4 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505003,"endpoint-url":"\/ani\/endpoint\/100505003\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 14","endpoint-response_units":"Litter size","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.3 \u00b1 2.4, 12.8 \u00b1 1.7, 12.1 \u00b1 0.7, 11.4 \u00b1 3","Doses and responses":"0 mg\/mL: 12.3 \u00b1 2.4, 1.4 mg\/mL: 12.8 \u00b1 1.7, 7 mg\/mL: 12.1 \u00b1 0.7, 35 mg\/mL: 11.4 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505004,"endpoint-url":"\/ani\/endpoint\/100505004\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 20","endpoint-response_units":"Litter size","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"12.3 \u00b1 2.4, 12.8 \u00b1 1.7, 12.1 \u00b1 0.7, 11.4 \u00b1 3","Doses and responses":"0 mg\/kg-day: 12.3 \u00b1 2.4, 7 mg\/kg-day: 12.8 \u00b1 1.7, 35 mg\/kg-day: 12.1 \u00b1 0.7, 175 mg\/kg-day: 11.4 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505004,"endpoint-url":"\/ani\/endpoint\/100505004\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Litter Size","endpoint-observation_time":"PND 20","endpoint-response_units":"Litter size","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"12.3 \u00b1 2.4, 12.8 \u00b1 1.7, 12.1 \u00b1 0.7, 11.4 \u00b1 3","Doses and responses":"0 mg\/mL: 12.3 \u00b1 2.4, 1.4 mg\/mL: 12.8 \u00b1 1.7, 7 mg\/mL: 12.1 \u00b1 0.7, 35 mg\/mL: 11.4 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505005,"endpoint-url":"\/ani\/endpoint\/100505005\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 0","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"1.6 \u00b1 0.1, 1.6 \u00b1 0.1, 1.6 \u00b1 0.1, 1.4 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 1.6 \u00b1 0.1, 7 mg\/kg-day: 1.6 \u00b1 0.1, 35 mg\/kg-day: 1.6 \u00b1 0.1, 175 mg\/kg-day: 1.4 \u00b1 0.2","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505005,"endpoint-url":"\/ani\/endpoint\/100505005\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 0","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"1.6 \u00b1 0.1, 1.6 \u00b1 0.1, 1.6 \u00b1 0.1, 1.4 \u00b1 0.2","Doses and responses":"0 mg\/mL: 1.6 \u00b1 0.1, 1.4 mg\/mL: 1.6 \u00b1 0.1, 7 mg\/mL: 1.6 \u00b1 0.1, 35 mg\/mL: 1.4 \u00b1 0.2","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505006,"endpoint-url":"\/ani\/endpoint\/100505006\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 4","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"2.8 \u00b1 0.3, 2.8 \u00b1 0.3, 3 \u00b1 0.3, 2.7 \u00b1 0.5","Doses and responses":"0 mg\/kg-day: 2.8 \u00b1 0.3, 7 mg\/kg-day: 2.8 \u00b1 0.3, 35 mg\/kg-day: 3 \u00b1 0.3, 175 mg\/kg-day: 2.7 \u00b1 0.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505006,"endpoint-url":"\/ani\/endpoint\/100505006\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 4","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"2.8 \u00b1 0.3, 2.8 \u00b1 0.3, 3 \u00b1 0.3, 2.7 \u00b1 0.5","Doses and responses":"0 mg\/mL: 2.8 \u00b1 0.3, 1.4 mg\/mL: 2.8 \u00b1 0.3, 7 mg\/mL: 3 \u00b1 0.3, 35 mg\/mL: 2.7 \u00b1 0.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505007,"endpoint-url":"\/ani\/endpoint\/100505007\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 7","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"4.2 \u00b1 0.6, 4.2 \u00b1 0.4, 4.4 \u00b1 0.4, 4.2 \u00b1 0.6","Doses and responses":"0 mg\/kg-day: 4.2 \u00b1 0.6, 7 mg\/kg-day: 4.2 \u00b1 0.4, 35 mg\/kg-day: 4.4 \u00b1 0.4, 175 mg\/kg-day: 4.2 \u00b1 0.6","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505007,"endpoint-url":"\/ani\/endpoint\/100505007\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 7","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"4.2 \u00b1 0.6, 4.2 \u00b1 0.4, 4.4 \u00b1 0.4, 4.2 \u00b1 0.6","Doses and responses":"0 mg\/mL: 4.2 \u00b1 0.6, 1.4 mg\/mL: 4.2 \u00b1 0.4, 7 mg\/mL: 4.4 \u00b1 0.4, 35 mg\/mL: 4.2 \u00b1 0.6","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505008,"endpoint-url":"\/ani\/endpoint\/100505008\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 14","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"6.8 \u00b1 1.2, 6.7 \u00b1 0.6, 7 \u00b1 0.7, 6.8 \u00b1 0.9","Doses and responses":"0 mg\/kg-day: 6.8 \u00b1 1.2, 7 mg\/kg-day: 6.7 \u00b1 0.6, 35 mg\/kg-day: 7 \u00b1 0.7, 175 mg\/kg-day: 6.8 \u00b1 0.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505008,"endpoint-url":"\/ani\/endpoint\/100505008\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 14","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"6.8 \u00b1 1.2, 6.7 \u00b1 0.6, 7 \u00b1 0.7, 6.8 \u00b1 0.9","Doses and responses":"0 mg\/mL: 6.8 \u00b1 1.2, 1.4 mg\/mL: 6.7 \u00b1 0.6, 7 mg\/mL: 7 \u00b1 0.7, 35 mg\/mL: 6.8 \u00b1 0.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505009,"endpoint-url":"\/ani\/endpoint\/100505009\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 20","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"10.2 \u00b1 1.8, 10 \u00b1 1.2, 10.8 \u00b1 1.3, 10.4 \u00b1 1.4","Doses and responses":"0 mg\/kg-day: 10.2 \u00b1 1.8, 7 mg\/kg-day: 10 \u00b1 1.2, 35 mg\/kg-day: 10.8 \u00b1 1.3, 175 mg\/kg-day: 10.4 \u00b1 1.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505009,"endpoint-url":"\/ani\/endpoint\/100505009\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 20","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"10.2 \u00b1 1.8, 10 \u00b1 1.2, 10.8 \u00b1 1.3, 10.4 \u00b1 1.4","Doses and responses":"0 mg\/mL: 10.2 \u00b1 1.8, 1.4 mg\/mL: 10 \u00b1 1.2, 7 mg\/mL: 10.8 \u00b1 1.3, 35 mg\/mL: 10.4 \u00b1 1.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505010,"endpoint-url":"\/ani\/endpoint\/100505010\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 10","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0.4 \u00b1 1.7, 2.1 \u00b1 4.8, 1 \u00b1 2.9, 1.3 \u00b1 3.2","Doses and responses":"0 mg\/kg-day: 0.4 \u00b1 1.7, 7 mg\/kg-day: 2.1 \u00b1 4.8, 35 mg\/kg-day: 1 \u00b1 2.9, 175 mg\/kg-day: 1.3 \u00b1 3.2","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505010,"endpoint-url":"\/ani\/endpoint\/100505010\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 10","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0.4 \u00b1 1.7, 2.1 \u00b1 4.8, 1 \u00b1 2.9, 1.3 \u00b1 3.2","Doses and responses":"0 mg\/mL: 0.4 \u00b1 1.7, 1.4 mg\/mL: 2.1 \u00b1 4.8, 7 mg\/mL: 1 \u00b1 2.9, 35 mg\/mL: 1.3 \u00b1 3.2","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505011,"endpoint-url":"\/ani\/endpoint\/100505011\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 11","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"0.4 \u00b1 1.7, 2.2 \u00b1 4.1, 1.7 \u00b1 3.5, 1.2 \u00b1 3.1","Doses and responses":"0 mg\/kg-day: 0.4 \u00b1 1.7, 7 mg\/kg-day: 2.2 \u00b1 4.1, 35 mg\/kg-day: 1.7 \u00b1 3.5, 175 mg\/kg-day: 1.2 \u00b1 3.1","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505011,"endpoint-url":"\/ani\/endpoint\/100505011\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 11","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"0.4 \u00b1 1.7, 2.2 \u00b1 4.1, 1.7 \u00b1 3.5, 1.2 \u00b1 3.1","Doses and responses":"0 mg\/mL: 0.4 \u00b1 1.7, 1.4 mg\/mL: 2.2 \u00b1 4.1, 7 mg\/mL: 1.7 \u00b1 3.5, 35 mg\/mL: 1.2 \u00b1 3.1","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505013,"endpoint-url":"\/ani\/endpoint\/100505013\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 13","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"37.6 \u00b1 34.1, 35.3 \u00b1 23.5, 50.4 \u00b1 35.5, 29.7 \u00b1 25.6","Doses and responses":"0 mg\/kg-day: 37.6 \u00b1 34.1, 7 mg\/kg-day: 35.3 \u00b1 23.5, 35 mg\/kg-day: 50.4 \u00b1 35.5, 175 mg\/kg-day: 29.7 \u00b1 25.6","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505013,"endpoint-url":"\/ani\/endpoint\/100505013\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 13","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"37.6 \u00b1 34.1, 35.3 \u00b1 23.5, 50.4 \u00b1 35.5, 29.7 \u00b1 25.6","Doses and responses":"0 mg\/mL: 37.6 \u00b1 34.1, 1.4 mg\/mL: 35.3 \u00b1 23.5, 7 mg\/mL: 50.4 \u00b1 35.5, 35 mg\/mL: 29.7 \u00b1 25.6","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505014,"endpoint-url":"\/ani\/endpoint\/100505014\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 14","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"85.5 \u00b1 22.7, 87.6 \u00b1 24.4, 89.3 \u00b1 22.7, 78.9 \u00b1 27.4","Doses and responses":"0 mg\/kg-day: 85.5 \u00b1 22.7, 7 mg\/kg-day: 87.6 \u00b1 24.4, 35 mg\/kg-day: 89.3 \u00b1 22.7, 175 mg\/kg-day: 78.9 \u00b1 27.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505014,"endpoint-url":"\/ani\/endpoint\/100505014\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 14","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"85.5 \u00b1 22.7, 87.6 \u00b1 24.4, 89.3 \u00b1 22.7, 78.9 \u00b1 27.4","Doses and responses":"0 mg\/mL: 85.5 \u00b1 22.7, 1.4 mg\/mL: 87.6 \u00b1 24.4, 7 mg\/mL: 89.3 \u00b1 22.7, 35 mg\/mL: 78.9 \u00b1 27.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505015,"endpoint-url":"\/ani\/endpoint\/100505015\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 15","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"99.6 \u00b1 1.6, 99.2 \u00b1 3.3, 99.6 \u00b1 1.9, 94.2 \u00b1 22.3","Doses and responses":"0 mg\/kg-day: 99.6 \u00b1 1.6, 7 mg\/kg-day: 99.2 \u00b1 3.3, 35 mg\/kg-day: 99.6 \u00b1 1.9, 175 mg\/kg-day: 94.2 \u00b1 22.3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505015,"endpoint-url":"\/ani\/endpoint\/100505015\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 15","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"99.6 \u00b1 1.6, 99.2 \u00b1 3.3, 99.6 \u00b1 1.9, 94.2 \u00b1 22.3","Doses and responses":"0 mg\/mL: 99.6 \u00b1 1.6, 1.4 mg\/mL: 99.2 \u00b1 3.3, 7 mg\/mL: 99.6 \u00b1 1.9, 35 mg\/mL: 94.2 \u00b1 22.3","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505016,"endpoint-url":"\/ani\/endpoint\/100505016\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 16","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"100 \u00b1 0, 100 \u00b1 0, 100 \u00b1 0, 100 \u00b1 0","Doses and responses":"0 mg\/kg-day: 100 \u00b1 0, 7 mg\/kg-day: 100 \u00b1 0, 35 mg\/kg-day: 100 \u00b1 0, 175 mg\/kg-day: 100 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505016,"endpoint-url":"\/ani\/endpoint\/100505016\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening","endpoint-observation_time":"PND 16","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"100 \u00b1 0, 100 \u00b1 0, 100 \u00b1 0, 100 \u00b1 0","Doses and responses":"0 mg\/mL: 100 \u00b1 0, 1.4 mg\/mL: 100 \u00b1 0, 7 mg\/mL: 100 \u00b1 0, 35 mg\/mL: 100 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505017,"endpoint-url":"\/ani\/endpoint\/100505017\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening, Criterion Day","endpoint-observation_time":"6-18 PND","endpoint-response_units":"Day","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"13.8 \u00b1 0.7, 13.8 \u00b1 0.6, 13.4 \u00b1 0.6, 14 \u00b1 0.8","Doses and responses":"0 mg\/kg-day: 13.8 \u00b1 0.7, 7 mg\/kg-day: 13.8 \u00b1 0.6, 35 mg\/kg-day: 13.4 \u00b1 0.6, 175 mg\/kg-day: 14 \u00b1 0.8","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=16-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505017,"endpoint-url":"\/ani\/endpoint\/100505017\/","endpoint-system":"Developmental","endpoint-organ":"Eye","endpoint-effect":"Developmental Milestone","endpoint-name":"Eye Opening, Criterion Day","endpoint-observation_time":"6-18 PND","endpoint-response_units":"Day","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"13.8 \u00b1 0.7, 13.8 \u00b1 0.6, 13.4 \u00b1 0.6, 14 \u00b1 0.8","Doses and responses":"0 mg\/mL: 13.8 \u00b1 0.7, 1.4 mg\/mL: 13.8 \u00b1 0.6, 7 mg\/mL: 13.4 \u00b1 0.6, 35 mg\/mL: 14 \u00b1 0.8","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-246)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505018,"endpoint-url":"\/ani\/endpoint\/100505018\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"245, 205, 230, 227","Doses and responses":"0 mg\/kg-day: 245, 7 mg\/kg-day: 205, 35 mg\/kg-day: 230, 175 mg\/kg-day: 227","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Combined Crl:CD1 Mice (Phase 2)","animal_group-sex":"Combined","animal description (with n)":"F1 Mouse, CD-1 (\u2642\u2640, N=205-246)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505018,"endpoint-url":"\/ani\/endpoint\/100505018\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Offspring Viability","endpoint-name":"Viability Index","endpoint-observation_time":"PND 4-20","endpoint-response_units":"N","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"245, 205, 230, 227","Doses and responses":"0 mg\/mL: 245, 1.4 mg\/mL: 205, 7 mg\/mL: 230, 35 mg\/mL: 227","Response direction":"?"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 1)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=18-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505019,"endpoint-url":"\/ani\/endpoint\/100505019\/","endpoint-system":"Male Reproductive","endpoint-organ":"Prepuce","endpoint-effect":"Developmental Milestone","endpoint-name":"Preputial Separation","endpoint-observation_time":"PND 26-41","endpoint-response_units":"days","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"29.4 \u00b1 1.9, 29.8 \u00b1 2.2, 29.3 \u00b1 2.3, 29.4 \u00b1 1.7","Doses and responses":"0 mg\/kg-day: 29.4 \u00b1 1.9, 100 mg\/kg-day: 29.8 \u00b1 2.2, 350 mg\/kg-day: 29.3 \u00b1 2.3, 500 mg\/kg-day: 29.4 \u00b1 1.7","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 1)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=18-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505020,"endpoint-url":"\/ani\/endpoint\/100505020\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Preputial Separation","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"24.49 \u00b1 3.03, 23.22 \u00b1 2.11, 22.4 \u00b1 2.27, 22.8 \u00b1 2.68","Doses and responses":"0 mg\/kg-day: 24.49 \u00b1 3.03, 100 mg\/kg-day: 23.22 \u00b1 2.11, 350 mg\/kg-day: 22.4 \u00b1 2.27, 500 mg\/kg-day: 22.8 \u00b1 2.68","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 1)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505021,"endpoint-url":"\/ani\/endpoint\/100505021\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"30.9 \u00b1 2.3, 31.3 \u00b1 3.4, 30.9 \u00b1 1.1, 30.1 \u00b1 2","Doses and responses":"0 mg\/kg-day: 30.9 \u00b1 2.3, 100 mg\/kg-day: 31.3 \u00b1 3.4, 350 mg\/kg-day: 30.9 \u00b1 1.1, 500 mg\/kg-day: 30.1 \u00b1 2","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 1)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505022,"endpoint-url":"\/ani\/endpoint\/100505022\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"2.11 \u00b1 0.14, 2.121 \u00b1 0.254, 2.22 \u00b1 0.126, 1.93 \u00b1 0.155","Doses and responses":"0 mg\/kg-day: 2.11 \u00b1 0.14, 100 mg\/kg-day: 2.121 \u00b1 0.254, 350 mg\/kg-day: 2.22 \u00b1 0.126, 500 mg\/kg-day: 1.93 \u00b1 0.155","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 1)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505023,"endpoint-url":"\/ani\/endpoint\/100505023\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"PND 21-41","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"6.83 \u00b1 0.341, 6.782 \u00b1 0.277, 7.192 \u00b1 0.251, 6.412 \u00b1 0.267","Doses and responses":"0 mg\/kg-day: 6.83 \u00b1 0.341, 100 mg\/kg-day: 6.782 \u00b1 0.277, 350 mg\/kg-day: 7.192 \u00b1 0.251, 500 mg\/kg-day: 6.412 \u00b1 0.267","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 1)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=18-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505024,"endpoint-url":"\/ani\/endpoint\/100505024\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"20, 20.5, 20.5, 20.5","Doses and responses":"0 mg\/kg-day: 20, 100 mg\/kg-day: 20.5, 350 mg\/kg-day: 20.5, 500 mg\/kg-day: 20.5","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=18-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505025,"endpoint-url":"\/ani\/endpoint\/100505025\/","endpoint-system":"Female Reproductive","endpoint-organ":"Vagina","endpoint-effect":"Sexual Maturation","endpoint-name":"Vaginal Patency","endpoint-observation_time":"PND 20-41","endpoint-response_units":"days","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"26.8 \u00b1 2, 27.5 \u00b1 1.1, 27.6 \u00b1 2, 27.5 \u00b1 2.1","Doses and responses":"0 mg\/kg-day: 26.8 \u00b1 2, 100 mg\/kg-day: 27.5 \u00b1 1.1, 350 mg\/kg-day: 27.6 \u00b1 2, 500 mg\/kg-day: 27.5 \u00b1 2.1","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=18-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505026,"endpoint-url":"\/ani\/endpoint\/100505026\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Vaginal Patency","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"18.08 \u00b1 1.44, 17.38 \u00b1 2.82, 16.31 \u00b1 1.7, 17.57 \u00b1 2.2","Doses and responses":"0 mg\/kg-day: 18.08 \u00b1 1.44, 100 mg\/kg-day: 17.38 \u00b1 2.82, 350 mg\/kg-day: 16.31 \u00b1 1.7, 500 mg\/kg-day: 17.57 \u00b1 2.2","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505027,"endpoint-url":"\/ani\/endpoint\/100505027\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"25.4 \u00b1 1.4, 26.1 \u00b1 1.9, 22.8 \u00b1 1.2, 25.4 \u00b1 1.4","Doses and responses":"0 mg\/kg-day: 25.4 \u00b1 1.4, 100 mg\/kg-day: 26.1 \u00b1 1.9, 350 mg\/kg-day: 22.8 \u00b1 1.2, 500 mg\/kg-day: 25.4 \u00b1 1.4","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505028,"endpoint-url":"\/ani\/endpoint\/100505028\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"PND 21-41","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"6.056 \u00b1 0.232, 5.928 \u00b1 0.239, 6.392 \u00b1 0.522, 6.18 \u00b1 0.395","Doses and responses":"0 mg\/kg-day: 6.056 \u00b1 0.232, 100 mg\/kg-day: 5.928 \u00b1 0.239, 350 mg\/kg-day: 6.392 \u00b1 0.522, 500 mg\/kg-day: 6.18 \u00b1 0.395","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505029,"endpoint-url":"\/ani\/endpoint\/100505029\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"1.536 \u00b1 0.104, 1.549 \u00b1 0.168, 1.457 \u00b1 0.174, 1.569 \u00b1 0.08","Doses and responses":"0 mg\/kg-day: 1.536 \u00b1 0.104, 100 mg\/kg-day: 1.549 \u00b1 0.168, 350 mg\/kg-day: 1.457 \u00b1 0.174, 500 mg\/kg-day: 1.569 \u00b1 0.08","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 1)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=18-20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505030,"endpoint-url":"\/ani\/endpoint\/100505030\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 100, 350, 500","Responses":"13.839, 14.546, 13.636, 14.041","Doses and responses":"0 mg\/kg-day: 13.839, 100 mg\/kg-day: 14.546, 350 mg\/kg-day: 13.636, 500 mg\/kg-day: 14.041","Response direction":"\u2191"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505031,"endpoint-url":"\/ani\/endpoint\/100505031\/","endpoint-system":"Male Reproductive","endpoint-organ":"Prepuce","endpoint-effect":"Developmental Milestone","endpoint-name":"Preputial Separation","endpoint-observation_time":"PND 26-41","endpoint-response_units":"days","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"29.2 \u00b1 1, 29 \u00b1 1.1, 28 \u00b1 1, 28.4 \u00b1 1","Doses and responses":"0 mg\/kg-day: 29.2 \u00b1 1, 7 mg\/kg-day: 29 \u00b1 1.1, 35 mg\/kg-day: 28 \u00b1 1, 175 mg\/kg-day: 28.4 \u00b1 1","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505031,"endpoint-url":"\/ani\/endpoint\/100505031\/","endpoint-system":"Male Reproductive","endpoint-organ":"Prepuce","endpoint-effect":"Developmental Milestone","endpoint-name":"Preputial Separation","endpoint-observation_time":"PND 26-41","endpoint-response_units":"days","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"29.2 \u00b1 1, 29 \u00b1 1.1, 28 \u00b1 1, 28.4 \u00b1 1","Doses and responses":"0 mg\/mL: 29.2 \u00b1 1, 1.4 mg\/mL: 29 \u00b1 1.1, 7 mg\/mL: 28 \u00b1 1, 35 mg\/mL: 28.4 \u00b1 1","Response direction":"\u2193"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505032,"endpoint-url":"\/ani\/endpoint\/100505032\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Preputial Separation","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"23.6 \u00b1 2.2, 23.9 \u00b1 2.1, 22.8 \u00b1 2.3, 22.6 \u00b1 2.4","Doses and responses":"0 mg\/kg-day: 23.6 \u00b1 2.2, 7 mg\/kg-day: 23.9 \u00b1 2.1, 35 mg\/kg-day: 22.8 \u00b1 2.3, 175 mg\/kg-day: 22.6 \u00b1 2.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505032,"endpoint-url":"\/ani\/endpoint\/100505032\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Preputial Separation","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"23.6 \u00b1 2.2, 23.9 \u00b1 2.1, 22.8 \u00b1 2.3, 22.6 \u00b1 2.4","Doses and responses":"0 mg\/mL: 23.6 \u00b1 2.2, 1.4 mg\/mL: 23.9 \u00b1 2.1, 7 mg\/mL: 22.8 \u00b1 2.3, 35 mg\/mL: 22.6 \u00b1 2.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505033,"endpoint-url":"\/ani\/endpoint\/100505033\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"31.8 \u00b1 1.7, 32 \u00b1 0.7, 31.4 \u00b1 2.1, 31.4 \u00b1 1.4","Doses and responses":"0 mg\/kg-day: 31.8 \u00b1 1.7, 7 mg\/kg-day: 32 \u00b1 0.7, 35 mg\/kg-day: 31.4 \u00b1 2.1, 175 mg\/kg-day: 31.4 \u00b1 1.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505033,"endpoint-url":"\/ani\/endpoint\/100505033\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"31.8 \u00b1 1.7, 32 \u00b1 0.7, 31.4 \u00b1 2.1, 31.4 \u00b1 1.4","Doses and responses":"0 mg\/mL: 31.8 \u00b1 1.7, 1.4 mg\/mL: 32 \u00b1 0.7, 7 mg\/mL: 31.4 \u00b1 2.1, 35 mg\/mL: 31.4 \u00b1 1.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505034,"endpoint-url":"\/ani\/endpoint\/100505034\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"2.231 \u00b1 0.354, 2.365 \u00b1 0.116, 2.134 \u00b1 0.08, 2.246 \u00b1 0.151","Doses and responses":"0 mg\/kg-day: 2.231 \u00b1 0.354, 7 mg\/kg-day: 2.365 \u00b1 0.116, 35 mg\/kg-day: 2.134 \u00b1 0.08, 175 mg\/kg-day: 2.246 \u00b1 0.151","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505034,"endpoint-url":"\/ani\/endpoint\/100505034\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"2.231 \u00b1 0.354, 2.365 \u00b1 0.116, 2.134 \u00b1 0.08, 2.246 \u00b1 0.151","Doses and responses":"0 mg\/mL: 2.231 \u00b1 0.354, 1.4 mg\/mL: 2.365 \u00b1 0.116, 7 mg\/mL: 2.134 \u00b1 0.08, 35 mg\/mL: 2.246 \u00b1 0.151","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505035,"endpoint-url":"\/ani\/endpoint\/100505035\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"PND 21-41","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"6.976 \u00b1 0.762, 7.396 \u00b1 0.452, 6.81 \u00b1 0.419, 7.156 \u00b1 0.236","Doses and responses":"0 mg\/kg-day: 6.976 \u00b1 0.762, 7 mg\/kg-day: 7.396 \u00b1 0.452, 35 mg\/kg-day: 6.81 \u00b1 0.419, 175 mg\/kg-day: 7.156 \u00b1 0.236","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505035,"endpoint-url":"\/ani\/endpoint\/100505035\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"PND 21-41","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"6.976 \u00b1 0.762, 7.396 \u00b1 0.452, 6.81 \u00b1 0.419, 7.156 \u00b1 0.236","Doses and responses":"0 mg\/mL: 6.976 \u00b1 0.762, 1.4 mg\/mL: 7.396 \u00b1 0.452, 7 mg\/mL: 6.81 \u00b1 0.419, 35 mg\/mL: 7.156 \u00b1 0.236","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505036,"endpoint-url":"\/ani\/endpoint\/100505036\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"19.762, 20.26, 19.74, 18.961","Doses and responses":"0 mg\/kg-day: 19.762, 7 mg\/kg-day: 20.26, 35 mg\/kg-day: 19.74, 175 mg\/kg-day: 18.961","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Male Crl:CD1 Mice (Phase 2)","animal_group-sex":"Male","animal description (with n)":"F1 Mouse, CD-1 (\u2642, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505036,"endpoint-url":"\/ani\/endpoint\/100505036\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"19.762, 20.26, 19.74, 18.961","Doses and responses":"0 mg\/mL: 19.762, 1.4 mg\/mL: 20.26, 7 mg\/mL: 19.74, 35 mg\/mL: 18.961","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505037,"endpoint-url":"\/ani\/endpoint\/100505037\/","endpoint-system":"Female Reproductive","endpoint-organ":"Vagina","endpoint-effect":"Sexual Maturation","endpoint-name":"Vaginal Patency","endpoint-observation_time":"PND 20-41","endpoint-response_units":"days","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"26.4 \u00b1 2.8, 25.8 \u00b1 2.9, 25.8 \u00b1 1.6, 25.2 \u00b1 1.9","Doses and responses":"0 mg\/kg-day: 26.4 \u00b1 2.8, 7 mg\/kg-day: 25.8 \u00b1 2.9, 35 mg\/kg-day: 25.8 \u00b1 1.6, 175 mg\/kg-day: 25.2 \u00b1 1.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505037,"endpoint-url":"\/ani\/endpoint\/100505037\/","endpoint-system":"Female Reproductive","endpoint-organ":"Vagina","endpoint-effect":"Sexual Maturation","endpoint-name":"Vaginal Patency","endpoint-observation_time":"PND 20-41","endpoint-response_units":"days","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"26.4 \u00b1 2.8, 25.8 \u00b1 2.9, 25.8 \u00b1 1.6, 25.2 \u00b1 1.9","Doses and responses":"0 mg\/mL: 26.4 \u00b1 2.8, 1.4 mg\/mL: 25.8 \u00b1 2.9, 7 mg\/mL: 25.8 \u00b1 1.6, 35 mg\/mL: 25.2 \u00b1 1.9","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505038,"endpoint-url":"\/ani\/endpoint\/100505038\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Vaginal Patency","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"16.8 \u00b1 2.6, 16.2 \u00b1 2.9, 17.2 \u00b1 1.7, 15.7 \u00b1 2.4","Doses and responses":"0 mg\/kg-day: 16.8 \u00b1 2.6, 7 mg\/kg-day: 16.2 \u00b1 2.9, 35 mg\/kg-day: 17.2 \u00b1 1.7, 175 mg\/kg-day: 15.7 \u00b1 2.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505038,"endpoint-url":"\/ani\/endpoint\/100505038\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Vaginal Patency","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"16.8 \u00b1 2.6, 16.2 \u00b1 2.9, 17.2 \u00b1 1.7, 15.7 \u00b1 2.4","Doses and responses":"0 mg\/mL: 16.8 \u00b1 2.6, 1.4 mg\/mL: 16.2 \u00b1 2.9, 7 mg\/mL: 17.2 \u00b1 1.7, 35 mg\/mL: 15.7 \u00b1 2.4","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505039,"endpoint-url":"\/ani\/endpoint\/100505039\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"23.9 \u00b1 2.1, 23.1 \u00b1 1.6, 23.5 \u00b1 1.4, 23.9 \u00b1 2.1","Doses and responses":"0 mg\/kg-day: 23.9 \u00b1 2.1, 7 mg\/kg-day: 23.1 \u00b1 1.6, 35 mg\/kg-day: 23.5 \u00b1 1.4, 175 mg\/kg-day: 23.9 \u00b1 2.1","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505039,"endpoint-url":"\/ani\/endpoint\/100505039\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight, Terminal","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"23.9 \u00b1 2.1, 23.1 \u00b1 1.6, 23.5 \u00b1 1.4, 23.9 \u00b1 2.1","Doses and responses":"0 mg\/mL: 23.9 \u00b1 2.1, 1.4 mg\/mL: 23.1 \u00b1 1.6, 7 mg\/mL: 23.5 \u00b1 1.4, 35 mg\/mL: 23.9 \u00b1 2.1","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505040,"endpoint-url":"\/ani\/endpoint\/100505040\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"1.444 \u00b1 0.184, 1.479 \u00b1 0.198, 1.38 \u00b1 0.149, 1.503 \u00b1 0.167","Doses and responses":"0 mg\/kg-day: 1.444 \u00b1 0.184, 7 mg\/kg-day: 1.479 \u00b1 0.198, 35 mg\/kg-day: 1.38 \u00b1 0.149, 175 mg\/kg-day: 1.503 \u00b1 0.167","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505040,"endpoint-url":"\/ani\/endpoint\/100505040\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"1.444 \u00b1 0.184, 1.479 \u00b1 0.198, 1.38 \u00b1 0.149, 1.503 \u00b1 0.167","Doses and responses":"0 mg\/mL: 1.444 \u00b1 0.184, 1.4 mg\/mL: 1.479 \u00b1 0.198, 7 mg\/mL: 1.38 \u00b1 0.149, 35 mg\/mL: 1.503 \u00b1 0.167","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505041,"endpoint-url":"\/ani\/endpoint\/100505041\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"PND 21-41","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"6.018 \u00b1 0.408, 6.398 \u00b1 0.504, 5.866 \u00b1 0.359, 6.27 \u00b1 0.256","Doses and responses":"0 mg\/kg-day: 6.018 \u00b1 0.408, 7 mg\/kg-day: 6.398 \u00b1 0.504, 35 mg\/kg-day: 5.866 \u00b1 0.359, 175 mg\/kg-day: 6.27 \u00b1 0.256","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=5)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505041,"endpoint-url":"\/ani\/endpoint\/100505041\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"PND 21-41","endpoint-response_units":"%","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"6.018 \u00b1 0.408, 6.398 \u00b1 0.504, 5.866 \u00b1 0.359, 6.27 \u00b1 0.256","Doses and responses":"0 mg\/mL: 6.018 \u00b1 0.408, 1.4 mg\/mL: 6.398 \u00b1 0.504, 7 mg\/mL: 5.866 \u00b1 0.359, 35 mg\/mL: 6.27 \u00b1 0.256","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505042,"endpoint-url":"\/ani\/endpoint\/100505042\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 7, 35, 175","Responses":"13.889, 12.987, 12.716, 12.987","Doses and responses":"0 mg\/kg-day: 13.889, 7 mg\/kg-day: 12.987, 35 mg\/kg-day: 12.716, 175 mg\/kg-day: 12.987","Response direction":"\u2194"},{"study-short_citation":"Iwai, 2014, 2821611","study-study_identifier":"","experiment-chemical":"PFHxA","animal_group-name":"F1 Female Crl:CD1 Mice (Phase 2)","animal_group-sex":"Female","animal description (with n)":"F1 Mouse, CD-1 (\u2640, N=20)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"reproductive (GD 6-18)","species-name":"Mouse","strain-name":"CD-1","endpoint-id":100505042,"endpoint-url":"\/ani\/endpoint\/100505042\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Change","endpoint-observation_time":"PND 21-41","endpoint-response_units":"g","Dose units":"mg\/mL","Doses":"0, 1.4, 7, 35","Responses":"13.889, 12.987, 12.716, 12.987","Doses and responses":"0 mg\/mL: 13.889, 1.4 mg\/mL: 12.987, 7 mg\/mL: 12.716, 35 mg\/mL: 12.987","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505043,"endpoint-url":"\/ani\/endpoint\/100505043\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Metabolic Indicators","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Day 92","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"69 \u00b1 12, 120 \u00b1 94, 86 \u00b1 17, 96 \u00b1 26","Doses and responses":"0 mg\/kg-day: 69 \u00b1 12, 20 mg\/kg-day: 120 \u00b1 94, 100 mg\/kg-day: 86 \u00b1 17, 500 mg\/kg-day: 96 \u00b1 26","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505044,"endpoint-url":"\/ani\/endpoint\/100505044\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Metabolic Indicators","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Day 92","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"27 \u00b1 5, 63 \u00b1 64, 39 \u00b1 12, 42 \u00b1 9","Doses and responses":"0 mg\/kg-day: 27 \u00b1 5, 20 mg\/kg-day: 63 \u00b1 64, 100 mg\/kg-day: 39 \u00b1 12, 500 mg\/kg-day: 42 \u00b1 9","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505045,"endpoint-url":"\/ani\/endpoint\/100505045\/","endpoint-system":"Multi-system","endpoint-organ":"Multiple Organs","endpoint-effect":"Sorbitol Dehydrogenase","endpoint-name":"Sorbitol Dehydrogenase (SDH)","endpoint-observation_time":"Day 92","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"25 \u00b1 6.1, 32 \u00b1 12, 27 \u00b1 4.5, 18 \u00b1 5.5","Doses and responses":"0 mg\/kg-day: 25 \u00b1 6.1, 20 mg\/kg-day: 32 \u00b1 12, 100 mg\/kg-day: 27 \u00b1 4.5, 500 mg\/kg-day: 18 \u00b1 5.5","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505047,"endpoint-url":"\/ani\/endpoint\/100505047\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bilirubin","endpoint-name":"Bilirubin (BILI)","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.12 \u00b1 0.01, 0.13 \u00b1 0.02, 0.1 \u00b1 0.02, 0.09 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.12 \u00b1 0.01, 20 mg\/kg-day: 0.13 \u00b1 0.02, 100 mg\/kg-day: 0.1 \u00b1 0.02, 500 mg\/kg-day: 0.09 \u00b1 0.01","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505048,"endpoint-url":"\/ani\/endpoint\/100505048\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Blood Urea Nitrogen","endpoint-name":"Blood Urea Nitrogen (BUN)","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"13 \u00b1 1, 13 \u00b1 1, 15 \u00b1 1, 16 \u00b1 2","Doses and responses":"0 mg\/kg-day: 13 \u00b1 1, 20 mg\/kg-day: 13 \u00b1 1, 100 mg\/kg-day: 15 \u00b1 1, 500 mg\/kg-day: 16 \u00b1 2","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505049,"endpoint-url":"\/ani\/endpoint\/100505049\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Creatinine","endpoint-name":"Creatinine (CREAT)","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.39 \u00b1 0.03, 0.38 \u00b1 0.04, 0.38 \u00b1 0.04, 0.34 \u00b1 0.03","Doses and responses":"0 mg\/kg-day: 0.39 \u00b1 0.03, 20 mg\/kg-day: 0.38 \u00b1 0.04, 100 mg\/kg-day: 0.38 \u00b1 0.04, 500 mg\/kg-day: 0.34 \u00b1 0.03","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505050,"endpoint-url":"\/ani\/endpoint\/100505050\/","endpoint-system":"Hematologic","endpoint-organ":"Serum","endpoint-effect":"Cholesterol","endpoint-name":"Cholesterol (CHOL)","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"62 \u00b1 19, 50 \u00b1 15, 40 \u00b1 11, 55 \u00b1 12","Doses and responses":"0 mg\/kg-day: 62 \u00b1 19, 20 mg\/kg-day: 50 \u00b1 15, 100 mg\/kg-day: 40 \u00b1 11, 500 mg\/kg-day: 55 \u00b1 12","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505051,"endpoint-url":"\/ani\/endpoint\/100505051\/","endpoint-system":"Hematologic","endpoint-organ":"Plasma","endpoint-effect":"Triglycerides","endpoint-name":"Triglyceride (TRIG)","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"49 \u00b1 23, 9 \u00b1 21, 43 \u00b1 12, 55 \u00b1 15","Doses and responses":"0 mg\/kg-day: 49 \u00b1 23, 20 mg\/kg-day: 9 \u00b1 21, 100 mg\/kg-day: 43 \u00b1 12, 500 mg\/kg-day: 55 \u00b1 15","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505053,"endpoint-url":"\/ani\/endpoint\/100505053\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Day 92","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"6.5 \u00b1 0.4, 6.5 \u00b1 0.3, 6.1 \u00b1 0.3, 5.6 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 6.5 \u00b1 0.4, 20 mg\/kg-day: 6.5 \u00b1 0.3, 100 mg\/kg-day: 6.1 \u00b1 0.3, 500 mg\/kg-day: 5.6 \u00b1 0.4","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505054,"endpoint-url":"\/ani\/endpoint\/100505054\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Metabolic Indicators","endpoint-name":"Albumin (A)","endpoint-observation_time":"Day 92","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"3.3 \u00b1 0.2, 3.3 \u00b1 0.1, 3.3 \u00b1 0.1, 3.3 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 3.3 \u00b1 0.2, 20 mg\/kg-day: 3.3 \u00b1 0.1, 100 mg\/kg-day: 3.3 \u00b1 0.1, 500 mg\/kg-day: 3.3 \u00b1 0.2","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505055,"endpoint-url":"\/ani\/endpoint\/100505055\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Day 92","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"3.2 \u00b1 0.3, 3.2 \u00b1 0.2, 2.8 \u00b1 0.2, 2.3 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 3.2 \u00b1 0.3, 20 mg\/kg-day: 3.2 \u00b1 0.2, 100 mg\/kg-day: 2.8 \u00b1 0.2, 500 mg\/kg-day: 2.3 \u00b1 0.2","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505061,"endpoint-url":"\/ani\/endpoint\/100505061\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Plasma Fl","endpoint-name":"Plasma Fluoride","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/\u00b5L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.1 \u00b1 0.1, 0.1 \u00b1 0.1, 0.1 \u00b1 0.1, 0.1 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.1 \u00b1 0.1, 20 mg\/kg-day: 0.1 \u00b1 0.1, 100 mg\/kg-day: 0.1 \u00b1 0.1, 500 mg\/kg-day: 0.1 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505062,"endpoint-url":"\/ani\/endpoint\/100505062\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urine Volume","endpoint-name":"Total Urine Volume","endpoint-observation_time":"Day 92","endpoint-response_units":"mL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"7.2 \u00b1 3.4, 8.3 \u00b1 3.7, 8.8 \u00b1 3.1, 22.1 \u00b1 10.5","Doses and responses":"0 mg\/kg-day: 7.2 \u00b1 3.4, 20 mg\/kg-day: 8.3 \u00b1 3.7, 100 mg\/kg-day: 8.8 \u00b1 3.1, 500 mg\/kg-day: 22.1 \u00b1 10.5","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505063,"endpoint-url":"\/ani\/endpoint\/100505063\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Osmolality","endpoint-name":"Osmolality","endpoint-observation_time":"Day 92","endpoint-response_units":"mOsm\/kg","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1512 \u00b1 492, 1252 \u00b1 382, 1396 \u00b1 676, 797 \u00b1 250","Doses and responses":"0 mg\/kg-day: 1512 \u00b1 492, 20 mg\/kg-day: 1252 \u00b1 382, 100 mg\/kg-day: 1396 \u00b1 676, 500 mg\/kg-day: 797 \u00b1 250","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505064,"endpoint-url":"\/ani\/endpoint\/100505064\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"pH","endpoint-name":"Urine pH","endpoint-observation_time":"Day 92","endpoint-response_units":"pH","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"6.7 \u00b1 0.2, 6.7 \u00b1 0.3, 6.7 \u00b1 10.2, 6.6 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 6.7 \u00b1 0.2, 20 mg\/kg-day: 6.7 \u00b1 0.3, 100 mg\/kg-day: 6.7 \u00b1 10.2, 500 mg\/kg-day: 6.6 \u00b1 0.2","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505065,"endpoint-url":"\/ani\/endpoint\/100505065\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urobilinogen","endpoint-name":"Urobilinogen","endpoint-observation_time":"Day 92","endpoint-response_units":"Eu\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.4 \u00b1 0.3, 0.2 \u00b1 0, 0.3 \u00b1 0.3, 0.2 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.4 \u00b1 0.3, 20 mg\/kg-day: 0.2 \u00b1 0, 100 mg\/kg-day: 0.3 \u00b1 0.3, 500 mg\/kg-day: 0.2 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505066,"endpoint-url":"\/ani\/endpoint\/100505066\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Fluoride","endpoint-name":"Fluoride, Urinalysis","endpoint-observation_time":"Day 92","endpoint-response_units":"\u00b5g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"4.5 \u00b1 0.8, 4.5 \u00b1 0.7, 5.2 \u00b1 0.9, 7.8 \u00b1 1.9","Doses and responses":"0 mg\/kg-day: 4.5 \u00b1 0.8, 20 mg\/kg-day: 4.5 \u00b1 0.7, 100 mg\/kg-day: 5.2 \u00b1 0.9, 500 mg\/kg-day: 7.8 \u00b1 1.9","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505067,"endpoint-url":"\/ani\/endpoint\/100505067\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Red Blood Cell","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Day 92","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"8.89 \u00b1 0.36, 8.95 \u00b1 0.34, 8.46 \u00b1 0.41, 6.09 \u00b1 1.27","Doses and responses":"0 mg\/kg-day: 8.89 \u00b1 0.36, 20 mg\/kg-day: 8.95 \u00b1 0.34, 100 mg\/kg-day: 8.46 \u00b1 0.41, 500 mg\/kg-day: 6.09 \u00b1 1.27","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505068,"endpoint-url":"\/ani\/endpoint\/100505068\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Day 92","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"15.4 \u00b1 0.5, 15.5 \u00b1 0.41, 4.5 \u00b1 0.7, 9.9 \u00b1 2.8","Doses and responses":"0 mg\/kg-day: 15.4 \u00b1 0.5, 20 mg\/kg-day: 15.5 \u00b1 0.41, 100 mg\/kg-day: 4.5 \u00b1 0.7, 500 mg\/kg-day: 9.9 \u00b1 2.8","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505069,"endpoint-url":"\/ani\/endpoint\/100505069\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"49 \u00b1 1.4, 49.2 \u00b1 1.7, 46.2 \u00b1 1.8, 34 \u00b1 7.8","Doses and responses":"0 mg\/kg-day: 49 \u00b1 1.4, 20 mg\/kg-day: 49.2 \u00b1 1.7, 100 mg\/kg-day: 46.2 \u00b1 1.8, 500 mg\/kg-day: 34 \u00b1 7.8","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505070,"endpoint-url":"\/ani\/endpoint\/100505070\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Day 92","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"55.1 \u00b1 1.7, 55.1 \u00b1 2.1, 54.7 \u00b1 2.4, 55.8 \u00b1 4.3","Doses and responses":"0 mg\/kg-day: 55.1 \u00b1 1.7, 20 mg\/kg-day: 55.1 \u00b1 2.1, 100 mg\/kg-day: 54.7 \u00b1 2.4, 500 mg\/kg-day: 55.8 \u00b1 4.3","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505071,"endpoint-url":"\/ani\/endpoint\/100505071\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Day 92","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"17.3 \u00b1 0.6, 17.3 \u00b1 0.6, 17.2 \u00b1 0.8, 16.1 \u00b1 1.9","Doses and responses":"0 mg\/kg-day: 17.3 \u00b1 0.6, 20 mg\/kg-day: 17.3 \u00b1 0.6, 100 mg\/kg-day: 17.2 \u00b1 0.8, 500 mg\/kg-day: 16.1 \u00b1 1.9","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505072,"endpoint-url":"\/ani\/endpoint\/100505072\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Mean Corpuscular Hemoglobin Concentration","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Day 92","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"31.4 \u00b1 0.5, 31.5 \u00b1 0.5, 31.5 \u00b1 0.3, 28.8 \u00b1 1.8","Doses and responses":"0 mg\/kg-day: 31.4 \u00b1 0.5, 20 mg\/kg-day: 31.5 \u00b1 0.5, 100 mg\/kg-day: 31.5 \u00b1 0.3, 500 mg\/kg-day: 28.8 \u00b1 1.8","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505073,"endpoint-url":"\/ani\/endpoint\/100505073\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Day 92","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"174 \u00b1 30.4, 150 \u00b1 24, 167 \u00b1 23.6, 540 \u00b1 212","Doses and responses":"0 mg\/kg-day: 174 \u00b1 30.4, 20 mg\/kg-day: 150 \u00b1 24, 100 mg\/kg-day: 167 \u00b1 23.6, 500 mg\/kg-day: 540 \u00b1 212","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505074,"endpoint-url":"\/ani\/endpoint\/100505074\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Day 92","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1129 \u00b1 98, 1075 \u00b1 91, 1151 \u00b1 133, 1807 \u00b1 253","Doses and responses":"0 mg\/kg-day: 1129 \u00b1 98, 20 mg\/kg-day: 1075 \u00b1 91, 100 mg\/kg-day: 1151 \u00b1 133, 500 mg\/kg-day: 1807 \u00b1 253","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505075,"endpoint-url":"\/ani\/endpoint\/100505075\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Day 92","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"9.44 \u00b1 0.9, 11.1 \u00b1 1.91, 11.2 \u00b1 3.29, 10.3 \u00b1 2.63","Doses and responses":"0 mg\/kg-day: 9.44 \u00b1 0.9, 20 mg\/kg-day: 11.1 \u00b1 1.91, 100 mg\/kg-day: 11.2 \u00b1 3.29, 500 mg\/kg-day: 10.3 \u00b1 2.63","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505076,"endpoint-url":"\/ani\/endpoint\/100505076\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Neutrophils","endpoint-observation_time":"Day 92","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1.2 \u00b1 0.27, 1.9 \u00b1 0.7, 1.6 \u00b1 0.35, 1.9 \u00b1 0.65","Doses and responses":"0 mg\/kg-day: 1.2 \u00b1 0.27, 20 mg\/kg-day: 1.9 \u00b1 0.7, 100 mg\/kg-day: 1.6 \u00b1 0.35, 500 mg\/kg-day: 1.9 \u00b1 0.65","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505077,"endpoint-url":"\/ani\/endpoint\/100505077\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Lymphocyte","endpoint-observation_time":"Day 92","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"7.86 \u00b1 0.75, 8.72 \u00b1 1.96, 9.25 \u00b1 3.05, 8.19 \u00b1 2.36","Doses and responses":"0 mg\/kg-day: 7.86 \u00b1 0.75, 20 mg\/kg-day: 8.72 \u00b1 1.96, 100 mg\/kg-day: 9.25 \u00b1 3.05, 500 mg\/kg-day: 8.19 \u00b1 2.36","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505078,"endpoint-url":"\/ani\/endpoint\/100505078\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Monocytes","endpoint-observation_time":"Day 92","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.21 \u00b1 0.09, 0.29 \u00b1 0.14, 0.18 \u00b1 0.06, 0.15 \u00b1 0.1","Doses and responses":"0 mg\/kg-day: 0.21 \u00b1 0.09, 20 mg\/kg-day: 0.29 \u00b1 0.14, 100 mg\/kg-day: 0.18 \u00b1 0.06, 500 mg\/kg-day: 0.15 \u00b1 0.1","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505079,"endpoint-url":"\/ani\/endpoint\/100505079\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Eosinophils","endpoint-observation_time":"Day 92","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.12 \u00b1 0.05, 0.1 \u00b1 0.03, 0.1 \u00b1 3.03, 0.04 \u00b1 0.03","Doses and responses":"0 mg\/kg-day: 0.12 \u00b1 0.05, 20 mg\/kg-day: 0.1 \u00b1 0.03, 100 mg\/kg-day: 0.1 \u00b1 3.03, 500 mg\/kg-day: 0.04 \u00b1 0.03","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505080,"endpoint-url":"\/ani\/endpoint\/100505080\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Basophils","endpoint-observation_time":"Day 92","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.04 \u00b1 0.02, 0.04 \u00b1 0.01, 0.04 \u00b1 0.02, 0.03 \u00b1 0.04","Doses and responses":"0 mg\/kg-day: 0.04 \u00b1 0.02, 20 mg\/kg-day: 0.04 \u00b1 0.01, 100 mg\/kg-day: 0.04 \u00b1 0.02, 500 mg\/kg-day: 0.03 \u00b1 0.04","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505081,"endpoint-url":"\/ani\/endpoint\/100505081\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Coagulation","endpoint-name":"Prothrombin Time (PT)","endpoint-observation_time":"Day 92","endpoint-response_units":"s","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"14.9 \u00b1 0.9, 14.8 \u00b1 0.5, 15 \u00b1 0.8, 14.2 \u00b1 0.9","Doses and responses":"0 mg\/kg-day: 14.9 \u00b1 0.9, 20 mg\/kg-day: 14.8 \u00b1 0.5, 100 mg\/kg-day: 15 \u00b1 0.8, 500 mg\/kg-day: 14.2 \u00b1 0.9","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505082,"endpoint-url":"\/ani\/endpoint\/100505082\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Coagulation","endpoint-name":"Activated Partial Thromboplastin Time (APTT)","endpoint-observation_time":"Day 92","endpoint-response_units":"s","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"16 \u00b1 1.6, 14.2 \u00b1 1.1, 14.5 \u00b1 0.8, 12.7 \u00b1 1.5","Doses and responses":"0 mg\/kg-day: 16 \u00b1 1.6, 20 mg\/kg-day: 14.2 \u00b1 1.1, 100 mg\/kg-day: 14.5 \u00b1 0.8, 500 mg\/kg-day: 12.7 \u00b1 1.5","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505083,"endpoint-url":"\/ani\/endpoint\/100505083\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.071 \u00b1 0.012, 0.066 \u00b1 0.008, 0.064 \u00b1 0.008, 0.062 \u00b1 0.012","Doses and responses":"0 mg\/kg-day: 0.071 \u00b1 0.012, 20 mg\/kg-day: 0.066 \u00b1 0.008, 100 mg\/kg-day: 0.064 \u00b1 0.008, 500 mg\/kg-day: 0.062 \u00b1 0.012","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505084,"endpoint-url":"\/ani\/endpoint\/100505084\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.013 \u00b1 0.001, 0.012 \u00b1 0.001, 0.012 \u00b1 0.002, 0.012 \u00b1 0.002","Doses and responses":"0 mg\/kg-day: 0.013 \u00b1 0.001, 20 mg\/kg-day: 0.012 \u00b1 0.001, 100 mg\/kg-day: 0.012 \u00b1 0.002, 500 mg\/kg-day: 0.012 \u00b1 0.002","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505085,"endpoint-url":"\/ani\/endpoint\/100505085\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"2.19 \u00b1 0.095, 2.17 \u00b1 0.108, 2.17 \u00b1 0.131, 2.14 \u00b1 0.096","Doses and responses":"0 mg\/kg-day: 2.19 \u00b1 0.095, 20 mg\/kg-day: 2.17 \u00b1 0.108, 100 mg\/kg-day: 2.17 \u00b1 0.131, 500 mg\/kg-day: 2.14 \u00b1 0.096","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505086,"endpoint-url":"\/ani\/endpoint\/100505086\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.392 \u00b1 0.028, 0.387 \u00b1 0.028, 0.395 \u00b1 0.02, 0.427 \u00b1 0.041","Doses and responses":"0 mg\/kg-day: 0.392 \u00b1 0.028, 20 mg\/kg-day: 0.387 \u00b1 0.028, 100 mg\/kg-day: 0.395 \u00b1 0.02, 500 mg\/kg-day: 0.427 \u00b1 0.041","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505087,"endpoint-url":"\/ani\/endpoint\/100505087\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Organ Weight","endpoint-name":"Epididymides Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.287 \u00b1 0.014, 0.294 \u00b1 0.039, 0.29 \u00b1 0.02, 0.31 \u00b1 0.024","Doses and responses":"0 mg\/kg-day: 0.287 \u00b1 0.014, 20 mg\/kg-day: 0.294 \u00b1 0.039, 100 mg\/kg-day: 0.29 \u00b1 0.02, 500 mg\/kg-day: 0.31 \u00b1 0.024","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505088,"endpoint-url":"\/ani\/endpoint\/100505088\/","endpoint-system":"Male Reproductive","endpoint-organ":"Epididymis","endpoint-effect":"Organ Weight","endpoint-name":"Epididymides Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1.61 \u00b1 0.122, 1.64 \u00b1 0.161, 1.59 \u00b1 0.099, 1.56 \u00b1 0.107","Doses and responses":"0 mg\/kg-day: 1.61 \u00b1 0.122, 20 mg\/kg-day: 1.64 \u00b1 0.161, 100 mg\/kg-day: 1.59 \u00b1 0.099, 500 mg\/kg-day: 1.56 \u00b1 0.107","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505089,"endpoint-url":"\/ani\/endpoint\/100505089\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1.77 \u00b1 0.19, 1.71 \u00b1 0.13, 1.78 \u00b1 0.17, 1.7 \u00b1 0.15","Doses and responses":"0 mg\/kg-day: 1.77 \u00b1 0.19, 20 mg\/kg-day: 1.71 \u00b1 0.13, 100 mg\/kg-day: 1.78 \u00b1 0.17, 500 mg\/kg-day: 1.7 \u00b1 0.15","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505090,"endpoint-url":"\/ani\/endpoint\/100505090\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.315 \u00b1 0.016, 0.305 \u00b1 0.023, 0.325 \u00b1 0.018, 0.339 \u00b1 0.034","Doses and responses":"0 mg\/kg-day: 0.315 \u00b1 0.016, 20 mg\/kg-day: 0.305 \u00b1 0.023, 100 mg\/kg-day: 0.325 \u00b1 0.018, 500 mg\/kg-day: 0.339 \u00b1 0.034","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505091,"endpoint-url":"\/ani\/endpoint\/100505091\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"4.09 \u00b1 0.57, 4.07 \u00b1 0.33, 4.43 \u00b1 0.77, 4.25 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 4.09 \u00b1 0.57, 20 mg\/kg-day: 4.07 \u00b1 0.33, 100 mg\/kg-day: 4.43 \u00b1 0.77, 500 mg\/kg-day: 4.25 \u00b1 0.4","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505092,"endpoint-url":"\/ani\/endpoint\/100505092\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.728 \u00b1 0.082, 0.725 \u00b1 0.046, 0.806 \u00b1 0.108, 0.849 \u00b1 0.105","Doses and responses":"0 mg\/kg-day: 0.728 \u00b1 0.082, 20 mg\/kg-day: 0.725 \u00b1 0.046, 100 mg\/kg-day: 0.806 \u00b1 0.108, 500 mg\/kg-day: 0.849 \u00b1 0.105","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505093,"endpoint-url":"\/ani\/endpoint\/100505093\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"15.09 \u00b1 1.59, 15.18 \u00b1 2.07, 16.49 \u00b1 2.38, 21.98 \u00b1 2.35","Doses and responses":"0 mg\/kg-day: 15.09 \u00b1 1.59, 20 mg\/kg-day: 15.18 \u00b1 2.07, 100 mg\/kg-day: 16.49 \u00b1 2.38, 500 mg\/kg-day: 21.98 \u00b1 2.35","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505094,"endpoint-url":"\/ani\/endpoint\/100505094\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"2.687 \u00b1 0.165, 2.696 \u00b1 0.255, 2.994 \u00b1 0.231, 4.378 \u00b1 0.485","Doses and responses":"0 mg\/kg-day: 2.687 \u00b1 0.165, 20 mg\/kg-day: 2.696 \u00b1 0.255, 100 mg\/kg-day: 2.994 \u00b1 0.231, 500 mg\/kg-day: 4.378 \u00b1 0.485","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505058,"endpoint-url":"\/ani\/endpoint\/100505058\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Sodium (NA)","endpoint-observation_time":"Day 92","endpoint-response_units":"mmol\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"149 \u00b1 1.5, 149 \u00b1 1.4, 149 \u00b1 0.9, 147 \u00b1 1.8","Doses and responses":"0 mg\/kg-day: 149 \u00b1 1.5, 20 mg\/kg-day: 149 \u00b1 1.4, 100 mg\/kg-day: 149 \u00b1 0.9, 500 mg\/kg-day: 147 \u00b1 1.8","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505060,"endpoint-url":"\/ani\/endpoint\/100505060\/","endpoint-system":"Metabolic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Chloride (CL)","endpoint-observation_time":"Day 92","endpoint-response_units":"mmol\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"101 \u00b1 2.1, 101 \u00b1 1.8, 103 \u00b1 1.4, 104 \u00b1 3.3","Doses and responses":"0 mg\/kg-day: 101 \u00b1 2.1, 20 mg\/kg-day: 101 \u00b1 1.8, 100 mg\/kg-day: 103 \u00b1 1.4, 500 mg\/kg-day: 104 \u00b1 3.3","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505056,"endpoint-url":"\/ani\/endpoint\/100505056\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Calcium (CA)","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"10.7 \u00b1 0.3, 10.5 \u00b1 0.4, 10.3 \u00b1 0.3, 10.2 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 10.7 \u00b1 0.3, 20 mg\/kg-day: 10.5 \u00b1 0.4, 100 mg\/kg-day: 10.3 \u00b1 0.3, 500 mg\/kg-day: 10.2 \u00b1 0.4","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505057,"endpoint-url":"\/ani\/endpoint\/100505057\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Phosphorus (PHOS)","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"7.6 \u00b1 0.6, 7.9 \u00b1 0.8, 8.2 \u00b1 0.6, 8.2 \u00b1 0.6","Doses and responses":"0 mg\/kg-day: 7.6 \u00b1 0.6, 20 mg\/kg-day: 7.9 \u00b1 0.8, 100 mg\/kg-day: 8.2 \u00b1 0.6, 500 mg\/kg-day: 8.2 \u00b1 0.6","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505095,"endpoint-url":"\/ani\/endpoint\/100505095\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.86 \u00b1 0.14, 0.79 \u00b1 0.11, 0.8 \u00b1 0.12, 0.72 \u00b1 0.09","Doses and responses":"0 mg\/kg-day: 0.86 \u00b1 0.14, 20 mg\/kg-day: 0.79 \u00b1 0.11, 100 mg\/kg-day: 0.8 \u00b1 0.12, 500 mg\/kg-day: 0.72 \u00b1 0.09","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505096,"endpoint-url":"\/ani\/endpoint\/100505096\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.153 \u00b1 0.017, 0.141 \u00b1 0.022, 0.145 \u00b1 0.019, 0.144 \u00b1 0.021","Doses and responses":"0 mg\/kg-day: 0.153 \u00b1 0.017, 20 mg\/kg-day: 0.141 \u00b1 0.022, 100 mg\/kg-day: 0.145 \u00b1 0.019, 500 mg\/kg-day: 0.144 \u00b1 0.021","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505097,"endpoint-url":"\/ani\/endpoint\/100505097\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Organ Weight","endpoint-name":"Testes Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"3.69 \u00b1 0.29, 3.74 \u00b1 0.3, 3.73 \u00b1 0.33, 3.85 \u00b1 0.34","Doses and responses":"0 mg\/kg-day: 3.69 \u00b1 0.29, 20 mg\/kg-day: 3.74 \u00b1 0.3, 100 mg\/kg-day: 3.73 \u00b1 0.33, 500 mg\/kg-day: 3.85 \u00b1 0.34","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505098,"endpoint-url":"\/ani\/endpoint\/100505098\/","endpoint-system":"Male Reproductive","endpoint-organ":"Testis","endpoint-effect":"Organ Weight","endpoint-name":"Testes Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.659 \u00b1 0.035, 0.668 \u00b1 0.063, 0.681 \u00b1 0.062, 0.767 \u00b1 0.08","Doses and responses":"0 mg\/kg-day: 0.659 \u00b1 0.035, 20 mg\/kg-day: 0.668 \u00b1 0.063, 100 mg\/kg-day: 0.681 \u00b1 0.062, 500 mg\/kg-day: 0.767 \u00b1 0.08","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505099,"endpoint-url":"\/ani\/endpoint\/100505099\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.42 \u00b1 0.13, 0.37 \u00b1 0.09, 0.35 \u00b1 0.11, 0.29 \u00b1 0.07","Doses and responses":"0 mg\/kg-day: 0.42 \u00b1 0.13, 20 mg\/kg-day: 0.37 \u00b1 0.09, 100 mg\/kg-day: 0.35 \u00b1 0.11, 500 mg\/kg-day: 0.29 \u00b1 0.07","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505100,"endpoint-url":"\/ani\/endpoint\/100505100\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.75 \u00b1 0.023, 0.067 \u00b1 0.019, 0.063 \u00b1 0.018, 0.057 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.75 \u00b1 0.023, 20 mg\/kg-day: 0.067 \u00b1 0.019, 100 mg\/kg-day: 0.063 \u00b1 0.018, 500 mg\/kg-day: 0.057 \u00b1 0.01","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505101,"endpoint-url":"\/ani\/endpoint\/100505101\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Organ Weight","endpoint-name":"Thyroid Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.025 \u00b1 0.003, 0.024 \u00b1 0.004, 0.022 \u00b1 0.004, 0.024 \u00b1 0.003","Doses and responses":"0 mg\/kg-day: 0.025 \u00b1 0.003, 20 mg\/kg-day: 0.024 \u00b1 0.004, 100 mg\/kg-day: 0.022 \u00b1 0.004, 500 mg\/kg-day: 0.024 \u00b1 0.003","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505102,"endpoint-url":"\/ani\/endpoint\/100505102\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Organ Weight","endpoint-name":"Thyroid Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.005 \u00b1 0, 0.004 \u00b1 0.001, 0.004 \u00b1 0.001, 0.005 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.005 \u00b1 0, 20 mg\/kg-day: 0.004 \u00b1 0.001, 100 mg\/kg-day: 0.004 \u00b1 0.001, 500 mg\/kg-day: 0.005 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505103,"endpoint-url":"\/ani\/endpoint\/100505103\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Degeneration","endpoint-name":"Nasal Cavity Degeneration\/Atrophy","endpoint-observation_time":"Day 92","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 4, 7","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 4, 500 mg\/kg-day: 7","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505104,"endpoint-url":"\/ani\/endpoint\/100505104\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Adhesions","endpoint-name":"Nasal Cavity Adhesions, Turbinates","endpoint-observation_time":"Day 92","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 3","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 3","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505105,"endpoint-url":"\/ani\/endpoint\/100505105\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Microcysts","endpoint-name":"Nasal Cavity Intraepithelial Microcysts","endpoint-observation_time":"Day 92","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505106,"endpoint-url":"\/ani\/endpoint\/100505106\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Metaplasia","endpoint-name":"Nasal Cavity Respiratory Metaplasia","endpoint-observation_time":"Day 92","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 4","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 4","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505107,"endpoint-url":"\/ani\/endpoint\/100505107\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Hypertrophy","endpoint-name":"Hepatocellular Hypertrophy","endpoint-observation_time":"Day 92","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 4, 10","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 4, 500 mg\/kg-day: 10","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505108,"endpoint-url":"\/ani\/endpoint\/100505108\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Hypertrophy","endpoint-name":"Thyroid Hypertrophy","endpoint-observation_time":"Day 92","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 1, 2","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 1, 500 mg\/kg-day: 2","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505109,"endpoint-url":"\/ani\/endpoint\/100505109\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Degeneration","endpoint-name":"Nasal Cavity Degeneration\/Atrophy (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 0","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505110,"endpoint-url":"\/ani\/endpoint\/100505110\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Degeneration","endpoint-name":"Nasal Cavity Degeneration\/Atrophy (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505111,"endpoint-url":"\/ani\/endpoint\/100505111\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Adhesions","endpoint-name":"Nasal Cavity Adhesions, Turbinates (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 2","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 2","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505112,"endpoint-url":"\/ani\/endpoint\/100505112\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Adhesions","endpoint-name":"Nasal Cavity Adhesions, Turbinates (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 5","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 5","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505113,"endpoint-url":"\/ani\/endpoint\/100505113\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Microcysts","endpoint-name":"Nasal Cavity Intraepithelial Microcysts (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 3","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 3","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505114,"endpoint-url":"\/ani\/endpoint\/100505114\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Microcysts","endpoint-name":"Nasal Cavity Intraepithelial Microcysts (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 4","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 4","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505115,"endpoint-url":"\/ani\/endpoint\/100505115\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Metaplasia","endpoint-name":"Nasal Cavity Respiratory Metaplasia (30-Day recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 8","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 8","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505116,"endpoint-url":"\/ani\/endpoint\/100505116\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Metaplasia","endpoint-name":"Nasal Cavity Respiratory Metaplasia (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 8","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 8","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505117,"endpoint-url":"\/ani\/endpoint\/100505117\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Hypertrophy","endpoint-name":"Hepatocellular Hypertrophy (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 9","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 9","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505118,"endpoint-url":"\/ani\/endpoint\/100505118\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Hypertrophy","endpoint-name":"Hepatocellular Hypertrophy (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 6","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 6","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505119,"endpoint-url":"\/ani\/endpoint\/100505119\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Hypertrophy","endpoint-name":"Thyroid Hypertrophy (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 3","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 3","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505120,"endpoint-url":"\/ani\/endpoint\/100505120\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Hypertrophy","endpoint-name":"Thyroid Hypertrophy (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 2","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 2","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505121,"endpoint-url":"\/ani\/endpoint\/100505121\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"570 \u00b1 50, 570 \u00b1 50, 570 \u00b1 50, 530 \u00b1 40","Doses and responses":"0 mg\/kg-day: 570 \u00b1 50, 20 mg\/kg-day: 570 \u00b1 50, 100 mg\/kg-day: 570 \u00b1 50, 500 mg\/kg-day: 530 \u00b1 40","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505122,"endpoint-url":"\/ani\/endpoint\/100505122\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Peroxisomal B-Oxidation","endpoint-name":"Peroxisomal Beta Oxidation","endpoint-observation_time":"Day 10","endpoint-response_units":"nmol\/min\/mg protein","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"9.505 \u00b1 1.787, 10.02 \u00b1 1.46, 11.881 \u00b1 1.665, 29.505 \u00b1 6.144","Doses and responses":"0 mg\/kg-day: 9.505 \u00b1 1.787, 20 mg\/kg-day: 10.02 \u00b1 1.46, 100 mg\/kg-day: 11.881 \u00b1 1.665, 500 mg\/kg-day: 29.505 \u00b1 6.144","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505123,"endpoint-url":"\/ani\/endpoint\/100505123\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Peroxisomal B-Oxidation","endpoint-name":"Peroxisomal Beta Oxidation","endpoint-observation_time":"Day 92","endpoint-response_units":"nmol\/min\/mg protein","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"12.079 \u00b1 2.851, 14.257 \u00b1 4.801, 23.96 \u00b1 6.049, 52.673 \u00b1 8.713","Doses and responses":"0 mg\/kg-day: 12.079 \u00b1 2.851, 20 mg\/kg-day: 14.257 \u00b1 4.801, 100 mg\/kg-day: 23.96 \u00b1 6.049, 500 mg\/kg-day: 52.673 \u00b1 8.713","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505124,"endpoint-url":"\/ani\/endpoint\/100505124\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Peroxisomal B-Oxidation","endpoint-name":"Peroxisomal Beta Oxidation (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"nmol\/min\/mg protein","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"10.029 \u00b1 2.218, , , 23.366 \u00b1 2.387","Doses and responses":"0 mg\/kg-day: 10.029 \u00b1 2.218, 500 mg\/kg-day: 23.366 \u00b1 2.387","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505125,"endpoint-url":"\/ani\/endpoint\/100505125\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Protein","endpoint-name":"Protein, Urine","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"59 \u00b1 23, 30 \u00b1 11, 34 \u00b1 18, 7 \u00b1 2","Doses and responses":"0 mg\/kg-day: 59 \u00b1 23, 20 mg\/kg-day: 30 \u00b1 11, 100 mg\/kg-day: 34 \u00b1 18, 500 mg\/kg-day: 7 \u00b1 2","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505126,"endpoint-url":"\/ani\/endpoint\/100505126\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Metabolic Indicators","endpoint-name":"Aspartate Aminotransferase (AST)","endpoint-observation_time":"Day 93","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"171 \u00b1 168, 72 \u00b1 19, 95 \u00b1 40, 110 \u00b1 82","Doses and responses":"0 mg\/kg-day: 171 \u00b1 168, 20 mg\/kg-day: 72 \u00b1 19, 100 mg\/kg-day: 95 \u00b1 40, 500 mg\/kg-day: 110 \u00b1 82","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505127,"endpoint-url":"\/ani\/endpoint\/100505127\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Metabolic Indicators","endpoint-name":"Alanine Aminotransferase (ALT)","endpoint-observation_time":"Day 93","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"69 \u00b1 48, 37 \u00b1 10, 52 \u00b1 36, 66 \u00b1 60","Doses and responses":"0 mg\/kg-day: 69 \u00b1 48, 20 mg\/kg-day: 37 \u00b1 10, 100 mg\/kg-day: 52 \u00b1 36, 500 mg\/kg-day: 66 \u00b1 60","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505128,"endpoint-url":"\/ani\/endpoint\/100505128\/","endpoint-system":"Multi-system","endpoint-organ":"Multi-organ","endpoint-effect":"Sorbitol Dehydrogenase","endpoint-name":"Sorbitol Dehydrogenase (SDH)","endpoint-observation_time":"Day 93","endpoint-response_units":"U\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"29 \u00b1 18, 18 \u00b1 4.4, 21 \u00b1 6.7, 30 \u00b1 21","Doses and responses":"0 mg\/kg-day: 29 \u00b1 18, 20 mg\/kg-day: 18 \u00b1 4.4, 100 mg\/kg-day: 21 \u00b1 6.7, 500 mg\/kg-day: 30 \u00b1 21","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505130,"endpoint-url":"\/ani\/endpoint\/100505130\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Bilirubin","endpoint-name":"Bilirubin (BILI)","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.17 \u00b1 0.01, 0.16 \u00b1 0.02, 0.14 \u00b1 0.01, 0.09 \u00b1 0.01","Doses and responses":"0 mg\/kg-day: 0.17 \u00b1 0.01, 20 mg\/kg-day: 0.16 \u00b1 0.02, 100 mg\/kg-day: 0.14 \u00b1 0.01, 500 mg\/kg-day: 0.09 \u00b1 0.01","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505131,"endpoint-url":"\/ani\/endpoint\/100505131\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Blood Urea Nitrogen","endpoint-name":"Blood Urea Nitrogen (BUN)","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"16 \u00b1 2, 16 \u00b1 2, 16 \u00b1 2, 14 \u00b1 3","Doses and responses":"0 mg\/kg-day: 16 \u00b1 2, 20 mg\/kg-day: 16 \u00b1 2, 100 mg\/kg-day: 16 \u00b1 2, 500 mg\/kg-day: 14 \u00b1 3","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505132,"endpoint-url":"\/ani\/endpoint\/100505132\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Creatinine","endpoint-name":"Creatinine (CREAT)","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.43 \u00b1 0.03, 0.43 \u00b1 0.05, 0.43 \u00b1 0.04, 0.37 \u00b1 0.04","Doses and responses":"0 mg\/kg-day: 0.43 \u00b1 0.03, 20 mg\/kg-day: 0.43 \u00b1 0.05, 100 mg\/kg-day: 0.43 \u00b1 0.04, 500 mg\/kg-day: 0.37 \u00b1 0.04","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505133,"endpoint-url":"\/ani\/endpoint\/100505133\/","endpoint-system":"Hematologic","endpoint-organ":"Plasma","endpoint-effect":"Cholesterol","endpoint-name":"Cholesterol (CHOL)","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"93 \u00b1 23, 90 \u00b1 27, 78 \u00b1 9, 88 \u00b1 16","Doses and responses":"0 mg\/kg-day: 93 \u00b1 23, 20 mg\/kg-day: 90 \u00b1 27, 100 mg\/kg-day: 78 \u00b1 9, 500 mg\/kg-day: 88 \u00b1 16","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505134,"endpoint-url":"\/ani\/endpoint\/100505134\/","endpoint-system":"Hematologic","endpoint-organ":"Plasma","endpoint-effect":"Triglycerides","endpoint-name":"Triglyceride (TRIG)","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"47 \u00b1 10, 64 \u00b1 70, 40 \u00b1 10, 47 \u00b1 13","Doses and responses":"0 mg\/kg-day: 47 \u00b1 10, 20 mg\/kg-day: 64 \u00b1 70, 100 mg\/kg-day: 40 \u00b1 10, 500 mg\/kg-day: 47 \u00b1 13","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505136,"endpoint-url":"\/ani\/endpoint\/100505136\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Total Protein","endpoint-name":"Total Protein (TP)","endpoint-observation_time":"Day 93","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"7.8 \u00b1 0.7, 7.7 \u00b1 0.6, 7.7 \u00b1 0.4, 7.6 \u00b1 0.5","Doses and responses":"0 mg\/kg-day: 7.8 \u00b1 0.7, 20 mg\/kg-day: 7.7 \u00b1 0.6, 100 mg\/kg-day: 7.7 \u00b1 0.4, 500 mg\/kg-day: 7.6 \u00b1 0.5","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505137,"endpoint-url":"\/ani\/endpoint\/100505137\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Metabolic Indicators","endpoint-name":"Albumin (A)","endpoint-observation_time":"Day 93","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"4 \u00b1 0.4, 3.9 \u00b1 0.4, 4 \u00b1 0.1, 4.2 \u00b1 0.2","Doses and responses":"0 mg\/kg-day: 4 \u00b1 0.4, 20 mg\/kg-day: 3.9 \u00b1 0.4, 100 mg\/kg-day: 4 \u00b1 0.1, 500 mg\/kg-day: 4.2 \u00b1 0.2","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505138,"endpoint-url":"\/ani\/endpoint\/100505138\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Total Globulin","endpoint-name":"Globulin (G)","endpoint-observation_time":"Day 93","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"3.8 \u00b1 0.4, 3.8 \u00b1 0.3, 3.7 \u00b1 0.3, 3.4 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 3.8 \u00b1 0.4, 20 mg\/kg-day: 3.8 \u00b1 0.3, 100 mg\/kg-day: 3.7 \u00b1 0.3, 500 mg\/kg-day: 3.4 \u00b1 0.4","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505144,"endpoint-url":"\/ani\/endpoint\/100505144\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Plasma Fl","endpoint-name":"Plasma Fluoride","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/uL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.1 \u00b1 0.1, 0.1 \u00b1 0, 0.1 \u00b1 0, 0.1 \u00b1 0.1","Doses and responses":"0 mg\/kg-day: 0.1 \u00b1 0.1, 20 mg\/kg-day: 0.1 \u00b1 0, 100 mg\/kg-day: 0.1 \u00b1 0, 500 mg\/kg-day: 0.1 \u00b1 0.1","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505145,"endpoint-url":"\/ani\/endpoint\/100505145\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urine Volume","endpoint-name":"Total Urine Volume","endpoint-observation_time":"Day 93","endpoint-response_units":"mL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"6.1 \u00b1 2.6, 7.3 \u00b1 3.1, 6.9 \u00b1 2.8, 11.4 \u00b1 5.9","Doses and responses":"0 mg\/kg-day: 6.1 \u00b1 2.6, 20 mg\/kg-day: 7.3 \u00b1 3.1, 100 mg\/kg-day: 6.9 \u00b1 2.8, 500 mg\/kg-day: 11.4 \u00b1 5.9","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505146,"endpoint-url":"\/ani\/endpoint\/100505146\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Osmolality","endpoint-name":"Osmolality","endpoint-observation_time":"Day 93","endpoint-response_units":"mOsm\/kg","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1255 \u00b1 461, 1107 \u00b1 298, 1176 \u00b1 404, 889 \u00b1 414","Doses and responses":"0 mg\/kg-day: 1255 \u00b1 461, 20 mg\/kg-day: 1107 \u00b1 298, 100 mg\/kg-day: 1176 \u00b1 404, 500 mg\/kg-day: 889 \u00b1 414","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505147,"endpoint-url":"\/ani\/endpoint\/100505147\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"pH","endpoint-name":"Urine pH","endpoint-observation_time":"Day 93","endpoint-response_units":"pH","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"6.6 \u00b1 0.3, 6.8 \u00b1 0.4, 6.9 \u00b1 0.3, 6.8 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 6.6 \u00b1 0.3, 20 mg\/kg-day: 6.8 \u00b1 0.4, 100 mg\/kg-day: 6.9 \u00b1 0.3, 500 mg\/kg-day: 6.8 \u00b1 0.4","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505148,"endpoint-url":"\/ani\/endpoint\/100505148\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Urobilinogen","endpoint-name":"Urobilinogen","endpoint-observation_time":"Day 93","endpoint-response_units":"Eu\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.2 \u00b1 0, 0.2 \u00b1 0, 0.2 \u00b1 0, 0.2 \u00b1 0","Doses and responses":"0 mg\/kg-day: 0.2 \u00b1 0, 20 mg\/kg-day: 0.2 \u00b1 0, 100 mg\/kg-day: 0.2 \u00b1 0, 500 mg\/kg-day: 0.2 \u00b1 0","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505149,"endpoint-url":"\/ani\/endpoint\/100505149\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Protein","endpoint-name":"Protein, Urine","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"22 \u00b1 25, 10 \u00b1 5, 10 \u00b1 5, 7 \u00b1 4","Doses and responses":"0 mg\/kg-day: 22 \u00b1 25, 20 mg\/kg-day: 10 \u00b1 5, 100 mg\/kg-day: 10 \u00b1 5, 500 mg\/kg-day: 7 \u00b1 4","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505150,"endpoint-url":"\/ani\/endpoint\/100505150\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Fluoride","endpoint-name":"Fluoride, Urinalysis","endpoint-observation_time":"Day 93","endpoint-response_units":"\u00b5g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"3.3 \u00b1 0.8, 3.8 \u00b1 1.2, 3.8 \u00b1 1, 5.4 \u00b1 1.6","Doses and responses":"0 mg\/kg-day: 3.3 \u00b1 0.8, 20 mg\/kg-day: 3.8 \u00b1 1.2, 100 mg\/kg-day: 3.8 \u00b1 1, 500 mg\/kg-day: 5.4 \u00b1 1.6","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505151,"endpoint-url":"\/ani\/endpoint\/100505151\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Red Blood Cell","endpoint-name":"Red Blood Cell (RBC)","endpoint-observation_time":"Day 93","endpoint-response_units":"million\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"8.34 \u00b1 0.43, 8.53 \u00b1 0.52, 8.32 \u00b1 0.27, 6.85 \u00b1 0.63","Doses and responses":"0 mg\/kg-day: 8.34 \u00b1 0.43, 20 mg\/kg-day: 8.53 \u00b1 0.52, 100 mg\/kg-day: 8.32 \u00b1 0.27, 500 mg\/kg-day: 6.85 \u00b1 0.63","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505152,"endpoint-url":"\/ani\/endpoint\/100505152\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hemoglobin (HGB)","endpoint-observation_time":"Day 93","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"15.6 \u00b1 0.7, 15.8 \u00b1 0.8, 15.6 \u00b1 0.4, 13.3 \u00b1 0.9","Doses and responses":"0 mg\/kg-day: 15.6 \u00b1 0.7, 20 mg\/kg-day: 15.8 \u00b1 0.8, 100 mg\/kg-day: 15.6 \u00b1 0.4, 500 mg\/kg-day: 13.3 \u00b1 0.9","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505153,"endpoint-url":"\/ani\/endpoint\/100505153\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Hematocrit (HCT)","endpoint-observation_time":"Day 93","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"47.2 \u00b1 2.3, 47.7 \u00b1 2.5, 47.1 \u00b1 1.4, 41.2 \u00b1 2.4","Doses and responses":"0 mg\/kg-day: 47.2 \u00b1 2.3, 20 mg\/kg-day: 47.7 \u00b1 2.5, 100 mg\/kg-day: 47.1 \u00b1 1.4, 500 mg\/kg-day: 41.2 \u00b1 2.4","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505154,"endpoint-url":"\/ani\/endpoint\/100505154\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Volume (MCV)","endpoint-observation_time":"Day 93","endpoint-response_units":"fL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"56.7 \u00b1 1, 56 \u00b1 2, 56.6 \u00b1 1.7, 60.3 \u00b1 3.2","Doses and responses":"0 mg\/kg-day: 56.7 \u00b1 1, 20 mg\/kg-day: 56 \u00b1 2, 100 mg\/kg-day: 56.6 \u00b1 1.7, 500 mg\/kg-day: 60.3 \u00b1 3.2","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505155,"endpoint-url":"\/ani\/endpoint\/100505155\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin (MCH)","endpoint-observation_time":"Day 93","endpoint-response_units":"pg","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"18.7 \u00b1 0.3, 18.6 \u00b1 0.8, 18.8 \u00b1 0.6, 19.5 \u00b1 0.8","Doses and responses":"0 mg\/kg-day: 18.7 \u00b1 0.3, 20 mg\/kg-day: 18.6 \u00b1 0.8, 100 mg\/kg-day: 18.8 \u00b1 0.6, 500 mg\/kg-day: 19.5 \u00b1 0.8","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505156,"endpoint-url":"\/ani\/endpoint\/100505156\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Mean Corpuscular Hemoglobin Concentration (MCHC)","endpoint-observation_time":"Day 93","endpoint-response_units":"g\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"33 \u00b1 0.4, 33.2 \u00b1 0.4, 33.1 \u00b1 0.7, 32.3 \u00b1 0.6","Doses and responses":"0 mg\/kg-day: 33 \u00b1 0.4, 20 mg\/kg-day: 33.2 \u00b1 0.4, 100 mg\/kg-day: 33.1 \u00b1 0.7, 500 mg\/kg-day: 32.3 \u00b1 0.6","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505157,"endpoint-url":"\/ani\/endpoint\/100505157\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Reticulocytes (RET)","endpoint-observation_time":"Day 93","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"142.9 \u00b1 34.3, 153.4 \u00b1 36.8, 161.8 \u00b1 43.5, 401.7 \u00b1 158.9","Doses and responses":"0 mg\/kg-day: 142.9 \u00b1 34.3, 20 mg\/kg-day: 153.4 \u00b1 36.8, 100 mg\/kg-day: 161.8 \u00b1 43.5, 500 mg\/kg-day: 401.7 \u00b1 158.9","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505158,"endpoint-url":"\/ani\/endpoint\/100505158\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Platelet (PLAT)","endpoint-observation_time":"Day 93","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1206 \u00b1 247, 1063 \u00b1 187, 1154 \u00b1 156, 1506 \u00b1 322","Doses and responses":"0 mg\/kg-day: 1206 \u00b1 247, 20 mg\/kg-day: 1063 \u00b1 187, 100 mg\/kg-day: 1154 \u00b1 156, 500 mg\/kg-day: 1506 \u00b1 322","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505159,"endpoint-url":"\/ani\/endpoint\/100505159\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"White Blood Cell (WBC)","endpoint-observation_time":"Day 93","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"8.51 \u00b1 2.21, 8.23 \u00b1 1.6, 7.04 \u00b1 1.12, 9.11 \u00b1 1.74","Doses and responses":"0 mg\/kg-day: 8.51 \u00b1 2.21, 20 mg\/kg-day: 8.23 \u00b1 1.6, 100 mg\/kg-day: 7.04 \u00b1 1.12, 500 mg\/kg-day: 9.11 \u00b1 1.74","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505160,"endpoint-url":"\/ani\/endpoint\/100505160\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Neutrophils","endpoint-observation_time":"Day 93","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1.1 \u00b1 0.42, 1.1 \u00b1 0.45, 0.97 \u00b1 0.43, 1.4 \u00b1 0.71","Doses and responses":"0 mg\/kg-day: 1.1 \u00b1 0.42, 20 mg\/kg-day: 1.1 \u00b1 0.45, 100 mg\/kg-day: 0.97 \u00b1 0.43, 500 mg\/kg-day: 1.4 \u00b1 0.71","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505161,"endpoint-url":"\/ani\/endpoint\/100505161\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Lymphocyte","endpoint-observation_time":"Day 93","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"6.96 \u00b1 1.77, 6.7 \u00b1 1.16, 5.72 \u00b1 1.03, 7.31 \u00b1 1.46","Doses and responses":"0 mg\/kg-day: 6.96 \u00b1 1.77, 20 mg\/kg-day: 6.7 \u00b1 1.16, 100 mg\/kg-day: 5.72 \u00b1 1.03, 500 mg\/kg-day: 7.31 \u00b1 1.46","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505162,"endpoint-url":"\/ani\/endpoint\/100505162\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Monocytes","endpoint-observation_time":"Day 93","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.24 \u00b1 0.13, 0.22 \u00b1 0.09, 0.17 \u00b1 0.05, 0.2 \u00b1 0.08","Doses and responses":"0 mg\/kg-day: 0.24 \u00b1 0.13, 20 mg\/kg-day: 0.22 \u00b1 0.09, 100 mg\/kg-day: 0.17 \u00b1 0.05, 500 mg\/kg-day: 0.2 \u00b1 0.08","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505163,"endpoint-url":"\/ani\/endpoint\/100505163\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Eosinophils","endpoint-observation_time":"Day 93","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.11 \u00b1 0.05, 0.1 \u00b1 0.04, 0.09 \u00b1 0.03, 0.08 \u00b1 0.04","Doses and responses":"0 mg\/kg-day: 0.11 \u00b1 0.05, 20 mg\/kg-day: 0.1 \u00b1 0.04, 100 mg\/kg-day: 0.09 \u00b1 0.03, 500 mg\/kg-day: 0.08 \u00b1 0.04","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505164,"endpoint-url":"\/ani\/endpoint\/100505164\/","endpoint-system":"Immune","endpoint-organ":"Blood","endpoint-effect":"Blood Count","endpoint-name":"Basophils","endpoint-observation_time":"Day 93","endpoint-response_units":"thousand\/\u03bcL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.08 \u00b1 0.05, 0.09 \u00b1 0.05, 0.07 \u00b1 0.06, 0.07 \u00b1 0.05","Doses and responses":"0 mg\/kg-day: 0.08 \u00b1 0.05, 20 mg\/kg-day: 0.09 \u00b1 0.05, 100 mg\/kg-day: 0.07 \u00b1 0.06, 500 mg\/kg-day: 0.07 \u00b1 0.05","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505165,"endpoint-url":"\/ani\/endpoint\/100505165\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Coagulation","endpoint-name":"Prothrombin Time (PT)","endpoint-observation_time":"Day 93","endpoint-response_units":"s","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"14.8 \u00b1 0.6, 14.7 \u00b1 0.6, 14.7 \u00b1 0.3, 14.1 \u00b1 0.3","Doses and responses":"0 mg\/kg-day: 14.8 \u00b1 0.6, 20 mg\/kg-day: 14.7 \u00b1 0.6, 100 mg\/kg-day: 14.7 \u00b1 0.3, 500 mg\/kg-day: 14.1 \u00b1 0.3","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505166,"endpoint-url":"\/ani\/endpoint\/100505166\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Coagulation","endpoint-name":"Activated Partial Thromboplastin Time (APTT)","endpoint-observation_time":"Day 93","endpoint-response_units":"s","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"13.9 \u00b1 0.8, 13.7 \u00b1 1.4, 13.6 \u00b1 1.7, 13.9 \u00b1 1.9","Doses and responses":"0 mg\/kg-day: 13.9 \u00b1 0.8, 20 mg\/kg-day: 13.7 \u00b1 1.4, 100 mg\/kg-day: 13.6 \u00b1 1.7, 500 mg\/kg-day: 13.9 \u00b1 1.9","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505167,"endpoint-url":"\/ani\/endpoint\/100505167\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Absolute","endpoint-observation_time":"Day 93","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.073 \u00b1 0.011, 0.079 \u00b1 0.009, 0.074 \u00b1 0.011, 0.075 \u00b1 0.007","Doses and responses":"0 mg\/kg-day: 0.073 \u00b1 0.011, 20 mg\/kg-day: 0.079 \u00b1 0.009, 100 mg\/kg-day: 0.074 \u00b1 0.011, 500 mg\/kg-day: 0.075 \u00b1 0.007","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505168,"endpoint-url":"\/ani\/endpoint\/100505168\/","endpoint-system":"Endocrine","endpoint-organ":"Adrenal Gland","endpoint-effect":"Organ Weight","endpoint-name":"Adrenal Glands Weight, Relative","endpoint-observation_time":"Day 93","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.025 \u00b1 0.004, 0.026 \u00b1 0.005, 0.26 \u00b1 0.003, 0.026 \u00b1 0.002","Doses and responses":"0 mg\/kg-day: 0.025 \u00b1 0.004, 20 mg\/kg-day: 0.026 \u00b1 0.005, 100 mg\/kg-day: 0.26 \u00b1 0.003, 500 mg\/kg-day: 0.026 \u00b1 0.002","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505169,"endpoint-url":"\/ani\/endpoint\/100505169\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Absolute","endpoint-observation_time":"Day 93","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1.98 \u00b1 0.09, 1.95 \u00b1 0.12, 2.02 \u00b1 0.1, 2 \u00b1 0.1","Doses and responses":"0 mg\/kg-day: 1.98 \u00b1 0.09, 20 mg\/kg-day: 1.95 \u00b1 0.12, 100 mg\/kg-day: 2.02 \u00b1 0.1, 500 mg\/kg-day: 2 \u00b1 0.1","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505170,"endpoint-url":"\/ani\/endpoint\/100505170\/","endpoint-system":"Nervous","endpoint-organ":"Brain","endpoint-effect":"Organ Weight","endpoint-name":"Brain Weight, Relative","endpoint-observation_time":"Day 93","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.671 \u00b1 0.077, 0.641 \u00b1 0.071, 0.708 \u00b1 0.073, 0.68 \u00b1 0.026","Doses and responses":"0 mg\/kg-day: 0.671 \u00b1 0.077, 20 mg\/kg-day: 0.641 \u00b1 0.071, 100 mg\/kg-day: 0.708 \u00b1 0.073, 500 mg\/kg-day: 0.68 \u00b1 0.026","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505171,"endpoint-url":"\/ani\/endpoint\/100505171\/","endpoint-system":"Cardiovascular","endpoint-organ":"Heart","endpoint-effect":"Organ Weight","endpoint-name":"Heart Weight, Absolute","endpoint-observation_time":"Day 93","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"1.1 \u00b1 0.09, 1.1 \u00b1 0.08, 1.04 \u00b1 0.11, 1.08 \u00b1 0.06","Doses and responses":"0 mg\/kg-day: 1.1 \u00b1 0.09, 20 mg\/kg-day: 1.1 \u00b1 0.08, 100 mg\/kg-day: 1.04 \u00b1 0.11, 500 mg\/kg-day: 1.08 \u00b1 0.06","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-11)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505172,"endpoint-url":"\/ani\/endpoint\/100505172\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Degeneration","endpoint-name":"Nasal Cavity Degeneration\/Atrophy","endpoint-observation_time":"Day 93","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 5, 4","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 5, 500 mg\/kg-day: 4","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505173,"endpoint-url":"\/ani\/endpoint\/100505173\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Degeneration","endpoint-name":"Nasal Cavity Degeneration\/Atrophy (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 0","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505174,"endpoint-url":"\/ani\/endpoint\/100505174\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Degeneration","endpoint-name":"Nasal Cavity Degeneration\/Atrophy (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505142,"endpoint-url":"\/ani\/endpoint\/100505142\/","endpoint-system":"Metabolic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Potassium (K)","endpoint-observation_time":"Day 93","endpoint-response_units":"mmol\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"5.7 \u00b1 0.25, 5.7 \u00b1 0.35, 5.6 \u00b1 0.39, 5.4 \u00b1 0.33","Doses and responses":"0 mg\/kg-day: 5.7 \u00b1 0.25, 20 mg\/kg-day: 5.7 \u00b1 0.35, 100 mg\/kg-day: 5.6 \u00b1 0.39, 500 mg\/kg-day: 5.4 \u00b1 0.33","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505135,"endpoint-url":"\/ani\/endpoint\/100505135\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Glucose (GLUC)","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"104 \u00b1 15, 100 \u00b1 9, 107 \u00b1 27, 107 \u00b1 8","Doses and responses":"0 mg\/kg-day: 104 \u00b1 15, 20 mg\/kg-day: 100 \u00b1 9, 100 mg\/kg-day: 107 \u00b1 27, 500 mg\/kg-day: 107 \u00b1 8","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505143,"endpoint-url":"\/ani\/endpoint\/100505143\/","endpoint-system":"Metabolic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Chloride (CL)","endpoint-observation_time":"Day 93","endpoint-response_units":"mmol\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"101 \u00b1 2.9, 100 \u00b1 1.3, 101 \u00b1 1.9, 101 \u00b1 3.2","Doses and responses":"0 mg\/kg-day: 101 \u00b1 2.9, 20 mg\/kg-day: 100 \u00b1 1.3, 100 mg\/kg-day: 101 \u00b1 1.9, 500 mg\/kg-day: 101 \u00b1 3.2","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505139,"endpoint-url":"\/ani\/endpoint\/100505139\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Calcium (CA)","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"11.6 \u00b1 0.5, 11.8 \u00b1 0.5, 11.6 \u00b1 0.4, 11.9 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 11.6 \u00b1 0.5, 20 mg\/kg-day: 11.8 \u00b1 0.5, 100 mg\/kg-day: 11.6 \u00b1 0.4, 500 mg\/kg-day: 11.9 \u00b1 0.4","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505140,"endpoint-url":"\/ani\/endpoint\/100505140\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Phosphorus (PHOS)","endpoint-observation_time":"Day 93","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"5.8 \u00b1 0.7, 6 \u00b1 0.6, 5.9 \u00b1 0.6, 6.2 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 5.8 \u00b1 0.7, 20 mg\/kg-day: 6 \u00b1 0.6, 100 mg\/kg-day: 5.9 \u00b1 0.6, 500 mg\/kg-day: 6.2 \u00b1 0.4","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-11)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505175,"endpoint-url":"\/ani\/endpoint\/100505175\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Histopathology","endpoint-name":"Nasal Cavity Adhesions, Turbinates","endpoint-observation_time":"Day 93","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 3","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 3","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505176,"endpoint-url":"\/ani\/endpoint\/100505176\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Adhesions","endpoint-name":"Nasal Cavity Adhesions, Turbinates (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 3","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 3","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505177,"endpoint-url":"\/ani\/endpoint\/100505177\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Adhesions","endpoint-name":"Nasal Cavity Adhesions, Turbinates (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 2","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 2","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-11)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505178,"endpoint-url":"\/ani\/endpoint\/100505178\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Microcysts","endpoint-name":"Nasal Cavity Intraepithelial Microcysts","endpoint-observation_time":"Day 93","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505179,"endpoint-url":"\/ani\/endpoint\/100505179\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Microcysts","endpoint-name":"Nasal Cavity Intraepithelial Microcysts (30-Day recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 1","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 1","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505180,"endpoint-url":"\/ani\/endpoint\/100505180\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Microcysts","endpoint-name":"Nasal Cavity Intraepithelial Microcysts (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-11)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505181,"endpoint-url":"\/ani\/endpoint\/100505181\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Histopathology","endpoint-name":"Hepatocellular Hypertrophy","endpoint-observation_time":"Day 93","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 5","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 5","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505182,"endpoint-url":"\/ani\/endpoint\/100505182\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Histopathology","endpoint-name":"Hepatocellular Hypertrophy (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 4","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 4","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505183,"endpoint-url":"\/ani\/endpoint\/100505183\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Hypertrophy","endpoint-name":"Hepatocellular Hypertrophy (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-11)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505184,"endpoint-url":"\/ani\/endpoint\/100505184\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Hypertrophy","endpoint-name":"Thyroid Hypertrophy","endpoint-observation_time":"Day 93","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 4","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 4","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505185,"endpoint-url":"\/ani\/endpoint\/100505185\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Hypertrophy","endpoint-name":"Thyroid Hypertrophy (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 6","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 6","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505186,"endpoint-url":"\/ani\/endpoint\/100505186\/","endpoint-system":"Endocrine","endpoint-organ":"Thyroid","endpoint-effect":"Hypertrophy","endpoint-name":"Thyroid Hypertrophy (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 0","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 0","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505187,"endpoint-url":"\/ani\/endpoint\/100505187\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"Day 93","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"310 \u00b1 30, 310 \u00b1 30, 310 \u00b1 30, 310 \u00b1 30","Doses and responses":"0 mg\/kg-day: 310 \u00b1 30, 20 mg\/kg-day: 310 \u00b1 30, 100 mg\/kg-day: 310 \u00b1 30, 500 mg\/kg-day: 310 \u00b1 30","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505188,"endpoint-url":"\/ani\/endpoint\/100505188\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Peroxisomal B-Oxidation","endpoint-name":"Peroxisomal Beta Oxidation","endpoint-observation_time":"Day 10","endpoint-response_units":"nmol\/min\/mg protein","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"9.307 \u00b1 0.594, 10.495 \u00b1 2.386, 10.297 \u00b1 2.769, 13.465 \u00b1 1.981","Doses and responses":"0 mg\/kg-day: 9.307 \u00b1 0.594, 20 mg\/kg-day: 10.495 \u00b1 2.386, 100 mg\/kg-day: 10.297 \u00b1 2.769, 500 mg\/kg-day: 13.465 \u00b1 1.981","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505189,"endpoint-url":"\/ani\/endpoint\/100505189\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Peroxisomal B-Oxidation","endpoint-name":"Peroxisomal Beta Oxidation","endpoint-observation_time":"Day 93","endpoint-response_units":"nmol\/min\/mg protein","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"13.465 \u00b1 3.767, 15.446 \u00b1 3.674, 17.228 \u00b1 2.772, 36.04 \u00b1 7.534","Doses and responses":"0 mg\/kg-day: 13.465 \u00b1 3.767, 20 mg\/kg-day: 15.446 \u00b1 3.674, 100 mg\/kg-day: 17.228 \u00b1 2.772, 500 mg\/kg-day: 36.04 \u00b1 7.534","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=5)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505190,"endpoint-url":"\/ani\/endpoint\/100505190\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Peroxisomal B-Oxidation","endpoint-name":"Peroxisomal Beta Oxidation (30-Day Recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"nmol\/min\/mg protein","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"10.495 \u00b1 1.98, , , 21.386 \u00b1 0.9","Doses and responses":"0 mg\/kg-day: 10.495 \u00b1 1.98, 500 mg\/kg-day: 21.386 \u00b1 0.9","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505191,"endpoint-url":"\/ani\/endpoint\/100505191\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Relative","endpoint-observation_time":"Day 93","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"2.682 \u00b1 0.3, 2.65 \u00b1 0.158, 2.807 \u00b1 0.147, 3.678 \u00b1 0.176","Doses and responses":"0 mg\/kg-day: 2.682 \u00b1 0.3, 20 mg\/kg-day: 2.65 \u00b1 0.158, 100 mg\/kg-day: 2.807 \u00b1 0.147, 500 mg\/kg-day: 3.678 \u00b1 0.176","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505192,"endpoint-url":"\/ani\/endpoint\/100505192\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Relative","endpoint-observation_time":"Day 93","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.709 \u00b1 0.073, 0.691 \u00b1 0.074, 0.747 \u00b1 0.062, 0.823 \u00b1 0.086","Doses and responses":"0 mg\/kg-day: 0.709 \u00b1 0.073, 20 mg\/kg-day: 0.691 \u00b1 0.074, 100 mg\/kg-day: 0.747 \u00b1 0.062, 500 mg\/kg-day: 0.823 \u00b1 0.086","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505193,"endpoint-url":"\/ani\/endpoint\/100505193\/","endpoint-system":"Hepatic","endpoint-organ":"Liver","endpoint-effect":"Organ Weight","endpoint-name":"Liver Weight, Absolute","endpoint-observation_time":"Day 93","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"7.98 \u00b1 1.07, 8.29 \u00b1 1.05, 8.04 \u00b1 0.71, 10.82 \u00b1 1.05","Doses and responses":"0 mg\/kg-day: 7.98 \u00b1 1.07, 20 mg\/kg-day: 8.29 \u00b1 1.05, 100 mg\/kg-day: 8.04 \u00b1 0.71, 500 mg\/kg-day: 10.82 \u00b1 1.05","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505194,"endpoint-url":"\/ani\/endpoint\/100505194\/","endpoint-system":"Urinary","endpoint-organ":"Kidney","endpoint-effect":"Organ Weight","endpoint-name":"Kidney Weight, Absolute","endpoint-observation_time":"Day 93","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"2.12 \u00b1 0.34, 2.12 \u00b1 0.21, 2.14 \u00b1 0.21, 2.42 \u00b1 0.34","Doses and responses":"0 mg\/kg-day: 2.12 \u00b1 0.34, 20 mg\/kg-day: 2.12 \u00b1 0.21, 100 mg\/kg-day: 2.14 \u00b1 0.21, 500 mg\/kg-day: 2.42 \u00b1 0.34","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-11)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505195,"endpoint-url":"\/ani\/endpoint\/100505195\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Metaplasia","endpoint-name":"Nasal Cavity Respiratory Metaplasia","endpoint-observation_time":"Day 93","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 1, 7","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 1, 500 mg\/kg-day: 7","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505196,"endpoint-url":"\/ani\/endpoint\/100505196\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Metaplasia","endpoint-name":"Nasal Cavity Respiratory Metaplasia (30-Day recovery)","endpoint-observation_time":"30 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, , , 8","Doses and responses":"0 mg\/kg-day: 0, 500 mg\/kg-day: 8","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505197,"endpoint-url":"\/ani\/endpoint\/100505197\/","endpoint-system":"Respiratory","endpoint-organ":"Nasal Cavity","endpoint-effect":"Metaplasia","endpoint-name":"Nasal Cavity Respiratory Metaplasia (90-Day Recovery)","endpoint-observation_time":"90 d PE","endpoint-response_units":"Incidence","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0, 0, 0, 4","Doses and responses":"0 mg\/kg-day: 0, 20 mg\/kg-day: 0, 100 mg\/kg-day: 0, 500 mg\/kg-day: 4","Response direction":"?"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505198,"endpoint-url":"\/ani\/endpoint\/100505198\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.29 \u00b1 0.06, 0.29 \u00b1 0.11, 0.25 \u00b1 0.04, 0.26 \u00b1 0.05","Doses and responses":"0 mg\/kg-day: 0.29 \u00b1 0.06, 20 mg\/kg-day: 0.29 \u00b1 0.11, 100 mg\/kg-day: 0.25 \u00b1 0.04, 500 mg\/kg-day: 0.26 \u00b1 0.05","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505199,"endpoint-url":"\/ani\/endpoint\/100505199\/","endpoint-system":"Immune","endpoint-organ":"Thymus","endpoint-effect":"Organ Weight","endpoint-name":"Thymus Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.096 \u00b1 0.016, 0.092 \u00b1 0.028, 0.089 \u00b1 0.014, 0.088 \u00b1 0.017","Doses and responses":"0 mg\/kg-day: 0.096 \u00b1 0.016, 20 mg\/kg-day: 0.092 \u00b1 0.028, 100 mg\/kg-day: 0.089 \u00b1 0.014, 500 mg\/kg-day: 0.088 \u00b1 0.017","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505200,"endpoint-url":"\/ani\/endpoint\/100505200\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Absolute","endpoint-observation_time":"Day 92","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.55 \u00b1 0.09, 0.51 \u00b1 0.09, 0.51 \u00b1 0.05, 0.53 \u00b1 0.08","Doses and responses":"0 mg\/kg-day: 0.55 \u00b1 0.09, 20 mg\/kg-day: 0.51 \u00b1 0.09, 100 mg\/kg-day: 0.51 \u00b1 0.05, 500 mg\/kg-day: 0.53 \u00b1 0.08","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505201,"endpoint-url":"\/ani\/endpoint\/100505201\/","endpoint-system":"Immune","endpoint-organ":"Spleen","endpoint-effect":"Organ Weight","endpoint-name":"Spleen Weight, Relative","endpoint-observation_time":"Day 92","endpoint-response_units":"%","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"0.185 \u00b1 0.034, 0.168 \u00b1 0.026, 0.177 \u00b1 0.019, 0.179 \u00b1 0.02","Doses and responses":"0 mg\/kg-day: 0.185 \u00b1 0.034, 20 mg\/kg-day: 0.168 \u00b1 0.026, 100 mg\/kg-day: 0.177 \u00b1 0.019, 500 mg\/kg-day: 0.179 \u00b1 0.02","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"P0 Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"P0 Rat, Crl:CD(SD) (\u2640, N=22)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"developmental (GD 6-20)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505202,"endpoint-url":"\/ani\/endpoint\/100505202\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gains","endpoint-observation_time":"GD 6-21","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"165 \u00b1 18, 167 \u00b1 13, 161 \u00b1 17, 134 \u00b1 27","Doses and responses":"0 mg\/kg-day: 165 \u00b1 18, 20 mg\/kg-day: 167 \u00b1 13, 100 mg\/kg-day: 161 \u00b1 17, 500 mg\/kg-day: 134 \u00b1 27","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"P0 Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"P0 Rat, Crl:CD(SD) (\u2640, N=22)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"developmental (GD 6-20)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505203,"endpoint-url":"\/ani\/endpoint\/100505203\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gain (GD6-21) minus products of conception on day 21","endpoint-observation_time":"GD 6-21","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"69 \u00b1 10, 69 \u00b1 10, 62 \u00b1 11, 51 \u00b1 20","Doses and responses":"0 mg\/kg-day: 69 \u00b1 10, 20 mg\/kg-day: 69 \u00b1 10, 100 mg\/kg-day: 62 \u00b1 11, 500 mg\/kg-day: 51 \u00b1 20","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"F1 Combined Crl:CD(SD) Rats","animal_group-sex":"Combined","animal description (with n)":"F1 Rat, Crl:CD(SD) (\u2642\u2640, N=22)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"developmental (GD 6-20)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505204,"endpoint-url":"\/ani\/endpoint\/100505204\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"GD 21","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"5.8 \u00b1 0.3, 5.7 \u00b1 0.3, 5.8 \u00b1 0.3, 5.3 \u00b1 0.6","Doses and responses":"0 mg\/kg-day: 5.8 \u00b1 0.3, 20 mg\/kg-day: 5.7 \u00b1 0.3, 100 mg\/kg-day: 5.8 \u00b1 0.3, 500 mg\/kg-day: 5.3 \u00b1 0.6","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"P1 Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"P0 Rat, Crl:CD(SD) (\u2640, N=20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"1-generation reproductive (126 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505205,"endpoint-url":"\/ani\/endpoint\/100505205\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gains (Gestation)","endpoint-observation_time":"GD 0-7","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"36 \u00b1 10, 38 \u00b1 8, 37 \u00b1 10, 25 \u00b1 8","Doses and responses":"0 mg\/kg-day: 36 \u00b1 10, 20 mg\/kg-day: 38 \u00b1 8, 100 mg\/kg-day: 37 \u00b1 10, 500 mg\/kg-day: 25 \u00b1 8","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"P1 Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"P0 Rat, Crl:CD(SD) (\u2640, N=20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"1-generation reproductive (126 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505206,"endpoint-url":"\/ani\/endpoint\/100505206\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gains (Gestation)","endpoint-observation_time":"GD 0-21","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"140 \u00b1 25, 145 \u00b1 16, 147 \u00b1 23, 134 \u00b1 19","Doses and responses":"0 mg\/kg-day: 140 \u00b1 25, 20 mg\/kg-day: 145 \u00b1 16, 100 mg\/kg-day: 147 \u00b1 23, 500 mg\/kg-day: 134 \u00b1 19","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"P1 Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"P0 Rat, Crl:CD(SD) (\u2640, N=20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"1-generation reproductive (126 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505207,"endpoint-url":"\/ani\/endpoint\/100505207\/","endpoint-system":"Female Reproductive","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gains (Lactation)","endpoint-observation_time":"GD 0-21","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"5.1 \u00b1 26, 7.4 \u00b1 20, 20 \u00b1 15, 25 \u00b1 12","Doses and responses":"0 mg\/kg-day: 5.1 \u00b1 26, 20 mg\/kg-day: 7.4 \u00b1 20, 100 mg\/kg-day: 20 \u00b1 15, 500 mg\/kg-day: 25 \u00b1 12","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"P1 Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"P0 Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"1-generation reproductive (110 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505208,"endpoint-url":"\/ani\/endpoint\/100505208\/","endpoint-system":"Whole Body","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gains (Test)","endpoint-observation_time":"Day 105","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"340 \u00b1 44, 329 \u00b1 47, 299 \u00b1 43, 241 \u00b1 40","Doses and responses":"0 mg\/kg-day: 340 \u00b1 44, 20 mg\/kg-day: 329 \u00b1 47, 100 mg\/kg-day: 299 \u00b1 43, 500 mg\/kg-day: 241 \u00b1 40","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"F1 Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"F1 Rat, Crl:CD(SD) (\u2640, N=22)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"1-generation reproductive (56 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505209,"endpoint-url":"\/ani\/endpoint\/100505209\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gain, Postweaning","endpoint-observation_time":"PND 21-60","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"183 \u00b1 21, 178 \u00b1 18, 173 \u00b1 21, 183 \u00b1 24","Doses and responses":"0 mg\/kg-day: 183 \u00b1 21, 20 mg\/kg-day: 178 \u00b1 18, 100 mg\/kg-day: 173 \u00b1 21, 500 mg\/kg-day: 183 \u00b1 24","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"F1 Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"F1 Rat, Crl:CD(SD) (\u2642)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"1-generation reproductive (56 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505210,"endpoint-url":"\/ani\/endpoint\/100505210\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gain, Postweaning","endpoint-observation_time":"PND 21-60","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"320 \u00b1 25, 327 \u00b1 42, 320 \u00b1 27, 321 \u00b1 25","Doses and responses":"0 mg\/kg-day: 320 \u00b1 25, 20 mg\/kg-day: 327 \u00b1 42, 100 mg\/kg-day: 320 \u00b1 27, 500 mg\/kg-day: 321 \u00b1 25","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"F1 Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"F1 Rat, Crl:CD(SD) (\u2640, N=22)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"1-generation reproductive (56 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505211,"endpoint-url":"\/ani\/endpoint\/100505211\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight Gain, Postweaning","endpoint-observation_time":"PND 21-60","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"183 \u00b1 21, 178 \u00b1 18, 173 \u00b1 21, 183 \u00b1 24","Doses and responses":"0 mg\/kg-day: 183 \u00b1 21, 20 mg\/kg-day: 178 \u00b1 18, 100 mg\/kg-day: 173 \u00b1 21, 500 mg\/kg-day: 183 \u00b1 24","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"F1 Combined Crl:CD(SD) Rats","animal_group-sex":"Combined","animal description (with n)":"F1 Rat, Crl:CD(SD) (\u2642\u2640)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"1-generation reproductive (56 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505212,"endpoint-url":"\/ani\/endpoint\/100505212\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 0","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"7.1 \u00b1 0.9, 6.8 \u00b1 0.6, 6.3 \u00b1 0.4, 5.8 \u00b1 0.4","Doses and responses":"0 mg\/kg-day: 7.1 \u00b1 0.9, 20 mg\/kg-day: 6.8 \u00b1 0.6, 100 mg\/kg-day: 6.3 \u00b1 0.4, 500 mg\/kg-day: 5.8 \u00b1 0.4","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"F1 Combined Crl:CD(SD) Rats","animal_group-sex":"Combined","animal description (with n)":"F1 Rat, Crl:CD(SD) (\u2642\u2640)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"1-generation reproductive (56 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505213,"endpoint-url":"\/ani\/endpoint\/100505213\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 7","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"18 \u00b1 2.7, 18 \u00b1 2.2, 17 \u00b1 1.3, 15 \u00b1 1.4","Doses and responses":"0 mg\/kg-day: 18 \u00b1 2.7, 20 mg\/kg-day: 18 \u00b1 2.2, 100 mg\/kg-day: 17 \u00b1 1.3, 500 mg\/kg-day: 15 \u00b1 1.4","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"F1 Combined Crl:CD(SD) Rats","animal_group-sex":"Combined","animal description (with n)":"F1 Rat, Crl:CD(SD) (\u2642\u2640)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"1-generation reproductive (56 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505214,"endpoint-url":"\/ani\/endpoint\/100505214\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 14","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"36 \u00b1 3.4, 37 \u00b1 3, 34 \u00b1 2.6, 30 \u00b1 2.5","Doses and responses":"0 mg\/kg-day: 36 \u00b1 3.4, 20 mg\/kg-day: 37 \u00b1 3, 100 mg\/kg-day: 34 \u00b1 2.6, 500 mg\/kg-day: 30 \u00b1 2.5","Response direction":"\u2193"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"F1 Combined Crl:CD(SD) Rats","animal_group-sex":"Combined","animal description (with n)":"F1 Rat, Crl:CD(SD) (\u2642\u2640)","dosing_regime-route_of_exposure":"Parental","dosing_regime-duration_exposure_text":"1-generation reproductive (56 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505215,"endpoint-url":"\/ani\/endpoint\/100505215\/","endpoint-system":"Developmental","endpoint-organ":"Whole Body","endpoint-effect":"Body Weight","endpoint-name":"Body Weight","endpoint-observation_time":"PND 21","endpoint-response_units":"g","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"60 \u00b1 5.3, 62 \u00b1 5, 57 \u00b1 5.3, 49 \u00b1 4.1","Doses and responses":"0 mg\/kg-day: 60 \u00b1 5.3, 20 mg\/kg-day: 62 \u00b1 5, 100 mg\/kg-day: 57 \u00b1 5.3, 500 mg\/kg-day: 49 \u00b1 4.1","Response direction":"\u2193"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504438,"endpoint-url":"\/ani\/endpoint\/100504438\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Calcium (CA), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"10.7 \u00b1 0.24, , , 10.5 \u00b1 0.48","Doses and responses":"0 mg\/kg-day: 10.7 \u00b1 0.24, 200 mg\/kg-day: 10.5 \u00b1 0.48","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504515,"endpoint-url":"\/ani\/endpoint\/100504515\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Calcium (CA)","endpoint-observation_time":"Day 90","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"11 \u00b1 0.44, 11.3 \u00b1 0.53, 11.2 \u00b1 0.43, 11 \u00b1 0.51","Doses and responses":"0 mg\/kg-day: 11 \u00b1 0.44, 10 mg\/kg-day: 11.3 \u00b1 0.53, 50 mg\/kg-day: 11.2 \u00b1 0.43, 200 mg\/kg-day: 11 \u00b1 0.51","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crj:CD(SD) (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (91 days)","species-name":"Rat","strain-name":"Crj:CD(SD)","endpoint-id":100504533,"endpoint-url":"\/ani\/endpoint\/100504533\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Calcium (CA), Recovery","endpoint-observation_time":"Day 118","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"11 \u00b1 0.45, , , 11.1 \u00b1 0.3","Doses and responses":"0 mg\/kg-day: 11 \u00b1 0.45, 200 mg\/kg-day: 11.1 \u00b1 0.3","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504244,"endpoint-url":"\/ani\/endpoint\/100504244\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Phosphorus (PHOS)","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"7 \u00b1 0.47, 6.9 \u00b1 0.46, 7.1 \u00b1 0.43, 6.8 \u00b1 0.39","Doses and responses":"0 mg\/kg-day: 7 \u00b1 0.47, 2.5 mg\/kg-day: 6.9 \u00b1 0.46, 15 mg\/kg-day: 7.1 \u00b1 0.43, 100 mg\/kg-day: 6.8 \u00b1 0.39","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504246,"endpoint-url":"\/ani\/endpoint\/100504246\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Sodium (NA)","endpoint-observation_time":"Week 26","endpoint-response_units":"mEq\/l","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"146 \u00b1 1.2, 146 \u00b1 1.6, 145 \u00b1 1.6, 146 \u00b1 1.6","Doses and responses":"0 mg\/kg-day: 146 \u00b1 1.2, 2.5 mg\/kg-day: 146 \u00b1 1.6, 15 mg\/kg-day: 145 \u00b1 1.6, 100 mg\/kg-day: 146 \u00b1 1.6","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 weeks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504247,"endpoint-url":"\/ani\/endpoint\/100504247\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Sodium (NA)","endpoint-observation_time":"Week 52","endpoint-response_units":"mEq\/l","Dose units":"mg\/kg-day","Doses":"0, 2.5, 15, 100","Responses":"143 \u00b1 1, 144 \u00b1 1.1, 143 \u00b1 0.8, 144 \u00b1 1.4","Doses and responses":"0 mg\/kg-day: 143 \u00b1 1, 2.5 mg\/kg-day: 144 \u00b1 1.1, 15 mg\/kg-day: 143 \u00b1 0.8, 100 mg\/kg-day: 144 \u00b1 1.4","Response direction":"\u2191"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505059,"endpoint-url":"\/ani\/endpoint\/100505059\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Potassium (K)","endpoint-observation_time":"Day 92","endpoint-response_units":"mmol\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"6 \u00b1 0.28, 6.4 \u00b1 0.48, 6.3 \u00b1 0.46, 7 \u00b1 0.72","Doses and responses":"0 mg\/kg-day: 6 \u00b1 0.28, 20 mg\/kg-day: 6.4 \u00b1 0.48, 100 mg\/kg-day: 6.3 \u00b1 0.46, 500 mg\/kg-day: 7 \u00b1 0.72","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504346,"endpoint-url":"\/ani\/endpoint\/100504346\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Sodium (NA)","endpoint-observation_time":"Week 26","endpoint-response_units":"mEq\/l","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"145 \u00b1 2.4, 145 \u00b1 1.2, 145 \u00b1 2.3, 145 \u00b1 2","Doses and responses":"0 mg\/kg-day: 145 \u00b1 2.4, 5 mg\/kg-day: 145 \u00b1 1.2, 30 mg\/kg-day: 145 \u00b1 2.3, 200 mg\/kg-day: 145 \u00b1 2","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Female Crl:CD(SD) Rats","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505141,"endpoint-url":"\/ani\/endpoint\/100505141\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Sodium (NA)","endpoint-observation_time":"Day 93","endpoint-response_units":"mmol\/L","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"145 \u00b1 2, 146 \u00b1 2.1, 145 \u00b1 1.3, 143 \u00b1 2.5","Doses and responses":"0 mg\/kg-day: 145 \u00b1 2, 20 mg\/kg-day: 146 \u00b1 2.1, 100 mg\/kg-day: 145 \u00b1 1.3, 500 mg\/kg-day: 143 \u00b1 2.5","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2642, N=9-10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504706,"endpoint-url":"\/ani\/endpoint\/100504706\/","endpoint-system":"Systemic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Glucose (GLUC)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.5, 125, 250, 500, 1000","Responses":"169 \u00b1 7.4, 172.1 \u00b1 8.4, 186.6 \u00b1 9.3, 173.6 \u00b1 14.9, 209.8 \u00b1 6.8, 171.2 \u00b1 7.2","Doses and responses":"0 mg\/kg-day: 169 \u00b1 7.4, 62.5 mg\/kg-day: 172.1 \u00b1 8.4, 125 mg\/kg-day: 186.6 \u00b1 9.3, 250 mg\/kg-day: 173.6 \u00b1 14.9, 500 mg\/kg-day: 209.8 \u00b1 6.8, 1000 mg\/kg-day: 171.2 \u00b1 7.2","Response direction":"\u2191"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504344,"endpoint-url":"\/ani\/endpoint\/100504344\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Phosphorus (PHOS)","endpoint-observation_time":"Week 26","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"6.8 \u00b1 1.7, 6.8 \u00b1 0.82, 6.9 \u00b1 1.31, 6.6 \u00b1 0.7","Doses and responses":"0 mg\/kg-day: 6.8 \u00b1 1.7, 5 mg\/kg-day: 6.8 \u00b1 0.82, 30 mg\/kg-day: 6.9 \u00b1 1.31, 200 mg\/kg-day: 6.6 \u00b1 0.7","Response direction":"\u2194"},{"study-short_citation":"Klaunig, 2015, 2850075","study-study_identifier":"{Klaunig, 2015, 2850075}","experiment-chemical":"PFHxA","animal_group-name":"Female Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Crl:CD(SD) (\u2640, N=10-20)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"cancer (104 wks)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504345,"endpoint-url":"\/ani\/endpoint\/100504345\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Phosphorus (PHOS)","endpoint-observation_time":"Week 52","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 5, 30, 200","Responses":"6 \u00b1 0.6, 5.6 \u00b1 0.57, 5.6 \u00b1 0.51, 5.9 \u00b1 0.69","Doses and responses":"0 mg\/kg-day: 6 \u00b1 0.6, 5 mg\/kg-day: 5.6 \u00b1 0.57, 30 mg\/kg-day: 5.6 \u00b1 0.51, 200 mg\/kg-day: 5.9 \u00b1 0.69","Response direction":"\u2194"},{"study-short_citation":"NTP, 2018, 4309149","study-study_identifier":"4309149","experiment-chemical":"PFHxA","animal_group-name":"Female Harlan Sprague Dawley Rat","animal_group-sex":"Female","animal description (with n)":"Rat, Harlan Sprague-Dawley (\u2640, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"short-term  (28 Days)","species-name":"Rat","strain-name":"Harlan Sprague-Dawley","endpoint-id":100504862,"endpoint-url":"\/ani\/endpoint\/100504862\/","endpoint-system":"Systemic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Glucose (GLUC)","endpoint-observation_time":"Day 29","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 62.6, 125, 250, 500, 1000","Responses":"172.2 \u00b1 5.8, 171.7 \u00b1 3, 166.1 \u00b1 6.5, 181.8 \u00b1 8.6, 182.9 \u00b1 9.2, 153.2 \u00b1 5.3","Doses and responses":"0 mg\/kg-day: 172.2 \u00b1 5.8, 62.6 mg\/kg-day: 171.7 \u00b1 3, 125 mg\/kg-day: 166.1 \u00b1 6.5, 250 mg\/kg-day: 181.8 \u00b1 8.6, 500 mg\/kg-day: 182.9 \u00b1 9.2, 1000 mg\/kg-day: 153.2 \u00b1 5.3","Response direction":"\u2194"},{"study-short_citation":"Loveless, 2009, 2850369","study-study_identifier":"","experiment-chemical":"NaPFHx","animal_group-name":"Male Crl:CD(SD) Rats","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 d)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100505052,"endpoint-url":"\/ani\/endpoint\/100505052\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Glucose (GLUC)","endpoint-observation_time":"Day 92","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 20, 100, 500","Responses":"104 \u00b1 10, 97 \u00b1 15, 105 \u00b1 24, 102 \u00b1 7","Doses and responses":"0 mg\/kg-day: 104 \u00b1 10, 20 mg\/kg-day: 97 \u00b1 15, 100 mg\/kg-day: 105 \u00b1 24, 500 mg\/kg-day: 102 \u00b1 7","Response direction":"\u2194"},{"study-short_citation":"Chengelis, 2009, 2850404","study-study_identifier":"2850404","experiment-chemical":"PFHxA","animal_group-name":"Male Sprague Dawley Rat","animal_group-sex":"Male","animal description (with n)":"Rat, Crl:CD(SD) (\u2642, N=10)","dosing_regime-route_of_exposure":"Oral gavage","dosing_regime-duration_exposure_text":"subchronic  (90 days)","species-name":"Rat","strain-name":"Crl:CD(SD)","endpoint-id":100504407,"endpoint-url":"\/ani\/endpoint\/100504407\/","endpoint-system":"Hematologic","endpoint-organ":"Blood","endpoint-effect":"Clinical Chemistry","endpoint-name":"Calcium (CA)","endpoint-observation_time":"Day 90","endpoint-response_units":"mg\/dL","Dose units":"mg\/kg-day","Doses":"0, 10, 50, 200","Responses":"10.9 \u00b1 0.17, 10.7 \u00b1 0.34, 10.6 \u00b1 0.23, 10.6 \u00b1 0.21","Doses and responses":"0 mg\/kg-day: 10.9 \u00b1 0.17, 10 mg\/kg-day: 10.7 \u00b1 0.34, 50 mg\/kg-day: 10.6 \u00b1 0.23, 200 mg\/kg-day: 10.6 \u00b1 0.21","Response direction":"\u2193"}]